data_1jjg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jjg _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.8 p -115.17 157.43 23.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -1.179 . . . . 0.0 109.532 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.9 150.3 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.424 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 4.0 m-70 -156.54 163.71 39.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 0.0 109.715 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.03 137.04 43.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 108.979 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.74 176.9 28.22 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.445 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 7.1 mt -96.51 152.51 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.346 -1.091 . . . . 0.0 108.636 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.483 HG13 HG13 ' A' ' 80' ' ' VAL . 76.2 t -99.58 148.08 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.68 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -142.72 164.52 29.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.051 -1.03 . . . . 0.0 109.872 -179.784 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 pt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.452 ' HB2' HD23 ' A' ' 61' ' ' LEU . 50.0 m-85 -113.9 173.85 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.16 -0.963 . . . . 0.0 109.387 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.14 132.78 22.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.371 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.461 ' CG2' HD12 ' A' ' 61' ' ' LEU . 45.8 t -104.62 115.15 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.194 -0.941 . . . . 0.0 109.591 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.46 ' CZ ' HD23 ' A' ' 52' ' ' LEU . 7.0 ttt180 -98.64 130.51 45.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.161 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -96.33 95.13 7.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 109.643 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.46 HD23 ' CZ ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -69.44 145.52 52.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.426 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.91 -39.96 2.7 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.23 -27.64 29.79 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -1.15 . . . . 0.0 109.292 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 57.87 96.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.239 -0.913 . . . . 0.0 109.649 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . 110.72 10.32 21.47 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.423 ' NE2' ' CG2' ' A' ' 96' ' ' VAL . 20.0 t-160 -109.82 96.9 6.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -1.202 . . . . 0.0 109.552 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -109.08 131.67 54.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.534 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.438 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.6 m -124.67 162.87 23.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 109.422 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.431 ' C ' HD12 ' A' ' 62' ' ' LEU . 2.5 pt -116.01 130.23 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.89 . . . . 0.0 109.29 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.461 HD12 ' CG2' ' A' ' 49' ' ' VAL . 6.0 tt -99.35 118.07 35.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.248 -0.907 . . . . 0.0 109.876 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 2.1 mp . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.479 -0.763 . . . . 0.0 109.091 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.483 HG13 HG13 ' A' ' 40' ' ' VAL . 14.3 t . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.357 0.599 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 87.28 -50.93 4.16 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.448 ' NH1' ' HG2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -37.86 156.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.664 -0.903 . . . . 0.0 110.295 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 84' ' ' ILE . 14.2 t -98.47 134.21 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 109.138 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.512 HD11 ' N ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -143.58 174.27 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 0.0 109.868 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 1.8 ttmt -104.66 124.98 50.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.446 -0.784 . . . . 0.0 109.087 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.474 ' OG1' HD11 ' A' ' 98' ' ' LEU . 24.5 p -127.95 175.44 8.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.509 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.536 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -98.55 152.85 19.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.091 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.455 ' HA ' HD23 ' A' ' 98' ' ' LEU . 2.7 t -97.61 131.37 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.982 . . . . 0.0 109.473 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.522 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 94.6 t -92.83 -35.7 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.34 -0.85 . . . . 0.0 109.86 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.475 ' O ' HG13 ' A' ' 96' ' ' VAL . 9.9 ttt85 178.46 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.978 . . . . 0.0 109.335 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.534 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . . . -95.88 117.63 30.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.502 -0.749 . . . . 0.0 109.554 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -110.01 -21.6 12.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -0.935 . . . . 0.0 109.477 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 94' ' ' LEU . . . 123.33 115.31 2.21 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.576 ' CB ' ' O ' ' A' ' 93' ' ' GLY . 1.5 tp 84.39 -57.13 0.12 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.759 -0.848 . . . . 0.0 109.448 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -116.8 119.6 35.91 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 108.841 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.534 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 69.1 t -129.89 159.11 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 110.332 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.522 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 9.6 m-20 -98.66 143.27 29.22 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.536 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -135.49 141.78 45.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.809 -1.182 . . . . 0.0 110.97 -178.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -133.72 112.27 11.25 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.642 -0.661 . . . . 0.0 109.399 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.102 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -172.76 161.78 4.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -1.165 . . . . 0.0 109.598 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.496 HG11 ' NE ' ' A' ' 87' ' ' ARG . 2.3 m -122.5 125.44 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 0.0 109.311 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -133.01 168.72 17.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.125 -0.984 . . . . 0.0 109.67 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.69 147.03 25.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.273 -0.892 . . . . 0.0 109.107 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.431 ' O ' ' CG1' ' A' ' 83' ' ' VAL . . . -159.13 176.8 35.89 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.499 ' CD1' HG21 ' A' ' 83' ' ' VAL . 2.4 mm -96.8 154.42 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -1.158 . . . . 0.0 108.82 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.487 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 34.9 t -105.8 146.75 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 110.329 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.409 ' N ' HG12 ' A' ' 40' ' ' VAL . 2.0 t80 -137.3 145.71 43.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 109.216 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 42.9 p90 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.095 -1.003 . . . . 0.0 109.657 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.511 ' CG2' HD23 ' A' ' 62' ' ' LEU . 3.7 mt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.479 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 60.0 m-85 -105.79 169.75 8.3 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.046 -1.034 . . . . 0.0 109.157 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.7 135.67 24.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.519 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 60.3 t -104.48 119.64 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.225 -0.922 . . . . 0.0 109.736 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -98.88 120.9 40.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 109.075 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.1 OUTLIER -86.06 84.88 7.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.668 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.49 138.95 54.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.391 -0.818 . . . . 0.0 109.506 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.48 -41.48 2.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.455 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -81.37 -30.26 33.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -1.161 . . . . 0.0 109.578 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 62.53 84.49 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.85 -20.15 6.44 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -71.51 94.47 1.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -1.134 . . . . 0.0 109.649 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -108.15 105.82 15.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 109.368 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.452 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.0 m -102.58 158.38 16.27 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.24 -0.913 . . . . 0.0 109.153 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 97' ' ' ASP . 25.4 pt -103.81 129.18 56.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.259 -0.901 . . . . 0.0 109.055 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.537 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 50.2 tp -98.68 108.66 21.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.659 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.511 HD23 ' CG2' ' A' ' 46' ' ' ILE . 3.5 mm? . . . . . 0 N--CA 1.487 1.42 0 O-C-N 121.496 -0.752 . . . . 0.0 109.205 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 81' ' ' GLY . 54.5 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 87.4 -48.63 3.8 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 81' ' ' GLY . 5.9 mtp180 -38.96 156.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.702 -0.881 . . . . 0.0 110.016 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.499 HG21 ' CD1' ' A' ' 39' ' ' ILE . 4.1 t -98.4 145.33 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 109.162 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.57 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -148.99 164.5 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.0 109.622 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.18 104.16 16.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.408 -0.808 . . . . 0.0 109.209 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.516 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 22.3 p -112.91 175.59 5.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.537 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -99.94 154.28 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.089 -1.007 . . . . 0.0 109.464 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.459 ' HA ' HD21 ' A' ' 98' ' ' LEU . 63.7 t -97.58 110.49 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 0.0 108.863 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.543 HG23 ' CA ' ' A' ' 98' ' ' LEU . 2.2 t -64.33 -35.34 73.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.866 . . . . 0.0 110.082 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.03 101.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.938 . . . . 0.0 109.559 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HA ' HG12 ' A' ' 96' ' ' VAL . . . -95.87 124.65 39.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.279 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.46 -43.69 2.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.17 -138.76 2.51 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -24.7 4.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -1.129 . . . . 0.0 109.753 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -112.34 125.55 54.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' A' ' 97' ' ' ASP . 49.7 t -133.27 166.62 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -0.89 . . . . 0.0 109.491 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.526 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 0.9 OUTLIER -110.37 146.96 34.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 108.732 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.543 ' CA ' HG23 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -134.15 128.09 33.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.998 -1.064 . . . . 0.0 110.881 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.523 ' N ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -122.37 133.18 54.65 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.579 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.405 ' HB3' ' NE2' ' A' ' 36' ' ' HIS . 0.5 OUTLIER -114.14 156.41 24.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -1.121 . . . . 0.0 109.366 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 35' ' ' VAL . 4.0 m -115.56 127.49 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.309 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.405 ' NE2' ' HB3' ' A' ' 34' ' ' SER . 47.4 m-70 -143.36 168.01 20.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.789 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.34 141.58 34.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.255 -0.903 . . . . 0.0 109.368 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' ' CG2' ' A' ' 83' ' ' VAL . . . -150.29 176.88 28.71 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.505 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 15.7 mt -96.42 153.87 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.243 . . . . 0.0 108.444 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.46 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 38.8 t -98.99 151.8 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 110.431 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.95 150.4 35.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.428 ' N ' HG13 ' A' ' 80' ' ' VAL . 20.5 t80 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.552 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.443 HD13 ' O ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.471 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.8 m-85 -102.97 174.93 5.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.083 -1.011 . . . . 0.0 108.975 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 59' ' ' CYS . 1.6 tttp -148.31 148.9 30.94 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.198 -0.939 . . . . 0.0 109.624 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 2.4 t -126.02 116.72 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 109.199 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.37 131.75 44.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 109.375 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.57 95.6 10.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.192 -0.942 . . . . 0.0 109.765 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.62 138.72 55.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.35 -30.02 9.38 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 55' ' ' GLU . 2.1 m-85 -117.16 66.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -1.06 . . . . 0.0 109.073 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -41.38 107.3 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.396 -0.815 . . . . 0.0 109.665 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.02 32.54 0.79 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.94 92.91 2.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -1.105 . . . . 0.0 109.782 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.57 123.1 48.86 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.988 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.439 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.2 m -116.08 167.72 10.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 109.567 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 5.9 pt -122.37 130.66 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.364 -0.835 . . . . 0.0 109.087 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' HB3' ' CB ' ' A' ' 47' ' ' PHE . 12.3 tp -97.91 116.67 30.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.969 . . . . 0.0 109.251 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.768 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.459 HG11 HG12 ' A' ' 40' ' ' VAL . 21.4 t . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.313 0.577 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.505 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 87.73 -48.73 3.75 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -40.8 152.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.481 -1.011 . . . . 0.0 110.023 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.436 ' C ' HG22 ' A' ' 84' ' ' ILE . 7.4 p -99.05 137.29 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.847 . . . . 0.0 109.109 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.532 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -145.23 170.98 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 110.013 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.7 120.65 40.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 0.0 109.047 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.52 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -128.0 176.07 7.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.305 -0.872 . . . . 0.0 109.582 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.483 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 9.0 mpt_? -97.91 155.0 17.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.454 ' HA ' HD21 ' A' ' 98' ' ' LEU . 3.0 t -97.41 121.23 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.272 -0.892 . . . . 0.0 109.661 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.541 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 40.9 t -77.0 -39.49 29.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.494 -0.754 . . . . 0.0 109.494 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.46 ' O ' HG13 ' A' ' 96' ' ' VAL . 3.5 mtp180 178.63 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.119 -0.988 . . . . 0.0 109.618 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.541 ' CB ' HG21 ' A' ' 96' ' ' VAL . . . -101.87 129.76 48.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.533 -0.729 . . . . 0.0 109.175 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -131.28 -39.83 1.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.064 -1.023 . . . . 0.0 109.511 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -151.97 -127.45 1.32 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.39 -17.74 57.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -1.139 . . . . 0.0 109.808 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -110.24 121.59 45.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -0.989 . . . . 0.0 109.282 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.541 HG21 ' CB ' ' A' ' 91' ' ' ALA . 96.0 t -132.86 156.44 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -0.884 . . . . 0.0 109.745 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.541 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 1.7 m-20 -98.35 150.03 22.02 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.52 ' CD1' ' HB ' ' A' ' 86' ' ' THR . 0.2 OUTLIER -134.31 134.81 42.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.859 -1.151 . . . . 0.0 111.085 -178.573 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.529 ' CD ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -121.72 124.55 44.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.474 ' NH1' HG13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.557 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.6 t -149.78 138.93 21.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -1.15 . . . . 0.0 109.592 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.5 m -102.25 155.65 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.421 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -165.07 162.29 20.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.947 . . . . 0.0 109.5 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.79 137.85 36.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.07 176.11 29.72 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mt -97.39 154.66 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.317 -1.108 . . . . 0.0 108.812 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.471 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 17.6 t -104.96 159.94 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 0.0 110.12 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -146.61 170.33 17.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 0.0 109.208 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.954 . . . . 0.0 109.378 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.6 pt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.491 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 44.4 m-85 -112.69 160.19 18.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.951 -1.093 . . . . 0.0 109.08 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -127.16 151.42 48.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 0.0 109.762 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.471 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 63.5 t -129.42 115.14 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.409 -0.807 . . . . 0.0 109.076 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -100.36 127.55 46.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.172 -0.955 . . . . 0.0 109.571 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 3.1 mp -95.17 76.33 3.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 109.485 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.0 162.75 3.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.75 -43.15 3.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.457 ' O ' ' O ' ' A' ' 55' ' ' GLU . 68.4 m-85 -85.29 -30.56 23.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -1.105 . . . . 0.0 109.686 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' TYR . 3.5 mt-10 61.04 146.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.192 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . 63.52 12.51 46.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -116.64 82.95 1.88 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -1.146 . . . . 0.0 109.264 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -100.29 105.92 17.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.309 -0.87 . . . . 0.0 109.52 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.403 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.4 m -100.19 172.67 7.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.925 . . . . 0.0 109.267 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.84 140.83 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 109.241 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.491 ' HB3' ' CB ' ' A' ' 47' ' ' PHE . 34.9 tp -98.14 116.82 31.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.962 . . . . 0.0 109.339 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.1 tp . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.491 -0.755 . . . . 0.0 109.724 -179.606 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.411 HG12 HG12 ' A' ' 40' ' ' VAL . 28.1 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 85.19 -47.54 3.87 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -40.2 162.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.467 -1.019 . . . . 0.0 110.048 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.43 ' C ' HG22 ' A' ' 84' ' ' ILE . 34.1 m -98.84 144.35 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.047 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.543 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -149.17 173.69 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -0.966 . . . . 0.0 109.629 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -104.14 106.64 17.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.148 -0.97 . . . . 0.0 109.332 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.515 ' CB ' HD13 ' A' ' 98' ' ' LEU . 8.5 p -112.0 175.75 5.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 0.0 109.55 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.534 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 10.4 mpt_? -98.73 159.58 14.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.811 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.502 ' HA ' HD23 ' A' ' 98' ' ' LEU . 11.6 t -96.96 117.54 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.468 -0.77 . . . . 0.0 109.205 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.529 HG21 ' CG ' ' A' ' 99' ' ' ARG . 72.6 t -77.84 -40.33 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.519 -0.738 . . . . 0.0 110.092 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 175.99 104.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.163 -0.961 . . . . 0.0 109.585 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.534 ' CB ' HG22 ' A' ' 96' ' ' VAL . . . -96.86 135.4 38.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.66 -36.98 1.59 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.99 . . . . 0.0 109.767 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.04 -134.71 1.69 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -63.48 -17.3 62.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -1.141 . . . . 0.0 109.538 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.56 130.64 56.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 109.506 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.534 HG22 ' CB ' ' A' ' 91' ' ' ALA . 53.9 t -137.2 157.19 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.505 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 49.8 m-20 -98.32 147.21 24.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.232 -0.917 . . . . 0.0 108.661 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -134.91 136.89 42.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.048 -1.032 . . . . 0.0 110.263 -178.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.529 ' CG ' HG21 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -136.53 124.56 22.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.589 -0.695 . . . . 0.0 109.232 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.341 -0.85 . . . . 0.0 109.386 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 p -170.56 158.6 6.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -1.122 . . . . 0.0 109.58 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.8 m -107.29 149.4 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.254 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.09 166.35 31.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.173 -0.955 . . . . 0.0 109.823 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -99.69 151.25 21.43 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 109.14 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.38 176.63 43.32 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.514 HG22 ' N ' ' A' ' 40' ' ' VAL . 8.2 mt -97.04 149.92 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -1.184 . . . . 0.0 108.389 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.514 ' CG2' HG12 ' A' ' 84' ' ' ILE . 24.4 t -98.14 166.38 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.074 -1.016 . . . . 0.0 110.482 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.491 ' HB3' ' CB ' ' A' ' 48' ' ' LYS . 9.1 t80 -150.75 139.94 21.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.054 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.412 ' HB2' HG21 ' A' ' 80' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.015 . . . . 0.0 109.661 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.4 pt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 12.8 m-85 -105.9 157.61 17.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.415 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.491 ' CB ' ' HB3' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -130.19 151.18 50.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.435 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.21 120.67 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 109.45 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -99.81 127.16 45.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.925 . . . . 0.0 109.327 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.435 ' CB ' ' HB3' ' A' ' 57' ' ' HIS . 0.1 OUTLIER -92.8 75.48 4.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 109.598 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.28 124.36 19.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 109.425 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 132.6 -41.13 1.53 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.482 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 61.7 t80 -83.8 -19.48 34.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -1.113 . . . . 0.0 109.507 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 9.1 tp10 62.85 88.68 0.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.347 -0.845 . . . . 0.0 109.792 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.8 25.28 5.74 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 54' ' ' TYR . 2.3 t-160 -108.9 92.36 4.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.075 -1.25 . . . . 0.0 109.75 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.08 115.1 29.82 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.41 -0.806 . . . . 0.0 109.278 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -116.13 163.26 16.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 60' ' ' ILE . 24.1 pt -129.52 125.59 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 109.23 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.484 HD12 ' N ' ' A' ' 100' ' ' ARG . 6.8 tp -98.2 121.72 40.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.007 -1.058 . . . . 0.0 109.592 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.659 -0.651 . . . . 0.0 109.286 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.569 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 80' ' ' VAL . . . 84.84 -43.38 3.23 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.518 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -45.31 178.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.652 -0.911 . . . . 0.0 110.503 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.476 ' O ' HG22 ' A' ' 83' ' ' VAL . 20.7 m -96.13 146.33 7.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.124 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.514 HG12 ' CG2' ' A' ' 40' ' ' VAL . 2.5 pp -156.69 175.29 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.445 -0.784 . . . . 0.0 109.402 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 10.0 pttm -101.73 143.47 31.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.317 -0.864 . . . . 0.0 109.204 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.511 ' CG2' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -146.48 175.14 10.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.197 -0.94 . . . . 0.0 109.552 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.533 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 3.9 mmm-85 -101.56 153.66 19.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.448 ' HA ' HD23 ' A' ' 98' ' ' LEU . 54.9 t -97.71 123.04 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 109.078 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.515 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 54.4 t -82.89 -38.43 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.834 . . . . 0.0 109.923 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 172.78 105.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.993 . . . . 0.0 109.547 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.528 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . . . -91.35 127.39 36.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.34 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -116.03 -50.45 2.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.582 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -154.91 -124.97 0.93 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -30.77 70.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.425 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -104.6 134.13 48.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 109.235 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 50.5 t -135.57 163.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.939 . . . . 0.0 110.068 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.515 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 97.7 m-20 -98.73 150.9 21.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.841 . . . . 0.0 108.753 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.533 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -137.39 135.14 36.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.965 -1.085 . . . . 0.0 110.799 -179.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.485 ' N ' HD13 ' A' ' 98' ' ' LEU . 30.9 ttp180 -128.21 124.95 37.98 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.484 ' N ' HD12 ' A' ' 61' ' ' LEU . 3.4 ttt85 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.05 -1.031 . . . . 0.0 109.985 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.2 t -109.67 166.4 10.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.234 -1.156 . . . . 0.0 109.456 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -104.53 157.81 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.79 160.12 30.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.789 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.64 124.79 50.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.352 -0.843 . . . . 0.0 109.087 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.46 ' O ' HG11 ' A' ' 83' ' ' VAL . . . -138.93 176.36 20.96 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 13.0 mt -96.85 167.04 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.143 -1.21 . . . . 0.0 108.731 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.454 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 60.4 t -108.66 158.61 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.043 -1.036 . . . . 0.0 110.733 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.65 152.0 30.33 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 0.0 109.769 -179.841 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.517 ' CD1' ' O ' ' A' ' 61' ' ' LEU . 4.1 pt . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.402 ' O ' HD11 ' A' ' 46' ' ' ILE . 1.2 m-85 -116.28 166.98 11.43 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.854 -1.154 . . . . 0.0 109.424 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -141.26 143.06 33.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 88.2 t -116.37 136.96 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.4 mtt-85 -108.4 123.4 48.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.219 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.0 OUTLIER -94.6 68.43 3.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.159 -0.963 . . . . 0.0 109.498 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 tt -50.87 142.25 11.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.431 -0.793 . . . . 0.0 109.436 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.56 -53.33 0.6 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 55' ' ' GLU . 1.1 m-85 -68.35 -21.55 64.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.489 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 54' ' ' TYR . 4.4 mt-10 61.49 119.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.1 29.43 62.58 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -116.12 89.97 3.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 0.0 109.328 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.9 112.43 25.4 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 0.0 109.76 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 25.7 m -102.56 164.75 11.48 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.302 -0.874 . . . . 0.0 109.045 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.26 131.81 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.128 -0.983 . . . . 0.0 109.367 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.517 ' O ' ' CD1' ' A' ' 46' ' ' ILE . 2.2 tp -98.04 118.3 34.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 109.355 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 tt . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.804 . . . . 0.0 109.66 -179.582 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 16.4 t . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.334 0.587 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 84.24 -46.52 3.68 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -45.88 172.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -1.159 . . . . 0.0 109.874 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 38' ' ' GLY . 1.6 t -98.71 150.79 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.25 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.564 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -152.93 172.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 109.836 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 13.5 pttm -103.97 115.3 30.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.378 -0.827 . . . . 0.0 109.308 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.463 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 24.9 p -125.16 175.42 7.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.204 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.529 ' HD3' ' N ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -101.63 157.96 16.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.52 ' HA ' HD22 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -96.76 120.04 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.548 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 91.3 t -80.21 -37.43 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.443 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 170.65 104.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.931 -1.106 . . . . 0.0 109.826 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.455 ' CA ' HG12 ' A' ' 96' ' ' VAL . . . -87.55 153.97 20.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 109.215 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -167.26 53.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.146 -0.971 . . . . 0.0 109.755 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.18 -158.42 14.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.491 ' CD2' ' C ' ' A' ' 94' ' ' LEU . 4.0 tt -60.12 -18.55 48.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.379 -1.071 . . . . 0.0 109.6 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -107.1 134.21 50.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.645 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 97' ' ' ASP . 74.2 t -134.29 157.39 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.839 . . . . 0.0 109.407 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.548 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 8.8 m-20 -98.39 152.43 19.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 108.811 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.52 HD22 ' HA ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -141.57 133.77 27.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.968 -1.083 . . . . 0.0 110.701 -178.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.516 ' N ' HD11 ' A' ' 98' ' ' LEU . 8.7 ttt180 -131.0 131.37 44.31 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.453 ' HB2' HD13 ' A' ' 61' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.073 -1.017 . . . . 0.0 109.556 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.02 168.55 19.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -1.185 . . . . 0.0 109.542 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.9 m -116.34 168.06 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.289 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 46.2 t60 -170.33 163.9 8.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.679 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.69 125.37 50.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.212 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.77 175.73 22.37 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 mt -97.7 155.0 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.405 -1.056 . . . . 0.0 108.98 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.493 HG12 ' CG1' ' A' ' 80' ' ' VAL . 45.7 t -98.79 157.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.063 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.416 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -154.38 141.43 19.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.438 -0.789 . . . . 0.0 109.006 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.5 t80 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.034 . . . . 0.0 109.555 -179.855 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 47' ' ' PHE . 40.4 pt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 67.1 m-85 -117.9 169.76 9.37 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.879 -1.138 . . . . 0.0 109.411 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.48 ' CG ' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -143.16 139.24 30.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 109.698 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t -115.8 104.28 16.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 130.56 45.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.115 -0.991 . . . . 0.0 109.966 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.89 93.22 7.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 109.303 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.432 ' CD1' ' N ' ' A' ' 53' ' ' GLY . 0.9 OUTLIER -83.69 134.97 34.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 109.596 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' ' CD1' ' A' ' 52' ' ' LEU . . . 92.85 -5.81 76.47 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.505 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -123.9 51.34 1.54 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.269 -1.136 . . . . 0.0 109.596 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.505 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 1.6 mt-10 75.87 -170.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.399 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 58' ' ' GLU . . . -81.66 9.76 54.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -41.42 97.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -1.067 . . . . 0.0 109.63 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 56' ' ' GLY . 27.9 tt0 -110.58 110.58 21.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -104.66 167.4 9.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.48 HG23 ' CG ' ' A' ' 48' ' ' LYS . 1.1 pt -129.58 139.0 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.405 -0.81 . . . . 0.0 109.039 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 47' ' ' PHE . 49.0 tp -98.4 117.25 32.39 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.026 -1.046 . . . . 0.0 109.26 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.309 -0.869 . . . . 0.0 109.664 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.493 ' CG1' HG12 ' A' ' 40' ' ' VAL . 13.0 t . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 88.13 -48.03 3.58 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -41.56 164.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.406 -1.055 . . . . 0.0 109.892 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.464 ' O ' HG21 ' A' ' 84' ' ' ILE . 23.5 m -98.15 150.16 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.079 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.582 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -155.95 175.29 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.937 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 4.3 mtmt -104.25 112.87 26.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.409 -0.807 . . . . 0.0 109.253 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.3 p -118.94 175.24 5.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.571 ' N ' ' CD ' ' A' ' 87' ' ' ARG . 9.9 mpt_? -99.32 156.36 17.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 0.0 109.335 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.5 ' HA ' HD21 ' A' ' 98' ' ' LEU . 3.9 t -97.21 124.24 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.167 -0.958 . . . . 0.0 109.309 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.493 ' CG2' ' CB ' ' A' ' 99' ' ' ARG . 24.4 t -80.75 -30.3 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.413 -0.804 . . . . 0.0 109.653 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.9 OUTLIER 168.01 106.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.136 -0.977 . . . . 0.0 109.311 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HA ' HG12 ' A' ' 96' ' ' VAL . . . -95.73 132.36 41.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 0.0 109.617 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -165.84 88.27 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.47 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.73 -160.6 13.57 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.7 -22.62 53.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -1.155 . . . . 0.0 109.443 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -103.65 138.99 39.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.272 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 91' ' ' ALA . 77.2 t -136.74 161.8 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.185 -0.947 . . . . 0.0 109.918 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 89' ' ' VAL . 15.3 m-20 -98.36 150.9 21.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.509 HD11 ' N ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -138.53 135.0 34.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.932 -1.105 . . . . 0.0 110.91 -178.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.509 ' N ' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -136.91 131.8 33.59 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.476 ' NH2' HG13 ' A' ' 84' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.175 -0.953 . . . . 0.0 109.33 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 p -119.13 154.67 32.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -1.102 . . . . 0.0 109.575 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.4 m -101.03 131.89 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.375 -0.828 . . . . 0.0 109.06 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.86 172.53 13.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.06 -1.025 . . . . 0.0 109.954 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.55 158.61 15.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.367 -0.833 . . . . 0.0 108.897 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.06 177.46 39.1 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 6.6 mt -95.96 152.43 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.425 -1.044 . . . . 0.0 108.451 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.477 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 21.9 t -98.65 149.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.061 -1.024 . . . . 0.0 110.731 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.47 132.46 15.21 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 t80 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 120.932 -1.105 . . . . 0.0 109.742 -179.632 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 mm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.538 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 10.1 m-85 -109.54 172.45 6.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.12 -0.988 . . . . 0.0 109.409 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 147.78 26.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.945 . . . . 0.0 109.704 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 2.5 t -121.74 122.02 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.399 -0.813 . . . . 0.0 109.253 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.402 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 54.8 ttt-85 -98.73 121.74 41.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.0 109.338 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.413 HD11 ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -90.7 86.64 6.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.023 -1.048 . . . . 0.0 109.624 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.7 tp -59.41 162.99 4.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.835 . . . . 0.0 109.351 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.99 -31.05 5.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.49 -31.69 12.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 109.342 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 55.79 85.81 0.07 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.369 -0.832 . . . . 0.0 109.548 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.68 -12.28 5.4 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -89.25 94.92 10.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -1.148 . . . . 0.0 109.545 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.14 111.01 23.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.525 -0.735 . . . . 0.0 109.129 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.8 m -100.69 156.85 17.09 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.23 -0.919 . . . . 0.0 109.539 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -110.72 124.99 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.538 ' HB3' ' CB ' ' A' ' 47' ' ' PHE . 29.9 tp -98.17 110.55 23.11 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.046 -1.034 . . . . 0.0 109.56 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.7 tt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.483 -0.76 . . . . 0.0 109.727 -179.643 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 81' ' ' GLY . 17.8 t . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.517 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 85.43 -48.46 4.02 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.8 OUTLIER -43.02 170.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.469 -1.018 . . . . 0.0 110.14 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.443 HG22 ' N ' ' A' ' 84' ' ' ILE . 4.3 p -97.27 143.6 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.145 -0.972 . . . . 0.0 109.64 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.497 ' C ' ' CD1' ' A' ' 84' ' ' ILE . 2.3 pp -145.83 174.16 2.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.456 -0.777 . . . . 0.0 109.391 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -102.89 141.78 35.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.505 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.488 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -153.33 174.55 14.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.277 -0.889 . . . . 0.0 109.46 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.466 ' O ' HD11 ' A' ' 98' ' ' LEU . 7.9 mmt180 -99.39 151.92 20.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.468 ' HA ' HD23 ' A' ' 98' ' ' LEU . 65.5 t -97.41 119.88 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.86 . . . . 0.0 109.002 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.529 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 71.2 t -82.64 -33.96 11.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.414 -0.804 . . . . 0.0 109.935 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 171.04 103.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.115 -0.99 . . . . 0.0 109.737 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.451 ' HA ' ' CG1' ' A' ' 96' ' ' VAL . . . -92.91 107.2 19.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.266 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.88 107.45 4.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.71 -176.39 54.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 mp -59.83 -16.17 26.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -1.095 . . . . 0.0 109.529 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -99.07 133.15 43.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.479 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 91' ' ' ALA . 61.7 t -138.59 151.29 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.597 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.529 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -101.17 145.5 28.72 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.488 ' CD1' ' HB ' ' A' ' 86' ' ' THR . 0.2 OUTLIER -138.31 137.86 37.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.966 -1.084 . . . . 0.0 110.669 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.526 ' HG3' ' CG2' ' A' ' 89' ' ' VAL . 9.2 mtt180 -146.19 126.41 13.87 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.566 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 62.2 m -138.59 165.65 26.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.93 146.61 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.509 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -168.71 166.0 11.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.165 -0.959 . . . . 0.0 109.612 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -104.0 138.89 39.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.322 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -154.98 176.13 32.77 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.7 mm -97.4 152.33 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.345 -1.091 . . . . 0.0 108.815 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.476 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 21.9 t -104.93 168.01 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.014 -1.054 . . . . 0.0 110.09 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -155.87 163.78 39.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 109.48 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.333 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 21.2 m-85 -111.94 153.9 26.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.034 -1.041 . . . . 0.0 109.51 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -129.72 149.32 51.52 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.464 ' HB ' ' HB2' ' A' ' 59' ' ' CYS . 47.4 t -128.52 135.44 62.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.083 -1.011 . . . . 0.0 109.544 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.96 131.86 56.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.122 -0.986 . . . . 0.0 109.022 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.46 78.19 9.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 109.666 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.8 tp -62.73 125.17 23.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.351 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.49 -16.41 6.26 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.41 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 10.8 t80 -118.23 -26.13 6.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -1.127 . . . . 0.0 109.382 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 56.56 91.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.454 ' O ' HD23 ' A' ' 94' ' ' LEU . . . 131.38 0.36 5.0 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.41 ' CE1' ' CD2' ' A' ' 54' ' ' TYR . 9.6 m170 -109.63 105.28 14.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -1.213 . . . . 0.0 109.483 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.67 111.41 22.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.887 . . . . 0.0 110.014 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.464 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.3 m -103.56 170.63 7.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.309 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.2 pt -132.39 128.57 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.068 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 20.5 tp -97.47 117.54 31.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.969 -1.082 . . . . 0.0 109.372 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.404 ' CD1' ' C ' ' A' ' 62' ' ' LEU . 3.6 pp . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.374 -0.829 . . . . 0.0 109.794 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.56 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 1.6 p . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.705 0.764 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.56 ' N ' ' CG2' ' A' ' 80' ' ' VAL . . . 85.31 -47.19 3.79 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -41.24 165.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.436 -1.037 . . . . 0.0 110.21 -179.539 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 83' ' ' VAL . 7.4 p -98.04 141.78 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.411 -0.805 . . . . 0.0 108.882 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.569 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -151.37 175.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.001 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -98.9 103.52 15.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 108.957 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.417 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 68.0 p -107.49 175.12 5.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.475 ' O ' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -102.95 156.56 17.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 0.0 109.254 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.494 ' HA ' HD21 ' A' ' 98' ' ' LEU . 60.1 t -96.95 106.6 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.282 -0.886 . . . . 0.0 108.817 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.559 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 24.1 t -60.6 -44.54 97.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.464 -0.773 . . . . 0.0 109.87 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 9.4 ttm180 177.27 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.746 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.533 ' CB ' HG22 ' A' ' 96' ' ' VAL . . . -78.12 152.12 32.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.901 . . . . 0.0 109.322 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -167.7 62.16 0.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.924 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.87 -156.04 16.2 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -61.42 -27.33 68.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -1.096 . . . . 0.0 109.647 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -101.18 138.74 37.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.612 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.533 HG22 ' CB ' ' A' ' 91' ' ' ALA . 40.8 t -133.69 162.86 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.774 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.559 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -99.26 145.96 26.72 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.533 HD12 ' N ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -138.02 138.63 39.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.965 -1.085 . . . . 0.0 110.899 -178.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.533 ' N ' HD12 ' A' ' 98' ' ' LEU . 31.0 ttp180 -134.57 129.28 34.76 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 109.429 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 t -100.52 172.13 7.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -1.114 . . . . 0.0 109.461 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.487 HG23 ' NH1' ' A' ' 87' ' ' ARG . 10.3 t -118.89 161.97 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.2 -0.937 . . . . 0.0 109.426 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.35 167.51 5.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.872 . . . . 0.0 109.457 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -98.7 130.63 45.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 0.0 109.26 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.41 175.69 29.34 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 4.0 mt -97.91 158.29 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -1.048 . . . . 0.0 108.984 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.513 ' C ' ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -116.28 175.75 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 110.072 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.62 147.91 22.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 108.856 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 50.8 t80 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 120.965 -1.084 . . . . 0.0 109.654 -179.639 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 47' ' ' PHE . 10.2 pt . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.544 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 4.4 m-85 -114.9 173.99 6.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.045 -1.035 . . . . 0.0 109.189 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 5.0 tttt -142.68 158.88 43.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.144 -0.973 . . . . 0.0 109.675 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 59' ' ' CYS . 2.8 t -139.98 107.71 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.406 -0.809 . . . . 0.0 109.376 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.96 134.27 42.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -97.38 96.97 8.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.94 . . . . 0.0 109.614 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.454 ' HB2' HD12 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -79.2 110.97 14.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.337 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.04 -35.96 1.64 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 4.4 m-85 -85.02 -31.62 23.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.272 -1.134 . . . . 0.0 109.18 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER 71.55 97.6 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.391 -0.818 . . . . 0.0 109.589 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.73 10.34 30.98 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -100.22 88.75 3.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 0.0 109.549 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.92 99.61 9.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.36 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.475 ' HB3' ' HB ' ' A' ' 49' ' ' VAL . 7.4 t -101.9 169.56 8.7 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.188 -0.945 . . . . 0.0 109.234 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 pt -137.03 140.84 41.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.544 ' HB3' ' CB ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -98.37 126.96 44.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.934 -1.104 . . . . 0.0 109.597 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.409 ' HG ' ' HB ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.599 -0.688 . . . . 0.0 109.507 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.493 HG13 ' N ' ' A' ' 81' ' ' GLY . 38.2 t . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.174 0.512 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.513 ' HA2' ' C ' ' A' ' 40' ' ' VAL . . . -80.69 15.65 18.76 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.233 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -49.05 175.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.94 -1.33 . . . . 0.0 108.695 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.433 ' C ' HG21 ' A' ' 84' ' ' ILE . 66.5 t -97.37 122.9 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.084 -1.01 . . . . 0.0 108.627 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.433 HG21 ' C ' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -141.3 174.63 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.112 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -104.19 118.13 35.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.428 -0.795 . . . . 0.0 109.127 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.512 ' OG1' ' CD1' ' A' ' 98' ' ' LEU . 55.5 p -125.95 175.08 7.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.521 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -102.15 159.88 15.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.338 -0.851 . . . . 0.0 109.477 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.47 ' HA ' HD23 ' A' ' 98' ' ' LEU . 40.7 t -97.48 123.1 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 109.031 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.542 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 79.6 t -81.84 -33.29 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.485 -0.759 . . . . 0.0 110.045 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.465 ' O ' HG12 ' A' ' 96' ' ' VAL . 47.3 ttp180 175.29 102.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.004 . . . . 0.0 109.629 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.537 ' HA ' ' CG1' ' A' ' 96' ' ' VAL . . . -95.83 108.37 20.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.537 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.45 -58.36 2.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.02 -93.79 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.67 -29.64 22.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -1.179 . . . . 0.0 109.194 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.14 131.08 53.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.091 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.537 ' CG1' ' HA ' ' A' ' 91' ' ' ALA . 59.5 t -135.0 157.61 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 109.954 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.542 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -99.91 153.89 18.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.544 HD11 ' N ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -136.81 134.2 36.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.971 -1.08 . . . . 0.0 110.878 -178.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.544 ' N ' HD11 ' A' ' 98' ' ' LEU . 28.6 ttm180 -124.17 111.56 16.04 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 110.041 -179.007 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -113.8 163.46 15.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -1.147 . . . . 0.0 109.482 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.558 ' CG1' ' NE ' ' A' ' 87' ' ' ARG . 18.9 m -103.65 158.1 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.511 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.501 ' CD2' HG21 ' A' ' 88' ' ' VAL . 20.4 p80 -167.08 163.13 15.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -99.37 135.08 41.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.067 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -146.08 176.77 24.85 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 81' ' ' GLY . 9.7 mt -96.61 154.34 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.302 -1.117 . . . . 0.0 108.641 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.514 HG13 ' CE2' ' A' ' 47' ' ' PHE . 53.0 t -105.54 151.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.016 -1.053 . . . . 0.0 110.481 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.479 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 2.6 t80 -142.34 145.87 34.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.425 -0.797 . . . . 0.0 108.968 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.535 ' O ' ' CG ' ' A' ' 42' ' ' PHE . 37.2 p90 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.096 -1.002 . . . . 0.0 109.779 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.458 HD12 ' O ' ' A' ' 61' ' ' LEU . 2.5 pt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.514 ' CE2' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -116.23 163.04 16.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.037 -1.04 . . . . 0.0 108.96 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.517 ' CG ' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -135.65 129.95 33.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.166 -0.959 . . . . 0.0 109.733 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 59' ' ' CYS . 5.4 t -109.45 124.83 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 109.358 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -105.55 129.4 53.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.977 . . . . 0.0 109.393 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.76 81.95 5.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.432 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.97 132.71 50.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.612 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.94 -42.46 1.86 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.466 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . 69.1 t80 -74.58 -29.54 61.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 109.556 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 30.4 tt0 63.54 89.3 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.53 15.28 9.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.466 ' CG ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -115.65 90.26 3.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 109.535 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -100.65 105.61 17.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.837 . . . . 0.0 109.444 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 49' ' ' VAL . 4.9 m -101.78 159.65 15.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.145 -0.972 . . . . 0.0 109.313 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.517 HG22 ' CG ' ' A' ' 48' ' ' LYS . 4.1 pt -131.13 141.07 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.848 . . . . 0.0 108.971 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -97.93 127.63 44.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.027 . . . . 0.0 109.738 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.441 HD13 ' CG2' ' A' ' 46' ' ' ILE . 14.9 tp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 42' ' ' PHE . 12.0 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 86.06 -46.86 3.68 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -41.09 164.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.579 -0.953 . . . . 0.0 110.021 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.425 ' C ' HG23 ' A' ' 84' ' ' ILE . 4.3 m -98.44 153.01 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.247 -0.908 . . . . 0.0 109.219 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.575 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -151.99 174.59 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.695 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.427 ' O ' HG22 ' A' ' 86' ' ' THR . 10.3 mtpt -99.35 138.17 36.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.362 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 85' ' ' LYS . 35.5 p -149.3 173.53 13.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.889 . . . . 0.0 109.443 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.558 ' NE ' ' CG1' ' A' ' 35' ' ' VAL . 13.3 mmm-85 -104.23 158.13 16.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.852 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.501 HG21 ' CD2' ' A' ' 36' ' ' HIS . 53.4 t -96.74 131.82 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 109.334 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 42.6 t -92.41 -31.1 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.284 -0.885 . . . . 0.0 110.056 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.488 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 164.49 107.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.139 -0.975 . . . . 0.0 109.58 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.532 ' HA ' ' CG1' ' A' ' 96' ' ' VAL . . . -84.65 117.72 23.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -110.54 27.98 9.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.581 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.24 -148.24 17.45 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -45.29 -31.25 1.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -1.133 . . . . 0.0 109.527 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -102.86 135.06 45.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 109.332 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.532 ' CG1' ' HA ' ' A' ' 91' ' ' ALA . 51.4 t -142.26 152.48 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.9 . . . . 0.0 109.695 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.479 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 50.1 m-20 -97.92 150.29 21.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.203 -0.935 . . . . 0.0 108.706 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -136.93 136.74 38.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.09 -1.006 . . . . 0.0 110.49 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.454 ' HB3' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -123.84 114.46 19.89 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.212 -0.93 . . . . 0.0 109.325 -179.922 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 m -128.68 161.41 29.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 0.0 109.553 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.0 m -109.7 132.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.59 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -147.03 170.01 18.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.259 -0.9 . . . . 0.0 109.43 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -100.23 153.39 19.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.852 . . . . 0.0 109.684 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.45 175.22 45.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.521 HG21 ' N ' ' A' ' 40' ' ' VAL . 1.9 mp -98.49 144.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.377 -1.072 . . . . 0.0 108.931 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.536 ' O ' ' CA ' ' A' ' 81' ' ' GLY . 2.1 t -100.94 172.36 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.461 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 1.4 t80 -156.19 147.92 22.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -0.95 . . . . 0.0 109.54 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.7 t80 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.455 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.404 HG21 ' CD1' ' A' ' 62' ' ' LEU . 45.4 pt . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.501 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.3 m-30 -107.9 155.1 20.67 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.021 -1.049 . . . . 0.0 109.17 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 24.3 tttt -126.07 150.46 48.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.507 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.501 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 3.4 t -138.55 112.84 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.434 -0.791 . . . . 0.0 109.104 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.73 127.55 45.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.23 85.44 5.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 53' ' ' GLY . 17.8 tp -59.92 145.64 45.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.241 -0.912 . . . . 0.0 109.402 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.439 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . 101.92 -54.43 0.77 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.09 -24.35 62.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.582 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 47.78 85.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.99 -9.84 3.89 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -97.46 98.16 9.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -1.144 . . . . 0.0 109.596 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.568 ' OE2' ' CZ ' ' A' ' 95' ' ' TYR . 26.4 tt0 -101.42 107.54 18.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.2 m -104.87 162.63 13.16 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.627 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -131.01 132.68 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.576 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.501 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -97.4 124.69 41.66 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 109.831 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.404 ' CD1' HG21 ' A' ' 46' ' ' ILE . 4.9 tp . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.545 -0.722 . . . . 0.0 109.462 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.531 ' CG1' ' N ' ' A' ' 81' ' ' GLY . 2.3 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.67 0.748 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 40' ' ' VAL . . . -75.33 15.4 4.43 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.808 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.503 ' O ' ' O ' ' A' ' 81' ' ' GLY . 8.5 ttp180 -50.63 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.969 -1.313 . . . . 0.0 109.724 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 83' ' ' VAL . 5.4 m -96.01 112.91 29.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 108.821 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.498 ' C ' ' CD1' ' A' ' 84' ' ' ILE . 2.7 pp -133.57 175.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.95 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.441 ' O ' HD11 ' A' ' 84' ' ' ILE . 6.3 mtpm? -98.28 151.37 20.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 109.038 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.523 ' CG2' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -154.91 170.86 20.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.524 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 6.1 mmt180 -99.78 154.16 18.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.194 -0.941 . . . . 0.0 109.244 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.441 ' HA ' HD22 ' A' ' 98' ' ' LEU . 19.5 t -97.78 125.9 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.13 -0.981 . . . . 0.0 108.908 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.56 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 78.7 t -85.36 -33.88 8.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.295 -0.878 . . . . 0.0 110.251 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' A' ' 89' ' ' VAL . 1.9 ptt180 166.45 108.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.03 -1.044 . . . . 0.0 109.601 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.507 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . . . -91.44 114.87 27.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.822 . . . . 0.0 109.244 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.7 64.86 1.58 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.109 -0.995 . . . . 0.0 109.794 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.75 -165.64 12.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -25.88 62.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -1.093 . . . . 0.0 109.676 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.568 ' CZ ' ' OE2' ' A' ' 58' ' ' GLU . 6.9 m-85 -99.59 140.63 33.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.353 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.507 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 79.9 t -142.2 162.89 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 109.944 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.56 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 30.8 m-20 -101.19 157.2 16.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.002 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.24 136.23 33.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.88 -1.137 . . . . 0.0 111.033 -178.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.474 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -120.8 114.78 22.11 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.523 ' HG2' ' CG2' ' A' ' 86' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.05 172.02 13.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -1.134 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.503 HG13 ' CZ ' ' A' ' 87' ' ' ARG . 12.9 m -120.44 128.43 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.0 109.218 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -149.93 166.87 28.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.554 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.56 133.27 45.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.204 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.453 ' O ' HG21 ' A' ' 83' ' ' VAL . . . -146.07 176.71 24.87 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 40' ' ' VAL . 2.9 mp -96.14 160.02 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -1.122 . . . . 0.0 108.581 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.5 ' N ' HG23 ' A' ' 39' ' ' ILE . 7.1 t -111.37 167.94 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.085 -1.009 . . . . 0.0 110.237 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.425 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 2.1 t80 -157.87 150.4 22.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.438 -0.789 . . . . 0.0 108.922 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 75.1 t80 . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.931 . . . . 0.0 109.704 -179.551 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.536 ' CG2' ' N ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.536 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.3 OUTLIER -107.04 164.43 12.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.738 -1.226 . . . . 0.0 109.157 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.07 147.64 49.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.083 -1.011 . . . . 0.0 110.219 -179.449 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.7 t -130.8 133.66 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -114.37 123.57 49.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.51 HD13 ' ND1' ' A' ' 57' ' ' HIS . 0.4 OUTLIER -86.11 67.69 10.05 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.174 -0.954 . . . . 0.0 109.242 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.63 147.28 1.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.701 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.24 -45.3 1.38 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.46 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -77.62 -17.03 58.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -1.152 . . . . 0.0 109.456 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.24 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.203 -0.936 . . . . 0.0 109.515 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.81 -23.96 7.66 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.51 ' ND1' HD13 ' A' ' 51' ' ' LEU . 1.6 t-160 -82.1 91.06 6.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.164 -1.198 . . . . 0.0 109.787 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.87 109.68 22.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.099 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.449 ' HA ' ' HB ' ' A' ' 96' ' ' VAL . 13.7 m -98.54 173.7 6.8 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.154 -0.966 . . . . 0.0 109.444 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 96' ' ' VAL . 1.8 pp -149.55 147.62 16.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.422 -0.798 . . . . 0.0 109.374 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.5 ' CB ' ' HB3' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -98.13 102.48 14.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.298 -0.876 . . . . 0.0 109.183 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.457 ' HA ' HG12 ' A' ' 46' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.563 ' N ' ' CG2' ' A' ' 80' ' ' VAL . . . 88.78 -37.41 3.31 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 81' ' ' GLY . 1.5 mmt180 -43.62 172.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.633 -0.922 . . . . 0.0 110.153 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 38' ' ' GLY . 9.1 p -97.18 147.1 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.601 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.575 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -155.74 176.02 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.352 -0.843 . . . . 0.0 109.605 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.1 110.4 22.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.323 -0.861 . . . . 0.0 108.949 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 100' ' ' ARG . 82.4 p -110.35 165.45 11.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.044 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 6.2 mpt_? -98.56 140.79 32.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 108.65 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.573 ' HA ' ' HB3' ' A' ' 98' ' ' LEU . 58.9 t -94.25 139.16 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.469 -0.769 . . . . 0.0 109.299 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.507 ' CG2' ' HA ' ' A' ' 98' ' ' LEU . 91.1 t -121.97 -10.31 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.47 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.524 ' O ' ' CG1' ' A' ' 96' ' ' VAL . 0.0 OUTLIER 174.38 105.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.496 -1.377 . . . . 0.0 110.444 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.55 ' CA ' HG13 ' A' ' 96' ' ' VAL . . . -116.54 88.03 2.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.506 -0.746 . . . . 0.0 109.172 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -121.65 84.19 2.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.766 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.36 -137.76 14.14 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mp -102.28 4.38 39.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -1.141 . . . . 0.0 109.674 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -124.4 131.96 53.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 109.212 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.579 ' CG1' ' CD2' ' A' ' 98' ' ' LEU . 22.0 t -132.8 145.86 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.213 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.503 ' C ' ' CD2' ' A' ' 98' ' ' LEU . 2.0 m-20 -112.8 141.2 46.88 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.579 ' CD2' ' CG1' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -165.2 178.91 6.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.592 -1.317 . . . . 0.0 112.041 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.1 ptt-85 -134.89 104.05 5.84 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.082 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.501 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 1.2 ptt180 . . . . . 0 N--CA 1.49 1.556 0 O-C-N 120.915 -1.115 . . . . 0.0 109.518 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.76 161.94 34.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -1.14 . . . . 0.0 109.386 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.551 ' O ' ' CG ' ' A' ' 36' ' ' HIS . 9.6 m -118.29 170.4 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.576 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 11.0 m-70 -172.55 168.16 5.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -99.17 147.31 25.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -158.75 175.67 35.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 6.0 mt -98.04 151.25 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -1.11 . . . . 0.0 109.053 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.499 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 66.9 t -99.72 147.16 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.059 -1.026 . . . . 0.0 110.19 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.56 172.29 14.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.438 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.928 . . . . 0.0 109.545 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.444 HG13 ' N ' ' A' ' 47' ' ' PHE . 35.3 pt . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.543 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.0 m-85 -111.6 173.91 6.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.119 -0.988 . . . . 0.0 109.217 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 1.8 mttp -148.08 127.2 12.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.638 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 2.4 t -101.68 111.63 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.427 -0.796 . . . . 0.0 109.287 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.54 130.63 45.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.24 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -92.7 93.4 8.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.554 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.431 ' HG ' ' N ' ' A' ' 53' ' ' GLY . 1.5 tt -66.35 143.11 57.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.189 -0.945 . . . . 0.0 109.461 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.431 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . 110.81 -43.19 1.77 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 55' ' ' GLU . 14.7 m-85 -88.6 -27.31 21.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -1.151 . . . . 0.0 109.391 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 54' ' ' TYR . 38.3 tt0 61.71 123.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.269 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 58' ' ' GLU . . . 97.27 -39.24 2.83 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -59.86 88.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -1.13 . . . . 0.0 109.33 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 56' ' ' GLY . 32.0 tt0 -104.02 104.02 13.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.447 -0.783 . . . . 0.0 109.438 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 44.4 m -99.04 155.39 17.46 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 109.095 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.9 pt -118.55 136.44 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 109.229 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.543 ' HB3' ' CB ' ' A' ' 47' ' ' PHE . 14.8 tp -98.02 110.38 22.97 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.105 -0.997 . . . . 0.0 109.053 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.414 ' C ' HD21 ' A' ' 62' ' ' LEU . 7.5 tt . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.474 -0.766 . . . . 0.0 109.381 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.438 HG12 HG11 ' A' ' 40' ' ' VAL . 21.9 t . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 86.15 -47.5 3.77 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -38.95 159.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.641 -0.917 . . . . 0.0 110.008 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.427 ' C ' HG23 ' A' ' 84' ' ' ILE . 22.2 t -98.48 141.46 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 109.028 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.474 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -141.45 166.86 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.822 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -103.59 106.97 17.63 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.464 HG23 ' CB ' ' A' ' 100' ' ' ARG . 1.3 p -118.08 174.77 6.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.54 ' N ' ' CD ' ' A' ' 87' ' ' ARG . 2.5 mpt_? -98.93 162.96 12.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.871 . . . . 0.0 109.21 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.448 ' HA ' HD21 ' A' ' 98' ' ' LEU . 60.0 t -96.9 129.33 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.275 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.55 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 57.2 t -85.27 -34.1 8.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.401 -0.812 . . . . 0.0 109.742 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 162.85 113.69 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.301 -0.874 . . . . 0.0 109.215 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.472 ' HA ' HG11 ' A' ' 96' ' ' VAL . . . -98.45 151.48 20.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.583 -0.698 . . . . 0.0 109.437 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -127.0 -69.32 0.76 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 109.326 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -141.35 -75.31 0.04 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.4 mp -111.52 -25.23 9.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -1.115 . . . . 0.0 109.172 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -100.4 135.57 41.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.037 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 91' ' ' ALA . 58.1 t -140.02 151.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.101 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.55 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 94.1 m-20 -98.49 155.57 17.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 108.624 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.472 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.39 139.25 35.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.821 -1.175 . . . . 0.0 110.831 -178.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.492 ' NH1' ' HB3' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -144.06 125.46 14.78 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.464 ' CB ' HG23 ' A' ' 86' ' ' THR . 3.8 ttt-85 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.486 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.56 162.15 17.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.238 -1.154 . . . . 0.0 109.577 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 86' ' ' THR . 1.9 t -109.33 156.23 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.326 -0.858 . . . . 0.0 109.441 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.3 169.58 20.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.613 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 154.5 17.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.234 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -168.67 176.58 42.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.523 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 32.3 mt -97.1 148.29 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -1.142 . . . . 0.0 108.719 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.523 ' CG2' HG12 ' A' ' 84' ' ' ILE . 59.7 t -98.54 146.96 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.024 -1.048 . . . . 0.0 110.42 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.506 ' N ' HG12 ' A' ' 40' ' ' VAL . 1.5 t80 -139.77 150.42 44.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.386 -0.821 . . . . 0.0 109.153 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 76.5 t80 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.038 . . . . 0.0 109.671 -179.836 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 pt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -109.45 167.75 9.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -143.13 131.92 22.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 109.442 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.6 t -106.96 116.72 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.52 127.68 44.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.314 -0.866 . . . . 0.0 109.313 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -96.13 70.56 2.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.052 -1.03 . . . . 0.0 109.567 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.443 ' HB2' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -58.2 139.16 55.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.226 -0.921 . . . . 0.0 109.324 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.74 -17.52 15.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -110.28 -30.08 7.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -1.131 . . . . 0.0 109.266 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 2.7 mm-40 66.05 90.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 0.0 109.622 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.56 -11.05 10.44 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 1.3 t-160 -92.26 87.87 6.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -1.132 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -107.94 107.79 18.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.26 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.9 m -104.37 165.39 11.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.278 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 pt -129.24 134.11 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.335 -0.853 . . . . 0.0 108.932 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.517 ' CD1' HG21 ' A' ' 86' ' ' THR . 0.5 OUTLIER -97.93 120.56 38.55 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.99 -1.069 . . . . 0.0 109.19 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.9 pp . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.684 -179.926 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.149 0.499 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.523 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 85.76 -47.42 3.79 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 81' ' ' GLY . 25.7 mmt180 -38.18 164.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.771 -0.84 . . . . 0.0 110.592 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 6.4 m -96.89 130.96 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 108.869 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.523 HG12 ' CG2' ' A' ' 40' ' ' VAL . 2.5 pp -135.67 174.64 12.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 109.74 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 144.26 33.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.044 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.529 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -152.38 173.62 14.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.903 . . . . 0.0 109.534 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.512 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 10.4 mpt_? -99.96 156.06 17.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.239 -0.913 . . . . 0.0 109.367 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.46 ' HA ' HD22 ' A' ' 98' ' ' LEU . 6.9 t -96.96 119.79 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.315 -0.865 . . . . 0.0 108.995 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.541 ' CG2' ' CB ' ' A' ' 99' ' ' ARG . 75.4 t -77.6 -31.22 17.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.374 -0.829 . . . . 0.0 109.928 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 1.6 ttm180 170.23 106.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.35 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.477 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . . . -88.12 133.82 33.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.416 -0.803 . . . . 0.0 109.172 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.66 88.31 0.34 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.67 -177.89 33.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.5 mp -58.9 -16.23 16.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -1.135 . . . . 0.0 109.662 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -108.52 127.96 54.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.644 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 55.4 t -129.6 158.97 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.852 . . . . 0.0 109.356 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.53 ' OD2' ' CG1' ' A' ' 89' ' ' VAL . 28.7 t0 -98.59 147.72 24.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.97 . . . . 0.0 108.742 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.529 ' CD1' ' HB ' ' A' ' 86' ' ' THR . 0.2 OUTLIER -132.76 135.51 45.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.04 -1.037 . . . . 0.0 111.088 -178.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.541 ' CB ' ' CG2' ' A' ' 89' ' ' VAL . 4.7 ttp-105 -132.63 129.41 38.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.436 ' HB2' ' CG2' ' A' ' 86' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.021 -1.049 . . . . 0.0 109.732 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 t -168.74 150.56 4.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -1.161 . . . . 0.0 109.37 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.2 t -102.55 163.33 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.381 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -172.86 163.85 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.772 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -101.35 142.05 33.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.387 -0.821 . . . . 0.0 109.305 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.53 176.6 31.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 28.5 mt -97.31 154.58 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -1.21 . . . . 0.0 108.9 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.487 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 77.0 t -98.66 150.61 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 110.16 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.527 ' HB3' ' CB ' ' A' ' 48' ' ' LYS . 42.9 t80 -141.98 155.03 45.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.344 -0.847 . . . . 0.0 109.142 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 42' ' ' PHE . 28.3 p90 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.95 . . . . 0.0 109.589 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.0 pt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.179 0.514 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.427 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 5.6 m-85 -107.54 159.18 16.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -133.47 128.37 35.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.17 -0.956 . . . . 0.0 109.761 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 1.8 t -106.18 118.93 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 108.878 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.53 121.04 40.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 109.855 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.28 72.64 8.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.227 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.72 129.13 38.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.69 -33.99 4.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.43 -71.02 0.41 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -1.167 . . . . 0.0 109.531 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -178.31 55.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 109.556 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.42 7.79 48.01 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.75 118.06 2.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -1.189 . . . . 0.0 109.171 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 95' ' ' TYR . 7.4 tt0 -106.34 111.11 23.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.691 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.418 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 13.0 m -109.95 165.91 11.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.315 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 pt -133.95 135.53 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 109.49 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.54 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 3.9 tp -98.56 127.83 44.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.8 tp . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.346 -0.847 . . . . 0.0 109.463 179.907 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 85.67 -45.61 3.51 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 81' ' ' GLY . 2.8 mmt180 -43.15 172.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.647 -0.914 . . . . 0.0 110.382 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.0 t -97.57 139.22 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.267 -0.895 . . . . 0.0 109.222 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.506 ' C ' ' CD1' ' A' ' 84' ' ' ILE . 2.0 pp -136.75 166.64 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 86' ' ' THR . 15.6 ptpt -101.7 128.58 47.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 109.07 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.529 ' CB ' HD13 ' A' ' 98' ' ' LEU . 40.6 p -141.89 175.43 9.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.851 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.573 ' N ' ' CD ' ' A' ' 87' ' ' ARG . 3.8 mpt_? -101.48 161.59 13.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.486 -0.759 . . . . 0.0 109.426 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.463 ' HA ' HD22 ' A' ' 98' ' ' LEU . 5.2 t -97.75 110.39 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.338 -0.851 . . . . 0.0 109.003 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.545 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 41.1 t -65.62 -40.29 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 0.0 110.103 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.49 103.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 109.501 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.471 ' HA ' ' CG1' ' A' ' 96' ' ' VAL . . . -82.76 122.18 27.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.527 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 91' ' ' ALA . 0.4 OUTLIER -156.26 92.19 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.286 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.5 -177.33 33.26 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -15.77 41.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -1.155 . . . . 0.0 109.445 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.5 OUTLIER -107.35 125.81 51.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.191 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.471 ' CG1' ' HA ' ' A' ' 91' ' ' ALA . 74.2 t -122.79 160.86 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.888 . . . . 0.0 109.468 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.545 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 0.9 OUTLIER -97.91 148.01 23.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.109 -0.994 . . . . 0.0 108.576 179.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.529 HD13 ' CB ' ' A' ' 86' ' ' THR . 0.2 OUTLIER -133.01 135.56 45.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 110.677 -178.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.511 ' CB ' ' CG2' ' A' ' 89' ' ' VAL . 4.0 ttp85 -132.84 120.61 21.78 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.458 ' HG3' HG21 ' A' ' 86' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.89 129.59 52.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -1.178 . . . . 0.0 109.515 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.51 HG11 ' CD ' ' A' ' 87' ' ' ARG . 16.5 m -99.56 136.65 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 35' ' ' VAL . 5.7 m-70 -147.7 166.74 26.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.449 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.05 152.01 21.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -163.89 176.41 39.93 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.532 HG23 ' N ' ' A' ' 40' ' ' VAL . 76.6 mt -96.83 146.72 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -1.097 . . . . 0.0 108.356 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.532 ' N ' HG23 ' A' ' 39' ' ' ILE . 57.2 t -99.46 137.67 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.963 -1.086 . . . . 0.0 110.591 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 2.9 t80 -122.46 154.57 37.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 109.043 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.502 ' O ' ' CG ' ' A' ' 42' ' ' PHE . 12.8 p90 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.948 . . . . 0.0 109.641 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.0 pt . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.531 ' HB2' ' CD2' ' A' ' 61' ' ' LEU . 76.1 m-85 -127.05 171.99 10.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.959 -1.088 . . . . 0.0 109.43 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HE3' HG23 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -136.79 125.4 23.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.251 -0.906 . . . . 0.0 109.669 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.9 t -98.07 105.81 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.115 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.483 ' CG ' ' HB ' ' A' ' 39' ' ' ILE . 2.3 ptm85 -101.34 128.9 47.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.7 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.26 85.54 7.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 109.364 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.84 149.07 45.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.212 -0.93 . . . . 0.0 109.538 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.48 -55.18 0.84 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -75.06 -27.8 60.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -1.151 . . . . 0.0 109.515 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 54' ' ' TYR . 20.3 mt-10 48.87 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.35 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.88 -17.76 3.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.7 92.86 5.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -1.182 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.65 109.06 20.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.339 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.5 m -107.05 145.65 32.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.908 . . . . 0.0 109.512 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 30.0 pt -99.56 135.95 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.337 -0.852 . . . . 0.0 109.0 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.531 ' CD2' ' HB2' ' A' ' 47' ' ' PHE . 25.2 tp -98.61 107.89 20.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 110.183 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.506 -0.746 . . . . 0.0 109.069 179.333 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.557 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.518 0.675 . . . . 0.0 109.31 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.557 ' N ' ' CG2' ' A' ' 80' ' ' VAL . . . 86.5 -47.45 3.74 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -36.97 161.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.966 -0.726 . . . . 0.0 110.69 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 99.5 t -97.14 136.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.281 -0.887 . . . . 0.0 108.967 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.521 ' CD1' HG22 ' A' ' 86' ' ' THR . 2.3 pp -138.96 174.93 8.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.334 -0.854 . . . . 0.0 109.883 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.462 ' O ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -107.47 141.22 39.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.372 -0.83 . . . . 0.0 109.198 179.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.521 HG22 ' CD1' ' A' ' 84' ' ' ILE . 19.0 p -151.37 175.26 12.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.192 -0.943 . . . . 0.0 109.315 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.52 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 1.2 mmm-85 -98.68 158.03 15.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.265 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.469 ' HA ' HD21 ' A' ' 98' ' ' LEU . 5.6 t -98.28 110.1 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.554 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 26.9 t -63.08 -36.23 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.7 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.443 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER 168.97 106.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.237 -0.914 . . . . 0.0 109.362 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.498 ' HA ' ' CG1' ' A' ' 96' ' ' VAL . . . -91.96 117.27 29.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.424 -0.797 . . . . 0.0 109.235 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -103.4 -62.74 1.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.645 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -146.09 -115.79 0.95 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.04 -23.97 60.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -1.106 . . . . 0.0 109.466 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.53 129.19 55.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.122 -0.986 . . . . 0.0 109.529 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.498 ' CG1' ' HA ' ' A' ' 91' ' ' ALA . 95.0 t -131.41 158.34 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.856 . . . . 0.0 109.472 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.554 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 9.5 m-20 -101.04 143.39 31.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.0 108.625 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -130.14 136.91 49.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.904 -1.122 . . . . 0.0 110.659 -178.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.542 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 1.0 OUTLIER -126.35 119.63 27.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 108.89 178.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.05 . . . . 0.0 109.695 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -163.95 169.62 17.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -1.133 . . . . 0.0 109.516 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.504 HG12 ' CD ' ' A' ' 87' ' ' ARG . 17.9 m -119.04 143.55 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.13 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.532 ' CD2' ' N ' ' A' ' 36' ' ' HIS . 1.9 p80 -165.35 166.8 18.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.006 -1.059 . . . . 0.0 109.956 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.499 ' HG2' ' CG1' ' A' ' 83' ' ' VAL . 1.7 tt0 -98.8 145.28 27.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 108.907 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.448 ' O ' HG12 ' A' ' 83' ' ' VAL . . . -151.64 176.16 30.15 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.046 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 40' ' ' VAL . 22.0 mt -97.09 150.56 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.515 -0.991 . . . . 0.0 108.544 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.485 ' N ' HG23 ' A' ' 39' ' ' ILE . 10.6 t -98.16 142.89 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 0.0 110.095 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.472 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 39.6 t80 -141.48 153.25 44.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.385 -0.822 . . . . 0.0 109.104 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.433 ' CD1' ' C ' ' A' ' 42' ' ' PHE . 21.8 t80 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.644 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.539 ' CG2' ' N ' ' A' ' 47' ' ' PHE . 2.2 mp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.539 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.8 OUTLIER -127.37 162.03 27.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.031 -1.043 . . . . 0.0 109.342 179.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -138.52 125.43 21.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -101.93 118.81 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 109.329 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -98.78 127.87 44.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.953 . . . . 0.0 109.527 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.444 HD22 ' SG ' ' A' ' 59' ' ' CYS . 1.7 mm? -93.83 69.18 3.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 0.0 109.421 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.421 ' HB3' HD11 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -65.03 128.82 37.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.908 . . . . 0.0 109.419 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.47 -30.27 9.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.452 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 1.1 t80 -99.69 51.07 0.92 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.325 -1.103 . . . . 0.0 109.279 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 72.64 -159.54 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 109.455 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' HIS . . . -82.62 11.81 50.22 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -42.72 108.69 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.329 -1.1 . . . . 0.0 109.772 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -115.15 109.83 18.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.275 -0.891 . . . . 0.0 109.407 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.444 ' SG ' HD22 ' A' ' 51' ' ' LEU . 31.0 m -102.0 156.29 17.63 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.22 -0.925 . . . . 0.0 109.666 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.468 HG23 ' CG ' ' A' ' 48' ' ' LYS . 2.1 pt -125.43 135.54 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.47 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -97.71 128.9 44.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.888 -1.133 . . . . 0.0 109.679 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.523 ' HG ' ' CD1' ' A' ' 46' ' ' ILE . 1.8 tt . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.571 -0.706 . . . . 0.0 109.482 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 81' ' ' GLY . 44.9 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.364 0.602 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.501 ' N ' HG13 ' A' ' 80' ' ' VAL . . . 85.47 -51.76 4.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -41.3 161.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -1.072 . . . . 0.0 110.011 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.499 ' CG1' ' HG2' ' A' ' 37' ' ' GLU . 52.9 t -98.75 140.5 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.024 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.516 HD11 ' N ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -139.65 175.28 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.735 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' O ' HG23 ' A' ' 86' ' ' THR . 2.1 mtpt -99.45 127.52 45.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.46 -0.775 . . . . 0.0 109.263 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 85' ' ' LYS . 69.6 p -139.25 173.61 11.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.134 -0.979 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.504 ' CD ' HG12 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -105.21 161.02 14.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.447 ' CG2' ' NE2' ' A' ' 36' ' ' HIS . 59.1 t -97.31 115.03 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.411 -0.806 . . . . 0.0 108.871 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.549 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 54.8 t -74.41 -39.05 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.468 -0.77 . . . . 0.0 110.259 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.428 ' O ' HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER 179.25 101.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.972 -1.08 . . . . 0.0 110.031 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.528 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . . . -90.02 122.54 33.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.69 -4.19 12.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 109.953 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 154.16 -113.4 0.57 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.89 -41.13 44.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 0.0 109.579 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -99.49 126.33 45.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.349 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 89.1 t -128.78 162.88 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.719 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.549 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 1.2 m-20 -98.51 154.4 17.92 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.504 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -137.74 136.51 37.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.884 -1.135 . . . . 0.0 111.119 -178.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.536 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -132.12 108.4 9.26 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.165 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.94 . . . . 0.0 109.413 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -113.12 162.98 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -1.166 . . . . 0.0 109.389 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 86' ' ' THR . 2.9 m -107.55 149.09 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.465 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.12 168.49 13.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.836 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -99.56 143.65 29.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.317 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -154.02 176.52 31.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 81' ' ' GLY . 8.8 mt -97.08 152.63 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -1.148 . . . . 0.0 108.685 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.47 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 88.6 t -105.92 149.94 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.102 -0.999 . . . . 0.0 110.607 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -148.42 175.42 11.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.475 -0.765 . . . . 0.0 109.009 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 58.7 t80 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.153 -0.967 . . . . 0.0 109.35 179.855 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.52 ' CG2' HD22 ' A' ' 62' ' ' LEU . 12.3 pt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.465 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 1.8 m-85 -110.64 164.69 12.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.301 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -135.55 119.72 17.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.643 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 2.7 t -103.9 108.86 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.271 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 135.64 39.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.41 107.72 19.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.1 tp -81.27 148.55 29.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.599 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.4 -21.93 32.65 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -99.31 -30.14 12.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -1.165 . . . . 0.0 109.58 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 54' ' ' TYR . 4.8 mt-10 60.93 149.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.513 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.41 40.71 78.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.76 86.61 2.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.121 -1.223 . . . . 0.0 109.48 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.72 120.31 41.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.325 -0.859 . . . . 0.0 109.556 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.2 m -117.15 170.94 8.28 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.368 -0.832 . . . . 0.0 109.204 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.3 pp -134.47 133.07 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 0.0 109.303 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.52 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 0.7 OUTLIER -98.19 131.14 44.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.078 -1.014 . . . . 0.0 109.386 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.52 HD22 ' CG2' ' A' ' 46' ' ' ILE . 25.3 tp . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.489 -0.757 . . . . 0.0 109.413 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.424 HG11 HG12 ' A' ' 40' ' ' VAL . 11.7 t . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.268 0.556 . . . . 0.0 109.768 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 85.9 -53.47 4.67 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 81' ' ' GLY . 31.0 mtt85 -39.17 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.959 . . . . 0.0 110.357 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.46 ' O ' HG21 ' A' ' 84' ' ' ILE . 66.4 t -98.47 140.46 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.524 HD11 ' N ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -146.64 174.83 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 110.157 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.517 ' O ' ' CG2' ' A' ' 86' ' ' THR . 1.5 tmmm? -100.23 147.06 26.15 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' A' ' 85' ' ' LYS . 67.1 p -158.51 174.22 15.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.963 . . . . 0.0 109.372 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.498 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 20.8 mmm-85 -103.52 162.45 13.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.484 ' HA ' HD21 ' A' ' 98' ' ' LEU . 14.2 t -96.71 122.48 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.314 -0.867 . . . . 0.0 109.269 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.535 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 42.0 t -81.2 -41.1 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.445 -0.785 . . . . 0.0 109.929 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 178.59 101.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.062 -1.024 . . . . 0.0 109.749 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.524 ' HA ' ' CG1' ' A' ' 96' ' ' VAL . . . -71.99 135.06 46.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.567 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -128.42 32.85 4.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.387 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.58 -107.86 3.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.455 ' N ' HD11 ' A' ' 94' ' ' LEU . 6.1 mp -79.52 -34.51 41.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -1.176 . . . . 0.0 109.311 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -102.01 131.76 48.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.887 . . . . 0.0 109.108 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 91' ' ' ALA . 94.2 t -137.45 155.57 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.04 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.535 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 6.0 m-20 -99.32 156.73 16.85 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.498 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.91 140.51 34.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.083 -1.011 . . . . 0.0 110.234 -179.219 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.524 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -125.16 120.4 31.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.27 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 25.3 ttt-85 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.394 -179.863 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 m -106.69 165.14 11.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -1.12 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.414 HG12 ' CZ ' ' A' ' 87' ' ' ARG . 3.7 m -108.26 140.3 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -156.18 167.99 28.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.651 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -101.0 143.28 31.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 109.348 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.41 ' O ' HG12 ' A' ' 83' ' ' VAL . . . -153.77 175.61 32.02 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 40' ' ' VAL . 4.3 mp -97.97 153.61 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -1.086 . . . . 0.0 108.756 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.527 ' N ' HG23 ' A' ' 39' ' ' ILE . 67.8 t -104.36 146.1 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.009 -1.057 . . . . 0.0 110.343 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.51 ' N ' HG13 ' A' ' 40' ' ' VAL . 3.2 t80 -146.98 -173.47 4.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 108.903 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.9 t80 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.0 . . . . 0.0 109.522 -179.912 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.448 ' CG2' ' CD1' ' A' ' 62' ' ' LEU . 21.2 pt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.494 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.4 m-85 -119.84 161.06 21.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.109 -0.994 . . . . 0.0 109.636 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 1.8 tttp -130.95 120.56 23.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.288 -0.882 . . . . 0.0 109.556 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.511 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 7.4 t -100.82 126.85 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.181 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.23 139.66 39.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 0.0 109.774 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.9 OUTLIER -103.02 73.23 1.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.399 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.423 ' HB2' HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -54.01 168.67 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.426 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.41 -36.65 3.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.539 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 5.5 t80 -98.01 -26.69 14.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -1.104 . . . . 0.0 109.305 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 54.77 26.31 7.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.493 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.33 25.92 0.3 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.539 ' CE1' ' CD2' ' A' ' 54' ' ' TYR . 23.0 m170 -131.12 98.94 4.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -1.102 . . . . 0.0 109.609 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -103.37 107.41 18.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.135 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.459 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 5.1 m -107.72 158.81 16.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.276 -0.89 . . . . 0.0 109.62 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 pt -127.73 137.74 56.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.45 -0.781 . . . . 0.0 108.959 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.511 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 4.3 tp -98.68 131.56 44.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.156 -0.965 . . . . 0.0 109.915 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.448 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.597 -0.689 . . . . 0.0 109.159 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.442 HG13 ' N ' ' A' ' 81' ' ' GLY . 57.3 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 85.18 -45.23 3.48 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.468 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -35.59 149.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.741 -0.858 . . . . 0.0 110.359 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.436 ' C ' HG23 ' A' ' 84' ' ' ILE . 65.1 t -98.81 142.69 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.465 -0.772 . . . . 0.0 109.523 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.56 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -149.22 170.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.602 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.22 112.46 24.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.134 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.476 ' OG1' ' CD1' ' A' ' 98' ' ' LEU . 74.1 p -116.58 175.17 5.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.635 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.519 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -102.19 161.53 13.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.505 ' HA ' HD23 ' A' ' 98' ' ' LEU . 67.6 t -96.85 124.67 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 108.985 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.544 ' CG2' ' HB3' ' A' ' 99' ' ' ARG . 96.4 t -85.28 -38.17 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.294 -0.879 . . . . 0.0 110.159 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.7 OUTLIER 176.9 103.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.135 -0.978 . . . . 0.0 109.637 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.464 ' HB1' HG12 ' A' ' 96' ' ' VAL . . . -99.35 123.7 43.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.377 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -115.43 -23.68 8.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 0.0 109.647 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.91 -137.7 2.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mp -57.12 -32.84 66.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -1.119 . . . . 0.0 109.627 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -99.03 131.51 45.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.464 HG12 ' HB1' ' A' ' 91' ' ' ALA . 78.3 t -135.64 158.61 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.056 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 98' ' ' LEU . 9.4 t0 -99.43 152.3 20.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 108.716 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -139.98 140.42 36.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 111.076 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.544 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 0.8 OUTLIER -126.04 119.88 28.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.502 -0.749 . . . . 0.0 109.093 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.422 ' HG3' HG23 ' A' ' 86' ' ' THR . 6.8 ttt-85 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.507 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -74.57 94.24 2.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.48 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.31 117.24 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.141 -0.974 . . . . 0.0 109.491 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -111.89 -68.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.9 tttm -118.82 82.82 21.3 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.867 . . . . 0.0 109.344 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.44 140.67 17.3 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.61 2.207 . . . . 0.0 110.445 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.96 107.57 18.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.76 77.75 0.9 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.945 . . . . 0.0 109.674 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -79.79 152.05 74.41 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.148 -0.97 . . . . 0.0 109.225 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.76 139.66 17.92 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.625 2.217 . . . . 0.0 110.307 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.412 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -150.56 67.17 7.95 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.743 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 35.2 Cg_endo -78.03 112.75 3.31 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.572 2.181 . . . . 0.0 110.255 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -147.5 70.87 1.18 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.59 161.92 19.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.422 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -122.67 127.06 48.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.338 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -144.21 115.15 7.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.381 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -160.81 87.32 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -0.866 . . . . 0.0 109.304 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.461 ' O ' ' O ' ' A' ' 19' ' ' LYS . 8.5 tp -110.94 -16.98 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.696 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 18' ' ' ILE . 5.6 tttt 45.98 93.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.143 -0.973 . . . . 0.0 109.413 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 p -124.39 97.15 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.908 . . . . 0.0 109.473 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -144.99 124.36 13.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.486 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -154.89 72.17 0.83 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.891 . . . . 0.0 109.565 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.69 95.78 5.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 25' ' ' THR . 0.0 OUTLIER 61.36 -169.6 0.17 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 109.661 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.44 ' O ' ' OG ' ' A' ' 26' ' ' SER . 9.8 t -44.75 142.52 1.7 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 109.53 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 63.4 m -168.89 170.48 9.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.323 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 26' ' ' SER . . . 74.34 147.81 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 109.397 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.475 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER 168.41 147.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.84 . . . . 0.0 109.286 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.85 140.12 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.104 -0.998 . . . . 0.0 109.872 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.06 21.93 0.76 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.38 -0.825 . . . . 0.0 109.075 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.78 149.31 87.96 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.419 -0.8 . . . . 0.0 109.7 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.39 171.23 17.23 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.664 2.243 . . . . 0.0 110.351 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.72 23.26 43.13 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.8 p -115.17 157.43 23.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -1.179 . . . . 0.0 109.532 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.9 150.3 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.424 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 4.0 m-70 -156.54 163.71 39.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 0.0 109.715 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.03 137.04 43.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 108.979 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.74 176.9 28.22 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.445 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 7.1 mt -96.51 152.51 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.346 -1.091 . . . . 0.0 108.636 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.483 HG13 HG13 ' A' ' 80' ' ' VAL . 76.2 t -99.58 148.08 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.68 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -142.72 164.52 29.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -126.37 134.88 50.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.051 -1.03 . . . . 0.0 109.872 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 7.4 tttt -178.95 142.46 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.502 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 43' ' ' LYS . 4.5 t70 69.51 9.77 7.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 109.494 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.39 -31.03 5.64 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 pt -88.29 -164.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.398 -1.06 . . . . 0.0 109.139 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.452 ' HB2' HD23 ' A' ' 61' ' ' LEU . 50.0 m-85 -113.9 173.85 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.16 -0.963 . . . . 0.0 109.387 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.14 132.78 22.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.371 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.461 ' CG2' HD12 ' A' ' 61' ' ' LEU . 45.8 t -104.62 115.15 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.194 -0.941 . . . . 0.0 109.591 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.46 ' CZ ' HD23 ' A' ' 52' ' ' LEU . 7.0 ttt180 -98.64 130.51 45.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.161 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -96.33 95.13 7.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 109.643 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.46 HD23 ' CZ ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -69.44 145.52 52.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.426 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.91 -39.96 2.7 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.23 -27.64 29.79 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -1.15 . . . . 0.0 109.292 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 57.87 96.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.239 -0.913 . . . . 0.0 109.649 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . 110.72 10.32 21.47 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.423 ' NE2' ' CG2' ' A' ' 96' ' ' VAL . 20.0 t-160 -109.82 96.9 6.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -1.202 . . . . 0.0 109.552 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -109.08 131.67 54.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.534 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.438 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.6 m -124.67 162.87 23.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 109.422 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.431 ' C ' HD12 ' A' ' 62' ' ' LEU . 2.5 pt -116.01 130.23 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.89 . . . . 0.0 109.29 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.461 HD12 ' CG2' ' A' ' 49' ' ' VAL . 6.0 tt -99.35 118.07 35.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.248 -0.907 . . . . 0.0 109.876 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 2.1 mp -132.69 7.92 4.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.479 -0.763 . . . . 0.0 109.091 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 t0 57.39 40.01 27.78 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.3 t80 60.93 31.32 19.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.476 -0.765 . . . . 0.0 108.979 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 5.5 mt -77.37 -82.54 0.08 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.678 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.72 23.89 8.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.194 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.484 ' CD1' ' HB2' ' A' ' 68' ' ' ARG . 15.3 t80 -176.84 112.34 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.236 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.484 ' HB2' ' CD1' ' A' ' 67' ' ' TYR . 0.4 OUTLIER 67.08 143.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.9 . . . . 0.0 109.448 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.74 175.57 5.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.578 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 4.6 p30 -156.06 49.41 0.51 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.346 -0.846 . . . . 0.0 109.574 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.502 ' O ' ' CD1' ' A' ' 72' ' ' LEU . 42.9 p -77.31 119.62 21.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.365 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.502 ' CD1' ' O ' ' A' ' 71' ' ' THR . 0.3 OUTLIER -157.94 44.79 0.33 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.211 -0.931 . . . . 0.0 109.384 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -151.71 89.3 1.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.506 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.57 -29.82 39.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.435 -0.791 . . . . 0.0 109.739 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 tp -58.9 -40.81 85.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.668 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.523 ' O ' ' CG2' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -52.92 -28.44 23.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 109.777 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.438 ' O ' HG22 ' A' ' 80' ' ' VAL . 8.4 tp10 -64.76 -42.2 95.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 109.942 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.24 -26.6 52.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.935 . . . . 0.0 110.242 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.463 ' O ' ' C ' ' A' ' 80' ' ' VAL . 1.3 mp -80.86 -24.57 38.27 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.013 -1.054 . . . . 0.0 110.227 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 76' ' ' LYS . 14.3 t -40.74 160.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.25 -0.907 . . . . 0.0 109.596 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 87.28 -50.93 4.16 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.448 ' NH1' ' HG2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -37.86 156.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.664 -0.903 . . . . 0.0 110.295 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 84' ' ' ILE . 14.2 t -98.47 134.21 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 109.138 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.512 HD11 ' N ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -143.58 174.27 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 0.0 109.868 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 1.8 ttmt -104.66 124.98 50.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.446 -0.784 . . . . 0.0 109.087 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.474 ' OG1' HD11 ' A' ' 98' ' ' LEU . 24.5 p -127.95 175.44 8.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.509 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.536 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -98.55 152.85 19.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.091 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.455 ' HA ' HD23 ' A' ' 98' ' ' LEU . 2.7 t -97.61 131.37 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.982 . . . . 0.0 109.473 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.522 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 94.6 t -92.83 -35.7 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.34 -0.85 . . . . 0.0 109.86 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.475 ' O ' HG13 ' A' ' 96' ' ' VAL . 9.9 ttt85 178.46 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.978 . . . . 0.0 109.335 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.534 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . . . -95.88 117.63 30.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.502 -0.749 . . . . 0.0 109.554 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -110.01 -21.6 12.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -0.935 . . . . 0.0 109.477 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 94' ' ' LEU . . . 123.33 115.31 2.21 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.576 ' CB ' ' O ' ' A' ' 93' ' ' GLY . 1.5 tp 84.39 -57.13 0.12 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.759 -0.848 . . . . 0.0 109.448 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -116.8 119.6 35.91 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 108.841 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.534 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 69.1 t -129.89 159.11 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 110.332 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.522 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 9.6 m-20 -98.66 143.27 29.22 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.536 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -135.49 141.78 45.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.809 -1.182 . . . . 0.0 110.97 -178.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -133.72 112.27 11.25 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.642 -0.661 . . . . 0.0 109.399 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.18 139.96 32.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.102 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.32 160.55 14.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.599 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.515 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.263 0.554 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.6 m -132.22 -54.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 109.362 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.12 40.69 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.374 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.438 ' O ' ' HG3' ' A' ' 5' ' ' LYS . 9.1 tp -76.25 -26.17 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 4' ' ' ILE . 2.2 mttm -172.65 67.15 0.38 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.562 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 5' ' ' LYS . 35.7 Cg_endo -78.34 -38.53 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.618 2.212 . . . . 0.0 110.412 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.51 124.45 25.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.3 p -118.16 147.13 43.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 109.4 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -154.93 85.95 3.51 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 109.543 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.462 ' O ' ' HD2' ' A' ' 11' ' ' ARG . 35.0 Cg_endo -78.38 121.71 5.33 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.544 2.163 . . . . 0.0 110.364 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.578 ' CB ' ' HD3' ' A' ' 12' ' ' PRO . 1.0 OUTLIER -179.02 -58.69 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 0.0 109.503 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.578 ' HD3' ' CB ' ' A' ' 11' ' ' ARG . 35.6 Cg_endo -76.31 76.12 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 122.19 1.927 . . . . 0.0 110.184 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -84.47 115.86 22.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.852 . . . . 0.0 109.589 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.91 153.96 3.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 109.458 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.52 98.84 8.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.941 . . . . 0.0 109.387 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.95 130.79 34.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.662 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -115.03 -31.38 6.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.274 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.3 mm -60.64 92.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.308 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -170.3 -36.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -0.934 . . . . 0.0 109.48 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 p -98.91 137.98 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 109.48 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -172.13 155.76 3.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.858 . . . . 0.0 109.305 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -169.4 51.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -123.59 75.58 1.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 109.67 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.519 ' O ' ' CD ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -163.05 58.47 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.401 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.4 t -49.93 167.69 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -0.917 . . . . 0.0 109.58 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.47 -164.93 1.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.91 . . . . 0.0 109.503 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.43 179.04 4.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.534 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.4 ttm -107.04 -21.17 13.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.425 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -138.68 121.14 16.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.885 . . . . 0.0 109.401 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.0 mt -51.7 157.31 1.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.862 . . . . 0.0 109.561 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.44 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 37.8 m -99.67 159.64 29.44 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.355 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 31' ' ' SER . 35.5 Cg_endo -77.59 131.54 11.51 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.605 2.203 . . . . 0.0 110.466 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.4 86.85 0.82 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -172.76 161.78 4.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -1.165 . . . . 0.0 109.598 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.496 HG11 ' NE ' ' A' ' 87' ' ' ARG . 2.3 m -122.5 125.44 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 0.0 109.311 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -133.01 168.72 17.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.125 -0.984 . . . . 0.0 109.67 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.69 147.03 25.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.273 -0.892 . . . . 0.0 109.107 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.431 ' O ' ' CG1' ' A' ' 83' ' ' VAL . . . -159.13 176.8 35.89 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.499 ' CD1' HG21 ' A' ' 83' ' ' VAL . 2.4 mm -96.8 154.42 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -1.158 . . . . 0.0 108.82 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.487 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 34.9 t -105.8 146.75 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 110.329 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.409 ' N ' HG12 ' A' ' 40' ' ' VAL . 2.0 t80 -137.3 145.71 43.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 109.216 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 42.9 p90 -98.48 138.82 35.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.095 -1.003 . . . . 0.0 109.657 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -160.24 125.19 3.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.639 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.5 t70 44.04 31.16 0.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.374 -0.829 . . . . 0.0 109.734 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.28 -42.51 3.09 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.511 ' CG2' HD23 ' A' ' 62' ' ' LEU . 3.7 mt -64.32 162.42 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -1.164 . . . . 0.0 109.176 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.479 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 60.0 m-85 -105.79 169.75 8.3 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.046 -1.034 . . . . 0.0 109.157 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.7 135.67 24.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.519 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 60.3 t -104.48 119.64 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.225 -0.922 . . . . 0.0 109.736 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -98.88 120.9 40.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 109.075 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.1 OUTLIER -86.06 84.88 7.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.668 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.49 138.95 54.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.391 -0.818 . . . . 0.0 109.506 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.48 -41.48 2.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.455 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -81.37 -30.26 33.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -1.161 . . . . 0.0 109.578 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 62.53 84.49 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.85 -20.15 6.44 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -71.51 94.47 1.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -1.134 . . . . 0.0 109.649 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -108.15 105.82 15.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 109.368 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.452 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.0 m -102.58 158.38 16.27 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.24 -0.913 . . . . 0.0 109.153 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' A' ' 97' ' ' ASP . 25.4 pt -103.81 129.18 56.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.259 -0.901 . . . . 0.0 109.055 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.537 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 50.2 tp -98.68 108.66 21.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.659 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.511 HD23 ' CG2' ' A' ' 46' ' ' ILE . 3.5 mm? -105.5 4.41 30.5 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.496 -0.752 . . . . 0.0 109.205 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 64' ' ' TYR . 0.5 OUTLIER 56.28 34.18 23.58 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.313 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.496 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 57.2 t80 62.64 36.58 13.5 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.511 ' O ' ' CB ' ' A' ' 66' ' ' ASN . 0.2 OUTLIER -66.7 -52.72 41.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.744 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 65' ' ' LEU . 9.1 t30 75.07 78.27 0.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.14 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 t80 64.0 177.86 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.132 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.0 -164.49 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.141 -0.974 . . . . 0.0 109.127 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -177.59 114.37 0.08 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.054 -1.029 . . . . 0.0 109.713 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -91.73 179.04 5.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.204 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -156.19 61.33 0.57 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.628 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.428 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -127.01 61.35 1.35 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.961 . . . . 0.0 109.332 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -143.97 75.58 1.47 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.37 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -77.26 -56.13 4.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.804 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.3 -42.24 90.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 109.836 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -53.47 -26.19 19.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.229 -0.919 . . . . 0.0 109.83 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 80' ' ' VAL . 8.3 mm-40 -58.35 -42.97 88.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.127 -0.983 . . . . 0.0 109.93 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -77.73 -30.58 51.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.09 -1.006 . . . . 0.0 110.103 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 80' ' ' VAL . 1.4 mp -78.7 -16.04 57.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.137 -0.977 . . . . 0.0 110.075 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.471 ' O ' ' O ' ' A' ' 79' ' ' LEU . 54.5 t -42.98 165.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.254 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 87.4 -48.63 3.8 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 81' ' ' GLY . 5.9 mtp180 -38.96 156.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.702 -0.881 . . . . 0.0 110.016 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.499 HG21 ' CD1' ' A' ' 39' ' ' ILE . 4.1 t -98.4 145.33 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 109.162 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.57 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -148.99 164.5 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.0 109.622 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.18 104.16 16.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.408 -0.808 . . . . 0.0 109.209 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.516 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 22.3 p -112.91 175.59 5.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.537 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -99.94 154.28 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.089 -1.007 . . . . 0.0 109.464 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.459 ' HA ' HD21 ' A' ' 98' ' ' LEU . 63.7 t -97.58 110.49 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 0.0 108.863 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.543 HG23 ' CA ' ' A' ' 98' ' ' LEU . 2.2 t -64.33 -35.34 73.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.866 . . . . 0.0 110.082 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.03 101.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.938 . . . . 0.0 109.559 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HA ' HG12 ' A' ' 96' ' ' VAL . . . -95.87 124.65 39.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.279 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.46 -43.69 2.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.17 -138.76 2.51 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -24.7 4.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -1.129 . . . . 0.0 109.753 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -112.34 125.55 54.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' A' ' 97' ' ' ASP . 49.7 t -133.27 166.62 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -0.89 . . . . 0.0 109.491 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.526 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 0.9 OUTLIER -110.37 146.96 34.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 108.732 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.543 ' CA ' HG23 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -134.15 128.09 33.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.998 -1.064 . . . . 0.0 110.881 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.523 ' N ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -122.37 133.18 54.65 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -91.12 150.25 21.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.579 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.513 ' HB3' ' NH2' ' A' ' 87' ' ' ARG . 43.3 t80 -129.29 156.37 44.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.493 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.414 ' N ' ' CD1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.502 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 tpt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.37 66.74 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.128 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.528 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 8.4 p -74.98 115.56 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.871 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.528 ' CG2' ' O ' ' A' ' 3' ' ' VAL . 2.7 tt 40.0 74.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.54 -0.725 . . . . 0.0 110.142 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.1 70.68 5.69 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.187 -0.946 . . . . 0.0 109.461 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.09 73.27 5.83 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.62 2.213 . . . . 0.0 110.471 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.18 -45.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.259 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.5 m 51.29 86.61 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.289 -0.882 . . . . 0.0 109.738 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -55.72 155.29 11.28 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 109.27 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.62 168.96 21.72 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.598 2.199 . . . . 0.0 110.274 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -135.31 77.24 54.71 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.572 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.69 102.68 1.62 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.627 2.218 . . . . 0.0 110.266 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -69.22 112.99 6.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.689 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.76 69.85 0.76 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.248 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -139.51 165.67 26.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.249 -0.907 . . . . 0.0 109.571 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.32 -89.85 0.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.277 -0.889 . . . . 0.0 109.425 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 m120 54.26 46.08 25.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.259 -0.9 . . . . 0.0 109.409 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.56 101.83 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -0.855 . . . . 0.0 109.579 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.42 99.73 6.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.278 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.3 m -93.22 119.19 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 109.587 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -166.75 87.04 0.3 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.531 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -124.41 139.66 53.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.485 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -91.36 62.22 4.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.214 -0.929 . . . . 0.0 109.411 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER 44.67 88.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.896 . . . . 0.0 109.408 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.49 132.27 55.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 0.0 109.511 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.92 137.91 21.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.363 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 67.13 129.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.302 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.6 ttt -91.8 98.45 11.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.175 -0.953 . . . . 0.0 109.7 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -164.25 -72.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.455 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.91 72.56 0.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 0.0 109.334 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.22 146.36 55.94 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 109.479 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.84 132.33 10.65 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.575 2.183 . . . . 0.0 110.398 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.25 29.48 5.7 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.405 ' HB3' ' NE2' ' A' ' 36' ' ' HIS . 0.5 OUTLIER -114.14 156.41 24.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -1.121 . . . . 0.0 109.366 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.415 ' O ' ' CG2' ' A' ' 35' ' ' VAL . 4.0 m -115.56 127.49 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.309 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.405 ' NE2' ' HB3' ' A' ' 34' ' ' SER . 47.4 m-70 -143.36 168.01 20.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.789 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.34 141.58 34.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.255 -0.903 . . . . 0.0 109.368 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' ' CG2' ' A' ' 83' ' ' VAL . . . -150.29 176.88 28.71 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.505 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 15.7 mt -96.42 153.87 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.243 . . . . 0.0 108.444 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.46 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 38.8 t -98.99 151.8 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 110.431 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.95 150.4 35.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.429 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 20.5 t80 -108.88 125.81 52.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.552 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER 174.72 148.93 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 109.833 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.514 ' HB3' ' CG1' ' A' ' 46' ' ' ILE . 0.5 OUTLIER 71.94 42.07 0.63 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.835 . . . . 0.0 109.503 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.426 ' O ' HG23 ' A' ' 46' ' ' ILE . . . 44.6 25.73 0.91 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.514 ' CG1' ' HB3' ' A' ' 44' ' ' ASP . 1.0 OUTLIER -151.37 -169.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.376 -1.073 . . . . 0.0 109.001 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.471 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.8 m-85 -102.97 174.93 5.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.083 -1.011 . . . . 0.0 108.975 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 59' ' ' CYS . 1.6 tttp -148.31 148.9 30.94 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.198 -0.939 . . . . 0.0 109.624 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 2.4 t -126.02 116.72 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 109.199 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.37 131.75 44.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 109.375 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.57 95.6 10.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.192 -0.942 . . . . 0.0 109.765 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.62 138.72 55.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.35 -30.02 9.38 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 55' ' ' GLU . 2.1 m-85 -117.16 66.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -1.06 . . . . 0.0 109.073 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -41.38 107.3 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.396 -0.815 . . . . 0.0 109.665 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.02 32.54 0.79 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.94 92.91 2.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -1.105 . . . . 0.0 109.782 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.57 123.1 48.86 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.988 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.439 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.2 m -116.08 167.72 10.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 109.567 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 5.9 pt -122.37 130.66 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.364 -0.835 . . . . 0.0 109.087 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' HB3' ' CB ' ' A' ' 47' ' ' PHE . 12.3 tp -97.91 116.67 30.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.969 . . . . 0.0 109.251 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -127.39 12.43 7.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.768 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.06 39.46 30.43 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 18.5 t80 64.37 30.89 13.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.481 -0.762 . . . . 0.0 109.108 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 4.7 mt -77.3 -79.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.898 . . . . 0.0 109.487 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 m120 55.76 38.51 30.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.38 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.36 -47.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 109.357 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.417 ' HB2' ' CD2' ' A' ' 65' ' ' LEU . 5.8 mmp_? -114.46 167.35 10.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.324 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -106.09 173.21 6.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.487 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -101.99 161.78 13.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.166 -0.958 . . . . 0.0 109.593 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.442 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 3.8 t -161.85 166.32 26.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.374 -0.828 . . . . 0.0 109.359 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.442 ' CB ' ' O ' ' A' ' 71' ' ' THR . 0.1 OUTLIER 71.37 43.74 0.59 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 109.459 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.419 ' OD2' ' CB ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -111.29 48.91 0.91 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.361 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -56.24 22.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.398 -0.814 . . . . 0.0 109.629 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.7 mt -75.64 -38.33 58.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.925 . . . . 0.0 109.615 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.425 ' O ' HG21 ' A' ' 80' ' ' VAL . 18.9 mmtt -57.03 -26.61 60.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.663 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.433 ' HA ' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -59.37 -37.68 78.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.196 -0.94 . . . . 0.0 109.218 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -77.43 -30.34 53.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.338 -0.851 . . . . 0.0 110.012 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -72.35 -29.98 64.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.966 . . . . 0.0 109.803 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 79' ' ' LEU . 21.4 t -40.91 163.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.546 -0.721 . . . . 0.0 109.693 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.505 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 87.73 -48.73 3.75 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -40.8 152.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.481 -1.011 . . . . 0.0 110.023 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.436 ' C ' HG22 ' A' ' 84' ' ' ILE . 7.4 p -99.05 137.29 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.847 . . . . 0.0 109.109 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.532 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -145.23 170.98 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 110.013 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.7 120.65 40.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 0.0 109.047 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.52 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -128.0 176.07 7.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.305 -0.872 . . . . 0.0 109.582 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.483 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 9.0 mpt_? -97.91 155.0 17.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.454 ' HA ' HD21 ' A' ' 98' ' ' LEU . 3.0 t -97.41 121.23 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.272 -0.892 . . . . 0.0 109.661 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.541 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 40.9 t -77.0 -39.49 29.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.494 -0.754 . . . . 0.0 109.494 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.46 ' O ' HG13 ' A' ' 96' ' ' VAL . 3.5 mtp180 178.63 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.119 -0.988 . . . . 0.0 109.618 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.541 ' CB ' HG21 ' A' ' 96' ' ' VAL . . . -101.87 129.76 48.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.533 -0.729 . . . . 0.0 109.175 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -131.28 -39.83 1.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.064 -1.023 . . . . 0.0 109.511 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -151.97 -127.45 1.32 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.39 -17.74 57.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -1.139 . . . . 0.0 109.808 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -110.24 121.59 45.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -0.989 . . . . 0.0 109.282 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.541 HG21 ' CB ' ' A' ' 91' ' ' ALA . 96.0 t -132.86 156.44 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -0.884 . . . . 0.0 109.745 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.541 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 1.7 m-20 -98.35 150.03 22.02 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.52 ' CD1' ' HB ' ' A' ' 86' ' ' THR . 0.2 OUTLIER -134.31 134.81 42.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.859 -1.151 . . . . 0.0 111.085 -178.573 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.529 ' CD ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -121.72 124.55 44.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.474 ' NH1' HG13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -92.58 130.18 38.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.557 -179.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -55.9 123.08 13.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.89 . . . . 0.0 109.432 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.353 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.424 ' O ' ' OG1' ' A' ' 2' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 1' ' ' MET . 21.9 p 45.94 56.7 5.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.399 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.64 174.46 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.592 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.507 HG23 ' N ' ' A' ' 5' ' ' LYS . 19.9 mm -91.13 161.42 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 109.45 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.507 ' N ' HG23 ' A' ' 4' ' ' ILE . 0.3 OUTLIER -149.73 173.29 4.38 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.498 ' HD2' ' CG ' ' A' ' 5' ' ' LYS . 35.3 Cg_endo -77.56 169.48 20.9 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.592 2.194 . . . . 0.0 110.428 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -129.1 -94.58 0.42 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.857 . . . . 0.0 109.537 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 p -100.27 52.48 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.047 -1.033 . . . . 0.0 109.377 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.551 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -67.31 -52.52 28.59 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.825 . . . . 0.0 109.863 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 9' ' ' ARG . 35.5 Cg_endo -77.89 127.46 8.63 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.507 2.138 . . . . 0.0 110.573 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.451 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 6.8 ptm180 -172.23 65.57 0.38 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.462 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 35.5 Cg_endo -78.28 96.04 1.08 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.642 2.228 . . . . 0.0 110.153 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 17' ' ' ASN . 5.1 ttm-85 51.57 91.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.187 -0.946 . . . . 0.0 109.275 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.93 -46.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -87.01 56.22 3.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 109.403 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.04 62.93 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 0.0 109.622 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -165.1 81.58 0.35 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 0.0 109.542 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.1 mt -102.66 -38.39 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.912 . . . . 0.0 109.371 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.66 103.68 11.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.435 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.5 m -112.05 68.68 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -49.25 -49.06 45.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.923 . . . . 0.0 109.549 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.79 77.98 8.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.4 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -83.82 119.53 24.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 0.0 109.299 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -81.93 124.2 29.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.347 -0.845 . . . . 0.0 109.574 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 26' ' ' SER . 5.3 t -110.7 54.09 0.68 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -51.31 -177.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.458 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 52.64 57.72 6.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.392 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -62.28 157.19 20.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 0.0 109.693 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t70 61.45 159.21 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.878 . . . . 0.0 109.66 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.62 176.41 5.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.352 -0.843 . . . . 0.0 109.496 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.471 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -142.15 165.55 26.81 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.484 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 31' ' ' SER . 35.2 Cg_endo -77.38 148.36 26.57 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.634 2.223 . . . . 0.0 110.438 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.83 63.52 2.55 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.6 t -149.78 138.93 21.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -1.15 . . . . 0.0 109.592 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.5 m -102.25 155.65 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.421 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -165.07 162.29 20.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.947 . . . . 0.0 109.5 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.79 137.85 36.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.07 176.11 29.72 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mt -97.39 154.66 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.317 -1.108 . . . . 0.0 108.812 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.471 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 17.6 t -104.96 159.94 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 0.0 110.12 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.45 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -146.61 170.33 17.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 0.0 109.208 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.65 109.8 9.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.954 . . . . 0.0 109.378 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -176.46 164.18 2.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.931 . . . . 0.0 109.452 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 2.6 m-20 72.05 3.77 4.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.323 -0.861 . . . . 0.0 109.714 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.2 -18.09 50.3 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.6 pt -115.35 -151.17 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -1.171 . . . . 0.0 109.223 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.491 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 44.4 m-85 -112.69 160.19 18.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.951 -1.093 . . . . 0.0 109.08 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -127.16 151.42 48.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 0.0 109.762 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.471 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 63.5 t -129.42 115.14 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.409 -0.807 . . . . 0.0 109.076 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -100.36 127.55 46.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.172 -0.955 . . . . 0.0 109.571 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 3.1 mp -95.17 76.33 3.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 109.485 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.0 162.75 3.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.75 -43.15 3.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.457 ' O ' ' O ' ' A' ' 55' ' ' GLU . 68.4 m-85 -85.29 -30.56 23.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -1.105 . . . . 0.0 109.686 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' TYR . 3.5 mt-10 61.04 146.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.192 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . 63.52 12.51 46.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -116.64 82.95 1.88 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -1.146 . . . . 0.0 109.264 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -100.29 105.92 17.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.309 -0.87 . . . . 0.0 109.52 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.403 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 4.4 m -100.19 172.67 7.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.925 . . . . 0.0 109.267 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.84 140.83 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 109.241 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.491 ' HB3' ' CB ' ' A' ' 47' ' ' PHE . 34.9 tp -98.14 116.82 31.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.962 . . . . 0.0 109.339 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.1 tp -128.51 -32.37 2.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.491 -0.755 . . . . 0.0 109.724 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.553 ' CB ' ' CB ' ' A' ' 99' ' ' ARG . 3.0 t70 -69.71 -47.37 63.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.621 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.451 ' HB3' ' CD2' ' A' ' 61' ' ' LEU . 26.5 t80 -43.25 -29.98 0.45 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 0.0 109.697 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.18 -70.15 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.153 -0.967 . . . . 0.0 109.437 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.0 t30 50.64 -159.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 19.4 p90 -103.83 153.16 21.05 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.882 . . . . 0.0 109.422 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -176.11 170.47 2.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -60.76 170.58 1.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.14 70.72 7.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.47 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -59.39 137.74 57.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 109.597 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.451 ' O ' ' CB ' ' A' ' 73' ' ' ASP . 0.5 OUTLIER -45.23 -31.63 1.6 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.404 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 72' ' ' LEU . 2.6 t70 71.88 4.49 5.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.48 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -54.53 35.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.388 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.04 -26.81 60.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.433 ' O ' ' CG2' ' A' ' 80' ' ' VAL . 28.2 tptp -67.28 -31.12 71.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.86 . . . . 0.0 109.639 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.452 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.9 OUTLIER -65.93 -34.5 78.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.091 -1.006 . . . . 0.0 109.489 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.473 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -77.22 -37.67 52.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.339 -0.85 . . . . 0.0 109.565 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 80' ' ' VAL . 30.1 tp -65.97 -35.79 81.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 77' ' ' GLU . 28.1 t -43.05 163.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.314 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 85.19 -47.54 3.87 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -40.2 162.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.467 -1.019 . . . . 0.0 110.048 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.43 ' C ' HG22 ' A' ' 84' ' ' ILE . 34.1 m -98.84 144.35 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.047 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.543 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -149.17 173.69 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -0.966 . . . . 0.0 109.629 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -104.14 106.64 17.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.148 -0.97 . . . . 0.0 109.332 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.515 ' CB ' HD13 ' A' ' 98' ' ' LEU . 8.5 p -112.0 175.75 5.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 0.0 109.55 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.558 ' NE ' ' CB ' ' A' ' 101' ' ' PHE . 10.4 mpt_? -98.73 159.58 14.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.811 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.502 ' HA ' HD23 ' A' ' 98' ' ' LEU . 11.6 t -96.96 117.54 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.468 -0.77 . . . . 0.0 109.205 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.529 HG21 ' CG ' ' A' ' 99' ' ' ARG . 72.6 t -77.84 -40.33 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.519 -0.738 . . . . 0.0 110.092 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 175.99 104.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.163 -0.961 . . . . 0.0 109.585 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.534 ' CB ' HG22 ' A' ' 96' ' ' VAL . . . -96.86 135.4 38.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.66 -36.98 1.59 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.99 . . . . 0.0 109.767 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.04 -134.71 1.69 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -63.48 -17.3 62.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -1.141 . . . . 0.0 109.538 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.56 130.64 56.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 109.506 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.534 HG22 ' CB ' ' A' ' 91' ' ' ALA . 53.9 t -137.2 157.19 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.505 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 49.8 m-20 -98.32 147.21 24.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.232 -0.917 . . . . 0.0 108.661 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -134.91 136.89 42.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.048 -1.032 . . . . 0.0 110.263 -178.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.553 ' CB ' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -136.53 124.56 22.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.589 -0.695 . . . . 0.0 109.232 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.23 127.15 31.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.341 -0.85 . . . . 0.0 109.386 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.558 ' CB ' ' NE ' ' A' ' 87' ' ' ARG . 18.4 t80 -86.84 171.65 10.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.575 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.404 ' CD2' ' OXT' ' A' ' 102' ' ' PHE . 79.8 t80 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.4 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.247 0.546 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 t -138.27 47.86 1.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.937 . . . . 0.0 109.637 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 75.8 t -54.06 -42.99 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 109.205 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 5' ' ' LYS . 10.1 tp -123.36 156.05 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.387 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.403 ' N ' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -93.97 169.0 10.64 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.152 -0.968 . . . . 0.0 109.577 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.23 117.57 4.13 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.627 2.218 . . . . 0.0 110.335 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.19 173.9 10.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.209 -0.932 . . . . 0.0 109.546 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.0 m -144.78 121.34 11.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 109.432 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -147.23 84.95 7.05 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.414 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.13 -168.36 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.593 2.195 . . . . 0.0 110.385 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -70.52 148.86 95.47 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.943 . . . . 0.0 109.534 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.41 95.91 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.607 2.205 . . . . 0.0 110.463 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.85 101.89 6.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.91 . . . . 0.0 109.439 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.43 -80.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.153 -0.967 . . . . 0.0 109.345 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -168.03 104.79 0.48 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.159 -0.963 . . . . 0.0 109.527 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.19 -73.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.312 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 45.82 65.17 1.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.619 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -101.11 -17.86 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.158 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 -7.8 7.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.317 -0.864 . . . . 0.0 109.403 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.79 63.67 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.329 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -126.44 92.71 3.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.216 -0.927 . . . . 0.0 109.481 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 t -121.51 49.12 1.57 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.486 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -83.16 131.64 35.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.354 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.45 -33.94 6.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 0.0 109.654 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.5 m -113.83 121.98 45.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.912 . . . . 0.0 109.531 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 t -124.74 69.21 1.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.65 67.85 1.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.459 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.453 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 17.3 mtp -110.64 74.51 0.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 28' ' ' MET . 64.2 m-20 63.15 -178.79 0.15 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.344 -0.848 . . . . 0.0 109.342 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.504 ' CD2' ' CB ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -90.5 130.31 36.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.571 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 p -127.39 160.25 61.17 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.48 134.29 12.38 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.641 2.228 . . . . 0.0 110.272 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.47 71.06 1.0 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 p -170.56 158.6 6.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -1.122 . . . . 0.0 109.58 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.8 m -107.29 149.4 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.254 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.09 166.35 31.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.173 -0.955 . . . . 0.0 109.823 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -99.69 151.25 21.43 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 109.14 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.38 176.63 43.32 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.514 HG22 ' N ' ' A' ' 40' ' ' VAL . 8.2 mt -97.04 149.92 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -1.184 . . . . 0.0 108.389 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.514 ' CG2' HG12 ' A' ' 84' ' ' ILE . 24.4 t -98.14 166.38 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.074 -1.016 . . . . 0.0 110.482 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.491 ' HB3' ' CB ' ' A' ' 48' ' ' LYS . 9.1 t80 -150.75 139.94 21.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.054 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.412 ' HB2' HG21 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -99.04 107.66 20.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.015 . . . . 0.0 109.661 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -94.27 171.22 8.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.278 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -89.22 8.14 31.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.933 . . . . 0.0 109.397 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.508 ' O ' ' CG2' ' A' ' 46' ' ' ILE . . . -135.57 -34.66 0.24 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.508 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 20.4 pt -158.38 -159.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -1.202 . . . . 0.0 109.134 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 12.8 m-85 -105.9 157.61 17.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.415 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.491 ' CB ' ' HB3' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -130.19 151.18 50.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.435 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.21 120.67 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 109.45 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -99.81 127.16 45.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.925 . . . . 0.0 109.327 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.435 ' CB ' ' HB3' ' A' ' 57' ' ' HIS . 0.1 OUTLIER -92.8 75.48 4.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 109.598 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.28 124.36 19.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 109.425 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 132.6 -41.13 1.53 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.482 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 61.7 t80 -83.8 -19.48 34.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -1.113 . . . . 0.0 109.507 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 9.1 tp10 62.85 88.68 0.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.347 -0.845 . . . . 0.0 109.792 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.8 25.28 5.74 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 54' ' ' TYR . 2.3 t-160 -108.9 92.36 4.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.075 -1.25 . . . . 0.0 109.75 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.08 115.1 29.82 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.41 -0.806 . . . . 0.0 109.278 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -116.13 163.26 16.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 60' ' ' ILE . 24.1 pt -129.52 125.59 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 109.23 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.484 HD12 ' N ' ' A' ' 100' ' ' ARG . 6.8 tp -98.2 121.72 40.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.007 -1.058 . . . . 0.0 109.592 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.2 -35.31 0.28 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.659 -0.651 . . . . 0.0 109.286 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 64' ' ' TYR . 0.9 OUTLIER -53.83 -30.84 47.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.126 -0.984 . . . . 0.0 108.966 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 63' ' ' ASP . 7.4 t80 -41.93 -51.07 4.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.466 -0.772 . . . . 0.0 109.234 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 66' ' ' ASN . 0.3 OUTLIER -54.51 -73.0 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.181 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER 43.05 43.23 3.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 0.0 109.538 179.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.84 68.46 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.868 . . . . 0.0 109.471 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.58 107.42 0.33 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.865 . . . . 0.0 109.502 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.61 -81.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.136 -0.978 . . . . 0.0 109.476 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.453 ' O ' ' HB ' ' A' ' 71' ' ' THR . 0.7 OUTLIER -153.38 168.25 26.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.598 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' A' ' 70' ' ' ASP . 3.8 t 175.26 136.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 0.0 109.332 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 mt -100.82 -4.59 27.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.751 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 46.49 48.9 13.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.348 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -31.61 71.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.945 . . . . 0.0 109.618 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -45.87 68.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.541 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -28.99 69.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 109.402 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -68.29 -32.36 72.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.878 . . . . 0.0 109.377 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.427 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -48.05 -56.38 7.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.318 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -169.61 60.16 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 109.637 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.569 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 0.9 OUTLIER -44.11 166.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.083 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 80' ' ' VAL . . . 84.84 -43.38 3.23 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.518 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -45.31 178.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.652 -0.911 . . . . 0.0 110.503 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.476 ' O ' HG22 ' A' ' 83' ' ' VAL . 20.7 m -96.13 146.33 7.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.124 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.514 HG12 ' CG2' ' A' ' 40' ' ' VAL . 2.5 pp -156.69 175.29 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.445 -0.784 . . . . 0.0 109.402 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 10.0 pttm -101.73 143.47 31.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.317 -0.864 . . . . 0.0 109.204 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.511 ' CG2' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -146.48 175.14 10.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.197 -0.94 . . . . 0.0 109.552 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.533 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 3.9 mmm-85 -101.56 153.66 19.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.448 ' HA ' HD23 ' A' ' 98' ' ' LEU . 54.9 t -97.71 123.04 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 109.078 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.515 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 54.4 t -82.89 -38.43 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.834 . . . . 0.0 109.923 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 172.78 105.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.993 . . . . 0.0 109.547 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.528 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . . . -91.35 127.39 36.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.34 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -116.03 -50.45 2.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.582 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -154.91 -124.97 0.93 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -30.77 70.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.425 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -104.6 134.13 48.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 109.235 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 50.5 t -135.57 163.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.939 . . . . 0.0 110.068 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.515 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 97.7 m-20 -98.73 150.9 21.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.841 . . . . 0.0 108.753 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.533 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -137.39 135.14 36.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.965 -1.085 . . . . 0.0 110.799 -179.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.485 ' N ' HD13 ' A' ' 98' ' ' LEU . 30.9 ttp180 -128.21 124.95 37.98 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.484 ' N ' HD12 ' A' ' 61' ' ' LEU . 3.4 ttt85 -101.82 158.24 16.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.05 -1.031 . . . . 0.0 109.985 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.41 ' CB ' ' O ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER 170.18 130.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.403 -0.811 . . . . 0.0 109.444 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.8 t80 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.075 -0.964 . . . . 0.0 109.549 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmm . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.0 m -159.73 99.24 1.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.578 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.8 t -138.33 143.68 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 109.61 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.5 pt -67.64 163.06 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.321 -0.862 . . . . 0.0 109.432 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.504 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 28.5 mtpt -144.84 61.23 8.06 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.128 -0.983 . . . . 0.0 109.626 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 5' ' ' LYS . 36.0 Cg_endo -77.68 78.94 3.35 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.58 2.187 . . . . 0.0 110.261 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 8' ' ' SER . 2.4 m 61.59 -169.86 0.17 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.189 -0.944 . . . . 0.0 109.518 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 7' ' ' SER . 2.9 t 61.81 120.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 109.726 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 51.01 71.23 1.6 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.665 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.464 ' O ' ' HB3' ' A' ' 11' ' ' ARG . 35.0 Cg_endo -77.85 -55.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.634 2.223 . . . . 0.0 110.48 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 1.0 OUTLIER 68.43 92.23 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.98 -168.3 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.656 2.237 . . . . 0.0 110.45 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.514 ' O ' ' CB ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -121.78 92.07 3.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER 76.41 78.93 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.461 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -112.31 130.72 55.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.931 . . . . 0.0 109.454 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.13 46.35 0.24 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.468 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -126.95 98.94 5.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.578 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.5 pt -127.36 77.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.28 27.73 1.73 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 109.531 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.458 HG21 ' OD1' ' A' ' 21' ' ' ASN . 2.4 p -150.75 122.15 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 0.0 109.535 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.458 ' OD1' HG21 ' A' ' 20' ' ' VAL . 3.9 m120 56.87 69.97 0.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 109.658 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.8 m -117.32 -65.03 1.23 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.294 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.3 t80 57.47 65.94 1.25 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.213 -0.929 . . . . 0.0 109.57 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.51 -172.31 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.521 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 p -146.99 31.43 0.94 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.7 p -117.35 50.71 1.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.487 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 177.25 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.158 -0.964 . . . . 0.0 109.411 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.39 -17.72 13.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.628 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.64 -179.36 5.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.749 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.41 ' CD1' ' HB1' ' A' ' 91' ' ' ALA . 4.6 mt -99.31 126.25 45.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.584 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.05 140.65 51.67 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.248 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.94 92.15 1.15 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.521 2.147 . . . . 0.0 110.471 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.49 22.87 2.46 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.2 t -109.67 166.4 10.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.234 -1.156 . . . . 0.0 109.456 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -104.53 157.81 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.79 160.12 30.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.789 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.64 124.79 50.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.352 -0.843 . . . . 0.0 109.087 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.46 ' O ' HG11 ' A' ' 83' ' ' VAL . . . -138.93 176.36 20.96 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 13.0 mt -96.85 167.04 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.143 -1.21 . . . . 0.0 108.731 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.454 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 60.4 t -108.66 158.61 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.043 -1.036 . . . . 0.0 110.733 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.65 152.0 30.33 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.472 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 4.3 p90 -103.61 125.34 50.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 0.0 109.769 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' A' ' 42' ' ' PHE . 0.5 OUTLIER 166.38 167.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 31.9 t70 69.01 30.23 4.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.627 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.456 ' O ' ' CG2' ' A' ' 46' ' ' ILE . . . 51.51 21.1 6.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.517 ' CD1' ' O ' ' A' ' 61' ' ' LEU . 4.1 pt -156.32 -140.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.386 -1.067 . . . . 0.0 108.628 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.402 ' O ' HD11 ' A' ' 46' ' ' ILE . 1.2 m-85 -116.28 166.98 11.43 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.854 -1.154 . . . . 0.0 109.424 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -141.26 143.06 33.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 88.2 t -116.37 136.96 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.4 mtt-85 -108.4 123.4 48.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.219 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.0 OUTLIER -94.6 68.43 3.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.159 -0.963 . . . . 0.0 109.498 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 tt -50.87 142.25 11.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.431 -0.793 . . . . 0.0 109.436 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.56 -53.33 0.6 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 55' ' ' GLU . 1.1 m-85 -68.35 -21.55 64.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.489 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 54' ' ' TYR . 4.4 mt-10 61.49 119.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.1 29.43 62.58 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -116.12 89.97 3.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 0.0 109.328 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.9 112.43 25.4 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 0.0 109.76 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 25.7 m -102.56 164.75 11.48 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.302 -0.874 . . . . 0.0 109.045 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.26 131.81 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.128 -0.983 . . . . 0.0 109.367 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.517 ' O ' ' CD1' ' A' ' 46' ' ' ILE . 2.2 tp -98.04 118.3 34.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 109.355 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 tt -139.27 -40.11 0.47 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.804 . . . . 0.0 109.66 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.532 ' HB3' ' CD ' ' A' ' 99' ' ' ARG . 0.5 OUTLIER -60.63 -31.75 70.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.548 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.566 ' CD1' ' HB3' ' A' ' 100' ' ' ARG . 2.8 t80 -50.13 -30.24 10.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.513 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.8 tp -73.43 -62.64 1.41 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 109.502 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.0 t30 57.64 -152.86 0.39 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.532 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -112.68 -39.87 4.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.348 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -48.43 -60.51 2.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.281 -0.887 . . . . 0.0 109.332 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -48.93 156.87 0.46 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.195 -0.941 . . . . 0.0 109.353 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.94 85.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.28 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -169.71 135.22 1.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.932 . . . . 0.0 109.582 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 mp -70.45 -27.49 64.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.455 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.438 ' HB3' ' HB2' ' A' ' 76' ' ' LYS . 70.6 m-20 53.29 83.96 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 109.662 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.12 -31.8 61.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 109.258 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -71.31 -36.41 71.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.262 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.528 ' O ' ' CG2' ' A' ' 80' ' ' VAL . 12.6 mmtt -58.43 -26.01 62.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.392 -0.817 . . . . 0.0 109.715 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.457 ' HA ' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -59.78 -38.26 81.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -77.48 -31.82 53.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.248 -0.907 . . . . 0.0 110.512 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -79.02 -21.26 47.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.959 -1.088 . . . . 0.0 109.859 -179.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 76' ' ' LYS . 16.4 t -43.66 160.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.622 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 84.24 -46.52 3.68 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -45.88 172.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -1.159 . . . . 0.0 109.874 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 38' ' ' GLY . 1.6 t -98.71 150.79 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.25 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.564 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -152.93 172.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 109.836 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 13.5 pttm -103.97 115.3 30.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.378 -0.827 . . . . 0.0 109.308 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.463 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 24.9 p -125.16 175.42 7.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.204 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.529 ' HD3' ' N ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -101.63 157.96 16.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.52 ' HA ' HD22 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -96.76 120.04 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.548 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 91.3 t -80.21 -37.43 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.443 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 170.65 104.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.931 -1.106 . . . . 0.0 109.826 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.455 ' CA ' HG12 ' A' ' 96' ' ' VAL . . . -87.55 153.97 20.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 109.215 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -167.26 53.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.146 -0.971 . . . . 0.0 109.755 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.18 -158.42 14.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.491 ' CD2' ' C ' ' A' ' 94' ' ' LEU . 4.0 tt -60.12 -18.55 48.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.379 -1.071 . . . . 0.0 109.6 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -107.1 134.21 50.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.645 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.516 HG13 ' N ' ' A' ' 97' ' ' ASP . 74.2 t -134.29 157.39 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.839 . . . . 0.0 109.407 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.548 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 8.8 m-20 -98.39 152.43 19.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 108.811 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.52 HD22 ' HA ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -141.57 133.77 27.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.968 -1.083 . . . . 0.0 110.701 -178.702 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.532 ' CD ' ' HB3' ' A' ' 63' ' ' ASP . 8.7 ttt180 -131.0 131.37 44.31 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.566 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -102.66 148.36 25.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.073 -1.017 . . . . 0.0 109.556 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -149.95 158.72 44.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 109.628 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.5 t80 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.463 -179.935 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.8 p -127.15 34.66 4.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 109.59 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.424 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 7.7 p -162.72 96.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.224 -0.923 . . . . 0.0 109.399 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pp -62.04 156.58 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.395 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.0 tptp 47.1 83.22 0.22 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.48 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 7' ' ' SER . 35.5 Cg_endo -77.73 118.15 4.43 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.574 2.183 . . . . 0.0 110.393 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER 169.32 156.8 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.0 109.866 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 79.5 p -167.4 139.6 3.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.528 -0.732 . . . . 0.0 109.081 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.519 ' O ' ' CG ' ' A' ' 9' ' ' ARG . 3.5 ttm180 -174.28 62.8 0.25 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.606 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.505 ' HD3' ' N ' ' A' ' 9' ' ' ARG . 36.2 Cg_endo -79.25 149.68 22.14 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.682 2.255 . . . . 0.0 110.616 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.522 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -147.81 62.92 7.24 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.325 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 36.3 Cg_endo -78.8 142.96 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.79 2.327 . . . . 0.0 110.559 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.38 56.26 0.75 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 0.0 109.326 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 tttp 68.48 45.84 1.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.925 . . . . 0.0 109.468 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' LYS . 4.2 m-20 57.11 -164.31 0.16 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.338 -0.851 . . . . 0.0 109.516 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 15' ' ' ASN . 2.9 mtpp -42.09 -68.38 0.19 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.957 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.84 -90.63 0.3 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.148 -0.97 . . . . 0.0 109.669 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.3 tt -150.84 124.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.878 . . . . 0.0 109.483 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -170.33 37.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.33 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.1 t -109.82 -3.48 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.289 -0.882 . . . . 0.0 109.551 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -102.79 22.58 13.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 0.0 109.569 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.52 147.48 34.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 109.446 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -98.85 162.45 13.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.203 -0.935 . . . . 0.0 109.395 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.452 ' HD3' ' N ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -117.7 59.52 0.78 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.395 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.15 -41.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.471 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.77 59.49 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.424 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.84 159.48 34.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.6 mtt -108.7 131.09 55.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.43 169.19 8.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.477 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.559 ' CD2' ' CB ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -82.56 166.2 19.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.542 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER 166.15 166.19 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 109.556 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 31' ' ' SER . 35.6 Cg_endo -78.03 148.74 25.02 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.638 2.225 . . . . 0.0 110.502 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.34 41.39 6.99 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.02 168.55 19.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -1.185 . . . . 0.0 109.542 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.9 m -116.34 168.06 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.289 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 46.2 t60 -170.33 163.9 8.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.679 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.69 125.37 50.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.212 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.77 175.73 22.37 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 mt -97.7 155.0 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.405 -1.056 . . . . 0.0 108.98 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.493 HG12 ' CG1' ' A' ' 80' ' ' VAL . 45.7 t -98.79 157.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.063 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.416 ' N ' ' CG1' ' A' ' 40' ' ' VAL . 0.6 OUTLIER -154.38 141.43 19.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.438 -0.789 . . . . 0.0 109.006 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -101.71 124.66 47.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.034 . . . . 0.0 109.555 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER 179.58 153.79 0.47 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.677 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER 74.2 5.01 4.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 109.829 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.51 -20.76 29.17 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.499 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 40.4 pt -109.16 -144.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -1.153 . . . . 0.0 108.868 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 67.1 m-85 -117.9 169.76 9.37 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.879 -1.138 . . . . 0.0 109.411 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.48 ' CG ' HG23 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -143.16 139.24 30.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 109.698 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t -115.8 104.28 16.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 130.56 45.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.115 -0.991 . . . . 0.0 109.966 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 mp -94.89 93.22 7.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 109.303 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.432 ' CD1' ' N ' ' A' ' 53' ' ' GLY . 0.9 OUTLIER -83.69 134.97 34.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 109.596 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' ' CD1' ' A' ' 52' ' ' LEU . . . 92.85 -5.81 76.47 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.505 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -123.9 51.34 1.54 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.269 -1.136 . . . . 0.0 109.596 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.505 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 1.6 mt-10 75.87 -170.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.399 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 58' ' ' GLU . . . -81.66 9.76 54.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -41.42 97.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -1.067 . . . . 0.0 109.63 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 56' ' ' GLY . 27.9 tt0 -110.58 110.58 21.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -104.66 167.4 9.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.48 HG23 ' CG ' ' A' ' 48' ' ' LYS . 1.1 pt -129.58 139.0 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.405 -0.81 . . . . 0.0 109.039 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' A' ' 64' ' ' TYR . 49.0 tp -98.4 117.25 32.39 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.026 -1.046 . . . . 0.0 109.26 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.84 -37.91 2.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.309 -0.869 . . . . 0.0 109.664 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.473 ' HB3' ' HG2' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -63.97 -49.42 72.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.346 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.54 ' CE1' ' HD2' ' A' ' 100' ' ' ARG . 12.3 t80 -49.02 -45.28 42.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.194 -0.941 . . . . 0.0 109.067 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.499 ' CD1' ' HA ' ' A' ' 46' ' ' ILE . 5.4 tt -57.27 -53.4 58.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.349 -0.845 . . . . 0.0 109.305 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.473 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 1.9 t-20 -52.64 156.15 1.99 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.163 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.473 ' HB3' ' O ' ' A' ' 66' ' ' ASN . 30.6 t80 72.53 111.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.74 -162.44 1.23 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 0.0 109.333 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -176.4 51.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.579 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 69' ' ' GLN . 20.2 t70 49.99 94.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.553 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.04 136.23 23.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.442 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -33.48 73.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.67 27.59 4.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.632 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -42.38 41.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.472 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -33.64 65.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.452 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.479 ' O ' ' CG2' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -59.73 -26.5 65.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 109.633 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.469 ' O ' HG22 ' A' ' 80' ' ' VAL . 7.9 mt-10 -60.44 -49.43 77.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.835 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -77.24 -26.27 52.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 109.996 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -71.21 -29.71 65.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.811 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.493 ' CG1' HG12 ' A' ' 40' ' ' VAL . 13.0 t -42.92 160.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.375 -0.828 . . . . 0.0 109.462 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 88.13 -48.03 3.58 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -41.56 164.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.406 -1.055 . . . . 0.0 109.892 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.464 ' O ' HG21 ' A' ' 84' ' ' ILE . 23.5 m -98.15 150.16 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.079 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.582 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -155.95 175.29 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.937 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 4.3 mtmt -104.25 112.87 26.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.409 -0.807 . . . . 0.0 109.253 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 71.3 p -118.94 175.24 5.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.571 ' N ' ' CD ' ' A' ' 87' ' ' ARG . 9.9 mpt_? -99.32 156.36 17.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 0.0 109.335 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.5 ' HA ' HD21 ' A' ' 98' ' ' LEU . 3.9 t -97.21 124.24 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.167 -0.958 . . . . 0.0 109.309 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.493 ' CG2' ' CB ' ' A' ' 99' ' ' ARG . 24.4 t -80.75 -30.3 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.413 -0.804 . . . . 0.0 109.653 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.9 OUTLIER 168.01 106.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.136 -0.977 . . . . 0.0 109.311 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.559 ' CB ' ' CD2' ' A' ' 30' ' ' LEU . . . -95.73 132.36 41.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 0.0 109.617 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -165.84 88.27 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.47 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.73 -160.6 13.57 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.7 -22.62 53.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -1.155 . . . . 0.0 109.443 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -103.65 138.99 39.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.272 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 91' ' ' ALA . 77.2 t -136.74 161.8 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.185 -0.947 . . . . 0.0 109.918 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 89' ' ' VAL . 15.3 m-20 -98.36 150.9 21.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.509 HD11 ' N ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -138.53 135.0 34.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.932 -1.105 . . . . 0.0 110.91 -178.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.509 ' N ' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -136.91 131.8 33.59 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.54 ' HD2' ' CE1' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -92.33 149.8 21.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.175 -0.953 . . . . 0.0 109.33 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -68.87 95.28 0.68 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.557 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 7.8 t80 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.482 179.892 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 mmt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.95 54.99 0.78 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.0 109.505 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.0 m -97.29 -165.5 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.39 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.6 mt -113.27 76.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.202 -0.936 . . . . 0.0 109.654 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.97 153.05 1.61 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.153 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.04 76.81 4.01 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.544 2.163 . . . . 0.0 110.469 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.82 162.77 6.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.9 t -96.4 21.94 8.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.388 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.534 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -77.19 -53.28 1.7 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.942 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 9' ' ' ARG . 34.8 Cg_endo -77.86 142.33 19.9 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.353 2.035 . . . . 0.0 110.357 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 55.77 71.96 1.13 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 0.0 109.28 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.85 141.83 19.53 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.666 2.244 . . . . 0.0 110.523 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.7 mtp85 -49.74 141.01 10.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.344 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -103.01 -51.67 3.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.619 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -168.83 -42.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.15 -0.969 . . . . 0.0 109.733 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -127.98 -94.72 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 109.842 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.61 -69.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 109.363 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.9 tt -125.49 127.66 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.479 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -111.2 151.19 28.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 109.477 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.64 15.64 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.537 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -121.16 -167.25 1.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 109.49 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.59 178.15 4.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.65 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -103.27 42.57 1.15 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.876 . . . . 0.0 109.339 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -81.0 -78.78 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.577 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 p -123.51 116.81 23.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.497 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.37 92.39 0.29 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 109.376 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.79 111.92 3.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.679 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.439 ' SD ' ' N ' ' A' ' 28' ' ' MET . 3.0 mpp? -97.92 -42.7 7.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.221 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 t0 50.63 -178.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 110.085 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.496 HD23 ' CB ' ' A' ' 91' ' ' ALA . 5.6 tp -155.99 102.69 2.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.444 -0.785 . . . . 0.0 109.111 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.84 157.43 43.16 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 109.5 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 155.4 31.39 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.666 2.244 . . . . 0.0 110.422 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.73 21.99 35.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 p -119.13 154.67 32.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -1.102 . . . . 0.0 109.575 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.4 m -101.03 131.89 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.375 -0.828 . . . . 0.0 109.06 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.86 172.53 13.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.06 -1.025 . . . . 0.0 109.954 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.55 158.61 15.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.367 -0.833 . . . . 0.0 108.897 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.06 177.46 39.1 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 6.6 mt -95.96 152.43 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.425 -1.044 . . . . 0.0 108.451 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.477 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 21.9 t -98.65 149.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.061 -1.024 . . . . 0.0 110.731 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.47 132.46 15.21 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -111.1 112.28 23.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.932 -1.105 . . . . 0.0 109.742 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -163.39 161.72 24.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.346 -0.846 . . . . 0.0 109.528 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER 68.7 6.83 5.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.852 . . . . 0.0 109.748 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.76 -13.45 60.82 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 mm -113.23 -160.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.114 -1.227 . . . . 0.0 109.15 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.538 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 10.1 m-85 -109.54 172.45 6.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.12 -0.988 . . . . 0.0 109.409 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 147.78 26.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.945 . . . . 0.0 109.704 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 2.5 t -121.74 122.02 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.399 -0.813 . . . . 0.0 109.253 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.402 ' HB3' ' HB ' ' A' ' 39' ' ' ILE . 54.8 ttt-85 -98.73 121.74 41.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.0 109.338 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.413 HD11 ' HA ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -90.7 86.64 6.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.023 -1.048 . . . . 0.0 109.624 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.7 tp -59.41 162.99 4.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.835 . . . . 0.0 109.351 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.99 -31.05 5.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.49 -31.69 12.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 109.342 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 55.79 85.81 0.07 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.369 -0.832 . . . . 0.0 109.548 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.68 -12.28 5.4 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -89.25 94.92 10.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -1.148 . . . . 0.0 109.545 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.14 111.01 23.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.525 -0.735 . . . . 0.0 109.129 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.8 m -100.69 156.85 17.09 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.23 -0.919 . . . . 0.0 109.539 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -110.72 124.99 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.593 ' CD2' ' CB ' ' A' ' 64' ' ' TYR . 29.9 tp -98.17 110.55 23.11 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.046 -1.034 . . . . 0.0 109.56 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.7 tt -113.6 -40.79 3.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.483 -0.76 . . . . 0.0 109.727 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.511 ' HB2' ' CB ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -63.07 -46.49 87.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.734 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.593 ' CB ' ' CD2' ' A' ' 61' ' ' LEU . 18.5 t80 -47.05 -29.3 2.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.063 -1.023 . . . . 0.0 109.606 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 66' ' ' ASN . 6.4 tt -54.84 -71.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.752 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.41 ' O ' ' O ' ' A' ' 65' ' ' LEU . 5.8 t-20 62.31 144.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.91 . . . . 0.0 109.356 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -74.5 158.19 34.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.712 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.29 146.17 16.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.641 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 1.3 pt20 -105.18 79.15 1.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.359 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 28.3 p-10 -172.62 134.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.5 p -126.26 88.61 2.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.892 . . . . 0.0 109.397 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.57 39.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.89 . . . . 0.0 109.593 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -104.37 64.33 0.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.94 -31.71 61.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.513 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.39 -45.46 91.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.589 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.7 ttpt -45.82 -26.52 0.68 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.899 . . . . 0.0 109.772 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 80' ' ' VAL . 21.0 tt0 -58.73 -53.82 54.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.851 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -27.35 61.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.01 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 80' ' ' VAL . 0.4 OUTLIER -66.5 -33.14 75.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.132 -0.98 . . . . 0.0 109.272 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 81' ' ' GLY . 17.8 t -44.11 161.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.335 -0.853 . . . . 0.0 109.336 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.517 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 85.43 -48.46 4.02 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.8 OUTLIER -43.02 170.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.469 -1.018 . . . . 0.0 110.14 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.443 HG22 ' N ' ' A' ' 84' ' ' ILE . 4.3 p -97.27 143.6 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.145 -0.972 . . . . 0.0 109.64 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.497 ' C ' ' CD1' ' A' ' 84' ' ' ILE . 2.3 pp -145.83 174.16 2.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.456 -0.777 . . . . 0.0 109.391 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -102.89 141.78 35.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.505 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.488 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -153.33 174.55 14.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.277 -0.889 . . . . 0.0 109.46 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.466 ' O ' HD11 ' A' ' 98' ' ' LEU . 7.9 mmt180 -99.39 151.92 20.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.468 ' HA ' HD23 ' A' ' 98' ' ' LEU . 65.5 t -97.41 119.88 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.86 . . . . 0.0 109.002 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.529 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 71.2 t -82.64 -33.96 11.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.414 -0.804 . . . . 0.0 109.935 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 171.04 103.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.115 -0.99 . . . . 0.0 109.737 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.496 ' CB ' HD23 ' A' ' 30' ' ' LEU . . . -92.91 107.2 19.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.266 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.88 107.45 4.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.71 -176.39 54.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.2 mp -59.83 -16.17 26.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -1.095 . . . . 0.0 109.529 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -99.07 133.15 43.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.479 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 91' ' ' ALA . 61.7 t -138.59 151.29 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.597 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.529 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -101.17 145.5 28.72 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.488 ' CD1' ' HB ' ' A' ' 86' ' ' THR . 0.2 OUTLIER -138.31 137.86 37.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.966 -1.084 . . . . 0.0 110.669 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.526 ' HG3' ' CG2' ' A' ' 89' ' ' VAL . 9.2 mtt180 -146.19 126.41 13.87 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -88.07 162.3 16.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.566 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 100' ' ' ARG . 11.7 t80 61.21 133.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.656 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.4 ' HB2' ' O ' ' A' ' 101' ' ' PHE . 3.0 t80 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.478 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ttt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.325 0.583 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.43 -44.63 1.54 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.948 . . . . 0.0 109.42 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.463 HG21 ' N ' ' A' ' 4' ' ' ILE . 5.2 p -137.71 139.37 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 109.223 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.463 ' N ' HG21 ' A' ' 3' ' ' VAL . 16.5 mm -100.74 -76.18 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.61 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.412 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -169.96 67.06 0.56 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.166 -0.959 . . . . 0.0 109.636 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -78.06 0.15 10.13 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.551 2.167 . . . . 0.0 110.319 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 54.28 76.94 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.373 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 t -139.26 120.99 15.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -0.954 . . . . 0.0 109.631 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.15 146.18 31.83 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.69 -78.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.567 2.178 . . . . 0.0 110.469 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.5 91.85 48.88 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.872 . . . . 0.0 109.386 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.8 125.22 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.614 2.21 . . . . 0.0 110.342 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.29 27.52 2.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 0.0 109.471 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.02 179.64 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 16' ' ' LYS . 11.8 m-80 -89.85 -67.13 0.86 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 109.189 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.527 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER 76.35 54.45 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.288 -0.883 . . . . 0.0 109.576 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.18 144.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.497 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 pt -106.74 131.38 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.208 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -121.03 151.18 40.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.169 -0.957 . . . . 0.0 109.994 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.509 HG11 ' N ' ' A' ' 21' ' ' ASN . 10.5 p -131.43 -37.31 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.412 -0.805 . . . . 0.0 109.02 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.509 ' N ' HG11 ' A' ' 20' ' ' VAL . 1.3 t-20 50.36 -172.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.365 -0.835 . . . . 0.0 109.761 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -159.78 148.09 17.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.347 -0.845 . . . . 0.0 109.264 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 60.06 179.21 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.45 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -106.09 -20.05 13.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 109.475 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.448 ' O ' ' OG ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -155.11 -47.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.424 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 25' ' ' THR . 3.0 m 177.96 168.17 0.73 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 109.477 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -99.35 104.46 16.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.905 . . . . 0.0 109.514 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.2 mtp -83.44 -72.81 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.145 -0.972 . . . . 0.0 109.401 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.63 36.53 16.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.397 -0.814 . . . . 0.0 109.351 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.67 7.67 46.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.375 -0.828 . . . . 0.0 109.625 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 1.3 p -62.55 164.13 12.93 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.114 -0.992 . . . . 0.0 109.493 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 31' ' ' SER . 35.6 Cg_endo -78.23 89.26 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.674 2.249 . . . . 0.0 110.435 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.65 86.16 0.67 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 62.2 m -138.59 165.65 26.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.93 146.61 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.509 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -168.71 166.0 11.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.165 -0.959 . . . . 0.0 109.612 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -104.0 138.89 39.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.322 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -154.98 176.13 32.77 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.7 mm -97.4 152.33 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.345 -1.091 . . . . 0.0 108.815 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.476 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 21.9 t -104.93 168.01 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.014 -1.054 . . . . 0.0 110.09 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -155.87 163.78 39.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 109.48 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.24 140.43 40.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.333 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.47 ' HG3' ' HD2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -143.47 96.75 2.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.036 -1.04 . . . . 0.0 109.997 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 43' ' ' LYS . 5.9 m-20 41.89 30.48 0.17 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 110.091 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.6 -53.21 0.6 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.43 HG22 ' CB ' ' A' ' 43' ' ' LYS . 5.8 tt -61.5 170.0 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.112 -1.228 . . . . 0.0 108.903 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.465 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 21.2 m-85 -111.94 153.9 26.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.034 -1.041 . . . . 0.0 109.51 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.47 ' HD2' ' HG3' ' A' ' 43' ' ' LYS . 3.3 tttt -129.72 149.32 51.52 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.464 ' HB ' ' HB2' ' A' ' 59' ' ' CYS . 47.4 t -128.52 135.44 62.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.083 -1.011 . . . . 0.0 109.544 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.96 131.86 56.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.122 -0.986 . . . . 0.0 109.022 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.46 78.19 9.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 109.666 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.8 tp -62.73 125.17 23.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.351 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.49 -16.41 6.26 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.41 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 10.8 t80 -118.23 -26.13 6.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -1.127 . . . . 0.0 109.382 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 56.56 91.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.454 ' O ' HD23 ' A' ' 94' ' ' LEU . . . 131.38 0.36 5.0 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.41 ' CE1' ' CD2' ' A' ' 54' ' ' TYR . 9.6 m170 -109.63 105.28 14.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -1.213 . . . . 0.0 109.483 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.67 111.41 22.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.887 . . . . 0.0 110.014 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.464 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.3 m -103.56 170.63 7.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.309 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.2 pt -132.39 128.57 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.068 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 20.5 tp -97.47 117.54 31.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.969 -1.082 . . . . 0.0 109.372 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.404 ' CD1' ' C ' ' A' ' 62' ' ' LEU . 3.6 pp -132.5 -33.99 1.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.374 -0.829 . . . . 0.0 109.794 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 99' ' ' ARG . 4.5 m-20 -64.14 -34.07 77.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.11 -0.994 . . . . 0.0 109.281 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.574 ' CD1' ' HB3' ' A' ' 100' ' ' ARG . 7.9 t80 -52.8 -48.58 66.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 109.713 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' O ' ' CB ' ' A' ' 66' ' ' ASN . 7.0 tp -44.04 -76.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.576 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER 70.12 152.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 109.495 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -63.74 95.18 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.348 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -146.85 -67.4 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 109.604 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.32 -171.9 2.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.622 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -150.34 -40.07 0.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 109.222 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -164.09 51.01 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.867 . . . . 0.0 109.248 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.0 mt -132.07 59.81 1.7 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.91 . . . . 0.0 109.591 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.482 ' HB3' ' CG ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -170.33 93.45 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.094 -1.004 . . . . 0.0 109.532 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.79 -28.49 65.77 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.553 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.4 mt -70.33 -26.78 63.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.529 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.482 ' CG ' ' HB3' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -62.84 -32.03 73.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 109.867 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -75.74 -28.87 58.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.0 109.665 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -77.48 -27.03 51.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 110.309 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -89.71 -39.97 12.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.09 -1.006 . . . . 0.0 110.391 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.56 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 1.6 p -41.79 164.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.92 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.56 ' N ' ' CG2' ' A' ' 80' ' ' VAL . . . 85.31 -47.19 3.79 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.47 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -41.24 165.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.436 -1.037 . . . . 0.0 110.21 -179.539 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 83' ' ' VAL . 7.4 p -98.04 141.78 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.411 -0.805 . . . . 0.0 108.882 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.569 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -151.37 175.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.001 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -98.9 103.52 15.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 108.957 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.417 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 68.0 p -107.49 175.12 5.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.475 ' O ' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -102.95 156.56 17.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 0.0 109.254 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.494 ' HA ' HD21 ' A' ' 98' ' ' LEU . 60.1 t -96.95 106.6 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.282 -0.886 . . . . 0.0 108.817 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.559 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 24.1 t -60.6 -44.54 97.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.464 -0.773 . . . . 0.0 109.87 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 9.4 ttm180 177.27 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.746 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.533 ' CB ' HG22 ' A' ' 96' ' ' VAL . . . -78.12 152.12 32.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.901 . . . . 0.0 109.322 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -167.7 62.16 0.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.924 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.87 -156.04 16.2 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.454 HD23 ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -61.42 -27.33 68.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -1.096 . . . . 0.0 109.647 -179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -101.18 138.74 37.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.612 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.533 HG22 ' CB ' ' A' ' 91' ' ' ALA . 40.8 t -133.69 162.86 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.774 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.559 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -99.26 145.96 26.72 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.533 HD12 ' N ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -138.02 138.63 39.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.965 -1.085 . . . . 0.0 110.899 -178.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.533 ' N ' HD12 ' A' ' 98' ' ' LEU . 31.0 ttp180 -134.57 129.28 34.76 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.574 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -95.16 103.63 15.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 109.429 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.465 ' CD1' ' CZ ' ' A' ' 87' ' ' ARG . 27.9 p90 -49.95 144.17 6.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.656 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.468 ' O ' ' CG ' ' A' ' 102' ' ' PHE . 70.2 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.502 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' O ' HG22 ' A' ' 2' ' ' THR . 13.9 mtp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 1' ' ' MET . 19.6 p -146.82 116.5 7.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 t -69.28 134.5 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.534 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.2 mt -122.4 -70.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 44.04 82.34 0.23 Allowed Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.251 -0.906 . . . . 0.0 109.472 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.39 125.61 7.1 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.657 2.238 . . . . 0.0 110.508 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.01 135.21 57.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.386 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.6 t -135.68 96.36 3.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.383 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -73.88 147.0 85.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.578 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.95 85.9 1.74 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.686 2.257 . . . . 0.0 110.47 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.31 69.66 0.57 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.07 -46.35 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.659 2.239 . . . . 0.0 110.559 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.441 ' O ' ' CG ' ' A' ' 13' ' ' ARG . 0.4 OUTLIER -174.91 30.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.143 -0.973 . . . . 0.0 109.735 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.99 85.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.617 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 26.2 p30 -127.02 12.76 7.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.373 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 17' ' ' ASN . 27.7 mtmm 62.27 -95.21 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.868 . . . . 0.0 109.712 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 16' ' ' LYS . 1.1 t30 73.44 -170.93 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.147 -0.971 . . . . 0.0 109.359 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.6 pt -136.91 172.23 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.595 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 tptt 58.59 52.94 6.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.688 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.446 ' O ' HG21 ' A' ' 20' ' ' VAL . 14.7 p -97.6 62.17 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.453 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -139.13 93.25 2.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.935 . . . . 0.0 109.611 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.07 27.44 4.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.287 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -53.95 -179.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.44 85.24 7.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 m 60.24 156.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.845 . . . . 0.0 109.592 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.45 119.58 1.05 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.459 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -163.99 75.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -0.815 . . . . 0.0 109.253 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.76 73.43 1.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.171 -0.956 . . . . 0.0 109.747 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -46.24 -27.92 1.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 109.25 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.28 90.94 3.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.353 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.06 106.93 0.61 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.53 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.43 110.82 2.92 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.362 2.042 . . . . 0.0 110.242 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.21 25.24 2.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 t -100.52 172.13 7.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -1.114 . . . . 0.0 109.461 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.487 HG23 ' NH1' ' A' ' 87' ' ' ARG . 10.3 t -118.89 161.97 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.2 -0.937 . . . . 0.0 109.426 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.35 167.51 5.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.872 . . . . 0.0 109.457 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -98.7 130.63 45.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 0.0 109.26 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.41 175.69 29.34 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 4.0 mt -97.91 158.29 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -1.048 . . . . 0.0 108.984 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.513 ' C ' ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -116.28 175.75 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 110.072 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.62 147.91 22.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 108.856 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 50.8 t80 -114.5 119.18 35.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.965 -1.084 . . . . 0.0 109.654 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER 174.41 174.21 0.18 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.567 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 91.1 m-20 62.99 10.96 4.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.421 -0.799 . . . . 0.0 109.854 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.74 -22.46 13.84 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 47' ' ' PHE . 10.2 pt -114.72 -153.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.294 . . . . 0.0 109.406 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.544 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 4.4 m-85 -114.9 173.99 6.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.045 -1.035 . . . . 0.0 109.189 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 5.0 tttt -142.68 158.88 43.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.144 -0.973 . . . . 0.0 109.675 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 59' ' ' CYS . 2.8 t -139.98 107.71 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.406 -0.809 . . . . 0.0 109.376 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.96 134.27 42.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -97.38 96.97 8.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.94 . . . . 0.0 109.614 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.454 ' HB2' HD12 ' A' ' 39' ' ' ILE . 0.4 OUTLIER -79.2 110.97 14.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.337 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.04 -35.96 1.64 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 4.4 m-85 -85.02 -31.62 23.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.272 -1.134 . . . . 0.0 109.18 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER 71.55 97.6 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.391 -0.818 . . . . 0.0 109.589 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.73 10.34 30.98 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -100.22 88.75 3.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 0.0 109.549 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.92 99.61 9.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.36 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.475 ' HB3' ' HB ' ' A' ' 49' ' ' VAL . 7.4 t -101.9 169.56 8.7 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.188 -0.945 . . . . 0.0 109.234 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 pt -137.03 140.84 41.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.544 ' HB3' ' CB ' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -98.37 126.96 44.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.934 -1.104 . . . . 0.0 109.597 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.409 ' HG ' ' HB ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER -162.5 -36.69 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.599 -0.688 . . . . 0.0 109.507 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' CB ' ' HB2' ' A' ' 99' ' ' ARG . 0.4 OUTLIER -48.22 -46.49 35.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 109.163 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -125.55 54.14 1.5 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.311 -0.868 . . . . 0.0 109.441 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.42 ' O ' ' O ' ' A' ' 66' ' ' ASN . 2.6 tt -66.64 -47.37 72.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.212 -0.93 . . . . 0.0 109.463 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.42 ' O ' ' O ' ' A' ' 65' ' ' LEU . 8.9 m120 54.19 100.19 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.232 -0.918 . . . . 0.0 109.367 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.41 123.29 23.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 109.684 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -116.94 104.49 11.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 109.307 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -116.77 93.94 4.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 109.613 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -139.66 167.52 21.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.42 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.65 161.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.931 . . . . 0.0 109.648 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 61.35 57.03 2.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.411 -0.806 . . . . 0.0 109.634 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.98 -30.62 17.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.402 -0.811 . . . . 0.0 109.31 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 75' ' ' LEU . 12.2 mtm180 -46.62 -55.68 7.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.569 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' ARG . 5.9 tp -43.01 -56.72 3.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.733 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 80' ' ' VAL . 6.2 tttt -48.67 -48.18 40.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.639 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.518 ' O ' ' CG2' ' A' ' 80' ' ' VAL . 2.3 tm-20 -53.59 -52.54 59.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 109.685 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 77' ' ' GLU . 0.5 OUTLIER -46.13 -62.08 1.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.407 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.517 ' O ' ' N ' ' A' ' 81' ' ' GLY . 4.5 mp -56.35 -78.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.224 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 77' ' ' GLU . 38.2 t 48.93 -90.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 110.078 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 79' ' ' LEU . . . -80.69 15.65 18.76 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.233 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -49.05 175.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.94 -1.33 . . . . 0.0 108.695 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.433 ' C ' HG21 ' A' ' 84' ' ' ILE . 66.5 t -97.37 122.9 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.084 -1.01 . . . . 0.0 108.627 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.433 HG21 ' C ' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -141.3 174.63 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.112 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -104.19 118.13 35.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.428 -0.795 . . . . 0.0 109.127 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.512 ' OG1' ' CD1' ' A' ' 98' ' ' LEU . 55.5 p -125.95 175.08 7.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.521 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -102.15 159.88 15.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.338 -0.851 . . . . 0.0 109.477 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.47 ' HA ' HD23 ' A' ' 98' ' ' LEU . 40.7 t -97.48 123.1 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 109.031 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.542 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 79.6 t -81.84 -33.29 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.485 -0.759 . . . . 0.0 110.045 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.465 ' O ' HG12 ' A' ' 96' ' ' VAL . 47.3 ttp180 175.29 102.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.004 . . . . 0.0 109.629 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.537 ' HA ' ' CG1' ' A' ' 96' ' ' VAL . . . -95.83 108.37 20.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.537 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.45 -58.36 2.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.02 -93.79 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.67 -29.64 22.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -1.179 . . . . 0.0 109.194 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.14 131.08 53.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.091 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.537 ' CG1' ' HA ' ' A' ' 91' ' ' ALA . 59.5 t -135.0 157.61 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 109.954 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.542 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -99.91 153.89 18.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.544 HD11 ' N ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -136.81 134.2 36.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.971 -1.08 . . . . 0.0 110.878 -178.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.544 ' N ' HD11 ' A' ' 98' ' ' LEU . 28.6 ttm180 -124.17 111.56 16.04 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.451 ' O ' ' HB3' ' A' ' 64' ' ' TYR . 4.2 ptm180 -95.9 163.48 13.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 110.041 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -147.19 158.59 44.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.334 -0.854 . . . . 0.0 109.164 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.8 t80 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.522 -179.882 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.4 t -90.45 145.45 24.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.565 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.52 154.34 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 109.463 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 pt -142.23 105.34 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.54 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.7 tttt 64.34 83.31 0.2 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 109.506 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.75 118.72 4.57 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.711 2.274 . . . . 0.0 110.443 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 8' ' ' SER . 0.7 OUTLIER -52.76 178.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 0.0 109.5 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 7' ' ' SER . 2.6 p 169.14 147.21 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.907 . . . . 0.0 109.5 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -47.77 146.49 3.84 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.388 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.32 113.15 3.32 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.614 2.209 . . . . 0.0 110.56 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.37 150.45 64.36 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 109.434 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.71 102.3 1.58 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.564 2.176 . . . . 0.0 110.336 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.38 36.76 0.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.76 -178.48 5.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.383 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 1.8 m120 -98.6 121.77 40.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 109.604 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 15' ' ' ASN . 41.7 mttp 65.15 102.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.479 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -99.41 58.91 1.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.19 -0.944 . . . . 0.0 109.501 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.408 ' CG2' ' N ' ' A' ' 19' ' ' LYS . 58.7 mt -63.48 160.39 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.222 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.408 ' N ' ' CG2' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -146.22 176.83 9.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.973 . . . . 0.0 109.678 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 21' ' ' ASN . 72.5 t -98.14 148.2 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.483 ' N ' HG13 ' A' ' 20' ' ' VAL . 2.1 t-20 -102.95 126.81 50.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.196 -0.94 . . . . 0.0 109.583 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 m -149.35 16.13 0.91 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 109.541 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -142.87 87.74 2.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.47 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.0 71.22 0.93 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.512 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.56 168.23 9.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.435 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 p -101.71 16.49 25.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.333 -0.854 . . . . 0.0 109.435 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 28' ' ' MET . . . -95.78 -46.57 6.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 109.467 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ALA . 1.1 tmm? 47.91 -172.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.409 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -141.99 132.65 25.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 109.667 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.496 HD11 ' N ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -117.27 133.9 55.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.329 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.496 ' N ' HD11 ' A' ' 30' ' ' LEU . 82.9 p -121.81 98.16 45.65 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.907 . . . . 0.0 109.491 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.46 172.26 16.19 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.539 2.16 . . . . 0.0 110.43 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.99 17.8 8.72 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -113.8 163.46 15.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -1.147 . . . . 0.0 109.482 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.558 ' CG1' ' NE ' ' A' ' 87' ' ' ARG . 18.9 m -103.65 158.1 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.511 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.501 ' CD2' HG21 ' A' ' 88' ' ' VAL . 20.4 p80 -167.08 163.13 15.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -99.37 135.08 41.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.067 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -146.08 176.77 24.85 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 81' ' ' GLY . 9.7 mt -96.61 154.34 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.302 -1.117 . . . . 0.0 108.641 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.514 HG13 ' CE2' ' A' ' 47' ' ' PHE . 53.0 t -105.54 151.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.016 -1.053 . . . . 0.0 110.481 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.479 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 2.6 t80 -142.34 145.87 34.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.425 -0.797 . . . . 0.0 108.968 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.535 ' O ' ' CG ' ' A' ' 42' ' ' PHE . 37.2 p90 -107.34 118.12 35.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.096 -1.002 . . . . 0.0 109.779 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 2.3 mttp 165.61 158.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 109.813 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER 77.72 36.26 0.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.688 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.525 ' O ' ' CG2' ' A' ' 46' ' ' ILE . . . 46.69 24.41 1.8 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 2.5 pt -159.3 -155.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -1.115 . . . . 0.0 108.969 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.514 ' CE2' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -116.23 163.04 16.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.037 -1.04 . . . . 0.0 108.96 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.517 ' CG ' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -135.65 129.95 33.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.166 -0.959 . . . . 0.0 109.733 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 59' ' ' CYS . 5.4 t -109.45 124.83 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 109.358 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -105.55 129.4 53.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.977 . . . . 0.0 109.393 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.76 81.95 5.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.432 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.97 132.71 50.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.612 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.94 -42.46 1.86 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.466 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . 69.1 t80 -74.58 -29.54 61.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 109.556 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 30.4 tt0 63.54 89.3 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.53 15.28 9.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.466 ' CG ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -115.65 90.26 3.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 109.535 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -100.65 105.61 17.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.837 . . . . 0.0 109.444 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 49' ' ' VAL . 4.9 m -101.78 159.65 15.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.145 -0.972 . . . . 0.0 109.313 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.517 HG22 ' CG ' ' A' ' 48' ' ' LYS . 4.1 pt -131.13 141.07 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.848 . . . . 0.0 108.971 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -97.93 127.63 44.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.027 . . . . 0.0 109.738 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.441 HD13 ' CG2' ' A' ' 46' ' ' ILE . 14.9 tp -173.68 -32.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.441 ' OD2' HG13 ' A' ' 89' ' ' VAL . 0.6 OUTLIER -55.3 -43.9 75.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.426 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.527 ' HB2' ' N ' ' A' ' 100' ' ' ARG . 1.4 m-30 -114.27 53.01 0.8 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 109.58 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 66' ' ' ASN . 0.6 OUTLIER -75.43 -10.08 59.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.491 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 65' ' ' LEU . 4.4 m120 43.81 45.31 6.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 109.288 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.418 ' C ' ' O ' ' A' ' 66' ' ' ASN . 43.9 t80 -42.98 142.34 0.94 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.44 -0.788 . . . . 0.0 109.725 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.463 ' O ' ' HB3' ' A' ' 69' ' ' GLN . 6.7 mtp180 -118.28 -75.71 0.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 109.234 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 68' ' ' ARG . 6.7 pt20 171.21 -44.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.434 -0.791 . . . . 0.0 109.151 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.06 164.81 6.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.34 -0.85 . . . . 0.0 109.291 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.29 165.37 16.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.54 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 mp -118.57 3.12 11.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.532 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -54.37 -52.6 61.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 109.481 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -62.26 -34.93 77.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.78 -31.48 48.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 109.44 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.483 ' CG ' HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -75.99 -38.27 57.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.585 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 78' ' ' ARG . 12.7 mt-10 -51.53 -28.32 13.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.656 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 79' ' ' LEU . 2.1 mtp-105 -44.35 -54.11 6.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -0.945 . . . . 0.0 109.488 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.483 ' CB ' ' O ' ' A' ' 78' ' ' ARG . 1.1 mt 165.36 48.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.645 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.483 HG22 ' CG ' ' A' ' 76' ' ' LYS . 12.0 t -43.01 163.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.414 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 86.06 -46.86 3.68 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -41.09 164.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.579 -0.953 . . . . 0.0 110.021 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.425 ' C ' HG23 ' A' ' 84' ' ' ILE . 4.3 m -98.44 153.01 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.247 -0.908 . . . . 0.0 109.219 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.575 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -151.99 174.59 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.695 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.427 ' O ' HG22 ' A' ' 86' ' ' THR . 10.3 mtpt -99.35 138.17 36.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.362 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 85' ' ' LYS . 35.5 p -149.3 173.53 13.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.889 . . . . 0.0 109.443 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.558 ' NE ' ' CG1' ' A' ' 35' ' ' VAL . 13.3 mmm-85 -104.23 158.13 16.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.852 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.501 HG21 ' CD2' ' A' ' 36' ' ' HIS . 53.4 t -96.74 131.82 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 109.334 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 90' ' ' ARG . 42.6 t -92.41 -31.1 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.284 -0.885 . . . . 0.0 110.056 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 164.49 107.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.139 -0.975 . . . . 0.0 109.58 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.532 ' HA ' ' CG1' ' A' ' 96' ' ' VAL . . . -84.65 117.72 23.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -110.54 27.98 9.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.581 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.24 -148.24 17.45 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -45.29 -31.25 1.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -1.133 . . . . 0.0 109.527 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -102.86 135.06 45.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 109.332 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.532 ' CG1' ' HA ' ' A' ' 91' ' ' ALA . 51.4 t -142.26 152.48 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.9 . . . . 0.0 109.695 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.479 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 50.1 m-20 -97.92 150.29 21.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.203 -0.935 . . . . 0.0 108.706 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -136.93 136.74 38.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.09 -1.006 . . . . 0.0 110.49 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.454 ' HB3' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -123.84 114.46 19.89 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.527 ' N ' ' HB2' ' A' ' 64' ' ' TYR . 16.2 ttm180 -47.22 159.33 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.212 -0.93 . . . . 0.0 109.325 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.411 ' N ' ' HG2' ' A' ' 100' ' ' ARG . 8.3 t80 -89.73 114.36 26.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.28 -0.888 . . . . 0.0 109.454 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.42 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 m -128.13 14.05 6.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.516 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.3 t -126.15 110.7 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.949 . . . . 0.0 109.566 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 mp -104.51 115.34 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.6 99.63 10.45 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.91 . . . . 0.0 109.403 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.446 ' O ' ' HB3' ' A' ' 7' ' ' SER . 34.6 Cg_endo -76.97 140.89 20.65 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.331 2.02 . . . . 0.0 110.171 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.446 ' HB3' ' O ' ' A' ' 6' ' ' PRO . 7.8 t 69.4 150.43 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.005 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.1 m -118.84 158.11 26.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.078 -1.013 . . . . 0.0 109.77 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.7 ptt85 -149.26 73.2 10.05 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.91 . . . . 0.0 109.161 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.53 -76.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.581 2.188 . . . . 0.0 110.506 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.24 157.73 70.42 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.585 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.09 162.27 28.97 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.744 2.296 . . . . 0.0 110.624 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.64 61.45 1.61 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 109.397 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.45 92.31 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.879 . . . . 0.0 109.458 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -47.66 141.39 5.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.522 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 mmtt -51.16 139.86 17.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.357 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -48.38 111.65 0.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.505 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.5 tt -73.64 -19.69 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.685 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -92.29 152.74 19.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.174 -0.954 . . . . 0.0 109.643 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 19' ' ' LYS . 4.2 t 71.8 6.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 0.0 109.707 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -139.56 111.64 7.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 109.648 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.7 p -68.4 133.04 48.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 109.301 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.415 ' O ' ' O ' ' A' ' 24' ' ' ARG . 0.7 OUTLIER -98.71 -36.53 9.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.619 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' A' ' 23' ' ' TYR . 0.3 OUTLIER 58.37 162.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -0.951 . . . . 0.0 109.284 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.19 -43.81 1.3 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.464 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.16 57.18 3.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.878 . . . . 0.0 109.579 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.4 50.64 0.82 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.487 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.6 tpp -84.49 104.71 14.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.354 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -179.65 36.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.599 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 tp -174.06 50.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.534 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.29 153.5 40.35 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.147 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.24 119.85 5.13 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.609 2.206 . . . . 0.0 110.505 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.73 40.29 0.62 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 m -128.68 161.41 29.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 0.0 109.553 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.0 m -109.7 132.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.59 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -147.03 170.01 18.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.259 -0.9 . . . . 0.0 109.43 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -100.23 153.39 19.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.852 . . . . 0.0 109.684 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.45 175.22 45.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.521 HG21 ' N ' ' A' ' 40' ' ' VAL . 1.9 mp -98.49 144.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.377 -1.072 . . . . 0.0 108.931 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.536 ' O ' ' CA ' ' A' ' 81' ' ' GLY . 2.1 t -100.94 172.36 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.461 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 1.4 t80 -156.19 147.92 22.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -0.95 . . . . 0.0 109.54 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -101.06 102.92 13.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.455 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -90.83 169.59 10.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 109.487 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -87.08 19.38 3.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 109.539 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.442 ' O ' ' CG2' ' A' ' 46' ' ' ILE . . . -145.78 -38.63 0.05 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 45.4 pt -155.64 -155.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.228 -1.16 . . . . 0.0 109.16 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.501 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.3 m-30 -107.9 155.1 20.67 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.021 -1.049 . . . . 0.0 109.17 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 24.3 tttt -126.07 150.46 48.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.507 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.501 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 3.4 t -138.55 112.84 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.434 -0.791 . . . . 0.0 109.104 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.73 127.55 45.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.23 85.44 5.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 53' ' ' GLY . 17.8 tp -59.92 145.64 45.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.241 -0.912 . . . . 0.0 109.402 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.439 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . 101.92 -54.43 0.77 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.09 -24.35 62.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.582 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 47.78 85.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.99 -9.84 3.89 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -97.46 98.16 9.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -1.144 . . . . 0.0 109.596 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.568 ' OE2' ' CZ ' ' A' ' 95' ' ' TYR . 26.4 tt0 -101.42 107.54 18.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.2 m -104.87 162.63 13.16 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.627 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -131.01 132.68 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.576 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.501 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -97.4 124.69 41.66 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 109.831 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.46 ' O ' HD21 ' A' ' 65' ' ' LEU . 4.9 tp -151.75 -38.05 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.545 -0.722 . . . . 0.0 109.462 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.457 ' HB3' ' HA ' ' A' ' 99' ' ' ARG . 23.0 t0 -47.13 -53.39 13.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.17 -0.956 . . . . 0.0 108.963 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.458 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -118.65 49.01 1.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 0.0 109.209 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.468 ' HA ' HD21 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -56.35 -19.75 16.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -0.827 . . . . 0.0 109.604 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 63.9 t30 69.22 159.86 0.18 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.71 167.6 12.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.445 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.499 ' CZ ' ' OD1' ' A' ' 73' ' ' ASP . 3.6 mmt180 -116.72 154.35 30.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -87.44 66.13 8.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -0.884 . . . . 0.0 109.523 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 69' ' ' GLN . 2.2 m-20 44.6 52.23 7.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 109.357 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.9 t -139.58 126.01 20.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.621 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.41 ' O ' ' CB ' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -50.34 -31.8 15.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.487 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.499 ' OD1' ' CZ ' ' A' ' 68' ' ' ARG . 0.7 OUTLIER 70.22 81.64 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.46 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -64.41 -26.57 68.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.516 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 1.6 tp -53.59 -47.47 70.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.796 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.446 ' HG3' ' HB3' ' A' ' 73' ' ' ASP . 0.9 OUTLIER -45.47 -44.58 12.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.22 -0.925 . . . . 0.0 109.639 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 78' ' ' ARG . 0.6 OUTLIER -51.48 -46.01 63.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.381 -0.824 . . . . 0.0 109.606 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -43.04 -67.1 0.3 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.237 -0.914 . . . . 0.0 109.495 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 82' ' ' ARG . 1.3 mt -172.8 70.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -0.96 . . . . 0.0 109.732 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.531 ' CG1' ' N ' ' A' ' 81' ' ' GLY . 2.3 p -59.91 -43.07 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.77 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 40' ' ' VAL . . . -75.33 15.4 4.43 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.808 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.503 ' O ' ' O ' ' A' ' 81' ' ' GLY . 8.5 ttp180 -50.63 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.969 -1.313 . . . . 0.0 109.724 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 83' ' ' VAL . 5.4 m -96.01 112.91 29.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 108.821 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.498 ' C ' ' CD1' ' A' ' 84' ' ' ILE . 2.7 pp -133.57 175.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.95 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.441 ' O ' HD11 ' A' ' 84' ' ' ILE . 6.3 mtpm? -98.28 151.37 20.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 109.038 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.523 ' CG2' ' HG2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -154.91 170.86 20.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.524 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 6.1 mmt180 -99.78 154.16 18.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.194 -0.941 . . . . 0.0 109.244 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.441 ' HA ' HD22 ' A' ' 98' ' ' LEU . 19.5 t -97.78 125.9 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.13 -0.981 . . . . 0.0 108.908 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.56 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 78.7 t -85.36 -33.88 8.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.295 -0.878 . . . . 0.0 110.251 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' A' ' 89' ' ' VAL . 1.9 ptt180 166.45 108.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.03 -1.044 . . . . 0.0 109.601 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.507 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . . . -91.44 114.87 27.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.822 . . . . 0.0 109.244 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.7 64.86 1.58 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.109 -0.995 . . . . 0.0 109.794 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.75 -165.64 12.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -25.88 62.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -1.093 . . . . 0.0 109.676 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.568 ' CZ ' ' OE2' ' A' ' 58' ' ' GLU . 6.9 m-85 -99.59 140.63 33.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.353 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.507 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 79.9 t -142.2 162.89 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 109.944 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.56 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 30.8 m-20 -101.19 157.2 16.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.002 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.24 136.23 33.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.88 -1.137 . . . . 0.0 111.033 -178.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.474 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -120.8 114.78 22.11 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.523 ' HG2' ' CG2' ' A' ' 86' ' ' THR . 0.0 OUTLIER -69.94 163.21 26.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 -179.241 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.411 ' HB3' ' NH1' ' A' ' 87' ' ' ARG . 2.5 t80 -142.62 67.61 1.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.415 -0.803 . . . . 0.0 109.213 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.9 t80 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.49 -179.879 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.29 0.567 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.97 135.73 9.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.0 m -137.01 131.71 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.326 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.87 24.81 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.086 -1.009 . . . . 0.0 109.506 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.542 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -50.44 -52.42 55.24 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.942 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 5' ' ' LYS . 35.0 Cg_endo -77.85 131.49 11.2 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.465 2.11 . . . . 0.0 110.625 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 m -142.27 74.1 1.44 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.495 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.81 142.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 109.56 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.3 ttt85 -123.7 84.3 53.73 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.599 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.72 -67.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.546 2.164 . . . . 0.0 110.218 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -139.78 144.0 37.09 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.923 . . . . 0.0 109.32 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.74 87.69 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.582 2.188 . . . . 0.0 110.273 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -160.6 77.74 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.552 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.441 ' O ' ' CB ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER -154.57 58.11 0.69 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 109.569 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 72.3 107.52 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 109.427 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -78.41 111.72 14.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 0.0 109.555 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -163.12 155.98 18.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 109.663 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.434 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 28.7 pt -132.22 -169.74 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 109.227 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 10.6 tttt 178.37 166.29 0.8 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.133 -0.979 . . . . 0.0 109.43 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.431 ' N ' ' CG ' ' A' ' 19' ' ' LYS . 93.8 t -144.12 116.51 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.872 . . . . 0.0 109.345 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -113.78 166.71 11.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.615 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.65 145.73 55.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.587 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.61 177.9 6.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.677 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.19 -37.52 61.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 109.414 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 p -76.04 123.71 26.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.506 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.59 130.33 41.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.577 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.61 114.76 28.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.242 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mmt -94.22 167.56 11.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.799 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.54 59.96 1.08 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.348 -0.845 . . . . 0.0 109.283 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 tt -122.67 102.08 7.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 109.419 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.57 165.08 5.38 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.18 90.34 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.674 2.249 . . . . 0.0 110.34 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.07 68.7 0.3 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.05 172.02 13.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -1.134 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.503 HG13 ' CZ ' ' A' ' 87' ' ' ARG . 12.9 m -120.44 128.43 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.0 109.218 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -149.93 166.87 28.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.554 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.56 133.27 45.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.204 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.453 ' O ' HG21 ' A' ' 83' ' ' VAL . . . -146.07 176.71 24.87 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.5 HG23 ' N ' ' A' ' 40' ' ' VAL . 2.9 mp -96.14 160.02 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -1.122 . . . . 0.0 108.581 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.5 ' N ' HG23 ' A' ' 39' ' ' ILE . 7.1 t -111.37 167.94 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.085 -1.009 . . . . 0.0 110.237 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.425 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 2.1 t80 -157.87 150.4 22.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.438 -0.789 . . . . 0.0 108.922 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -103.92 120.77 41.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.931 . . . . 0.0 109.704 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.29 168.47 9.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.275 -0.89 . . . . 0.0 109.471 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 8.5 t70 -87.92 6.45 35.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.771 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.53 -32.82 0.46 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.536 ' CG2' ' N ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -162.15 -152.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -1.179 . . . . 0.0 108.869 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.536 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.3 OUTLIER -107.04 164.43 12.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.738 -1.226 . . . . 0.0 109.157 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.07 147.64 49.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.083 -1.011 . . . . 0.0 110.219 -179.449 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.7 t -130.8 133.66 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -114.37 123.57 49.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.51 HD13 ' ND1' ' A' ' 57' ' ' HIS . 0.4 OUTLIER -86.11 67.69 10.05 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.174 -0.954 . . . . 0.0 109.242 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.63 147.28 1.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.701 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.24 -45.3 1.38 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.46 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -77.62 -17.03 58.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -1.152 . . . . 0.0 109.456 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.24 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.203 -0.936 . . . . 0.0 109.515 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.81 -23.96 7.66 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.51 ' ND1' HD13 ' A' ' 51' ' ' LEU . 1.6 t-160 -82.1 91.06 6.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.164 -1.198 . . . . 0.0 109.787 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.87 109.68 22.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.099 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.449 ' HA ' ' HB ' ' A' ' 96' ' ' VAL . 13.7 m -98.54 173.7 6.8 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.154 -0.966 . . . . 0.0 109.444 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 96' ' ' VAL . 1.8 pp -149.55 147.62 16.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.422 -0.798 . . . . 0.0 109.374 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.518 HD21 ' CD2' ' A' ' 64' ' ' TYR . 0.6 OUTLIER -98.13 102.48 14.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.298 -0.876 . . . . 0.0 109.183 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.457 ' HA ' HG12 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -123.3 -27.27 4.15 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.463 ' CB ' ' HB3' ' A' ' 99' ' ' ARG . 2.1 m-20 -85.86 -34.66 20.95 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.542 ' CD1' ' HG2' ' A' ' 100' ' ' ARG . 15.9 t80 -43.37 -43.65 5.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.553 -0.717 . . . . 0.0 109.106 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -65.74 -41.25 92.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.154 -0.966 . . . . 0.0 109.615 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 65' ' ' LEU . 50.5 t30 -43.24 146.49 0.45 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 109.401 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 48.65 70.97 0.4 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.301 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -101.02 87.45 3.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.242 -0.911 . . . . 0.0 109.541 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.74 -6.26 23.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.175 -0.953 . . . . 0.0 109.42 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.81 90.06 3.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.309 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.0 p -45.81 103.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 109.571 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.73 51.07 2.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.474 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.466 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 18.8 m-20 -100.04 -11.75 20.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.165 -0.959 . . . . 0.0 109.544 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -68.1 -40.99 82.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 109.505 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 74' ' ' ARG . 1.7 tt -44.54 -32.95 1.58 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.305 -0.872 . . . . 0.0 109.491 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 73' ' ' ASP . 6.7 mtmt -49.43 -63.78 1.0 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -51.47 -31.2 22.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.957 . . . . 0.0 109.506 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.86 -64.76 0.71 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.95 . . . . 0.0 109.476 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -174.58 54.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.401 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 0.9 OUTLIER -43.66 166.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.234 -0.916 . . . . 0.0 109.171 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.563 ' N ' ' CG2' ' A' ' 80' ' ' VAL . . . 88.78 -37.41 3.31 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 81' ' ' GLY . 1.5 mmt180 -43.62 172.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.633 -0.922 . . . . 0.0 110.153 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 38' ' ' GLY . 9.1 p -97.18 147.1 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.601 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.575 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -155.74 176.02 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.352 -0.843 . . . . 0.0 109.605 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.462 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -98.1 110.4 22.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.323 -0.861 . . . . 0.0 108.949 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 100' ' ' ARG . 82.4 p -110.35 165.45 11.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.044 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.541 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 6.2 mpt_? -98.56 140.79 32.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 108.65 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.573 ' HA ' ' HB3' ' A' ' 98' ' ' LEU . 58.9 t -94.25 139.16 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.469 -0.769 . . . . 0.0 109.299 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.507 ' CG2' ' HA ' ' A' ' 98' ' ' LEU . 91.1 t -121.97 -10.31 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.47 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.524 ' O ' ' CG1' ' A' ' 96' ' ' VAL . 0.0 OUTLIER 174.38 105.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.496 -1.377 . . . . 0.0 110.444 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.55 ' CA ' HG13 ' A' ' 96' ' ' VAL . . . -116.54 88.03 2.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.506 -0.746 . . . . 0.0 109.172 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -121.65 84.19 2.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.766 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.36 -137.76 14.14 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mp -102.28 4.38 39.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -1.141 . . . . 0.0 109.674 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -124.4 131.96 53.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 109.212 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.579 ' CG1' ' CD2' ' A' ' 98' ' ' LEU . 22.0 t -132.8 145.86 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.213 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.503 ' C ' ' CD2' ' A' ' 98' ' ' LEU . 2.0 m-20 -112.8 141.2 46.88 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.579 ' CD2' ' CG1' ' A' ' 96' ' ' VAL . 0.0 OUTLIER -165.2 178.91 6.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.592 -1.317 . . . . 0.0 112.041 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.515 ' HB3' ' N ' ' A' ' 64' ' ' TYR . 3.1 ptt-85 -134.89 104.05 5.84 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.082 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.542 ' HG2' ' CD1' ' A' ' 64' ' ' TYR . 1.2 ptt180 -51.91 159.44 0.85 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.915 -1.115 . . . . 0.0 109.518 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -158.66 131.44 7.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 109.453 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.462 ' CE2' ' HB2' ' A' ' 85' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.544 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tpp . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.438 ' O ' HD11 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -136.06 152.74 51.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 0.0 109.496 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.2 m -50.8 132.06 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.307 -0.871 . . . . 0.0 109.642 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.438 HD11 ' O ' ' A' ' 2' ' ' THR . 2.7 mp -125.02 85.3 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.499 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -133.37 147.28 64.27 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.552 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.87 -174.51 2.31 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.638 2.225 . . . . 0.0 110.224 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.0 t 179.88 -56.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 109.619 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 p -96.62 -31.58 12.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.62 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 mtm105 61.86 84.91 0.18 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.411 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 11' ' ' ARG . 35.5 Cg_endo -78.34 116.08 3.81 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.699 2.266 . . . . 0.0 110.353 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.528 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 4.9 ttt180 44.4 61.49 11.12 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.368 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 35.8 Cg_endo -78.11 162.49 28.77 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.654 2.236 . . . . 0.0 110.482 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -74.16 148.29 41.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.328 -0.858 . . . . 0.0 109.263 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -47.85 148.01 1.77 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.539 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -120.69 113.44 20.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 109.439 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.46 ' HD3' HD11 ' A' ' 18' ' ' ILE . 1.4 ttmm -82.65 178.51 8.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.318 -0.864 . . . . 0.0 109.512 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -152.3 33.62 0.52 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 109.407 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.46 HD11 ' HD3' ' A' ' 16' ' ' LYS . 23.0 pt -115.06 33.81 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.27 -0.894 . . . . 0.0 109.365 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -177.37 98.71 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.898 . . . . 0.0 109.589 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 20' ' ' VAL . 7.9 p -98.02 143.8 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 109.251 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.28 86.25 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.3 m -85.93 -59.85 2.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.249 -0.907 . . . . 0.0 109.464 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -52.73 173.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 109.387 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -148.22 144.09 27.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 0.0 109.555 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 m 54.23 88.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 109.464 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 t -135.17 40.42 2.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.316 -0.865 . . . . 0.0 109.457 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.26 109.94 19.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.437 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.9 mtt -76.06 122.56 24.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -0.936 . . . . 0.0 109.5 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.78 -0.3 4.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.701 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 59.38 102.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.172 -0.955 . . . . 0.0 109.341 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.89 150.25 37.23 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.619 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.12 175.15 11.19 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.734 2.289 . . . . 0.0 110.45 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.72 20.71 4.89 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.76 161.94 34.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -1.14 . . . . 0.0 109.386 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.551 ' O ' ' CG ' ' A' ' 36' ' ' HIS . 9.6 m -118.29 170.4 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.576 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 11.0 m-70 -172.55 168.16 5.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -99.17 147.31 25.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -158.75 175.67 35.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 49' ' ' VAL . 6.0 mt -98.04 151.25 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -1.11 . . . . 0.0 109.053 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.499 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 66.9 t -99.72 147.16 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.059 -1.026 . . . . 0.0 110.19 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.56 172.29 14.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.438 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.88 135.2 54.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.928 . . . . 0.0 109.545 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 44' ' ' ASP . 0.3 OUTLIER 175.07 154.09 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.62 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER 66.97 9.58 6.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.696 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.19 -15.75 47.5 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.444 HG13 ' N ' ' A' ' 47' ' ' PHE . 35.3 pt -112.03 -147.41 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -1.176 . . . . 0.0 109.103 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.543 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.0 m-85 -111.6 173.91 6.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.119 -0.988 . . . . 0.0 109.217 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 1.8 mttp -148.08 127.2 12.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.638 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 2.4 t -101.68 111.63 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.427 -0.796 . . . . 0.0 109.287 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.54 130.63 45.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.24 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -92.7 93.4 8.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.554 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.431 ' HG ' ' N ' ' A' ' 53' ' ' GLY . 1.5 tt -66.35 143.11 57.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.189 -0.945 . . . . 0.0 109.461 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.431 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . 110.81 -43.19 1.77 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 55' ' ' GLU . 14.7 m-85 -88.6 -27.31 21.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -1.151 . . . . 0.0 109.391 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 54' ' ' TYR . 38.3 tt0 61.71 123.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.269 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 58' ' ' GLU . . . 97.27 -39.24 2.83 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -59.86 88.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -1.13 . . . . 0.0 109.33 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 56' ' ' GLY . 32.0 tt0 -104.02 104.02 13.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.447 -0.783 . . . . 0.0 109.438 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 44.4 m -99.04 155.39 17.46 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 109.095 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.9 pt -118.55 136.44 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 109.229 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.543 ' HB3' ' CB ' ' A' ' 47' ' ' PHE . 14.8 tp -98.02 110.38 22.97 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.105 -0.997 . . . . 0.0 109.053 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.414 ' C ' HD21 ' A' ' 62' ' ' LEU . 7.5 tt -118.6 -38.02 3.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.474 -0.766 . . . . 0.0 109.381 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.546 ' CB ' ' HB2' ' A' ' 99' ' ' ARG . 2.7 t70 -61.9 -56.36 20.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 109.212 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.541 ' HB2' ' CB ' ' A' ' 100' ' ' ARG . 0.6 OUTLIER -118.43 54.7 0.93 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.639 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.452 ' HA ' ' HB2' ' A' ' 47' ' ' PHE . 1.9 pt? -64.11 -21.95 66.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.967 . . . . 0.0 109.383 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.414 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 45.9 p30 -166.94 -174.36 2.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.312 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.453 ' O ' ' O ' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -135.88 100.07 4.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.676 -179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 67' ' ' TYR . 1.5 mtm105 42.75 -164.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.347 -0.846 . . . . 0.0 109.645 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -154.73 -165.29 2.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 0.0 109.509 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 3.0 t0 176.13 -70.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.521 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 4.8 t -176.42 163.5 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.925 . . . . 0.0 109.374 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.515 ' CB ' ' O ' ' A' ' 71' ' ' THR . 0.3 OUTLIER 75.86 44.13 0.15 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.389 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -8.77 30.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.246 -0.909 . . . . 0.0 109.64 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -61.49 -39.19 90.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -0.96 . . . . 0.0 109.38 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.67 -26.76 66.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 109.266 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -64.76 -30.63 71.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.387 -0.821 . . . . 0.0 109.769 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -48.77 80.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 109.82 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -31.26 64.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.716 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -58.3 -50.97 71.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.177 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 79' ' ' LEU . 21.9 t -43.59 164.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.324 -0.86 . . . . 0.0 109.06 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 86.15 -47.5 3.77 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -38.95 159.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.641 -0.917 . . . . 0.0 110.008 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.427 ' C ' HG23 ' A' ' 84' ' ' ILE . 22.2 t -98.48 141.46 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 109.028 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.474 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -141.45 166.86 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.822 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -103.59 106.97 17.63 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.464 HG23 ' CB ' ' A' ' 100' ' ' ARG . 1.3 p -118.08 174.77 6.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.54 ' N ' ' CD ' ' A' ' 87' ' ' ARG . 2.5 mpt_? -98.93 162.96 12.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.871 . . . . 0.0 109.21 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.448 ' HA ' HD21 ' A' ' 98' ' ' LEU . 60.0 t -96.9 129.33 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.275 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.55 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 57.2 t -85.27 -34.1 8.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.401 -0.812 . . . . 0.0 109.742 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 162.85 113.69 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.301 -0.874 . . . . 0.0 109.215 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.472 ' HA ' HG11 ' A' ' 96' ' ' VAL . . . -98.45 151.48 20.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.583 -0.698 . . . . 0.0 109.437 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -127.0 -69.32 0.76 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 109.326 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -141.35 -75.31 0.04 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.4 mp -111.52 -25.23 9.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -1.115 . . . . 0.0 109.172 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -100.4 135.57 41.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.037 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.472 HG11 ' HA ' ' A' ' 91' ' ' ALA . 58.1 t -140.02 151.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.101 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.55 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 94.1 m-20 -98.49 155.57 17.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 108.624 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.472 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.39 139.25 35.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.821 -1.175 . . . . 0.0 110.831 -178.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.546 ' HB2' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -144.06 125.46 14.78 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.541 ' CB ' ' HB2' ' A' ' 64' ' ' TYR . 3.8 ttt-85 -87.75 170.62 11.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.486 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.464 ' O ' ' OXT' ' A' ' 102' ' ' PHE . 3.3 t80 -172.82 75.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.482 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.464 ' OXT' ' O ' ' A' ' 101' ' ' PHE . 3.2 m-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.551 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ptt? . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.0 m 53.08 42.52 32.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.375 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.4 t -92.55 103.02 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.89 . . . . 0.0 109.534 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 mt -98.31 -72.15 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.518 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -158.19 77.59 3.45 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.381 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.9 -161.83 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.644 2.229 . . . . 0.0 110.537 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.4 p -129.31 23.15 5.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.279 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.6 p -94.1 157.04 16.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.63 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -153.91 152.39 26.76 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.323 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.64 -24.25 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.643 2.229 . . . . 0.0 110.663 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.62 82.82 20.51 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.132 -0.98 . . . . 0.0 109.631 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.33 -33.26 1.97 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.714 2.276 . . . . 0.0 110.318 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 178.61 127.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.387 -0.821 . . . . 0.0 109.293 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -165.92 62.13 0.11 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 16' ' ' LYS . 88.0 m-20 -87.69 100.5 12.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.423 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 15' ' ' ASN . 0.9 OUTLIER 54.67 104.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.538 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.405 ' C ' ' OD1' ' A' ' 17' ' ' ASN . 20.3 t-20 -151.46 107.3 3.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.519 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 3.3 mt -52.85 152.95 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER 68.73 115.6 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 109.399 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.6 m -112.25 156.45 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 0.0 109.586 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.1 t30 51.1 -158.77 0.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.752 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -156.27 148.81 23.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.426 -0.796 . . . . 0.0 109.099 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' THR . 4.8 t80 61.41 119.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 0.0 109.003 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -115.23 166.52 11.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 109.645 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.96 1.37 45.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.357 -0.84 . . . . 0.0 109.596 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -86.28 154.84 20.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.449 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 26' ' ' SER . . . 61.28 140.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 109.432 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.52 153.1 21.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.473 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.21 0.16 57.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.568 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 tp -50.01 -70.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.498 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.03 74.54 0.9 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.424 -0.797 . . . . 0.0 109.455 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.38 118.96 4.4 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.656 2.237 . . . . 0.0 110.378 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 44.63 48.53 8.89 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.56 162.15 17.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.238 -1.154 . . . . 0.0 109.577 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 86' ' ' THR . 1.9 t -109.33 156.23 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.326 -0.858 . . . . 0.0 109.441 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.3 169.58 20.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.613 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 154.5 17.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.234 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -168.67 176.58 42.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.523 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 32.3 mt -97.1 148.29 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -1.142 . . . . 0.0 108.719 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.523 ' CG2' HG12 ' A' ' 84' ' ' ILE . 59.7 t -98.54 146.96 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.024 -1.048 . . . . 0.0 110.42 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.506 ' N ' HG12 ' A' ' 40' ' ' VAL . 1.5 t80 -139.77 150.42 44.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.386 -0.821 . . . . 0.0 109.153 179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -119.98 124.73 46.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.038 . . . . 0.0 109.671 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -163.21 144.71 9.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 59.86 13.82 3.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.393 -0.817 . . . . 0.0 109.833 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.41 -22.22 21.22 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 pt -91.06 -179.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -1.164 . . . . 0.0 109.178 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -109.45 167.75 9.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -143.13 131.92 22.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 109.442 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.6 t -106.96 116.72 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.52 127.68 44.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.314 -0.866 . . . . 0.0 109.313 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -96.13 70.56 2.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.052 -1.03 . . . . 0.0 109.567 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.443 ' HB2' HD13 ' A' ' 39' ' ' ILE . 0.2 OUTLIER -58.2 139.16 55.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.226 -0.921 . . . . 0.0 109.324 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.74 -17.52 15.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -110.28 -30.08 7.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -1.131 . . . . 0.0 109.266 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 2.7 mm-40 66.05 90.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 0.0 109.622 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.56 -11.05 10.44 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 1.3 t-160 -92.26 87.87 6.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -1.132 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -107.94 107.79 18.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.26 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.9 m -104.37 165.39 11.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.278 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 pt -129.24 134.11 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.335 -0.853 . . . . 0.0 108.932 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.517 ' CD1' HG21 ' A' ' 86' ' ' THR . 0.5 OUTLIER -97.93 120.56 38.55 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.99 -1.069 . . . . 0.0 109.19 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 63' ' ' ASP . 2.9 pp -155.47 -35.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.684 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' N ' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -49.93 -40.31 43.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.117 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.456 ' HB2' ' HG3' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -136.97 69.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.617 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.441 ' HG ' ' HA ' ' A' ' 62' ' ' LEU . 1.3 mp -59.0 -46.78 87.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.459 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 66.33 131.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.918 . . . . 0.0 109.548 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -130.16 136.72 49.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.43 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -108.97 31.09 5.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.0 109.488 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.474 ' HB2' ' O ' ' A' ' 68' ' ' ARG . 3.1 mp0 63.64 -92.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.703 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 69' ' ' GLN . 18.4 t0 70.22 137.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 109.338 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.6 t -65.52 88.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.595 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 67.14 8.3 6.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.641 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.65 37.81 15.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.406 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -52.41 57.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.473 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 mp -75.92 -34.09 59.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 109.438 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -63.87 -28.29 69.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.493 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 5.0 mm-40 -59.64 -46.12 89.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.194 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -26.58 55.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.345 -0.847 . . . . 0.0 109.452 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -63.96 -40.05 95.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 109.392 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.448 ' O ' ' O ' ' A' ' 79' ' ' LEU . 15.1 t -40.91 162.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.482 -0.761 . . . . 0.0 109.667 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.523 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 85.76 -47.42 3.79 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 81' ' ' GLY . 25.7 mmt180 -38.18 164.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.771 -0.84 . . . . 0.0 110.592 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 6.4 m -96.89 130.96 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 108.869 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.523 HG12 ' CG2' ' A' ' 40' ' ' VAL . 2.5 pp -135.67 174.64 12.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 109.74 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 144.26 33.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.044 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.529 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -152.38 173.62 14.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.903 . . . . 0.0 109.534 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.512 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 10.4 mpt_? -99.96 156.06 17.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.239 -0.913 . . . . 0.0 109.367 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.46 ' HA ' HD22 ' A' ' 98' ' ' LEU . 6.9 t -96.96 119.79 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.315 -0.865 . . . . 0.0 108.995 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.541 ' CG2' ' CB ' ' A' ' 99' ' ' ARG . 75.4 t -77.6 -31.22 17.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.374 -0.829 . . . . 0.0 109.928 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 1.6 ttm180 170.23 106.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.35 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.477 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . . . -88.12 133.82 33.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.416 -0.803 . . . . 0.0 109.172 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.66 88.31 0.34 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.67 -177.89 33.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.5 mp -58.9 -16.23 16.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -1.135 . . . . 0.0 109.662 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -108.52 127.96 54.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.644 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.477 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 55.4 t -129.6 158.97 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.852 . . . . 0.0 109.356 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.53 ' OD2' ' CG1' ' A' ' 89' ' ' VAL . 28.7 t0 -98.59 147.72 24.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.97 . . . . 0.0 108.742 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.529 ' CD1' ' HB ' ' A' ' 86' ' ' THR . 0.2 OUTLIER -132.76 135.51 45.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.04 -1.037 . . . . 0.0 111.088 -178.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.541 ' CB ' ' CG2' ' A' ' 89' ' ' VAL . 4.7 ttp-105 -132.63 129.41 38.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.436 ' HB2' ' CG2' ' A' ' 86' ' ' THR . 0.4 OUTLIER -100.77 149.31 23.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.021 -1.049 . . . . 0.0 109.732 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.4 ' N ' ' HG3' ' A' ' 100' ' ' ARG . 0.7 OUTLIER -142.89 147.66 35.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.342 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.441 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.18 39.24 1.43 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.924 . . . . 0.0 109.379 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p -79.89 135.35 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.385 -0.822 . . . . 0.0 109.352 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.509 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 65.2 mt -54.84 -36.8 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 109.27 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER 164.46 142.24 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.847 . . . . 0.0 109.257 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.78 -165.82 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.556 2.171 . . . . 0.0 110.479 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.6 m -125.85 48.29 2.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.403 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.1 59.05 0.83 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 0.0 109.522 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -63.73 160.66 43.03 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.94 140.55 18.27 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.691 2.261 . . . . 0.0 110.494 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.469 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -140.3 64.27 24.89 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.288 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 35.5 Cg_endo -77.45 134.6 14.07 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.735 2.29 . . . . 0.0 110.484 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -176.95 35.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.0 109.297 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 15' ' ' ASN . 1.1 ptmt -115.89 170.28 8.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.552 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 10.2 t30 170.78 138.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.05 -175.5 2.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.37 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.58 167.92 11.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 19' ' ' LYS . 1.8 mp -132.15 -86.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.349 -0.844 . . . . 0.0 109.286 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' N ' HG22 ' A' ' 18' ' ' ILE . 6.3 mttp -51.67 162.83 0.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.7 m -132.3 -149.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -132.22 120.57 22.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 0.0 109.383 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.73 52.26 1.78 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.399 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 57.94 41.43 24.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.36 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.01 -80.15 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.358 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.5 m -113.42 99.88 8.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.938 . . . . 0.0 109.327 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.6 p -143.57 81.51 1.7 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.958 . . . . 0.0 109.537 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.51 37.14 4.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.89 . . . . 0.0 109.295 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -87.63 124.05 33.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.581 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.422 ' CG ' ' O ' ' A' ' 28' ' ' MET . 6.1 m-20 -158.72 -74.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 109.414 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.419 HD21 HG13 ' A' ' 88' ' ' VAL . 0.2 OUTLIER -137.78 162.33 34.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.593 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.44 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -152.77 168.83 10.65 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.857 . . . . 0.0 109.354 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 31' ' ' SER . 35.1 Cg_endo -78.03 127.18 8.34 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.529 2.153 . . . . 0.0 110.411 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.52 83.04 1.0 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 t -168.74 150.56 4.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -1.161 . . . . 0.0 109.37 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.2 t -102.55 163.33 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.381 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -172.86 163.85 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.772 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -101.35 142.05 33.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.387 -0.821 . . . . 0.0 109.305 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.53 176.6 31.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 28.5 mt -97.31 154.58 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -1.21 . . . . 0.0 108.9 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.487 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 77.0 t -98.66 150.61 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 110.16 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.527 ' HB3' ' CB ' ' A' ' 48' ' ' LYS . 42.9 t80 -141.98 155.03 45.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.344 -0.847 . . . . 0.0 109.142 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 42' ' ' PHE . 28.3 p90 -106.64 124.7 50.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.95 . . . . 0.0 109.589 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.512 ' CG ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -98.51 -165.22 1.22 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.184 -0.948 . . . . 0.0 109.299 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -79.07 6.17 10.14 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.32 -0.862 . . . . 0.0 109.211 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.06 -26.62 0.08 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.449 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 3.0 pt -109.54 -174.56 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.0 -1.294 . . . . 0.0 109.687 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.427 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 5.6 m-85 -107.54 159.18 16.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -133.47 128.37 35.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.17 -0.956 . . . . 0.0 109.761 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.54 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 1.8 t -106.18 118.93 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 108.878 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.53 121.04 40.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 109.855 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.28 72.64 8.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.227 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.72 129.13 38.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.69 -33.99 4.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.43 -71.02 0.41 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -1.167 . . . . 0.0 109.531 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -178.31 55.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 109.556 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.42 7.79 48.01 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.75 118.06 2.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -1.189 . . . . 0.0 109.171 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 95' ' ' TYR . 7.4 tt0 -106.34 111.11 23.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.691 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.418 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 13.0 m -109.95 165.91 11.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.315 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 pt -133.95 135.53 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 109.49 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.54 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 3.9 tp -98.56 127.83 44.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 13.8 tp -143.98 -45.71 0.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.346 -0.847 . . . . 0.0 109.463 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.487 ' HB3' ' HG3' ' A' ' 99' ' ' ARG . 0.6 OUTLIER -53.0 -35.57 59.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 109.349 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.519 ' CB ' HD21 ' A' ' 61' ' ' LEU . 6.0 t80 -43.81 -68.25 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -0.895 . . . . 0.0 109.433 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 mp -54.13 -59.97 3.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.495 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.53 29.93 19.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 0.0 109.555 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.63 65.05 1.62 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.792 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.458 ' HG3' ' OE1' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -143.52 94.7 2.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.185 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.458 ' OE1' ' HG3' ' A' ' 68' ' ' ARG . 17.8 mp0 60.8 151.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.041 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.26 -58.72 2.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.687 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.71 96.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.168 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -43.48 98.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.556 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 51.62 77.04 0.15 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.655 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -44.74 -26.95 0.44 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.59 -49.56 39.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.892 . . . . 0.0 109.555 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.9 tptt -58.35 -26.68 63.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.728 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.448 ' O ' HG22 ' A' ' 80' ' ' VAL . 32.2 tt0 -54.62 -56.54 17.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 109.915 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.65 -26.74 57.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.139 -0.976 . . . . 0.0 110.044 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 80' ' ' VAL . 8.0 tp -65.82 -28.79 69.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.152 -0.967 . . . . 0.0 109.735 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 79' ' ' LEU . 43.2 t -43.23 165.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 0.0 109.434 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 85.67 -45.61 3.51 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 81' ' ' GLY . 2.8 mmt180 -43.15 172.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.647 -0.914 . . . . 0.0 110.382 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 56.0 t -97.57 139.22 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.267 -0.895 . . . . 0.0 109.222 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.506 ' C ' ' CD1' ' A' ' 84' ' ' ILE . 2.0 pp -136.75 166.64 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.433 ' O ' HG23 ' A' ' 86' ' ' THR . 15.6 ptpt -101.7 128.58 47.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 109.07 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.529 ' CB ' HD13 ' A' ' 98' ' ' LEU . 40.6 p -141.89 175.43 9.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.851 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.573 ' N ' ' CD ' ' A' ' 87' ' ' ARG . 3.8 mpt_? -101.48 161.59 13.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.486 -0.759 . . . . 0.0 109.426 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.463 ' HA ' HD22 ' A' ' 98' ' ' LEU . 5.2 t -97.75 110.39 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.338 -0.851 . . . . 0.0 109.003 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.545 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 41.1 t -65.62 -40.29 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 0.0 110.103 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.49 103.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 109.501 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.471 ' HA ' ' CG1' ' A' ' 96' ' ' VAL . . . -82.76 122.18 27.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.527 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 91' ' ' ALA . 0.4 OUTLIER -156.26 92.19 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.286 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.5 -177.33 33.26 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -15.77 41.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -1.155 . . . . 0.0 109.445 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.5 OUTLIER -107.35 125.81 51.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.191 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.471 ' CG1' ' HA ' ' A' ' 91' ' ' ALA . 74.2 t -122.79 160.86 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.888 . . . . 0.0 109.468 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.545 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 0.9 OUTLIER -97.91 148.01 23.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.109 -0.994 . . . . 0.0 108.576 179.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.529 HD13 ' CB ' ' A' ' 86' ' ' THR . 0.2 OUTLIER -133.01 135.56 45.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 110.677 -178.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.511 ' CB ' ' CG2' ' A' ' 89' ' ' VAL . 4.0 ttp85 -132.84 120.61 21.78 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.458 ' HG3' HG21 ' A' ' 86' ' ' THR . 0.2 OUTLIER -82.21 163.97 21.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -120.39 139.05 53.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 0.0 109.643 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.401 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.407 ' O ' ' HG2' ' A' ' 1' ' ' MET . 8.3 ttm . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.3 m -163.79 -50.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 109.647 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 p -162.48 127.8 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.927 . . . . 0.0 109.539 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.08 24.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.094 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -143.88 71.78 16.9 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.783 . . . . 0.0 109.427 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.12 -164.18 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.614 2.209 . . . . 0.0 110.393 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.7 t -110.07 79.97 1.26 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.175 -0.953 . . . . 0.0 109.789 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.0 m -115.96 -76.97 0.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.333 -0.854 . . . . 0.0 108.998 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.19 80.99 0.27 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.457 -0.777 . . . . 0.0 110.159 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -79.0 -176.46 3.3 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.607 2.205 . . . . 0.0 109.837 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -130.61 76.64 77.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.035 -1.041 . . . . 0.0 109.745 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.91 -20.49 10.24 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.694 2.263 . . . . 0.0 110.231 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.17 83.12 8.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -0.864 . . . . 0.0 109.55 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 57.63 3.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 109.476 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.45 48.68 1.64 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.9 . . . . 0.0 109.524 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.94 100.27 11.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -153.55 -57.32 0.12 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.604 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 tt -112.22 161.56 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.642 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -151.26 130.52 12.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.951 . . . . 0.0 109.366 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.12 110.57 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 109.611 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -150.01 138.67 20.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.859 . . . . 0.0 109.23 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.23 106.62 0.64 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.91 129.89 44.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 108.983 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 34.2 mtt85 -99.54 -1.68 37.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.172 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.467 ' O ' ' HB3' ' A' ' 26' ' ' SER . 7.3 m -86.83 51.87 2.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.052 -1.03 . . . . 0.0 109.54 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 25' ' ' THR . 93.7 p 178.21 166.02 0.76 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.645 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 64.95 38.95 6.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.813 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.1 ttp -90.67 -28.72 18.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.192 -0.943 . . . . 0.0 109.507 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.2 -157.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.514 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.47 -177.4 1.47 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.283 -0.886 . . . . 0.0 109.222 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -155.3 151.07 21.84 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.045 -1.035 . . . . 0.0 109.643 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.08 150.95 26.72 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.657 2.238 . . . . 0.0 110.394 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.12 48.61 4.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.89 129.59 52.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -1.178 . . . . 0.0 109.515 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.51 HG11 ' CD ' ' A' ' 87' ' ' ARG . 16.5 m -99.56 136.65 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 35' ' ' VAL . 5.7 m-70 -147.7 166.74 26.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.449 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.05 152.01 21.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -163.89 176.41 39.93 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.532 HG23 ' N ' ' A' ' 40' ' ' VAL . 76.6 mt -96.83 146.72 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -1.097 . . . . 0.0 108.356 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.532 ' N ' HG23 ' A' ' 39' ' ' ILE . 57.2 t -99.46 137.67 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.963 -1.086 . . . . 0.0 110.591 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.412 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 2.9 t80 -122.46 154.57 37.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 109.043 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.502 ' O ' ' CG ' ' A' ' 42' ' ' PHE . 12.8 p90 -112.69 124.42 52.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.948 . . . . 0.0 109.641 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -178.55 137.2 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.93 . . . . 0.0 109.694 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 43' ' ' LYS . 26.5 t0 76.06 6.26 3.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 109.692 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.65 -26.99 9.28 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.0 pt -92.83 -156.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.345 -1.091 . . . . 0.0 108.923 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.531 ' HB2' ' CD2' ' A' ' 61' ' ' LEU . 76.1 m-85 -127.05 171.99 10.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.959 -1.088 . . . . 0.0 109.43 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HE3' HG23 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -136.79 125.4 23.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.251 -0.906 . . . . 0.0 109.669 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.9 t -98.07 105.81 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.115 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.483 ' CG ' ' HB ' ' A' ' 39' ' ' ILE . 2.3 ptm85 -101.34 128.9 47.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.7 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.26 85.54 7.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 109.364 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.84 149.07 45.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.212 -0.93 . . . . 0.0 109.538 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.48 -55.18 0.84 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -75.06 -27.8 60.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -1.151 . . . . 0.0 109.515 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 54' ' ' TYR . 20.3 mt-10 48.87 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.35 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.88 -17.76 3.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.7 92.86 5.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -1.182 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.65 109.06 20.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.339 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.5 m -107.05 145.65 32.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.908 . . . . 0.0 109.512 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.471 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 30.0 pt -99.56 135.95 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.337 -0.852 . . . . 0.0 109.0 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.531 ' CD2' ' HB2' ' A' ' 47' ' ' PHE . 25.2 tp -98.61 107.89 20.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 110.183 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . 3.4 mt -103.29 4.81 36.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.506 -0.746 . . . . 0.0 109.069 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 0.5 OUTLIER 58.23 36.61 25.84 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 6.6 t80 67.78 28.57 7.11 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.381 -0.825 . . . . 0.0 109.103 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.423 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -44.72 -72.14 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.565 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 57.62 -92.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.975 . . . . 0.0 109.567 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -153.95 28.81 0.47 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.922 . . . . 0.0 109.757 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -128.88 161.72 29.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.103 -0.998 . . . . 0.0 109.54 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -74.16 161.69 29.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.305 -0.872 . . . . 0.0 109.731 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 48.3 p-10 -156.35 154.31 30.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.376 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.9 m -139.97 98.6 3.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.543 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -159.44 27.64 0.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.33 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -74.49 -17.39 60.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 109.316 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -51.53 -36.05 43.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.34 -0.85 . . . . 0.0 109.418 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -46.1 -45.5 16.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.612 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.23 -66.46 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 109.783 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -57.83 -30.55 65.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.869 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.44 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -55.18 -56.8 15.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.586 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER 173.21 60.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 109.39 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.557 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 1.0 OUTLIER -43.04 165.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.393 -0.817 . . . . 0.0 109.31 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.557 ' N ' ' CG2' ' A' ' 80' ' ' VAL . . . 86.5 -47.45 3.74 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -36.97 161.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.966 -0.726 . . . . 0.0 110.69 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 99.5 t -97.14 136.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.281 -0.887 . . . . 0.0 108.967 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.521 ' CD1' HG22 ' A' ' 86' ' ' THR . 2.3 pp -138.96 174.93 8.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.334 -0.854 . . . . 0.0 109.883 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.462 ' O ' HG23 ' A' ' 86' ' ' THR . 0.0 OUTLIER -107.47 141.22 39.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.372 -0.83 . . . . 0.0 109.198 179.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.521 HG22 ' CD1' ' A' ' 84' ' ' ILE . 19.0 p -151.37 175.26 12.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.192 -0.943 . . . . 0.0 109.315 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.52 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 1.2 mmm-85 -98.68 158.03 15.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.265 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.469 ' HA ' HD21 ' A' ' 98' ' ' LEU . 5.6 t -98.28 110.1 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.554 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 26.9 t -63.08 -36.23 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.7 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.443 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER 168.97 106.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.237 -0.914 . . . . 0.0 109.362 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.498 ' HA ' ' CG1' ' A' ' 96' ' ' VAL . . . -91.96 117.27 29.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.424 -0.797 . . . . 0.0 109.235 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -103.4 -62.74 1.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.645 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -146.09 -115.79 0.95 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.04 -23.97 60.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -1.106 . . . . 0.0 109.466 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.53 129.19 55.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.122 -0.986 . . . . 0.0 109.529 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.498 ' CG1' ' HA ' ' A' ' 91' ' ' ALA . 95.0 t -131.41 158.34 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.856 . . . . 0.0 109.472 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.554 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 9.5 m-20 -101.04 143.39 31.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.0 108.625 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -130.14 136.91 49.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.904 -1.122 . . . . 0.0 110.659 -178.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.542 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 1.0 OUTLIER -126.35 119.63 27.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 108.89 178.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.31 129.36 36.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.05 . . . . 0.0 109.695 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 101' ' ' PHE . 6.5 m-30 61.43 166.47 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.854 . . . . 0.0 109.636 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.9 t80 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.486 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 77.5 p -137.6 18.67 2.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.442 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.3 -45.93 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.87 . . . . 0.0 109.43 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.7 tt -141.4 143.84 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.94 . . . . 0.0 109.444 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.3 153.28 48.54 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.514 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.26 -64.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.677 2.251 . . . . 0.0 110.252 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.82 -151.02 0.37 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.291 -0.881 . . . . 0.0 109.376 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.8 m -142.1 147.55 36.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.228 -0.92 . . . . 0.0 109.431 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.558 ' N ' ' CD ' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -66.41 -52.03 39.07 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.876 . . . . 0.0 109.916 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.558 ' CD ' ' N ' ' A' ' 9' ' ' ARG . 35.4 Cg_endo -78.53 109.65 2.68 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.43 2.087 . . . . 0.0 110.831 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 62.31 91.66 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.957 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.52 -176.55 3.33 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.531 2.154 . . . . 0.0 110.283 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.44 53.52 0.26 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.456 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -46.79 -49.09 20.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -136.73 177.13 8.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -91.86 -8.6 46.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.491 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -156.09 123.17 5.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.489 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 19' ' ' LYS . 2.8 mt -101.84 -34.92 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.211 -0.93 . . . . 0.0 109.49 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -46.18 169.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.542 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.434 ' O ' ' CG2' ' A' ' 20' ' ' VAL . 3.6 p -127.08 -2.79 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.498 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -108.41 135.19 50.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -0.908 . . . . 0.0 109.519 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.0 t -69.86 165.89 20.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.395 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -62.35 99.85 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.409 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.402 ' HG2' ' N ' ' A' ' 25' ' ' THR . 34.7 ttm180 -74.34 -78.69 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.329 -0.857 . . . . 0.0 109.502 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.402 ' N ' ' HG2' ' A' ' 24' ' ' ARG . 71.5 m -132.89 -64.51 0.74 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.147 -0.97 . . . . 0.0 109.516 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 27' ' ' ALA . 8.0 p -144.83 -41.76 0.24 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.531 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 26' ' ' SER . . . 46.77 95.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.341 -0.849 . . . . 0.0 109.531 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.1 mmm 62.57 91.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.515 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -155.45 19.53 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.6 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.1 tp -70.11 88.44 0.6 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.515 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.531 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -81.25 176.57 3.69 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.369 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 31' ' ' SER . 35.7 Cg_endo -78.24 170.21 18.98 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.555 2.17 . . . . 0.0 110.506 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.09 91.88 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -163.95 169.62 17.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -1.133 . . . . 0.0 109.516 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.504 HG12 ' CD ' ' A' ' 87' ' ' ARG . 17.9 m -119.04 143.55 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.13 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.532 ' CD2' ' N ' ' A' ' 36' ' ' HIS . 1.9 p80 -165.35 166.8 18.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.006 -1.059 . . . . 0.0 109.956 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.499 ' HG2' ' CG1' ' A' ' 83' ' ' VAL . 1.7 tt0 -98.8 145.28 27.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 108.907 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.448 ' O ' HG12 ' A' ' 83' ' ' VAL . . . -151.64 176.16 30.15 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.046 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 40' ' ' VAL . 22.0 mt -97.09 150.56 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.515 -0.991 . . . . 0.0 108.544 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.485 ' N ' HG23 ' A' ' 39' ' ' ILE . 10.6 t -98.16 142.89 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 0.0 110.095 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.472 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 39.6 t80 -141.48 153.25 44.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.385 -0.822 . . . . 0.0 109.104 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.433 ' CD1' ' C ' ' A' ' 42' ' ' PHE . 21.8 t80 -98.92 121.97 41.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.644 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.26 163.03 15.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.848 . . . . 0.0 109.408 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 14.3 t0 -70.22 -8.46 50.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 109.627 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.67 -62.99 0.89 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.539 ' CG2' ' N ' ' A' ' 47' ' ' PHE . 2.2 mp -155.57 -94.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -1.136 . . . . 0.0 109.038 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.539 ' N ' ' CG2' ' A' ' 46' ' ' ILE . 0.8 OUTLIER -127.37 162.03 27.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.031 -1.043 . . . . 0.0 109.342 179.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 0.5 OUTLIER -138.52 125.43 21.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -101.93 118.81 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 109.329 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -98.78 127.87 44.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.953 . . . . 0.0 109.527 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.444 HD22 ' SG ' ' A' ' 59' ' ' CYS . 1.7 mm? -93.83 69.18 3.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 0.0 109.421 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.421 ' HB3' HD11 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -65.03 128.82 37.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.908 . . . . 0.0 109.419 -179.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.47 -30.27 9.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.452 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 1.1 t80 -99.69 51.07 0.92 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.325 -1.103 . . . . 0.0 109.279 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 72.64 -159.54 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 109.455 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' HIS . . . -82.62 11.81 50.22 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -42.72 108.69 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.329 -1.1 . . . . 0.0 109.772 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -115.15 109.83 18.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.275 -0.891 . . . . 0.0 109.407 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.444 ' SG ' HD22 ' A' ' 51' ' ' LEU . 31.0 m -102.0 156.29 17.63 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.22 -0.925 . . . . 0.0 109.666 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.468 HG23 ' CG ' ' A' ' 48' ' ' LYS . 2.1 pt -125.43 135.54 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.47 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -97.71 128.9 44.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.888 -1.133 . . . . 0.0 109.679 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.523 ' HG ' ' CD1' ' A' ' 46' ' ' ILE . 1.8 tt -164.86 -35.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.571 -0.706 . . . . 0.0 109.482 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.46 ' OD1' HG22 ' A' ' 89' ' ' VAL . 7.7 m-20 -50.37 -49.19 54.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.239 -0.913 . . . . 0.0 109.286 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.574 ' CD2' ' HG3' ' A' ' 100' ' ' ARG . 3.5 t80 -87.04 40.89 0.94 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.698 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 64' ' ' TYR . 1.2 tt -46.0 -38.04 7.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 0.0 109.152 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 36.5 t30 65.72 127.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.494 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -71.64 176.88 4.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.705 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.74 149.81 1.63 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.29 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -50.27 2.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.517 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.43 ' C ' HG23 ' A' ' 71' ' ' THR . 0.3 OUTLIER -75.94 179.56 5.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.937 . . . . 0.0 109.473 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.43 HG23 ' C ' ' A' ' 70' ' ' ASP . 70.4 p -136.13 65.06 1.54 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.867 . . . . 0.0 109.318 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.08 56.43 0.71 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.562 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 0.8 OUTLIER -107.65 38.84 2.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.376 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -39.87 45.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 0.0 109.668 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.32 -34.44 76.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -0.819 . . . . 0.0 109.831 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.467 ' O ' HG22 ' A' ' 80' ' ' VAL . 3.0 mttp -66.95 -28.45 68.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.963 . . . . 0.0 109.676 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.469 ' O ' HG21 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -58.37 -46.49 86.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 109.26 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -29.92 59.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.299 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 80' ' ' VAL . 5.4 tt -66.96 -26.84 67.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.345 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 81' ' ' GLY . 44.9 t -41.07 163.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.458 -0.776 . . . . 0.0 109.562 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.501 ' N ' HG13 ' A' ' 80' ' ' VAL . . . 85.47 -51.76 4.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.453 ' HB3' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -41.3 161.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -1.072 . . . . 0.0 110.011 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.499 ' CG1' ' HG2' ' A' ' 37' ' ' GLU . 52.9 t -98.75 140.5 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.024 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.516 HD11 ' N ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -139.65 175.28 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.735 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' O ' HG23 ' A' ' 86' ' ' THR . 2.1 mtpt -99.45 127.52 45.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.46 -0.775 . . . . 0.0 109.263 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 85' ' ' LYS . 69.6 p -139.25 173.61 11.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.134 -0.979 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.504 ' CD ' HG12 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -105.21 161.02 14.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.447 ' CG2' ' NE2' ' A' ' 36' ' ' HIS . 59.1 t -97.31 115.03 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.411 -0.806 . . . . 0.0 108.871 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.549 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 54.8 t -74.41 -39.05 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.468 -0.77 . . . . 0.0 110.259 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.428 ' O ' HG11 ' A' ' 96' ' ' VAL . 1.0 OUTLIER 179.25 101.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.972 -1.08 . . . . 0.0 110.031 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.528 ' HA ' ' CG2' ' A' ' 96' ' ' VAL . . . -90.02 122.54 33.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.69 -4.19 12.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 109.953 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 154.16 -113.4 0.57 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.89 -41.13 44.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 0.0 109.579 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -99.49 126.33 45.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.349 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 91' ' ' ALA . 89.1 t -128.78 162.88 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.719 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.549 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 1.2 m-20 -98.51 154.4 17.92 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.504 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -137.74 136.51 37.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.884 -1.135 . . . . 0.0 111.119 -178.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.536 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 0.4 OUTLIER -132.12 108.4 9.26 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.165 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.574 ' HG3' ' CD2' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -71.61 169.75 14.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.94 . . . . 0.0 109.413 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.451 ' O ' ' O ' ' A' ' 102' ' ' PHE . 24.1 t80 -145.96 98.96 3.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.675 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.451 ' O ' ' O ' ' A' ' 101' ' ' PHE . 7.4 m-85 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.631 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.254 0.549 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.43 135.13 45.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 109.253 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.07 147.45 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 109.839 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.518 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 12.7 tt -135.32 98.24 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -0.906 . . . . 0.0 109.097 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.449 ' HG2' ' HD2' ' A' ' 6' ' ' PRO . 2.3 tttt -104.43 141.02 21.67 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 109.867 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.449 ' HD2' ' HG2' ' A' ' 5' ' ' LYS . 36.5 Cg_endo -80.38 -48.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.594 2.196 . . . . 0.0 110.167 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 6' ' ' PRO . 9.4 p 168.9 136.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.21 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -170.88 106.4 0.27 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.073 -1.017 . . . . 0.0 109.812 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 8' ' ' SER . 0.0 OUTLIER 53.98 104.26 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.696 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.97 -162.72 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.418 2.079 . . . . 0.0 110.252 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.08 164.77 7.41 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.191 -0.943 . . . . 0.0 109.468 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.87 117.39 4.2 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.616 2.211 . . . . 0.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.93 -179.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 109.382 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.14 50.85 1.43 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -0.944 . . . . 0.0 109.573 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -110.98 147.86 33.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.301 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -107.92 -93.67 0.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.636 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -52.67 106.2 0.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.0 mt -52.06 119.88 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.941 . . . . 0.0 109.488 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -123.37 25.67 8.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.443 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.409 ' O ' HG23 ' A' ' 20' ' ' VAL . 24.4 m -128.38 106.62 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 22' ' ' THR . 4.1 m120 -61.65 -73.05 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 0.0 109.656 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.402 ' C ' ' O ' ' A' ' 21' ' ' ASN . 73.3 m 45.73 72.21 0.23 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.115 -0.991 . . . . 0.0 109.409 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -117.65 8.07 12.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.61 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.76 67.89 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 109.637 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' SER . 26.2 p -130.25 106.53 8.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.229 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER 44.43 70.16 0.36 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.311 -0.868 . . . . 0.0 109.168 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.95 14.33 7.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.683 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -131.2 149.3 52.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 109.432 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -166.76 65.93 0.09 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.559 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -111.29 128.63 56.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.394 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.43 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -121.29 164.24 25.32 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.388 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 31' ' ' SER . 35.1 Cg_endo -76.86 114.0 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.643 2.229 . . . . 0.0 110.557 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.26 55.76 3.4 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -113.12 162.98 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -1.166 . . . . 0.0 109.389 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 86' ' ' THR . 2.9 m -107.55 149.09 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.465 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.12 168.49 13.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.836 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -99.56 143.65 29.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.317 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -154.02 176.52 31.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 81' ' ' GLY . 8.8 mt -97.08 152.63 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -1.148 . . . . 0.0 108.685 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.47 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 88.6 t -105.92 149.94 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.102 -0.999 . . . . 0.0 110.607 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -148.42 175.42 11.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.475 -0.765 . . . . 0.0 109.009 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.566 ' CZ ' ' HA2' ' A' ' 45' ' ' GLY . 58.7 t80 -123.02 124.66 43.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.153 -0.967 . . . . 0.0 109.35 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 44' ' ' ASP . 1.6 mttm -159.93 145.55 15.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.748 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 0.8 OUTLIER 61.28 12.93 4.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.323 -0.861 . . . . 0.0 109.741 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.566 ' HA2' ' CZ ' ' A' ' 42' ' ' PHE . . . 86.57 -18.71 32.43 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.52 ' CG2' HD22 ' A' ' 62' ' ' LEU . 12.3 pt -95.33 -153.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.135 -1.215 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.465 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 1.8 m-85 -110.64 164.69 12.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.301 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -135.55 119.72 17.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.643 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 2.7 t -103.9 108.86 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.271 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 135.64 39.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.41 107.72 19.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.1 tp -81.27 148.55 29.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.599 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.4 -21.93 32.65 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -99.31 -30.14 12.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -1.165 . . . . 0.0 109.58 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 54' ' ' TYR . 4.8 mt-10 60.93 149.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.513 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.41 40.71 78.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.76 86.61 2.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.121 -1.223 . . . . 0.0 109.48 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.72 120.31 41.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.325 -0.859 . . . . 0.0 109.556 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.2 m -117.15 170.94 8.28 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.368 -0.832 . . . . 0.0 109.204 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.3 pp -134.47 133.07 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 0.0 109.303 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.52 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 0.7 OUTLIER -98.19 131.14 44.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.078 -1.014 . . . . 0.0 109.386 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.52 HD22 ' CG2' ' A' ' 46' ' ' ILE . 25.3 tp -175.69 -32.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.489 -0.757 . . . . 0.0 109.413 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.459 ' OD2' HG22 ' A' ' 89' ' ' VAL . 29.2 t0 -50.1 -46.74 53.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 109.239 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.465 ' HB2' ' N ' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -119.45 45.73 2.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.488 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 7.5 tp -75.6 -51.83 11.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 109.666 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER 62.16 160.11 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.497 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.402 ' CB ' ' O ' ' A' ' 66' ' ' ASN . 3.9 t80 67.87 43.6 1.7 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.096 -1.002 . . . . 0.0 109.235 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.416 ' C ' ' HG2' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -94.61 127.7 40.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 109.603 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.416 ' HG2' ' C ' ' A' ' 68' ' ' ARG . 0.4 OUTLIER 176.27 179.79 0.18 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.481 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -88.47 93.89 9.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.839 . . . . 0.0 109.566 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -132.74 126.49 32.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 109.479 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 71' ' ' THR . 0.7 OUTLIER -44.64 -40.04 5.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.504 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 48.92 70.85 0.42 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.589 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.07 -36.08 56.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.222 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mt -73.12 -39.76 65.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.386 -0.822 . . . . 0.0 109.497 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.462 ' O ' HG21 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -52.71 -26.44 13.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.79 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.13 -42.09 99.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 109.87 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.44 -29.27 52.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.98 . . . . 0.0 110.098 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.456 ' O ' ' C ' ' A' ' 80' ' ' VAL . 82.6 mt -66.35 -50.85 62.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.114 -0.991 . . . . 0.0 109.745 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 76' ' ' LYS . 11.7 t -40.29 159.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.492 -0.755 . . . . 0.0 109.768 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 85.9 -53.47 4.67 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 81' ' ' GLY . 31.0 mtt85 -39.17 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.959 . . . . 0.0 110.357 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.46 ' O ' HG21 ' A' ' 84' ' ' ILE . 66.4 t -98.47 140.46 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.524 HD11 ' N ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -146.64 174.83 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 110.157 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.517 ' O ' ' CG2' ' A' ' 86' ' ' THR . 1.5 tmmm? -100.23 147.06 26.15 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' A' ' 85' ' ' LYS . 67.1 p -158.51 174.22 15.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.963 . . . . 0.0 109.372 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.498 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 20.8 mmm-85 -103.52 162.45 13.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.484 ' HA ' HD21 ' A' ' 98' ' ' LEU . 14.2 t -96.71 122.48 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.314 -0.867 . . . . 0.0 109.269 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.535 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 42.0 t -81.2 -41.1 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.445 -0.785 . . . . 0.0 109.929 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 178.59 101.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.062 -1.024 . . . . 0.0 109.749 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.524 ' HA ' ' CG1' ' A' ' 96' ' ' VAL . . . -71.99 135.06 46.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.567 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -128.42 32.85 4.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.387 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.58 -107.86 3.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.455 ' N ' HD11 ' A' ' 94' ' ' LEU . 6.1 mp -79.52 -34.51 41.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -1.176 . . . . 0.0 109.311 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -102.01 131.76 48.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.887 . . . . 0.0 109.108 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 91' ' ' ALA . 94.2 t -137.45 155.57 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.04 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.535 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 6.0 m-20 -99.32 156.73 16.85 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.498 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.91 140.51 34.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.083 -1.011 . . . . 0.0 110.234 -179.219 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.524 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -125.16 120.4 31.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.27 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.465 ' N ' ' HB2' ' A' ' 64' ' ' TYR . 25.3 ttt-85 -63.51 168.28 4.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.394 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.473 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 16.7 t80 -112.49 134.52 53.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.473 ' CD2' ' CE2' ' A' ' 101' ' ' PHE . 11.9 m-85 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.494 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 2' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 44.37 67.74 0.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.915 . . . . 0.0 109.452 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.2 m -81.46 169.92 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 109.47 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.486 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 23.6 mm -111.32 66.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.36 79.8 28.61 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.454 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.95 -161.95 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.654 2.236 . . . . 0.0 110.476 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.0 m -155.24 94.13 1.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.892 . . . . 0.0 109.356 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.31 42.94 1.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 109.656 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.78 154.5 5.36 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.57 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.93 83.87 2.11 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.685 2.256 . . . . 0.0 110.303 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.33 81.63 20.35 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.509 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.83 136.08 14.76 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.647 2.231 . . . . 0.0 110.454 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.47 79.64 1.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.492 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 175.44 56.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.498 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 2.9 m120 -86.53 15.22 5.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.476 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER 61.84 39.2 14.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.897 . . . . 0.0 109.549 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -80.52 75.1 7.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.897 . . . . 0.0 109.44 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.402 ' CG2' ' HB2' ' A' ' 21' ' ' ASN . 7.3 mt -135.95 84.97 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.29 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -77.18 -16.56 59.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.731 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 t -108.96 56.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 109.635 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.461 ' O ' ' CB ' ' A' ' 22' ' ' THR . 2.3 t30 -124.52 -166.7 1.55 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.348 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER 72.67 146.17 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.243 -0.911 . . . . 0.0 109.446 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.93 -66.58 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.948 . . . . 0.0 109.329 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -93.43 144.57 25.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.876 . . . . 0.0 109.288 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 t -76.63 144.46 39.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.915 . . . . 0.0 109.778 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.19 147.99 25.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.355 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.12 43.08 1.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.098 -1.001 . . . . 0.0 109.67 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.77 -167.73 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.577 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -92.58 49.48 1.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 65.67 129.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.418 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.6 p -80.38 143.9 56.63 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.393 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.3 122.86 5.81 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.564 2.176 . . . . 0.0 110.408 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.44 28.71 2.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 m -106.69 165.14 11.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -1.12 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.414 HG12 ' CZ ' ' A' ' 87' ' ' ARG . 3.7 m -108.26 140.3 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -156.18 167.99 28.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.651 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -101.0 143.28 31.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 109.348 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.41 ' O ' HG12 ' A' ' 83' ' ' VAL . . . -153.77 175.61 32.02 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.527 HG23 ' N ' ' A' ' 40' ' ' VAL . 4.3 mp -97.97 153.61 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -1.086 . . . . 0.0 108.756 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.527 ' N ' HG23 ' A' ' 39' ' ' ILE . 67.8 t -104.36 146.1 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.009 -1.057 . . . . 0.0 110.343 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.51 ' N ' HG13 ' A' ' 40' ' ' VAL . 3.2 t80 -146.98 -173.47 4.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 108.903 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -135.01 146.78 49.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.0 . . . . 0.0 109.522 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.99 140.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.265 -0.897 . . . . 0.0 110.076 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.7 17.66 4.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 110.116 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.29 -33.68 4.02 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.448 ' CG2' ' CD1' ' A' ' 62' ' ' LEU . 21.2 pt -78.26 -153.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -1.185 . . . . 0.0 109.254 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.531 ' CD1' ' CD1' ' A' ' 65' ' ' LEU . 2.4 m-85 -119.84 161.06 21.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.109 -0.994 . . . . 0.0 109.636 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 1.8 tttp -130.95 120.56 23.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.288 -0.882 . . . . 0.0 109.556 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.511 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 7.4 t -100.82 126.85 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.181 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.23 139.66 39.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 0.0 109.774 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.413 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.9 OUTLIER -103.02 73.23 1.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.399 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.423 ' HB2' HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -54.01 168.67 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.426 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.41 -36.65 3.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.539 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 5.5 t80 -98.01 -26.69 14.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -1.104 . . . . 0.0 109.305 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 54.77 26.31 7.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.493 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.33 25.92 0.3 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.539 ' CE1' ' CD2' ' A' ' 54' ' ' TYR . 23.0 m170 -131.12 98.94 4.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -1.102 . . . . 0.0 109.609 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -103.37 107.41 18.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.135 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.459 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 5.1 m -107.72 158.81 16.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.276 -0.89 . . . . 0.0 109.62 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 pt -127.73 137.74 56.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.45 -0.781 . . . . 0.0 108.959 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.511 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 4.3 tp -98.68 131.56 44.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.156 -0.965 . . . . 0.0 109.915 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.448 ' CD1' ' CG2' ' A' ' 46' ' ' ILE . 0.5 OUTLIER -166.75 -36.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.597 -0.689 . . . . 0.0 109.159 179.76 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.404 ' HB2' HG21 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -49.03 -52.17 26.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.865 . . . . 0.0 109.049 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.476 ' CB ' ' O ' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -119.46 42.8 2.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.531 ' CD1' ' CD1' ' A' ' 47' ' ' PHE . 3.1 tp -55.62 -83.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -0.862 . . . . 0.0 109.369 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 51.0 p-10 -179.03 -150.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -103.79 156.59 17.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.33 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -85.13 46.18 1.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.615 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -53.05 142.85 18.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.26 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.98 78.19 9.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.066 -1.021 . . . . 0.0 109.673 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 m -159.68 122.26 3.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.343 -0.848 . . . . 0.0 109.257 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -32.74 69.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.408 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.46 80.55 0.15 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.242 -0.911 . . . . 0.0 109.344 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.14 -36.91 80.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.686 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 tp -54.73 -48.09 72.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.172 -0.955 . . . . 0.0 109.579 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.452 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -61.91 -26.81 68.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 109.4 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -55.4 -49.78 71.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -0.857 . . . . 0.0 109.457 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -77.35 -29.58 53.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.706 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -63.55 -29.99 71.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 109.693 -179.675 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 76' ' ' LYS . 57.3 t -44.22 165.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.146 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 85.18 -45.23 3.48 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.468 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -35.59 149.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.741 -0.858 . . . . 0.0 110.359 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.436 ' C ' HG23 ' A' ' 84' ' ' ILE . 65.1 t -98.81 142.69 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.465 -0.772 . . . . 0.0 109.523 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.56 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -149.22 170.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.602 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.22 112.46 24.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.134 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.476 ' OG1' ' CD1' ' A' ' 98' ' ' LEU . 74.1 p -116.58 175.17 5.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.635 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.519 ' O ' ' CD1' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -102.19 161.53 13.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.505 ' HA ' HD23 ' A' ' 98' ' ' LEU . 67.6 t -96.85 124.67 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 108.985 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.544 ' CG2' ' HB3' ' A' ' 99' ' ' ARG . 96.4 t -85.28 -38.17 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.294 -0.879 . . . . 0.0 110.159 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.7 OUTLIER 176.9 103.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.135 -0.978 . . . . 0.0 109.637 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.464 ' HB1' HG12 ' A' ' 96' ' ' VAL . . . -99.35 123.7 43.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.377 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -115.43 -23.68 8.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 0.0 109.647 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.91 -137.7 2.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mp -57.12 -32.84 66.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -1.119 . . . . 0.0 109.627 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -99.03 131.51 45.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.464 HG12 ' HB1' ' A' ' 91' ' ' ALA . 78.3 t -135.64 158.61 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.056 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 98' ' ' LEU . 9.4 t0 -99.43 152.3 20.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 108.716 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -139.98 140.42 36.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 111.076 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.544 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 0.8 OUTLIER -126.04 119.88 28.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.502 -0.749 . . . . 0.0 109.093 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.476 ' O ' ' CB ' ' A' ' 64' ' ' TYR . 6.8 ttt-85 -71.8 163.75 27.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.507 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 51.0 p90 -83.02 171.36 13.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.464 ' HB3' ' O ' ' A' ' 101' ' ' PHE . 29.9 t80 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.506 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.8 p -115.17 157.43 23.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -1.179 . . . . 0.0 109.532 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.9 150.3 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 4.0 m-70 -156.54 163.71 39.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 0.0 109.715 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.03 137.04 43.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 108.979 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.74 176.9 28.22 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.608 ' CD1' HD23 ' A' ' 52' ' ' LEU . 7.1 mt -96.51 152.51 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.346 -1.091 . . . . 0.0 108.636 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.606 ' CG2' HD12 ' A' ' 84' ' ' ILE . 76.2 t -99.58 148.08 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.68 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -142.72 164.52 29.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.051 -1.03 . . . . 0.0 109.872 -179.784 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 pt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 50.0 m-85 -113.9 173.85 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.16 -0.963 . . . . 0.0 109.387 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.14 132.78 22.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.371 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.773 HG23 ' HB2' ' A' ' 61' ' ' LEU . 45.8 t -104.62 115.15 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.194 -0.941 . . . . 0.0 109.591 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.701 ' NH1' HD21 ' A' ' 52' ' ' LEU . 7.0 ttt180 -98.64 130.51 45.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.161 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 51' ' ' LEU . 1.9 mm? -96.33 95.13 7.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 109.643 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.701 HD21 ' NH1' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -69.44 145.52 52.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.426 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.91 -39.96 2.7 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.23 -27.64 29.79 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -1.15 . . . . 0.0 109.292 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 57.87 96.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.239 -0.913 . . . . 0.0 109.649 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . 110.72 10.32 21.47 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.831 ' NE2' HG21 ' A' ' 96' ' ' VAL . 20.0 t-160 -109.82 96.9 6.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -1.202 . . . . 0.0 109.552 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -109.08 131.67 54.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.534 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.6 m -124.67 162.87 23.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 109.422 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.485 ' HB ' HD11 ' A' ' 62' ' ' LEU . 2.5 pt -116.01 130.23 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.89 . . . . 0.0 109.29 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.773 ' HB2' HG23 ' A' ' 49' ' ' VAL . 6.0 tt -99.35 118.07 35.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.248 -0.907 . . . . 0.0 109.876 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 62' ' ' LEU . 2.1 mp . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.479 -0.763 . . . . 0.0 109.091 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.524 HG13 HG12 ' A' ' 40' ' ' VAL . 14.3 t . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.357 0.599 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 87.28 -50.93 4.16 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -37.86 156.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.664 -0.903 . . . . 0.0 110.295 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.2 t -98.47 134.21 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 109.138 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.815 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -143.58 174.27 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 0.0 109.868 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 1.8 ttmt -104.66 124.98 50.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.446 -0.784 . . . . 0.0 109.087 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.72 HG22 ' CG ' ' A' ' 100' ' ' ARG . 24.5 p -127.95 175.44 8.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.509 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.873 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -98.55 152.85 19.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.091 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.61 131.37 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.982 . . . . 0.0 109.473 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.543 HG22 ' HG2' ' A' ' 99' ' ' ARG . 94.6 t -92.83 -35.7 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.34 -0.85 . . . . 0.0 109.86 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 96' ' ' VAL . 9.9 ttt85 178.46 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.978 . . . . 0.0 109.335 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.813 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -95.88 117.63 30.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.502 -0.749 . . . . 0.0 109.554 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -110.01 -21.6 12.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -0.935 . . . . 0.0 109.477 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 94' ' ' LEU . . . 123.33 115.31 2.21 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.576 ' CB ' ' O ' ' A' ' 93' ' ' GLY . 1.5 tp 84.39 -57.13 0.12 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.759 -0.848 . . . . 0.0 109.448 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -116.8 119.6 35.91 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 108.841 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.831 HG21 ' NE2' ' A' ' 57' ' ' HIS . 69.1 t -129.89 159.11 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 110.332 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.563 ' O ' HD22 ' A' ' 98' ' ' LEU . 9.6 m-20 -98.66 143.27 29.22 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.873 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -135.49 141.78 45.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.809 -1.182 . . . . 0.0 110.97 -178.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.543 ' HG2' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -133.72 112.27 11.25 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.642 -0.661 . . . . 0.0 109.399 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.72 ' CG ' HG22 ' A' ' 86' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.102 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -172.76 161.78 4.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -1.165 . . . . 0.0 109.598 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 35' ' ' VAL . 2.3 m -122.5 125.44 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 0.0 109.311 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -133.01 168.72 17.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.125 -0.984 . . . . 0.0 109.67 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.69 147.03 25.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.273 -0.892 . . . . 0.0 109.107 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.698 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -159.13 176.8 35.89 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.688 HD12 HG22 ' A' ' 83' ' ' VAL . 2.4 mm -96.8 154.42 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -1.158 . . . . 0.0 108.82 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 34.9 t -105.8 146.75 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 110.329 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -137.3 145.71 43.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 109.216 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 42.9 p90 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.095 -1.003 . . . . 0.0 109.657 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 47' ' ' PHE . 3.7 mt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.509 ' CB ' HD23 ' A' ' 61' ' ' LEU . 60.0 m-85 -105.79 169.75 8.3 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.046 -1.034 . . . . 0.0 109.157 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.7 135.67 24.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.519 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.848 HG23 ' HB2' ' A' ' 61' ' ' LEU . 60.3 t -104.48 119.64 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.225 -0.922 . . . . 0.0 109.736 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -98.88 120.9 40.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 109.075 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.1 OUTLIER -86.06 84.88 7.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.668 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.49 138.95 54.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.391 -0.818 . . . . 0.0 109.506 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.48 -41.48 2.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -81.37 -30.26 33.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -1.161 . . . . 0.0 109.578 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 62.53 84.49 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.85 -20.15 6.44 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -71.51 94.47 1.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -1.134 . . . . 0.0 109.649 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -108.15 105.82 15.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 109.368 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.0 m -102.58 158.38 16.27 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.24 -0.913 . . . . 0.0 109.153 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.518 HG12 ' HA ' ' A' ' 97' ' ' ASP . 25.4 pt -103.81 129.18 56.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.259 -0.901 . . . . 0.0 109.055 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.848 ' HB2' HG23 ' A' ' 49' ' ' VAL . 50.2 tp -98.68 108.66 21.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.659 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.423 ' HA ' HD13 ' A' ' 62' ' ' LEU . 3.5 mm? . . . . . 0 N--CA 1.487 1.42 0 O-C-N 121.496 -0.752 . . . . 0.0 109.205 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 81' ' ' GLY . 54.5 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.566 ' N ' HG12 ' A' ' 80' ' ' VAL . . . 87.4 -48.63 3.8 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 81' ' ' GLY . 5.9 mtp180 -38.96 156.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.702 -0.881 . . . . 0.0 110.016 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 38' ' ' GLY . 4.1 t -98.4 145.33 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 109.162 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.816 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -148.99 164.5 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.0 109.622 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.18 104.16 16.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.408 -0.808 . . . . 0.0 109.209 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.681 HG23 HG12 ' A' ' 84' ' ' ILE . 22.3 p -112.91 175.59 5.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.793 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -99.94 154.28 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.089 -1.007 . . . . 0.0 109.464 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.663 ' HA ' HD22 ' A' ' 98' ' ' LEU . 63.7 t -97.58 110.49 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 0.0 108.863 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 99' ' ' ARG . 2.2 t -64.33 -35.34 73.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.866 . . . . 0.0 110.082 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.03 101.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.938 . . . . 0.0 109.559 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.787 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -95.87 124.65 39.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.279 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.46 -43.69 2.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.17 -138.76 2.51 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -24.7 4.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -1.129 . . . . 0.0 109.753 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -112.34 125.55 54.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.787 HG22 ' HA ' ' A' ' 91' ' ' ALA . 49.7 t -133.27 166.62 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -0.89 . . . . 0.0 109.491 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.603 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -110.37 146.96 34.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 108.732 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -134.15 128.09 33.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.998 -1.064 . . . . 0.0 110.881 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.604 ' HB3' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -122.37 133.18 54.65 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.579 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.613 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . 0.5 OUTLIER -114.14 156.41 24.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -1.121 . . . . 0.0 109.366 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 35' ' ' VAL . 4.0 m -115.56 127.49 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.309 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.613 ' CE1' ' HB3' ' A' ' 34' ' ' SER . 62.8 m80 -143.36 168.01 20.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.789 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -101.34 141.58 34.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.255 -0.903 . . . . 0.0 109.368 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.673 ' O ' HG23 ' A' ' 83' ' ' VAL . . . -150.29 176.88 28.71 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.505 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 15.7 mt -96.42 153.87 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.243 . . . . 0.0 108.444 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 82' ' ' ARG . 38.8 t -98.99 151.8 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 110.431 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.95 150.4 35.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.419 ' HB2' HG21 ' A' ' 80' ' ' VAL . 20.5 t80 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.552 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.667 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.8 m-85 -102.97 174.93 5.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.083 -1.011 . . . . 0.0 108.975 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 59' ' ' CYS . 1.6 tttp -148.31 148.9 30.94 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.198 -0.939 . . . . 0.0 109.624 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.519 HG21 ' HG ' ' A' ' 98' ' ' LEU . 2.4 t -126.02 116.72 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 109.199 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.37 131.75 44.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 109.375 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.3 OUTLIER -88.57 95.6 10.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.192 -0.942 . . . . 0.0 109.765 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.62 138.72 55.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.35 -30.02 9.38 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 55' ' ' GLU . 2.1 m-85 -117.16 66.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -1.06 . . . . 0.0 109.073 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -41.38 107.3 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.396 -0.815 . . . . 0.0 109.665 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.02 32.54 0.79 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -140.94 92.91 2.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -1.105 . . . . 0.0 109.782 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.57 123.1 48.86 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.988 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.449 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.2 m -116.08 167.72 10.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 109.567 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 5.9 pt -122.37 130.66 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.364 -0.835 . . . . 0.0 109.087 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 100' ' ' ARG . 12.3 tp -97.91 116.67 30.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.969 . . . . 0.0 109.251 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.768 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 81' ' ' GLY . 21.4 t . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.313 0.577 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.505 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 87.73 -48.73 3.75 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.671 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -40.8 152.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.481 -1.011 . . . . 0.0 110.023 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 38' ' ' GLY . 7.4 p -99.05 137.29 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.847 . . . . 0.0 109.109 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.841 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -145.23 170.98 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 110.013 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.7 120.65 40.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 0.0 109.047 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.531 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -128.0 176.07 7.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.305 -0.872 . . . . 0.0 109.582 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.75 ' O ' HD13 ' A' ' 98' ' ' LEU . 9.0 mpt_? -97.91 155.0 17.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.0 t -97.41 121.23 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.272 -0.892 . . . . 0.0 109.661 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.55 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 40.9 t -77.0 -39.49 29.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.494 -0.754 . . . . 0.0 109.494 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.416 ' O ' HG13 ' A' ' 96' ' ' VAL . 3.5 mtp180 178.63 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.119 -0.988 . . . . 0.0 109.618 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.825 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -101.87 129.76 48.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.533 -0.729 . . . . 0.0 109.175 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -131.28 -39.83 1.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.064 -1.023 . . . . 0.0 109.511 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -151.97 -127.45 1.32 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.39 -17.74 57.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -1.139 . . . . 0.0 109.808 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -110.24 121.59 45.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -0.989 . . . . 0.0 109.282 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 91' ' ' ALA . 96.0 t -132.86 156.44 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -0.884 . . . . 0.0 109.745 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.55 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 1.7 m-20 -98.35 150.03 22.02 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -134.31 134.81 42.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.859 -1.151 . . . . 0.0 111.085 -178.573 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.446 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -121.72 124.55 44.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.749 ' HB2' HD11 ' A' ' 61' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.557 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.6 t -149.78 138.93 21.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -1.15 . . . . 0.0 109.592 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.477 HG12 ' NE ' ' A' ' 87' ' ' ARG . 16.5 m -102.25 155.65 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.421 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -165.07 162.29 20.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.947 . . . . 0.0 109.5 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.79 137.85 36.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.07 176.11 29.72 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mt -97.39 154.66 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.317 -1.108 . . . . 0.0 108.812 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.477 ' CG2' HD12 ' A' ' 84' ' ' ILE . 17.6 t -104.96 159.94 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 0.0 110.12 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.495 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -146.61 170.33 17.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 0.0 109.208 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.954 . . . . 0.0 109.378 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.6 pt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.495 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 44.4 m-85 -112.69 160.19 18.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.951 -1.093 . . . . 0.0 109.08 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -127.16 151.42 48.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 0.0 109.762 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 61' ' ' LEU . 63.5 t -129.42 115.14 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.409 -0.807 . . . . 0.0 109.076 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -100.36 127.55 46.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.172 -0.955 . . . . 0.0 109.571 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 3.1 mp -95.17 76.33 3.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 109.485 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.0 162.75 3.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.75 -43.15 3.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.457 ' O ' ' O ' ' A' ' 55' ' ' GLU . 68.4 m-85 -85.29 -30.56 23.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -1.105 . . . . 0.0 109.686 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' TYR . 3.5 mt-10 61.04 146.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.192 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . 63.52 12.51 46.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -116.64 82.95 1.88 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -1.146 . . . . 0.0 109.264 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -100.29 105.92 17.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.309 -0.87 . . . . 0.0 109.52 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.434 ' SG ' HD13 ' A' ' 51' ' ' LEU . 4.4 m -100.19 172.67 7.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.925 . . . . 0.0 109.267 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.84 140.83 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 109.241 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.514 ' HB2' HG23 ' A' ' 49' ' ' VAL . 34.9 tp -98.14 116.82 31.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.962 . . . . 0.0 109.339 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.1 tp . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.491 -0.755 . . . . 0.0 109.724 -179.606 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 81' ' ' GLY . 28.1 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.514 ' N ' HG12 ' A' ' 80' ' ' VAL . . . 85.19 -47.54 3.87 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.457 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -40.2 162.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.467 -1.019 . . . . 0.0 110.048 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 m -98.84 144.35 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.047 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.769 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -149.17 173.69 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -0.966 . . . . 0.0 109.629 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -104.14 106.64 17.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.148 -0.97 . . . . 0.0 109.332 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.483 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 8.5 p -112.0 175.75 5.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 0.0 109.55 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.802 ' O ' HD13 ' A' ' 98' ' ' LEU . 10.4 mpt_? -98.73 159.58 14.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.811 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.6 t -96.96 117.54 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.468 -0.77 . . . . 0.0 109.205 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.708 HG22 ' HG2' ' A' ' 99' ' ' ARG . 72.6 t -77.84 -40.33 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.519 -0.738 . . . . 0.0 110.092 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 175.99 104.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.163 -0.961 . . . . 0.0 109.585 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.808 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -96.86 135.4 38.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.66 -36.98 1.59 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.99 . . . . 0.0 109.767 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.04 -134.71 1.69 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -63.48 -17.3 62.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -1.141 . . . . 0.0 109.538 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.56 130.64 56.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 109.506 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.808 HG22 ' HA ' ' A' ' 91' ' ' ALA . 53.9 t -137.2 157.19 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.516 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 49.8 m-20 -98.32 147.21 24.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.232 -0.917 . . . . 0.0 108.661 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -134.91 136.89 42.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.048 -1.032 . . . . 0.0 110.263 -178.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.708 ' HG2' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -136.53 124.56 22.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.589 -0.695 . . . . 0.0 109.232 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.341 -0.85 . . . . 0.0 109.386 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 p -170.56 158.6 6.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -1.122 . . . . 0.0 109.58 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.41 HG12 ' NE ' ' A' ' 87' ' ' ARG . 17.8 m -107.29 149.4 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.254 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -152.09 166.35 31.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.173 -0.955 . . . . 0.0 109.823 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -99.69 151.25 21.43 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 109.14 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.38 176.63 43.32 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.729 HG23 ' O ' ' A' ' 81' ' ' GLY . 8.2 mt -97.04 149.92 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -1.184 . . . . 0.0 108.389 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 41' ' ' TYR . 24.4 t -98.14 166.38 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.074 -1.016 . . . . 0.0 110.482 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.568 ' N ' HG12 ' A' ' 40' ' ' VAL . 9.1 t80 -150.75 139.94 21.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.054 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.416 ' HB2' HG21 ' A' ' 80' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.015 . . . . 0.0 109.661 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.4 pt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 12.8 m-85 -105.9 157.61 17.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.415 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.512 ' CB ' ' HB3' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -130.19 151.18 50.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.435 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.21 120.67 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 109.45 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -99.81 127.16 45.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.925 . . . . 0.0 109.327 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.447 ' CB ' ' HB3' ' A' ' 57' ' ' HIS . 0.1 OUTLIER -92.8 75.48 4.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 109.598 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.28 124.36 19.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 109.425 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 132.6 -41.13 1.53 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.507 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 61.7 t80 -83.8 -19.48 34.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -1.113 . . . . 0.0 109.507 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 9.1 tp10 62.85 88.68 0.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.347 -0.845 . . . . 0.0 109.792 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.8 25.28 5.74 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 54' ' ' TYR . 2.3 t-160 -108.9 92.36 4.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.075 -1.25 . . . . 0.0 109.75 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.08 115.1 29.82 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.41 -0.806 . . . . 0.0 109.278 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -116.13 163.26 16.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 60' ' ' ILE . 24.1 pt -129.52 125.59 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 109.23 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.538 HD13 HG21 ' A' ' 86' ' ' THR . 6.8 tp -98.2 121.72 40.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.007 -1.058 . . . . 0.0 109.592 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.659 -0.651 . . . . 0.0 109.286 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.569 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.729 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 84.84 -43.38 3.23 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.518 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -45.31 178.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.652 -0.911 . . . . 0.0 110.503 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 84' ' ' ILE . 20.7 m -96.13 146.33 7.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.124 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.537 HG12 ' CG2' ' A' ' 40' ' ' VAL . 2.5 pp -156.69 175.29 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.445 -0.784 . . . . 0.0 109.402 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 85' ' ' LYS . 10.0 pttm -101.73 143.47 31.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.317 -0.864 . . . . 0.0 109.204 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.636 ' HB ' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -146.48 175.14 10.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.197 -0.94 . . . . 0.0 109.552 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.79 ' O ' HD13 ' A' ' 98' ' ' LEU . 3.9 mmm-85 -101.56 153.66 19.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.71 123.04 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 109.078 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 99' ' ' ARG . 54.4 t -82.89 -38.43 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.834 . . . . 0.0 109.923 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 172.78 105.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.993 . . . . 0.0 109.547 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.829 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -91.35 127.39 36.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.34 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -116.03 -50.45 2.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.582 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -154.91 -124.97 0.93 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -30.77 70.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.425 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -104.6 134.13 48.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 109.235 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.829 HG22 ' HA ' ' A' ' 91' ' ' ALA . 50.5 t -135.57 163.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.939 . . . . 0.0 110.068 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.547 ' N ' HG12 ' A' ' 96' ' ' VAL . 97.7 m-20 -98.73 150.9 21.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.841 . . . . 0.0 108.753 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -137.39 135.14 36.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.965 -1.085 . . . . 0.0 110.799 -179.048 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.615 ' N ' HG23 ' A' ' 89' ' ' VAL . 30.9 ttp180 -128.21 124.95 37.98 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.482 ' N ' HD11 ' A' ' 61' ' ' LEU . 3.4 ttt85 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.05 -1.031 . . . . 0.0 109.985 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.2 t -109.67 166.4 10.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.234 -1.156 . . . . 0.0 109.456 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -104.53 157.81 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.79 160.12 30.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.789 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.64 124.79 50.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.352 -0.843 . . . . 0.0 109.087 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.457 ' O ' ' CG1' ' A' ' 83' ' ' VAL . . . -138.93 176.36 20.96 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 40' ' ' VAL . 13.0 mt -96.85 167.04 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.143 -1.21 . . . . 0.0 108.731 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.518 ' N ' HG22 ' A' ' 39' ' ' ILE . 60.4 t -108.66 158.61 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.043 -1.036 . . . . 0.0 110.733 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.49 ' N ' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -153.65 152.0 30.33 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 0.0 109.769 -179.841 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 1.012 HD12 ' O ' ' A' ' 61' ' ' LEU . 4.1 pt . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.407 ' HB2' HD23 ' A' ' 61' ' ' LEU . 1.2 m-85 -116.28 166.98 11.43 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.854 -1.154 . . . . 0.0 109.424 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -141.26 143.06 33.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 59' ' ' CYS . 88.2 t -116.37 136.96 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.4 mtt-85 -108.4 123.4 48.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.219 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.523 HD13 ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -94.6 68.43 3.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.159 -0.963 . . . . 0.0 109.498 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 tt -50.87 142.25 11.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.431 -0.793 . . . . 0.0 109.436 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.56 -53.33 0.6 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 55' ' ' GLU . 1.1 m-85 -68.35 -21.55 64.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.489 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 54' ' ' TYR . 4.4 mt-10 61.49 119.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.1 29.43 62.58 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -116.12 89.97 3.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 0.0 109.328 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.9 112.43 25.4 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 0.0 109.76 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.523 ' SG ' HD13 ' A' ' 51' ' ' LEU . 25.7 m -102.56 164.75 11.48 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.302 -0.874 . . . . 0.0 109.045 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.26 131.81 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.128 -0.983 . . . . 0.0 109.367 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.012 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.2 tp -98.04 118.3 34.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 109.355 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.554 HD12 HD13 ' A' ' 46' ' ' ILE . 6.3 tt . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.804 . . . . 0.0 109.66 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 81' ' ' GLY . 16.4 t . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.334 0.587 . . . . 0.0 109.622 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 84.24 -46.52 3.68 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -45.88 172.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -1.159 . . . . 0.0 109.874 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.457 ' CG1' ' O ' ' A' ' 38' ' ' GLY . 1.6 t -98.71 150.79 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.25 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.722 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -152.93 172.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 109.836 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 85' ' ' LYS . 13.5 pttm -103.97 115.3 30.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.378 -0.827 . . . . 0.0 109.308 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.84 HG22 ' HG3' ' A' ' 100' ' ' ARG . 24.9 p -125.16 175.42 7.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.204 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.711 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -101.63 157.96 16.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.401 ' HA ' HD22 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -96.76 120.04 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.56 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 91.3 t -80.21 -37.43 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.443 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 170.65 104.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.931 -1.106 . . . . 0.0 109.826 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.498 ' CB ' HG22 ' A' ' 96' ' ' VAL . . . -87.55 153.97 20.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 109.215 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -167.26 53.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.146 -0.971 . . . . 0.0 109.755 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.18 -158.42 14.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.757 ' C ' HD23 ' A' ' 94' ' ' LEU . 4.0 tt -60.12 -18.55 48.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.379 -1.071 . . . . 0.0 109.6 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -107.1 134.21 50.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.645 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.498 HG22 ' CB ' ' A' ' 91' ' ' ALA . 74.2 t -134.29 157.39 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.839 . . . . 0.0 109.407 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.56 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 8.8 m-20 -98.39 152.43 19.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 108.811 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -141.57 133.77 27.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.968 -1.083 . . . . 0.0 110.701 -178.702 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.556 ' N ' HG23 ' A' ' 89' ' ' VAL . 8.7 ttt180 -131.0 131.37 44.31 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.84 ' HG3' HG22 ' A' ' 86' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.073 -1.017 . . . . 0.0 109.556 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.02 168.55 19.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -1.185 . . . . 0.0 109.542 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.9 m -116.34 168.06 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.289 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 46.2 t60 -170.33 163.9 8.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.679 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.69 125.37 50.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.212 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.77 175.73 22.37 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 52' ' ' LEU . 3.7 mt -97.7 155.0 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.405 -1.056 . . . . 0.0 108.98 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.484 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 45.7 t -98.79 157.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.063 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.435 ' N ' HG12 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -154.38 141.43 19.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.438 -0.789 . . . . 0.0 109.006 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.5 t80 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.034 . . . . 0.0 109.555 -179.855 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 47' ' ' PHE . 40.4 pt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 67.1 m-85 -117.9 169.76 9.37 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.879 -1.138 . . . . 0.0 109.411 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.678 ' HG3' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -143.16 139.24 30.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 109.698 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 61' ' ' LEU . 48.2 t -115.8 104.28 16.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 130.56 45.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.115 -0.991 . . . . 0.0 109.966 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 51' ' ' LEU . 10.9 mp -94.89 93.22 7.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 109.303 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.918 HD13 ' N ' ' A' ' 53' ' ' GLY . 0.9 OUTLIER -83.69 134.97 34.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 109.596 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.918 ' N ' HD13 ' A' ' 52' ' ' LEU . . . 92.85 -5.81 76.47 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.505 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -123.9 51.34 1.54 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.269 -1.136 . . . . 0.0 109.596 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.505 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 1.6 mt-10 75.87 -170.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.399 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 58' ' ' GLU . . . -81.66 9.76 54.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -41.42 97.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -1.067 . . . . 0.0 109.63 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 56' ' ' GLY . 27.9 tt0 -110.58 110.58 21.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -104.66 167.4 9.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.843 HD12 HD21 ' A' ' 62' ' ' LEU . 1.1 pt -129.58 139.0 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.405 -0.81 . . . . 0.0 109.039 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 47' ' ' PHE . 49.0 tp -98.4 117.25 32.39 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.026 -1.046 . . . . 0.0 109.26 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.843 HD21 HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.309 -0.869 . . . . 0.0 109.664 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.411 HG13 ' CG1' ' A' ' 40' ' ' VAL . 13.0 t . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 88.13 -48.03 3.58 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -41.56 164.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.406 -1.055 . . . . 0.0 109.892 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.467 ' C ' HG23 ' A' ' 84' ' ' ILE . 23.5 m -98.15 150.16 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.079 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.697 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -155.95 175.29 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.937 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 4.3 mtmt -104.25 112.87 26.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.409 -0.807 . . . . 0.0 109.253 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.614 ' OG1' HD11 ' A' ' 98' ' ' LEU . 71.3 p -118.94 175.24 5.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.725 ' O ' HD13 ' A' ' 98' ' ' LEU . 9.9 mpt_? -99.32 156.36 17.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 0.0 109.335 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 t -97.21 124.24 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.167 -0.958 . . . . 0.0 109.309 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.493 ' CG2' ' CB ' ' A' ' 99' ' ' ARG . 24.4 t -80.75 -30.3 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.413 -0.804 . . . . 0.0 109.653 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.9 OUTLIER 168.01 106.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.136 -0.977 . . . . 0.0 109.311 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.73 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -95.73 132.36 41.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 0.0 109.617 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -165.84 88.27 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.47 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.73 -160.6 13.57 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.7 -22.62 53.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -1.155 . . . . 0.0 109.443 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -103.65 138.99 39.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.272 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.73 HG13 ' HA ' ' A' ' 91' ' ' ALA . 77.2 t -136.74 161.8 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.185 -0.947 . . . . 0.0 109.918 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.519 ' N ' HG12 ' A' ' 96' ' ' VAL . 15.3 m-20 -98.36 150.9 21.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -138.53 135.0 34.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.932 -1.105 . . . . 0.0 110.91 -178.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.493 ' CB ' ' CG2' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -136.91 131.8 33.59 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.557 ' HG3' HG22 ' A' ' 86' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.175 -0.953 . . . . 0.0 109.33 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 p -119.13 154.67 32.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -1.102 . . . . 0.0 109.575 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.481 HG12 ' HD2' ' A' ' 87' ' ' ARG . 4.4 m -101.03 131.89 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.375 -0.828 . . . . 0.0 109.06 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.86 172.53 13.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.06 -1.025 . . . . 0.0 109.954 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.55 158.61 15.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.367 -0.833 . . . . 0.0 108.897 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.06 177.46 39.1 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.775 HD11 ' HB2' ' A' ' 52' ' ' LEU . 6.6 mt -95.96 152.43 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.425 -1.044 . . . . 0.0 108.451 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 82' ' ' ARG . 21.9 t -98.65 149.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.061 -1.024 . . . . 0.0 110.731 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.47 132.46 15.21 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 t80 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 120.932 -1.105 . . . . 0.0 109.742 -179.632 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.604 HG22 ' H ' ' A' ' 47' ' ' PHE . 2.5 mm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.604 ' H ' HG22 ' A' ' 46' ' ' ILE . 10.1 m-85 -109.54 172.45 6.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.12 -0.988 . . . . 0.0 109.409 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 147.78 26.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.945 . . . . 0.0 109.704 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.583 HG21 ' HG ' ' A' ' 98' ' ' LEU . 2.5 t -121.74 122.02 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.399 -0.813 . . . . 0.0 109.253 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.622 ' HB3' HD12 ' A' ' 39' ' ' ILE . 54.8 ttt-85 -98.73 121.74 41.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.0 109.338 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -90.7 86.64 6.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.023 -1.048 . . . . 0.0 109.624 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.775 ' HB2' HD11 ' A' ' 39' ' ' ILE . 5.7 tp -59.41 162.99 4.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.835 . . . . 0.0 109.351 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.99 -31.05 5.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.49 -31.69 12.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 109.342 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 55.79 85.81 0.07 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.369 -0.832 . . . . 0.0 109.548 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.68 -12.28 5.4 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -89.25 94.92 10.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -1.148 . . . . 0.0 109.545 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.14 111.01 23.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.525 -0.735 . . . . 0.0 109.129 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.553 ' HB3' HD23 ' A' ' 98' ' ' LEU . 3.8 m -100.69 156.85 17.09 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.23 -0.919 . . . . 0.0 109.539 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -110.72 124.99 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.539 ' HB3' ' CB ' ' A' ' 47' ' ' PHE . 29.9 tp -98.17 110.55 23.11 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.046 -1.034 . . . . 0.0 109.56 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 46' ' ' ILE . 1.7 tt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.483 -0.76 . . . . 0.0 109.727 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 81' ' ' GLY . 17.8 t . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.517 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 85.43 -48.46 4.02 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.497 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -43.02 170.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.469 -1.018 . . . . 0.0 110.14 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.3 p -97.27 143.6 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.145 -0.972 . . . . 0.0 109.64 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.712 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.3 pp -145.83 174.16 2.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.456 -0.777 . . . . 0.0 109.391 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -102.89 141.78 35.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.505 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.499 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -153.33 174.55 14.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.277 -0.889 . . . . 0.0 109.46 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.781 ' O ' HD13 ' A' ' 98' ' ' LEU . 7.9 mmt180 -99.39 151.92 20.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 65.5 t -97.41 119.88 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.86 . . . . 0.0 109.002 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.849 HG21 ' HG3' ' A' ' 99' ' ' ARG . 71.2 t -82.64 -33.96 11.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.414 -0.804 . . . . 0.0 109.935 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 171.04 103.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.115 -0.99 . . . . 0.0 109.737 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.817 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -92.91 107.2 19.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.266 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.88 107.45 4.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.71 -176.39 54.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 94' ' ' LEU . 5.2 mp -59.83 -16.17 26.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -1.095 . . . . 0.0 109.529 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -99.07 133.15 43.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.479 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.817 HG13 ' HA ' ' A' ' 91' ' ' ALA . 61.7 t -138.59 151.29 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.597 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.539 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -101.17 145.5 28.72 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.781 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -138.31 137.86 37.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.966 -1.084 . . . . 0.0 110.669 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.849 ' HG3' HG21 ' A' ' 89' ' ' VAL . 9.2 mtt180 -146.19 126.41 13.87 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.415 ' HB2' HG22 ' A' ' 86' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.566 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 62.2 m -138.59 165.65 26.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.93 146.61 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.509 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -168.71 166.0 11.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.165 -0.959 . . . . 0.0 109.612 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -104.0 138.89 39.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.322 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 83' ' ' VAL . . . -154.98 176.13 32.77 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.7 mm -97.4 152.33 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.345 -1.091 . . . . 0.0 108.815 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 41' ' ' TYR . 21.9 t -104.93 168.01 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.014 -1.054 . . . . 0.0 110.09 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.563 ' N ' HG12 ' A' ' 40' ' ' VAL . 6.3 t80 -155.87 163.78 39.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.333 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.704 ' CB ' HD23 ' A' ' 61' ' ' LEU . 21.2 m-85 -111.94 153.9 26.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.034 -1.041 . . . . 0.0 109.51 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -129.72 149.32 51.52 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 59' ' ' CYS . 47.4 t -128.52 135.44 62.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.083 -1.011 . . . . 0.0 109.544 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.96 131.86 56.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.122 -0.986 . . . . 0.0 109.022 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -85.46 78.19 9.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 109.666 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.8 tp -62.73 125.17 23.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.351 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.49 -16.41 6.26 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.41 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 10.8 t80 -118.23 -26.13 6.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -1.127 . . . . 0.0 109.382 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 56.56 91.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.38 0.36 5.0 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.41 ' CE1' ' CD2' ' A' ' 54' ' ' TYR . 9.6 m170 -109.63 105.28 14.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -1.213 . . . . 0.0 109.483 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 95' ' ' TYR . 0.2 OUTLIER -112.67 111.41 22.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.887 . . . . 0.0 110.014 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.483 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.3 m -103.56 170.63 7.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.309 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.2 pt -132.39 128.57 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.068 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.704 HD23 ' CB ' ' A' ' 47' ' ' PHE . 20.5 tp -97.47 117.54 31.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.969 -1.082 . . . . 0.0 109.372 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.62 HD12 ' C ' ' A' ' 62' ' ' LEU . 3.6 pp . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.374 -0.829 . . . . 0.0 109.794 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.563 HG22 ' N ' ' A' ' 81' ' ' GLY . 1.6 p . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.705 0.764 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.563 ' N ' HG22 ' A' ' 80' ' ' VAL . . . 85.31 -47.19 3.79 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.568 ' HE ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -41.24 165.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.436 -1.037 . . . . 0.0 110.21 -179.539 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.568 HG12 ' HE ' ' A' ' 82' ' ' ARG . 7.4 p -98.04 141.78 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.411 -0.805 . . . . 0.0 108.882 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.766 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -151.37 175.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.001 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -98.9 103.52 15.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 108.957 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.747 ' OG1' HD11 ' A' ' 98' ' ' LEU . 68.0 p -107.49 175.12 5.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.62 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -102.95 156.56 17.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 0.0 109.254 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.483 ' HA ' HD22 ' A' ' 98' ' ' LEU . 60.1 t -96.95 106.6 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.282 -0.886 . . . . 0.0 108.817 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.572 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 24.1 t -60.6 -44.54 97.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.464 -0.773 . . . . 0.0 109.87 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 9.4 ttm180 177.27 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.746 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.593 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -78.12 152.12 32.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.901 . . . . 0.0 109.322 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -167.7 62.16 0.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.924 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.87 -156.04 16.2 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -27.33 68.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -1.096 . . . . 0.0 109.647 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 2.7 m-85 -101.18 138.74 37.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.612 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 91' ' ' ALA . 40.8 t -133.69 162.86 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.774 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.572 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -99.26 145.96 26.72 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.747 HD11 ' OG1' ' A' ' 86' ' ' THR . 0.2 OUTLIER -138.02 138.63 39.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.965 -1.085 . . . . 0.0 110.899 -178.6 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.484 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 31.0 ttp180 -134.57 129.28 34.76 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 109.429 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 t -100.52 172.13 7.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -1.114 . . . . 0.0 109.461 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.751 HG22 ' HG3' ' A' ' 87' ' ' ARG . 10.3 t -118.89 161.97 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.2 -0.937 . . . . 0.0 109.426 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.409 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -172.35 167.51 5.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.872 . . . . 0.0 109.457 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -98.7 130.63 45.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 0.0 109.26 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.41 175.69 29.34 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 81' ' ' GLY . 4.0 mt -97.91 158.29 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -1.048 . . . . 0.0 108.984 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.545 ' C ' ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -116.28 175.75 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 110.072 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.62 147.91 22.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 108.856 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 50.8 t80 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 120.965 -1.084 . . . . 0.0 109.654 -179.639 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 47' ' ' PHE . 10.2 pt . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.562 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 4.4 m-85 -114.9 173.99 6.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.045 -1.035 . . . . 0.0 109.189 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 5.0 tttt -142.68 158.88 43.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.144 -0.973 . . . . 0.0 109.675 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 59' ' ' CYS . 2.8 t -139.98 107.71 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.406 -0.809 . . . . 0.0 109.376 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.96 134.27 42.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -97.38 96.97 8.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.94 . . . . 0.0 109.614 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -79.2 110.97 14.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.337 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.04 -35.96 1.64 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 4.4 m-85 -85.02 -31.62 23.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.272 -1.134 . . . . 0.0 109.18 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER 71.55 97.6 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.391 -0.818 . . . . 0.0 109.589 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.73 10.34 30.98 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -100.22 88.75 3.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 0.0 109.549 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.92 99.61 9.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.36 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.798 ' SG ' HD23 ' A' ' 98' ' ' LEU . 7.4 t -101.9 169.56 8.7 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.188 -0.945 . . . . 0.0 109.234 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 pt -137.03 140.84 41.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.747 HD21 ' HG2' ' A' ' 100' ' ' ARG . 0.5 OUTLIER -98.37 126.96 44.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.934 -1.104 . . . . 0.0 109.597 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.422 ' HG ' ' HB ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.599 -0.688 . . . . 0.0 109.507 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.699 HG12 ' N ' ' A' ' 81' ' ' GLY . 38.2 t . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.174 0.512 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.699 ' N ' HG12 ' A' ' 80' ' ' VAL . . . -80.69 15.65 18.76 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.233 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -49.05 175.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.94 -1.33 . . . . 0.0 108.695 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.5 t -97.37 122.9 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.084 -1.01 . . . . 0.0 108.627 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.744 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -141.3 174.63 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.112 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -104.19 118.13 35.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.428 -0.795 . . . . 0.0 109.127 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.851 ' OG1' HD11 ' A' ' 98' ' ' LEU . 55.5 p -125.95 175.08 7.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.751 ' HG3' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -102.15 159.88 15.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.338 -0.851 . . . . 0.0 109.477 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.451 ' HA ' HD22 ' A' ' 98' ' ' LEU . 40.7 t -97.48 123.1 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 109.031 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.586 HG23 ' N ' ' A' ' 99' ' ' ARG . 79.6 t -81.84 -33.29 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.485 -0.759 . . . . 0.0 110.045 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 47.3 ttp180 175.29 102.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.004 . . . . 0.0 109.629 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.853 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -95.83 108.37 20.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.537 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.45 -58.36 2.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.02 -93.79 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.67 -29.64 22.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -1.179 . . . . 0.0 109.194 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.14 131.08 53.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.091 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.853 HG13 ' HA ' ' A' ' 91' ' ' ALA . 59.5 t -135.0 157.61 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 109.954 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.551 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -99.91 153.89 18.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.851 HD11 ' OG1' ' A' ' 86' ' ' THR . 0.2 OUTLIER -136.81 134.2 36.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.971 -1.08 . . . . 0.0 110.878 -178.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.586 ' N ' HG23 ' A' ' 89' ' ' VAL . 28.6 ttm180 -124.17 111.56 16.04 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.747 ' HG2' HD21 ' A' ' 61' ' ' LEU . 4.2 ptm180 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 110.041 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -113.8 163.46 15.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -1.147 . . . . 0.0 109.482 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.877 HG12 ' NE ' ' A' ' 87' ' ' ARG . 18.9 m -103.65 158.1 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.511 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.531 ' CD2' HG23 ' A' ' 88' ' ' VAL . 20.4 p80 -167.08 163.13 15.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -99.37 135.08 41.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.067 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -146.08 176.77 24.85 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' A' ' 52' ' ' LEU . 9.7 mt -96.61 154.34 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.302 -1.117 . . . . 0.0 108.641 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.717 HG23 HD12 ' A' ' 84' ' ' ILE . 53.0 t -105.54 151.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.016 -1.053 . . . . 0.0 110.481 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.523 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 2.6 t80 -142.34 145.87 34.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.425 -0.797 . . . . 0.0 108.968 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.535 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 37.2 p90 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.096 -1.002 . . . . 0.0 109.779 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.826 ' CG2' HD13 ' A' ' 62' ' ' LEU . 2.5 pt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.519 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 0.5 OUTLIER -116.23 163.04 16.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.037 -1.04 . . . . 0.0 108.96 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.553 ' CG ' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -135.65 129.95 33.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.166 -0.959 . . . . 0.0 109.733 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 59' ' ' CYS . 5.4 t -109.45 124.83 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 109.358 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -105.55 129.4 53.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.977 . . . . 0.0 109.393 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -90.76 81.95 5.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.432 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.56 ' HB2' HD11 ' A' ' 39' ' ' ILE . 1.2 tp -64.97 132.71 50.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.94 -42.46 1.86 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.466 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . 69.1 t80 -74.58 -29.54 61.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 109.556 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 30.4 tt0 63.54 89.3 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.53 15.28 9.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.466 ' CG ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -115.65 90.26 3.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 109.535 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 1.6 tm-20 -100.65 105.61 17.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.837 . . . . 0.0 109.444 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.651 ' HB3' HD23 ' A' ' 98' ' ' LEU . 4.9 m -101.78 159.65 15.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.145 -0.972 . . . . 0.0 109.313 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.553 HG22 ' CG ' ' A' ' 48' ' ' LYS . 4.1 pt -131.13 141.07 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.848 . . . . 0.0 108.971 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -97.93 127.63 44.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.027 . . . . 0.0 109.738 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.826 HD13 ' CG2' ' A' ' 46' ' ' ILE . 14.9 tp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 81' ' ' GLY . 12.0 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 86.06 -46.86 3.68 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -41.09 164.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.579 -0.953 . . . . 0.0 110.021 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 4.3 m -98.44 153.01 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.247 -0.908 . . . . 0.0 109.219 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.781 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -151.99 174.59 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.695 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -99.35 138.17 36.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.362 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 35.5 p -149.3 173.53 13.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.889 . . . . 0.0 109.443 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.877 ' NE ' HG12 ' A' ' 35' ' ' VAL . 13.3 mmm-85 -104.23 158.13 16.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.852 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.531 HG23 ' CD2' ' A' ' 36' ' ' HIS . 53.4 t -96.74 131.82 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 109.334 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.649 HG22 ' CD ' ' A' ' 99' ' ' ARG . 42.6 t -92.41 -31.1 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.284 -0.885 . . . . 0.0 110.056 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.488 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 164.49 107.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.139 -0.975 . . . . 0.0 109.58 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.958 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -84.65 117.72 23.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -110.54 27.98 9.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.581 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.24 -148.24 17.45 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.7 OUTLIER -45.29 -31.25 1.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -1.133 . . . . 0.0 109.527 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -102.86 135.06 45.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 109.332 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.958 HG13 ' HA ' ' A' ' 91' ' ' ALA . 51.4 t -142.26 152.48 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.9 . . . . 0.0 109.695 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.488 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 50.1 m-20 -97.92 150.29 21.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.203 -0.935 . . . . 0.0 108.706 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.866 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -136.93 136.74 38.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.09 -1.006 . . . . 0.0 110.49 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.649 ' CD ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -123.84 114.46 19.89 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.212 -0.93 . . . . 0.0 109.325 -179.922 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 m -128.68 161.41 29.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 0.0 109.553 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 35' ' ' VAL . 6.0 m -109.7 132.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.59 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -147.03 170.01 18.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.259 -0.9 . . . . 0.0 109.43 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -100.23 153.39 19.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.852 . . . . 0.0 109.684 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.45 175.22 45.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.88 HG23 ' O ' ' A' ' 81' ' ' GLY . 1.9 mp -98.49 144.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.377 -1.072 . . . . 0.0 108.931 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.536 ' O ' ' CA ' ' A' ' 81' ' ' GLY . 2.1 t -100.94 172.36 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.514 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 1.4 t80 -156.19 147.92 22.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -0.95 . . . . 0.0 109.54 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.7 t80 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.455 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.606 HG21 HD13 ' A' ' 62' ' ' LEU . 45.4 pt . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.515 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.3 m-30 -107.9 155.1 20.67 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.021 -1.049 . . . . 0.0 109.17 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 24.3 tttt -126.07 150.46 48.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.507 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 3.4 t -138.55 112.84 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.434 -0.791 . . . . 0.0 109.104 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.73 127.55 45.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.23 85.44 5.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.634 ' HB2' HD13 ' A' ' 39' ' ' ILE . 17.8 tp -59.92 145.64 45.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.241 -0.912 . . . . 0.0 109.402 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.446 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . 101.92 -54.43 0.77 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.09 -24.35 62.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.582 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 47.78 85.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.99 -9.84 3.89 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -97.46 98.16 9.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -1.144 . . . . 0.0 109.596 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.568 ' OE2' ' CZ ' ' A' ' 95' ' ' TYR . 26.4 tt0 -101.42 107.54 18.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.2 m -104.87 162.63 13.16 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.627 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -131.01 132.68 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.576 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.525 HD12 HD12 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -97.4 124.69 41.66 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 109.831 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.606 HD13 HG21 ' A' ' 46' ' ' ILE . 4.9 tp . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.545 -0.722 . . . . 0.0 109.462 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.531 ' CG1' ' N ' ' A' ' 81' ' ' GLY . 2.3 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.67 0.748 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.88 ' O ' HG23 ' A' ' 39' ' ' ILE . . . -75.33 15.4 4.43 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.808 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.503 ' O ' ' O ' ' A' ' 81' ' ' GLY . 8.5 ttp180 -50.63 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.969 -1.313 . . . . 0.0 109.724 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.4 m -96.01 112.91 29.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 108.821 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.759 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.7 pp -133.57 175.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.95 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -98.28 151.37 20.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 109.038 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.738 ' HB ' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -154.91 170.86 20.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.812 ' O ' HD13 ' A' ' 98' ' ' LEU . 6.1 mmt180 -99.78 154.16 18.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.194 -0.941 . . . . 0.0 109.244 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.5 t -97.78 125.9 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.13 -0.981 . . . . 0.0 108.908 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.955 HG12 ' HG2' ' A' ' 90' ' ' ARG . 78.7 t -85.36 -33.88 8.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.295 -0.878 . . . . 0.0 110.251 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.955 ' HG2' HG12 ' A' ' 89' ' ' VAL . 1.9 ptt180 166.45 108.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.03 -1.044 . . . . 0.0 109.601 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.802 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -91.44 114.87 27.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.822 . . . . 0.0 109.244 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.7 64.86 1.58 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.109 -0.995 . . . . 0.0 109.794 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.75 -165.64 12.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -25.88 62.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -1.093 . . . . 0.0 109.676 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.568 ' CZ ' ' OE2' ' A' ' 58' ' ' GLU . 6.9 m-85 -99.59 140.63 33.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.353 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.802 HG22 ' HA ' ' A' ' 91' ' ' ALA . 79.9 t -142.2 162.89 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 109.944 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.573 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 30.8 m-20 -101.19 157.2 16.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.002 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.812 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.24 136.23 33.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.88 -1.137 . . . . 0.0 111.033 -178.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.589 ' N ' HG23 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -120.8 114.78 22.11 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.632 ' HA ' HG22 ' A' ' 86' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.05 172.02 13.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -1.134 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.623 HG12 ' NE ' ' A' ' 87' ' ' ARG . 12.9 m -120.44 128.43 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.0 109.218 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -149.93 166.87 28.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.554 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.56 133.27 45.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.204 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.07 176.71 24.87 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 39' ' ' ILE . 2.9 mp -96.14 160.02 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -1.122 . . . . 0.0 108.581 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.542 ' CG2' HD12 ' A' ' 84' ' ' ILE . 7.1 t -111.37 167.94 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.085 -1.009 . . . . 0.0 110.237 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.507 ' N ' HG12 ' A' ' 40' ' ' VAL . 2.1 t80 -157.87 150.4 22.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.438 -0.789 . . . . 0.0 108.922 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 75.1 t80 . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.931 . . . . 0.0 109.704 -179.551 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.811 HG23 ' N ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.811 ' N ' HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -107.04 164.43 12.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.738 -1.226 . . . . 0.0 109.157 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.07 147.64 49.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.083 -1.011 . . . . 0.0 110.219 -179.449 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.494 ' CG2' HD13 ' A' ' 61' ' ' LEU . 71.7 t -130.8 133.66 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -114.37 123.57 49.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.11 67.69 10.05 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.174 -0.954 . . . . 0.0 109.242 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.416 ' HB2' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -47.63 147.28 1.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.701 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.24 -45.3 1.38 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.497 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -77.62 -17.03 58.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -1.152 . . . . 0.0 109.456 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.24 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.203 -0.936 . . . . 0.0 109.515 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.81 -23.96 7.66 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.574 ' NE2' ' HB1' ' A' ' 91' ' ' ALA . 1.6 t-160 -82.1 91.06 6.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.164 -1.198 . . . . 0.0 109.787 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.87 109.68 22.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.099 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.461 ' HA ' ' HB ' ' A' ' 96' ' ' VAL . 13.7 m -98.54 173.7 6.8 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.154 -0.966 . . . . 0.0 109.444 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 96' ' ' VAL . 1.8 pp -149.55 147.62 16.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.422 -0.798 . . . . 0.0 109.374 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.558 HD21 ' CG ' ' A' ' 100' ' ' ARG . 0.6 OUTLIER -98.13 102.48 14.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.298 -0.876 . . . . 0.0 109.183 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.469 ' HA ' HG12 ' A' ' 46' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.563 ' N ' ' CG2' ' A' ' 80' ' ' VAL . . . 88.78 -37.41 3.31 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 81' ' ' GLY . 1.5 mmt180 -43.62 172.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.633 -0.922 . . . . 0.0 110.153 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.454 ' C ' HG23 ' A' ' 84' ' ' ILE . 9.1 p -97.18 147.1 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.601 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.687 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -155.74 176.02 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.352 -0.843 . . . . 0.0 109.605 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.1 110.4 22.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.323 -0.861 . . . . 0.0 108.949 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.995 HG22 ' HB2' ' A' ' 100' ' ' ARG . 82.4 p -110.35 165.45 11.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.044 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.623 ' NE ' HG12 ' A' ' 35' ' ' VAL . 6.2 mpt_? -98.56 140.79 32.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 108.65 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.605 ' HA ' ' HB3' ' A' ' 98' ' ' LEU . 58.9 t -94.25 139.16 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.469 -0.769 . . . . 0.0 109.299 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 89' ' ' VAL . 91.1 t -121.97 -10.31 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.47 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.884 ' O ' HG13 ' A' ' 96' ' ' VAL . 0.0 OUTLIER 174.38 105.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.496 -1.377 . . . . 0.0 110.444 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.813 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -116.54 88.03 2.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.506 -0.746 . . . . 0.0 109.172 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -121.65 84.19 2.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.766 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.36 -137.76 14.14 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mp -102.28 4.38 39.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -1.141 . . . . 0.0 109.674 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.458 ' CZ ' HG21 ' A' ' 60' ' ' ILE . 1.3 t80 -124.4 131.96 53.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 109.212 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.946 HG12 ' CD2' ' A' ' 98' ' ' LEU . 22.0 t -132.8 145.86 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.213 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.951 ' O ' HD23 ' A' ' 98' ' ' LEU . 2.0 m-20 -112.8 141.2 46.88 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.951 HD23 ' O ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -165.2 178.91 6.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.592 -1.317 . . . . 0.0 112.041 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.1 ptt-85 -134.89 104.05 5.84 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.082 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.995 ' HB2' HG22 ' A' ' 86' ' ' THR . 1.2 ptt180 . . . . . 0 N--CA 1.49 1.556 0 O-C-N 120.915 -1.115 . . . . 0.0 109.518 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.76 161.94 34.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -1.14 . . . . 0.0 109.386 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.733 HG12 ' HG3' ' A' ' 87' ' ' ARG . 9.6 m -118.29 170.4 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.576 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 11.0 m-70 -172.55 168.16 5.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -99.17 147.31 25.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.6 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -158.75 175.67 35.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 81' ' ' GLY . 6.0 mt -98.04 151.25 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -1.11 . . . . 0.0 109.053 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.567 ' CG2' HD12 ' A' ' 84' ' ' ILE . 66.9 t -99.72 147.16 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.059 -1.026 . . . . 0.0 110.19 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.56 172.29 14.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.438 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.928 . . . . 0.0 109.545 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.438 HG13 ' N ' ' A' ' 47' ' ' PHE . 35.3 pt . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.562 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.0 m-85 -111.6 173.91 6.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.119 -0.988 . . . . 0.0 109.217 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 1.8 mttp -148.08 127.2 12.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.638 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 2.4 t -101.68 111.63 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.427 -0.796 . . . . 0.0 109.287 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.54 130.63 45.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.24 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -92.7 93.4 8.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.554 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 53' ' ' GLY . 1.5 tt -66.35 143.11 57.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.189 -0.945 . . . . 0.0 109.461 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.436 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . 110.81 -43.19 1.77 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 55' ' ' GLU . 14.7 m-85 -88.6 -27.31 21.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -1.151 . . . . 0.0 109.391 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 54' ' ' TYR . 38.3 tt0 61.71 123.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.269 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 58' ' ' GLU . . . 97.27 -39.24 2.83 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -59.86 88.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -1.13 . . . . 0.0 109.33 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 56' ' ' GLY . 32.0 tt0 -104.02 104.02 13.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.447 -0.783 . . . . 0.0 109.438 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 44.4 m -99.04 155.39 17.46 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 109.095 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.9 pt -118.55 136.44 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 109.229 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.562 ' HB3' ' CB ' ' A' ' 47' ' ' PHE . 14.8 tp -98.02 110.38 22.97 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.105 -0.997 . . . . 0.0 109.053 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.655 ' C ' HD23 ' A' ' 62' ' ' LEU . 7.5 tt . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.474 -0.766 . . . . 0.0 109.381 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 81' ' ' GLY . 21.9 t . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 86.15 -47.5 3.77 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -38.95 159.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.641 -0.917 . . . . 0.0 110.008 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 38' ' ' GLY . 22.2 t -98.48 141.46 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 109.028 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.772 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -141.45 166.86 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.822 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -103.59 106.97 17.63 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.723 HG22 ' CG ' ' A' ' 100' ' ' ARG . 1.3 p -118.08 174.77 6.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.744 ' O ' HD13 ' A' ' 98' ' ' LEU . 2.5 mpt_? -98.93 162.96 12.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.871 . . . . 0.0 109.21 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.9 129.33 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.275 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.562 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 57.2 t -85.27 -34.1 8.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.401 -0.812 . . . . 0.0 109.742 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 162.85 113.69 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.301 -0.874 . . . . 0.0 109.215 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.454 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -98.45 151.48 20.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.583 -0.698 . . . . 0.0 109.437 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -127.0 -69.32 0.76 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 109.326 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.455 ' C ' HD12 ' A' ' 94' ' ' LEU . . . -141.35 -75.31 0.04 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.455 HD12 ' C ' ' A' ' 93' ' ' GLY . 8.4 mp -111.52 -25.23 9.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -1.115 . . . . 0.0 109.172 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -100.4 135.57 41.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.037 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.457 ' HB ' ' SG ' ' A' ' 59' ' ' CYS . 58.1 t -140.02 151.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.101 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.562 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 94.1 m-20 -98.49 155.57 17.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 108.624 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.744 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.39 139.25 35.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.821 -1.175 . . . . 0.0 110.831 -178.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.512 ' HG2' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -144.06 125.46 14.78 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.723 ' CG ' HG22 ' A' ' 86' ' ' THR . 3.8 ttt-85 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.486 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.56 162.15 17.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.238 -1.154 . . . . 0.0 109.577 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.727 HG13 ' HD2' ' A' ' 87' ' ' ARG . 1.9 t -109.33 156.23 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.326 -0.858 . . . . 0.0 109.441 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.3 169.58 20.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.613 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 154.5 17.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.234 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -168.67 176.58 42.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.693 HG23 ' O ' ' A' ' 81' ' ' GLY . 32.3 mt -97.1 148.29 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -1.142 . . . . 0.0 108.719 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.545 ' CG2' HG12 ' A' ' 84' ' ' ILE . 59.7 t -98.54 146.96 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.024 -1.048 . . . . 0.0 110.42 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -139.77 150.42 44.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.386 -0.821 . . . . 0.0 109.153 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 76.5 t80 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.038 . . . . 0.0 109.671 -179.836 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 pt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.608 ' HB2' HD23 ' A' ' 61' ' ' LEU . 7.2 m-85 -109.45 167.75 9.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.947 ' HG3' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -143.13 131.92 22.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 109.442 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.552 HG21 ' HG ' ' A' ' 98' ' ' LEU . 15.6 t -106.96 116.72 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.52 127.68 44.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.314 -0.866 . . . . 0.0 109.313 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -96.13 70.56 2.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.052 -1.03 . . . . 0.0 109.567 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -58.2 139.16 55.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.226 -0.921 . . . . 0.0 109.324 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.74 -17.52 15.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.28 -30.08 7.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -1.131 . . . . 0.0 109.266 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 66.05 90.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 0.0 109.622 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.56 -11.05 10.44 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 1.3 t-160 -92.26 87.87 6.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -1.132 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -107.94 107.79 18.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.26 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.9 m -104.37 165.39 11.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.278 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.947 HG22 ' HG3' ' A' ' 48' ' ' LYS . 1.6 pt -129.24 134.11 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.335 -0.853 . . . . 0.0 108.932 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.608 HD23 ' HB2' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -97.93 120.56 38.55 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.99 -1.069 . . . . 0.0 109.19 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.476 ' CD2' HD12 ' A' ' 60' ' ' ILE . 2.9 pp . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.684 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 81' ' ' GLY . 15.1 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.149 0.499 . . . . 0.0 109.667 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.693 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 85.76 -47.42 3.79 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 81' ' ' GLY . 25.7 mmt180 -38.18 164.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.771 -0.84 . . . . 0.0 110.592 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 6.4 m -96.89 130.96 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 108.869 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.644 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 pp -135.67 174.64 12.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 109.74 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 144.26 33.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.044 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.737 ' HB ' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -152.38 173.62 14.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.903 . . . . 0.0 109.534 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.752 ' O ' HD13 ' A' ' 98' ' ' LEU . 10.4 mpt_? -99.96 156.06 17.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.239 -0.913 . . . . 0.0 109.367 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.9 t -96.96 119.79 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.315 -0.865 . . . . 0.0 108.995 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.783 HG11 ' OD2' ' A' ' 97' ' ' ASP . 75.4 t -77.6 -31.22 17.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.374 -0.829 . . . . 0.0 109.928 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 1.6 ttm180 170.23 106.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.35 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.753 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -88.12 133.82 33.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.416 -0.803 . . . . 0.0 109.172 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.66 88.31 0.34 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.67 -177.89 33.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.5 mp -58.9 -16.23 16.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -1.135 . . . . 0.0 109.662 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -108.52 127.96 54.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.644 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.753 HG22 ' HA ' ' A' ' 91' ' ' ALA . 55.4 t -129.6 158.97 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.852 . . . . 0.0 109.356 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.783 ' OD2' HG11 ' A' ' 89' ' ' VAL . 28.7 t0 -98.59 147.72 24.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.97 . . . . 0.0 108.742 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -132.76 135.51 45.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.04 -1.037 . . . . 0.0 111.088 -178.73 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.549 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 4.7 ttp-105 -132.63 129.41 38.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.507 ' HB2' HG23 ' A' ' 86' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.021 -1.049 . . . . 0.0 109.732 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 t -168.74 150.56 4.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -1.161 . . . . 0.0 109.37 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 36' ' ' HIS . 20.2 t -102.55 163.33 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.476 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -172.86 163.85 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.772 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -101.35 142.05 33.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.387 -0.821 . . . . 0.0 109.305 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -153.53 176.6 31.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.511 HG23 ' O ' ' A' ' 81' ' ' GLY . 28.5 mt -97.31 154.58 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -1.21 . . . . 0.0 108.9 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 84' ' ' ILE . 77.0 t -98.66 150.61 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 110.16 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.538 ' HB3' ' CB ' ' A' ' 48' ' ' LYS . 42.9 t80 -141.98 155.03 45.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.344 -0.847 . . . . 0.0 109.142 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.506 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 28.3 p90 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.95 . . . . 0.0 109.589 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.623 HG22 HD13 ' A' ' 62' ' ' LEU . 3.0 pt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.179 0.514 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.43 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 5.6 m-85 -107.54 159.18 16.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.553 ' HG3' HG22 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -133.47 128.37 35.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.17 -0.956 . . . . 0.0 109.761 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.587 HG21 ' HG ' ' A' ' 98' ' ' LEU . 1.8 t -106.18 118.93 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 108.878 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.53 121.04 40.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 109.855 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.542 HD13 ' SG ' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -88.28 72.64 8.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.227 179.77 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.72 129.13 38.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.69 -33.99 4.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.43 -71.02 0.41 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -1.167 . . . . 0.0 109.531 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -178.31 55.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 109.556 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.42 7.79 48.01 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.75 118.06 2.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -1.189 . . . . 0.0 109.171 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 95' ' ' TYR . 7.4 tt0 -106.34 111.11 23.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.691 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.542 ' SG ' HD13 ' A' ' 51' ' ' LEU . 13.0 m -109.95 165.91 11.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.315 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.553 HG22 ' HG3' ' A' ' 48' ' ' LYS . 1.6 pt -133.95 135.53 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 109.49 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.654 HD12 ' HB3' ' A' ' 98' ' ' LEU . 3.9 tp -98.56 127.83 44.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.623 HD13 HG22 ' A' ' 46' ' ' ILE . 13.8 tp . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.346 -0.847 . . . . 0.0 109.463 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 81' ' ' GLY . 43.2 t . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.568 ' N ' HG12 ' A' ' 80' ' ' VAL . . . 85.67 -45.61 3.51 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 81' ' ' GLY . 2.8 mmt180 -43.15 172.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.647 -0.914 . . . . 0.0 110.382 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 38' ' ' GLY . 56.0 t -97.57 139.22 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.267 -0.895 . . . . 0.0 109.222 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.889 HD13 HG23 ' A' ' 86' ' ' THR . 2.0 pp -136.75 166.64 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 85' ' ' LYS . 15.6 ptpt -101.7 128.58 47.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 109.07 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.889 HG23 HD13 ' A' ' 84' ' ' ILE . 40.6 p -141.89 175.43 9.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.851 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.802 ' O ' HD13 ' A' ' 98' ' ' LEU . 3.8 mpt_? -101.48 161.59 13.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.486 -0.759 . . . . 0.0 109.426 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.2 t -97.75 110.39 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.338 -0.851 . . . . 0.0 109.003 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.575 HG23 ' N ' ' A' ' 99' ' ' ARG . 41.1 t -65.62 -40.29 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 0.0 110.103 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.49 103.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 109.501 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.763 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -82.76 122.18 27.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.527 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 91' ' ' ALA . 0.4 OUTLIER -156.26 92.19 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.286 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.5 -177.33 33.26 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -15.77 41.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -1.155 . . . . 0.0 109.445 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.5 OUTLIER -107.35 125.81 51.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.191 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.763 HG13 ' HA ' ' A' ' 91' ' ' ALA . 74.2 t -122.79 160.86 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.888 . . . . 0.0 109.468 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.56 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 0.9 OUTLIER -97.91 148.01 23.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.109 -0.994 . . . . 0.0 108.576 179.453 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -133.01 135.56 45.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 110.677 -178.614 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.575 ' N ' HG23 ' A' ' 89' ' ' VAL . 4.0 ttp85 -132.84 120.61 21.78 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.544 ' HG3' HG22 ' A' ' 86' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.89 129.59 52.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -1.178 . . . . 0.0 109.515 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.716 HG12 ' CD ' ' A' ' 87' ' ' ARG . 16.5 m -99.56 136.65 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -147.7 166.74 26.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.449 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.05 152.01 21.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.516 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -163.89 176.41 39.93 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.864 HG23 ' O ' ' A' ' 81' ' ' GLY . 76.6 mt -96.83 146.72 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -1.097 . . . . 0.0 108.356 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.517 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 57.2 t -99.46 137.67 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.963 -1.086 . . . . 0.0 110.591 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 2.9 t80 -122.46 154.57 37.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 109.043 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.502 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 12.8 p90 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.948 . . . . 0.0 109.641 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 47' ' ' PHE . 2.0 pt . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.947 ' HB2' HD23 ' A' ' 61' ' ' LEU . 76.1 m-85 -127.05 171.99 10.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.959 -1.088 . . . . 0.0 109.43 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.812 ' HE3' HG22 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -136.79 125.4 23.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.251 -0.906 . . . . 0.0 109.669 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.875 HG23 ' HB2' ' A' ' 61' ' ' LEU . 92.9 t -98.07 105.81 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.115 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.492 ' CG ' ' HB ' ' A' ' 39' ' ' ILE . 2.3 ptm85 -101.34 128.9 47.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.7 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.26 85.54 7.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 109.364 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HB2' HD12 ' A' ' 39' ' ' ILE . 2.6 tt -62.84 149.07 45.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.212 -0.93 . . . . 0.0 109.538 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.48 -55.18 0.84 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -75.06 -27.8 60.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -1.151 . . . . 0.0 109.515 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 54' ' ' TYR . 20.3 mt-10 48.87 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.35 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.88 -17.76 3.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.7 92.86 5.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -1.182 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.65 109.06 20.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.339 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.537 ' HB3' HD23 ' A' ' 98' ' ' LEU . 3.5 m -107.05 145.65 32.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.908 . . . . 0.0 109.512 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.812 HG22 ' HE3' ' A' ' 48' ' ' LYS . 30.0 pt -99.56 135.95 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.337 -0.852 . . . . 0.0 109.0 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.947 HD23 ' HB2' ' A' ' 47' ' ' PHE . 25.2 tp -98.61 107.89 20.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 110.183 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.559 HD21 HD12 ' A' ' 60' ' ' ILE . 3.4 mt . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.506 -0.746 . . . . 0.0 109.069 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.557 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.518 0.675 . . . . 0.0 109.31 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.864 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 86.5 -47.45 3.74 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -36.97 161.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.966 -0.726 . . . . 0.0 110.69 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 38' ' ' GLY . 99.5 t -97.14 136.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.281 -0.887 . . . . 0.0 108.967 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.712 HD13 HG23 ' A' ' 86' ' ' THR . 2.3 pp -138.96 174.93 8.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.334 -0.854 . . . . 0.0 109.883 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.47 141.22 39.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.372 -0.83 . . . . 0.0 109.198 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.712 HG23 HD13 ' A' ' 84' ' ' ILE . 19.0 p -151.37 175.26 12.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.192 -0.943 . . . . 0.0 109.315 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.831 ' O ' HD13 ' A' ' 98' ' ' LEU . 1.2 mmm-85 -98.68 158.03 15.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.265 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.6 t -98.28 110.1 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.564 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 26.9 t -63.08 -36.23 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.7 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.443 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER 168.97 106.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.237 -0.914 . . . . 0.0 109.362 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.787 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -91.96 117.27 29.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.424 -0.797 . . . . 0.0 109.235 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -103.4 -62.74 1.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.645 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -146.09 -115.79 0.95 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.04 -23.97 60.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -1.106 . . . . 0.0 109.466 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.53 129.19 55.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.122 -0.986 . . . . 0.0 109.529 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.787 HG13 ' HA ' ' A' ' 91' ' ' ALA . 95.0 t -131.41 158.34 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.856 . . . . 0.0 109.472 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.564 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 9.5 m-20 -101.04 143.39 31.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.0 108.625 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.831 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -130.14 136.91 49.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.904 -1.122 . . . . 0.0 110.659 -178.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.536 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 1.0 OUTLIER -126.35 119.63 27.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 108.89 178.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.497 ' HG3' HG22 ' A' ' 86' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.05 . . . . 0.0 109.695 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -163.95 169.62 17.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -1.133 . . . . 0.0 109.516 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.529 HG12 ' CD ' ' A' ' 87' ' ' ARG . 17.9 m -119.04 143.55 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.13 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.543 ' NE2' HG23 ' A' ' 88' ' ' VAL . 1.9 p80 -165.35 166.8 18.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.006 -1.059 . . . . 0.0 109.956 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.555 ' HG2' HG12 ' A' ' 83' ' ' VAL . 1.7 tt0 -98.8 145.28 27.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 108.907 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.693 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -151.64 176.16 30.15 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.046 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 81' ' ' GLY . 22.0 mt -97.09 150.56 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.515 -0.991 . . . . 0.0 108.544 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.912 ' CG2' HD12 ' A' ' 84' ' ' ILE . 10.6 t -98.16 142.89 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 0.0 110.095 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.512 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 39.6 t80 -141.48 153.25 44.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.385 -0.822 . . . . 0.0 109.104 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.433 ' CD1' ' C ' ' A' ' 42' ' ' PHE . 21.8 t80 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.644 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.926 HD13 ' HG ' ' A' ' 62' ' ' LEU . 2.2 mp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.781 ' N ' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -127.37 162.03 27.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.031 -1.043 . . . . 0.0 109.342 179.653 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.531 ' HG2' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -138.52 125.43 21.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -101.93 118.81 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 109.329 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -98.78 127.87 44.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.953 . . . . 0.0 109.527 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 51' ' ' LEU . 1.7 mm? -93.83 69.18 3.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 0.0 109.421 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.03 128.82 37.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.908 . . . . 0.0 109.419 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.47 -30.27 9.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 1.1 t80 -99.69 51.07 0.92 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.325 -1.103 . . . . 0.0 109.279 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 72.64 -159.54 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 109.455 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' HIS . . . -82.62 11.81 50.22 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -42.72 108.69 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.329 -1.1 . . . . 0.0 109.772 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -115.15 109.83 18.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.275 -0.891 . . . . 0.0 109.407 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.644 ' HB3' HD23 ' A' ' 98' ' ' LEU . 31.0 m -102.0 156.29 17.63 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.22 -0.925 . . . . 0.0 109.666 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.531 HG22 ' HG2' ' A' ' 48' ' ' LYS . 2.1 pt -125.43 135.54 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -97.71 128.9 44.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.888 -1.133 . . . . 0.0 109.679 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.926 ' HG ' HD13 ' A' ' 46' ' ' ILE . 1.8 tt . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.571 -0.706 . . . . 0.0 109.482 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.552 HG12 ' N ' ' A' ' 81' ' ' GLY . 44.9 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.364 0.602 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 85.47 -51.76 4.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -41.3 161.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -1.072 . . . . 0.0 110.011 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 38' ' ' GLY . 52.9 t -98.75 140.5 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.024 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.912 HD12 ' CG2' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -139.65 175.28 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.735 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -99.45 127.52 45.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.46 -0.775 . . . . 0.0 109.263 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.574 ' OG1' HD11 ' A' ' 98' ' ' LEU . 69.6 p -139.25 173.61 11.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.134 -0.979 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.794 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -105.21 161.02 14.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.543 HG23 ' NE2' ' A' ' 36' ' ' HIS . 59.1 t -97.31 115.03 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.411 -0.806 . . . . 0.0 108.871 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 99' ' ' ARG . 54.8 t -74.41 -39.05 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.468 -0.77 . . . . 0.0 110.259 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 179.25 101.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.972 -1.08 . . . . 0.0 110.031 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.824 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -90.02 122.54 33.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.69 -4.19 12.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 109.953 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 154.16 -113.4 0.57 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.89 -41.13 44.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 0.0 109.579 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -99.49 126.33 45.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.349 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.824 HG22 ' HA ' ' A' ' 91' ' ' ALA . 89.1 t -128.78 162.88 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.719 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.562 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 1.2 m-20 -98.51 154.4 17.92 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -137.74 136.51 37.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.884 -1.135 . . . . 0.0 111.119 -178.442 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.591 ' N ' HG23 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -132.12 108.4 9.26 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.165 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.42 ' HB3' HD11 ' A' ' 61' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.94 . . . . 0.0 109.413 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -113.12 162.98 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -1.166 . . . . 0.0 109.389 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.707 HG12 ' CD ' ' A' ' 87' ' ' ARG . 2.9 m -107.55 149.09 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.465 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.12 168.49 13.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.836 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 15.8 mt-10 -99.56 143.65 29.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.317 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -154.02 176.52 31.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 8.8 mt -97.08 152.63 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -1.148 . . . . 0.0 108.685 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.489 HG23 HD12 ' A' ' 84' ' ' ILE . 88.6 t -105.92 149.94 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.102 -0.999 . . . . 0.0 110.607 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.537 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -148.42 175.42 11.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.475 -0.765 . . . . 0.0 109.009 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 58.7 t80 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.153 -0.967 . . . . 0.0 109.35 179.855 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.77 HG21 HD22 ' A' ' 62' ' ' LEU . 12.3 pt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 1.8 m-85 -110.64 164.69 12.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.301 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -135.55 119.72 17.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.643 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 2.7 t -103.9 108.86 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.271 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 135.64 39.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.41 107.72 19.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.1 tp -81.27 148.55 29.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.599 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.4 -21.93 32.65 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -99.31 -30.14 12.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -1.165 . . . . 0.0 109.58 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 54' ' ' TYR . 4.8 mt-10 60.93 149.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.513 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.41 40.71 78.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.76 86.61 2.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.121 -1.223 . . . . 0.0 109.48 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.72 120.31 41.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.325 -0.859 . . . . 0.0 109.556 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.2 m -117.15 170.94 8.28 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.368 -0.832 . . . . 0.0 109.204 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.498 ' HB ' HD11 ' A' ' 46' ' ' ILE . 1.3 pp -134.47 133.07 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 0.0 109.303 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 0.7 OUTLIER -98.19 131.14 44.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.078 -1.014 . . . . 0.0 109.386 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.77 HD22 HG21 ' A' ' 46' ' ' ILE . 25.3 tp . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.489 -0.757 . . . . 0.0 109.413 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.462 HG13 HG12 ' A' ' 40' ' ' VAL . 11.7 t . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.268 0.556 . . . . 0.0 109.768 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 85.9 -53.47 4.67 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 81' ' ' GLY . 31.0 mtt85 -39.17 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.959 . . . . 0.0 110.357 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 66.4 t -98.47 140.46 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.737 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -146.64 174.83 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 110.157 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.517 ' O ' ' CG2' ' A' ' 86' ' ' THR . 1.5 tmmm? -100.23 147.06 26.15 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.686 ' OG1' HD11 ' A' ' 98' ' ' LEU . 67.1 p -158.51 174.22 15.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.963 . . . . 0.0 109.372 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.79 ' O ' HD13 ' A' ' 98' ' ' LEU . 20.8 mmm-85 -103.52 162.45 13.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 34' ' ' SER . 14.2 t -96.71 122.48 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.314 -0.867 . . . . 0.0 109.269 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.543 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 42.0 t -81.2 -41.1 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.445 -0.785 . . . . 0.0 109.929 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 178.59 101.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.062 -1.024 . . . . 0.0 109.749 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.852 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -71.99 135.06 46.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.567 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -128.42 32.85 4.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.387 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.58 -107.86 3.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.1 mp -79.52 -34.51 41.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -1.176 . . . . 0.0 109.311 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -102.01 131.76 48.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.887 . . . . 0.0 109.108 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.852 HG13 ' HA ' ' A' ' 91' ' ' ALA . 94.2 t -137.45 155.57 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.04 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.543 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 6.0 m-20 -99.32 156.73 16.85 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.91 140.51 34.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.083 -1.011 . . . . 0.0 110.234 -179.219 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.533 ' N ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -125.16 120.4 31.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.27 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 25.3 ttt-85 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.394 -179.863 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 m -106.69 165.14 11.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -1.12 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.658 HG12 ' HD2' ' A' ' 87' ' ' ARG . 3.7 m -108.26 140.3 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -156.18 167.99 28.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.651 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -101.0 143.28 31.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 109.348 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.611 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -153.77 175.61 32.02 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 81' ' ' GLY . 4.3 mp -97.97 153.61 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -1.086 . . . . 0.0 108.756 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.589 HG23 HD12 ' A' ' 84' ' ' ILE . 67.8 t -104.36 146.1 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.009 -1.057 . . . . 0.0 110.343 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 3.2 t80 -146.98 -173.47 4.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 108.903 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.9 t80 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.0 . . . . 0.0 109.522 -179.912 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.481 HG21 ' CD1' ' A' ' 62' ' ' LEU . 21.2 pt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.517 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 2.4 m-85 -119.84 161.06 21.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.109 -0.994 . . . . 0.0 109.636 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 1.8 tttp -130.95 120.56 23.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.288 -0.882 . . . . 0.0 109.556 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 7.4 t -100.82 126.85 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.181 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.23 139.66 39.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 0.0 109.774 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.9 OUTLIER -103.02 73.23 1.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.399 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.01 168.67 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.426 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.41 -36.65 3.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.521 ' CG ' ' CD2' ' A' ' 57' ' ' HIS . 5.5 t80 -98.01 -26.69 14.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -1.104 . . . . 0.0 109.305 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 54.77 26.31 7.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.493 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.33 25.92 0.3 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.521 ' CD2' ' CG ' ' A' ' 54' ' ' TYR . 9.7 m-70 -131.12 98.94 4.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -1.102 . . . . 0.0 109.609 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -103.37 107.41 18.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.135 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.485 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 5.1 m -107.72 158.81 16.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.276 -0.89 . . . . 0.0 109.62 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 pt -127.73 137.74 56.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.45 -0.781 . . . . 0.0 108.959 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.525 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 4.3 tp -98.68 131.56 44.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.156 -0.965 . . . . 0.0 109.915 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.481 ' CD1' HG21 ' A' ' 46' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.597 -0.689 . . . . 0.0 109.159 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.591 HG12 ' N ' ' A' ' 81' ' ' GLY . 57.3 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.661 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 85.18 -45.23 3.48 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.468 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -35.59 149.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.741 -0.858 . . . . 0.0 110.359 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 38' ' ' GLY . 65.1 t -98.81 142.69 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.465 -0.772 . . . . 0.0 109.523 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.832 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -149.22 170.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.602 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.22 112.46 24.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.134 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.613 ' OG1' HD11 ' A' ' 98' ' ' LEU . 74.1 p -116.58 175.17 5.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.635 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.801 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -102.19 161.53 13.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 67.6 t -96.85 124.67 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 108.985 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.538 ' CG2' ' HB3' ' A' ' 99' ' ' ARG . 96.4 t -85.28 -38.17 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.294 -0.879 . . . . 0.0 110.159 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.7 OUTLIER 176.9 103.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.135 -0.978 . . . . 0.0 109.637 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.659 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -99.35 123.7 43.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.377 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -115.43 -23.68 8.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 0.0 109.647 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.91 -137.7 2.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mp -57.12 -32.84 66.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -1.119 . . . . 0.0 109.627 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -99.03 131.51 45.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.659 HG13 ' HA ' ' A' ' 91' ' ' ALA . 78.3 t -135.64 158.61 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.056 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 98' ' ' LEU . 9.4 t0 -99.43 152.3 20.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 108.716 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -139.98 140.42 36.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 111.076 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.538 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 0.8 OUTLIER -126.04 119.88 28.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.502 -0.749 . . . . 0.0 109.093 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.46 ' N ' HD11 ' A' ' 61' ' ' LEU . 6.8 ttt-85 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.507 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -74.57 94.24 2.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.48 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.31 117.24 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.141 -0.974 . . . . 0.0 109.491 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -111.89 -68.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.9 tttm -118.82 82.82 21.3 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.867 . . . . 0.0 109.344 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.44 140.67 17.3 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.61 2.207 . . . . 0.0 110.445 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.96 107.57 18.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.76 77.75 0.9 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.945 . . . . 0.0 109.674 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -79.79 152.05 74.41 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.148 -0.97 . . . . 0.0 109.225 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.76 139.66 17.92 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.625 2.217 . . . . 0.0 110.307 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.417 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -150.56 67.17 7.95 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.743 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 35.2 Cg_endo -78.03 112.75 3.31 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.572 2.181 . . . . 0.0 110.255 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -147.5 70.87 1.18 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.59 161.92 19.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.422 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -122.67 127.06 48.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.338 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -144.21 115.15 7.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.381 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -160.81 87.32 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -0.866 . . . . 0.0 109.304 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 18' ' ' ILE . 8.5 tp -110.94 -16.98 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.696 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 18' ' ' ILE . 5.6 tttt 45.98 93.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.143 -0.973 . . . . 0.0 109.413 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 20' ' ' VAL . 2.6 p -124.39 97.15 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.908 . . . . 0.0 109.473 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -144.99 124.36 13.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.486 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -154.89 72.17 0.83 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.891 . . . . 0.0 109.565 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.69 95.78 5.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 25' ' ' THR . 0.0 OUTLIER 61.36 -169.6 0.17 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 109.661 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.418 ' O ' ' OG ' ' A' ' 26' ' ' SER . 9.8 t -44.75 142.52 1.7 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 109.53 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.678 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 63.4 m -168.89 170.48 9.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.323 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 26' ' ' SER . . . 74.34 147.81 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 109.397 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.456 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER 168.41 147.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.84 . . . . 0.0 109.286 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.85 140.12 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.104 -0.998 . . . . 0.0 109.872 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.06 21.93 0.76 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.38 -0.825 . . . . 0.0 109.075 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.78 149.31 87.96 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.419 -0.8 . . . . 0.0 109.7 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.39 171.23 17.23 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.664 2.243 . . . . 0.0 110.351 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.72 23.26 43.13 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.8 p -115.17 157.43 23.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -1.179 . . . . 0.0 109.532 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.9 150.3 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 4.0 m-70 -156.54 163.71 39.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 0.0 109.715 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.03 137.04 43.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 108.979 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.74 176.9 28.22 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.608 ' CD1' HD23 ' A' ' 52' ' ' LEU . 7.1 mt -96.51 152.51 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.346 -1.091 . . . . 0.0 108.636 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.606 ' CG2' HD12 ' A' ' 84' ' ' ILE . 76.2 t -99.58 148.08 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.68 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -142.72 164.52 29.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -126.37 134.88 50.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.051 -1.03 . . . . 0.0 109.872 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 7.4 tttt -178.95 142.46 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.502 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 43' ' ' LYS . 4.5 t70 69.51 9.77 7.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 109.494 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.39 -31.03 5.64 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 pt -88.29 -164.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.398 -1.06 . . . . 0.0 109.139 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 50.0 m-85 -113.9 173.85 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.16 -0.963 . . . . 0.0 109.387 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.14 132.78 22.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.371 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.773 HG23 ' HB2' ' A' ' 61' ' ' LEU . 45.8 t -104.62 115.15 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.194 -0.941 . . . . 0.0 109.591 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.701 ' NH1' HD21 ' A' ' 52' ' ' LEU . 7.0 ttt180 -98.64 130.51 45.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.161 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 51' ' ' LEU . 1.9 mm? -96.33 95.13 7.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 109.643 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.701 HD21 ' NH1' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -69.44 145.52 52.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.426 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.91 -39.96 2.7 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.23 -27.64 29.79 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -1.15 . . . . 0.0 109.292 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 57.87 96.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.239 -0.913 . . . . 0.0 109.649 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . 110.72 10.32 21.47 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.831 ' NE2' HG21 ' A' ' 96' ' ' VAL . 20.0 t-160 -109.82 96.9 6.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -1.202 . . . . 0.0 109.552 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -109.08 131.67 54.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.534 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.6 m -124.67 162.87 23.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 109.422 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.485 ' HB ' HD11 ' A' ' 62' ' ' LEU . 2.5 pt -116.01 130.23 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.89 . . . . 0.0 109.29 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.773 ' HB2' HG23 ' A' ' 49' ' ' VAL . 6.0 tt -99.35 118.07 35.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.248 -0.907 . . . . 0.0 109.876 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 62' ' ' LEU . 2.1 mp -132.69 7.92 4.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.479 -0.763 . . . . 0.0 109.091 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 t0 57.39 40.01 27.78 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.3 t80 60.93 31.32 19.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.476 -0.765 . . . . 0.0 108.979 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.541 HD22 ' O ' ' A' ' 68' ' ' ARG . 5.5 mt -77.37 -82.54 0.08 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.678 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.72 23.89 8.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.194 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.5 ' CD1' ' HB2' ' A' ' 68' ' ' ARG . 15.3 t80 -176.84 112.34 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.236 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.541 ' O ' HD22 ' A' ' 65' ' ' LEU . 0.4 OUTLIER 67.08 143.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.9 . . . . 0.0 109.448 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.74 175.57 5.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.578 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 4.6 p30 -156.06 49.41 0.51 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.346 -0.846 . . . . 0.0 109.574 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.996 ' O ' HD12 ' A' ' 72' ' ' LEU . 42.9 p -77.31 119.62 21.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.365 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.996 HD12 ' O ' ' A' ' 71' ' ' THR . 0.3 OUTLIER -157.94 44.79 0.33 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.211 -0.931 . . . . 0.0 109.384 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -151.71 89.3 1.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.506 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.57 -29.82 39.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.435 -0.791 . . . . 0.0 109.739 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 tp -58.9 -40.81 85.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.668 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.782 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -52.92 -28.44 23.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 109.777 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -64.76 -42.2 95.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 109.942 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.24 -26.6 52.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.935 . . . . 0.0 110.242 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.463 ' O ' ' C ' ' A' ' 80' ' ' VAL . 1.3 mp -80.86 -24.57 38.27 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.013 -1.054 . . . . 0.0 110.227 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 76' ' ' LYS . 14.3 t -40.74 160.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.25 -0.907 . . . . 0.0 109.596 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 87.28 -50.93 4.16 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -37.86 156.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.664 -0.903 . . . . 0.0 110.295 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.2 t -98.47 134.21 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 109.138 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.815 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -143.58 174.27 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 0.0 109.868 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 1.8 ttmt -104.66 124.98 50.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.446 -0.784 . . . . 0.0 109.087 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.72 HG22 ' CG ' ' A' ' 100' ' ' ARG . 24.5 p -127.95 175.44 8.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.509 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.873 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -98.55 152.85 19.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.091 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.61 131.37 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.982 . . . . 0.0 109.473 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.543 HG22 ' HG2' ' A' ' 99' ' ' ARG . 94.6 t -92.83 -35.7 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.34 -0.85 . . . . 0.0 109.86 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 96' ' ' VAL . 9.9 ttt85 178.46 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.978 . . . . 0.0 109.335 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.813 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -95.88 117.63 30.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.502 -0.749 . . . . 0.0 109.554 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -110.01 -21.6 12.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -0.935 . . . . 0.0 109.477 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 94' ' ' LEU . . . 123.33 115.31 2.21 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.576 ' CB ' ' O ' ' A' ' 93' ' ' GLY . 1.5 tp 84.39 -57.13 0.12 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.759 -0.848 . . . . 0.0 109.448 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -116.8 119.6 35.91 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 108.841 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.831 HG21 ' NE2' ' A' ' 57' ' ' HIS . 69.1 t -129.89 159.11 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 110.332 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.563 ' O ' HD22 ' A' ' 98' ' ' LEU . 9.6 m-20 -98.66 143.27 29.22 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.873 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -135.49 141.78 45.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.809 -1.182 . . . . 0.0 110.97 -178.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.543 ' HG2' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -133.72 112.27 11.25 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.642 -0.661 . . . . 0.0 109.399 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.72 ' CG ' HG22 ' A' ' 86' ' ' THR . 0.0 OUTLIER -84.18 139.96 32.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.102 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.32 160.55 14.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.599 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.515 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.263 0.554 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.534 HG22 HG13 ' A' ' 3' ' ' VAL . 34.6 m -132.22 -54.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 109.362 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.534 HG13 HG22 ' A' ' 2' ' ' THR . 3.2 m -132.12 40.69 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.374 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.442 ' O ' ' HG3' ' A' ' 5' ' ' LYS . 9.1 tp -76.25 -26.17 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 4' ' ' ILE . 2.2 mttm -172.65 67.15 0.38 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.562 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 5' ' ' LYS . 35.7 Cg_endo -78.34 -38.53 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.618 2.212 . . . . 0.0 110.412 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.51 124.45 25.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.3 p -118.16 147.13 43.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 109.4 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -154.93 85.95 3.51 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 109.543 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.451 ' O ' ' HD2' ' A' ' 11' ' ' ARG . 35.0 Cg_endo -78.38 121.71 5.33 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.544 2.163 . . . . 0.0 110.364 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.596 ' CB ' ' HD3' ' A' ' 12' ' ' PRO . 1.0 OUTLIER -179.02 -58.69 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 0.0 109.503 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 11' ' ' ARG . 35.6 Cg_endo -76.31 76.12 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 122.19 1.927 . . . . 0.0 110.184 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -84.47 115.86 22.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.852 . . . . 0.0 109.589 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.91 153.96 3.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 109.458 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.52 98.84 8.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.941 . . . . 0.0 109.387 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.95 130.79 34.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.662 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -115.03 -31.38 6.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.274 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.3 mm -60.64 92.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.308 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -170.3 -36.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -0.934 . . . . 0.0 109.48 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 p -98.91 137.98 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 109.48 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -172.13 155.76 3.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.858 . . . . 0.0 109.305 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -169.4 51.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -123.59 75.58 1.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 109.67 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.519 ' CD ' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -163.05 58.47 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.401 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.4 t -49.93 167.69 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -0.917 . . . . 0.0 109.58 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.47 -164.93 1.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.91 . . . . 0.0 109.503 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.43 179.04 4.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.534 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.4 ttm -107.04 -21.17 13.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.425 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -138.68 121.14 16.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.885 . . . . 0.0 109.401 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 91' ' ' ALA . 77.0 mt -51.7 157.31 1.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.862 . . . . 0.0 109.561 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 37.8 m -99.67 159.64 29.44 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.355 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 31' ' ' SER . 35.5 Cg_endo -77.59 131.54 11.51 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.605 2.203 . . . . 0.0 110.466 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.4 86.85 0.82 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -172.76 161.78 4.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -1.165 . . . . 0.0 109.598 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 35' ' ' VAL . 2.3 m -122.5 125.44 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 0.0 109.311 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -133.01 168.72 17.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.125 -0.984 . . . . 0.0 109.67 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.69 147.03 25.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.273 -0.892 . . . . 0.0 109.107 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.698 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -159.13 176.8 35.89 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.688 HD12 HG22 ' A' ' 83' ' ' VAL . 2.4 mm -96.8 154.42 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -1.158 . . . . 0.0 108.82 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 34.9 t -105.8 146.75 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 110.329 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -137.3 145.71 43.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 109.216 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 42.9 p90 -98.48 138.82 35.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.095 -1.003 . . . . 0.0 109.657 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -160.24 125.19 3.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.639 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.5 t70 44.04 31.16 0.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.374 -0.829 . . . . 0.0 109.734 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.28 -42.51 3.09 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 47' ' ' PHE . 3.7 mt -64.32 162.42 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -1.164 . . . . 0.0 109.176 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.509 ' CB ' HD23 ' A' ' 61' ' ' LEU . 60.0 m-85 -105.79 169.75 8.3 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.046 -1.034 . . . . 0.0 109.157 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.7 135.67 24.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.519 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.848 HG23 ' HB2' ' A' ' 61' ' ' LEU . 60.3 t -104.48 119.64 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.225 -0.922 . . . . 0.0 109.736 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -98.88 120.9 40.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 109.075 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.1 OUTLIER -86.06 84.88 7.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.668 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.49 138.95 54.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.391 -0.818 . . . . 0.0 109.506 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.48 -41.48 2.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -81.37 -30.26 33.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -1.161 . . . . 0.0 109.578 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 62.53 84.49 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.85 -20.15 6.44 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -71.51 94.47 1.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -1.134 . . . . 0.0 109.649 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -108.15 105.82 15.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 109.368 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.0 m -102.58 158.38 16.27 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.24 -0.913 . . . . 0.0 109.153 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.518 HG12 ' HA ' ' A' ' 97' ' ' ASP . 25.4 pt -103.81 129.18 56.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.259 -0.901 . . . . 0.0 109.055 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.848 ' HB2' HG23 ' A' ' 49' ' ' VAL . 50.2 tp -98.68 108.66 21.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.659 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 3.5 mm? -105.5 4.41 30.5 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.496 -0.752 . . . . 0.0 109.205 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 64' ' ' TYR . 0.5 OUTLIER 56.28 34.18 23.58 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.313 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.496 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 57.2 t80 62.64 36.58 13.5 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.511 ' O ' ' CB ' ' A' ' 66' ' ' ASN . 0.2 OUTLIER -66.7 -52.72 41.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.744 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 65' ' ' LEU . 9.1 t30 75.07 78.27 0.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.14 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 t80 64.0 177.86 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.132 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.0 -164.49 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.141 -0.974 . . . . 0.0 109.127 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -177.59 114.37 0.08 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.054 -1.029 . . . . 0.0 109.713 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 71' ' ' THR . 1.6 m-20 -91.73 179.04 5.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.204 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -156.19 61.33 0.57 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.628 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.428 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -127.01 61.35 1.35 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.961 . . . . 0.0 109.332 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.426 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 3.1 p-10 -143.97 75.58 1.47 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.37 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -77.26 -56.13 4.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.804 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.3 -42.24 90.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 109.836 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.764 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -53.47 -26.19 19.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.229 -0.919 . . . . 0.0 109.83 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -58.35 -42.97 88.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.127 -0.983 . . . . 0.0 109.93 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.415 ' HA ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -77.73 -30.58 51.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.09 -1.006 . . . . 0.0 110.103 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 80' ' ' VAL . 1.4 mp -78.7 -16.04 57.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.137 -0.977 . . . . 0.0 110.075 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 76' ' ' LYS . 54.5 t -42.98 165.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.254 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.566 ' N ' HG12 ' A' ' 80' ' ' VAL . . . 87.4 -48.63 3.8 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 81' ' ' GLY . 5.9 mtp180 -38.96 156.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.702 -0.881 . . . . 0.0 110.016 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 38' ' ' GLY . 4.1 t -98.4 145.33 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 109.162 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.816 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -148.99 164.5 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.0 109.622 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.18 104.16 16.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.408 -0.808 . . . . 0.0 109.209 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.681 HG23 HG12 ' A' ' 84' ' ' ILE . 22.3 p -112.91 175.59 5.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.793 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -99.94 154.28 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.089 -1.007 . . . . 0.0 109.464 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.663 ' HA ' HD22 ' A' ' 98' ' ' LEU . 63.7 t -97.58 110.49 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 0.0 108.863 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 99' ' ' ARG . 2.2 t -64.33 -35.34 73.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.866 . . . . 0.0 110.082 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.03 101.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.938 . . . . 0.0 109.559 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.787 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -95.87 124.65 39.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.279 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.46 -43.69 2.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.17 -138.76 2.51 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -24.7 4.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -1.129 . . . . 0.0 109.753 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -112.34 125.55 54.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.787 HG22 ' HA ' ' A' ' 91' ' ' ALA . 49.7 t -133.27 166.62 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -0.89 . . . . 0.0 109.491 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.603 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -110.37 146.96 34.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 108.732 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -134.15 128.09 33.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.998 -1.064 . . . . 0.0 110.881 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.604 ' HB3' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -122.37 133.18 54.65 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -91.12 150.25 21.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.579 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.526 ' HB3' ' NH2' ' A' ' 87' ' ' ARG . 43.3 t80 -129.29 156.37 44.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.493 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.414 ' N ' ' CD1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.502 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 tpt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.37 66.74 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.128 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.885 HG22 HG22 ' A' ' 4' ' ' ILE . 8.4 p -74.98 115.56 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.871 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.885 HG22 HG22 ' A' ' 3' ' ' VAL . 2.7 tt 40.0 74.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.54 -0.725 . . . . 0.0 110.142 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.1 70.68 5.69 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.187 -0.946 . . . . 0.0 109.461 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.09 73.27 5.83 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.62 2.213 . . . . 0.0 110.471 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.18 -45.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.259 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.5 m 51.29 86.61 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.289 -0.882 . . . . 0.0 109.738 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -55.72 155.29 11.28 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 109.27 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.62 168.96 21.72 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.598 2.199 . . . . 0.0 110.274 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -135.31 77.24 54.71 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.572 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.69 102.68 1.62 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.627 2.218 . . . . 0.0 110.266 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -69.22 112.99 6.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.689 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.76 69.85 0.76 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.248 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -139.51 165.67 26.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.249 -0.907 . . . . 0.0 109.571 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.32 -89.85 0.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.277 -0.889 . . . . 0.0 109.425 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 m120 54.26 46.08 25.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.259 -0.9 . . . . 0.0 109.409 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.56 101.83 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -0.855 . . . . 0.0 109.579 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.42 99.73 6.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.278 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 20' ' ' VAL . 5.3 m -93.22 119.19 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 109.587 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -166.75 87.04 0.3 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.531 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -124.41 139.66 53.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.485 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -91.36 62.22 4.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.214 -0.929 . . . . 0.0 109.411 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER 44.67 88.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.896 . . . . 0.0 109.408 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.49 132.27 55.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 0.0 109.511 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.551 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -148.92 137.91 21.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.363 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 26' ' ' SER . . . 67.13 129.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.302 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.6 ttt -91.8 98.45 11.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.175 -0.953 . . . . 0.0 109.7 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -164.25 -72.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.455 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.91 72.56 0.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 0.0 109.334 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.22 146.36 55.94 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 109.479 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.84 132.33 10.65 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.575 2.183 . . . . 0.0 110.398 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.25 29.48 5.7 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.613 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . 0.5 OUTLIER -114.14 156.41 24.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -1.121 . . . . 0.0 109.366 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 35' ' ' VAL . 4.0 m -115.56 127.49 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.309 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.613 ' CE1' ' HB3' ' A' ' 34' ' ' SER . 62.8 m80 -143.36 168.01 20.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.789 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -101.34 141.58 34.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.255 -0.903 . . . . 0.0 109.368 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.673 ' O ' HG23 ' A' ' 83' ' ' VAL . . . -150.29 176.88 28.71 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.505 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 15.7 mt -96.42 153.87 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.243 . . . . 0.0 108.444 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 82' ' ' ARG . 38.8 t -98.99 151.8 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 110.431 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.95 150.4 35.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.429 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 20.5 t80 -108.88 125.81 52.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.552 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER 174.72 148.93 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 109.833 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.531 ' HB3' ' CG1' ' A' ' 46' ' ' ILE . 0.5 OUTLIER 71.94 42.07 0.63 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.835 . . . . 0.0 109.503 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 44.6 25.73 0.91 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -151.37 -169.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.376 -1.073 . . . . 0.0 109.001 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.667 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.8 m-85 -102.97 174.93 5.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.083 -1.011 . . . . 0.0 108.975 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 59' ' ' CYS . 1.6 tttp -148.31 148.9 30.94 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.198 -0.939 . . . . 0.0 109.624 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.519 HG21 ' HG ' ' A' ' 98' ' ' LEU . 2.4 t -126.02 116.72 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 109.199 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.37 131.75 44.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 109.375 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.3 OUTLIER -88.57 95.6 10.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.192 -0.942 . . . . 0.0 109.765 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.62 138.72 55.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.35 -30.02 9.38 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 55' ' ' GLU . 2.1 m-85 -117.16 66.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -1.06 . . . . 0.0 109.073 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -41.38 107.3 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.396 -0.815 . . . . 0.0 109.665 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.02 32.54 0.79 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -140.94 92.91 2.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -1.105 . . . . 0.0 109.782 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.57 123.1 48.86 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.988 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.449 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.2 m -116.08 167.72 10.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 109.567 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 5.9 pt -122.37 130.66 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.364 -0.835 . . . . 0.0 109.087 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 100' ' ' ARG . 12.3 tp -97.91 116.67 30.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.969 . . . . 0.0 109.251 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -127.39 12.43 7.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.768 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.06 39.46 30.43 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 18.5 t80 64.37 30.89 13.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.481 -0.762 . . . . 0.0 109.108 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.513 HD22 ' HB2' ' A' ' 68' ' ' ARG . 4.7 mt -77.3 -79.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.898 . . . . 0.0 109.487 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 m120 55.76 38.51 30.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.38 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.36 -47.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 109.357 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.513 ' HB2' HD22 ' A' ' 65' ' ' LEU . 5.8 mmp_? -114.46 167.35 10.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.324 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -106.09 173.21 6.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.487 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -101.99 161.78 13.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.166 -0.958 . . . . 0.0 109.593 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.442 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 3.8 t -161.85 166.32 26.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.374 -0.828 . . . . 0.0 109.359 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.442 ' CB ' ' O ' ' A' ' 71' ' ' THR . 0.1 OUTLIER 71.37 43.74 0.59 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 109.459 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.43 ' OD2' ' HB2' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -111.29 48.91 0.91 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.361 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -56.24 22.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.398 -0.814 . . . . 0.0 109.629 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.7 mt -75.64 -38.33 58.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.925 . . . . 0.0 109.615 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.65 ' O ' HG23 ' A' ' 80' ' ' VAL . 18.9 mmtt -57.03 -26.61 60.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.663 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -37.68 78.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.196 -0.94 . . . . 0.0 109.218 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -77.43 -30.34 53.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.338 -0.851 . . . . 0.0 110.012 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -72.35 -29.98 64.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.966 . . . . 0.0 109.803 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 76' ' ' LYS . 21.4 t -40.91 163.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.546 -0.721 . . . . 0.0 109.693 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.505 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 87.73 -48.73 3.75 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.671 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -40.8 152.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.481 -1.011 . . . . 0.0 110.023 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 38' ' ' GLY . 7.4 p -99.05 137.29 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.847 . . . . 0.0 109.109 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.841 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -145.23 170.98 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 110.013 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.7 120.65 40.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 0.0 109.047 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.531 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -128.0 176.07 7.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.305 -0.872 . . . . 0.0 109.582 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.75 ' O ' HD13 ' A' ' 98' ' ' LEU . 9.0 mpt_? -97.91 155.0 17.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.0 t -97.41 121.23 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.272 -0.892 . . . . 0.0 109.661 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.55 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 40.9 t -77.0 -39.49 29.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.494 -0.754 . . . . 0.0 109.494 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.416 ' O ' HG13 ' A' ' 96' ' ' VAL . 3.5 mtp180 178.63 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.119 -0.988 . . . . 0.0 109.618 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.825 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -101.87 129.76 48.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.533 -0.729 . . . . 0.0 109.175 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -131.28 -39.83 1.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.064 -1.023 . . . . 0.0 109.511 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -151.97 -127.45 1.32 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.39 -17.74 57.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -1.139 . . . . 0.0 109.808 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -110.24 121.59 45.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -0.989 . . . . 0.0 109.282 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 91' ' ' ALA . 96.0 t -132.86 156.44 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -0.884 . . . . 0.0 109.745 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.55 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 1.7 m-20 -98.35 150.03 22.02 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -134.31 134.81 42.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.859 -1.151 . . . . 0.0 111.085 -178.573 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.446 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -121.72 124.55 44.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.749 ' HB2' HD11 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -92.58 130.18 38.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.557 -179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -55.9 123.08 13.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.89 . . . . 0.0 109.432 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.353 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.9 p 45.94 56.7 5.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.399 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.64 174.46 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.592 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 5' ' ' LYS . 19.9 mm -91.13 161.42 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 109.45 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.527 ' CG ' ' HD2' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -149.73 173.29 4.38 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.527 ' HD2' ' CG ' ' A' ' 5' ' ' LYS . 35.3 Cg_endo -77.56 169.48 20.9 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.592 2.194 . . . . 0.0 110.428 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -129.1 -94.58 0.42 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.857 . . . . 0.0 109.537 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 p -100.27 52.48 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.047 -1.033 . . . . 0.0 109.377 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.571 ' N ' ' HD2' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -67.31 -52.52 28.59 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.825 . . . . 0.0 109.863 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 35.5 Cg_endo -77.89 127.46 8.63 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.507 2.138 . . . . 0.0 110.573 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.458 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 6.8 ptm180 -172.23 65.57 0.38 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.462 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 35.5 Cg_endo -78.28 96.04 1.08 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.642 2.228 . . . . 0.0 110.153 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 17' ' ' ASN . 5.1 ttm-85 51.57 91.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.187 -0.946 . . . . 0.0 109.275 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.93 -46.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -87.01 56.22 3.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 109.403 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.04 62.93 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 0.0 109.622 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -165.1 81.58 0.35 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 0.0 109.542 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.1 mt -102.66 -38.39 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.912 . . . . 0.0 109.371 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.66 103.68 11.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.435 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.5 m -112.05 68.68 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -49.25 -49.06 45.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.923 . . . . 0.0 109.549 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.79 77.98 8.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.4 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -83.82 119.53 24.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 0.0 109.299 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -81.93 124.2 29.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.347 -0.845 . . . . 0.0 109.574 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 26' ' ' SER . 5.3 t -110.7 54.09 0.68 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -51.31 -177.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.458 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 52.64 57.72 6.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.392 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -62.28 157.19 20.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 0.0 109.693 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t70 61.45 159.21 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.878 . . . . 0.0 109.66 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -113.62 176.41 5.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.352 -0.843 . . . . 0.0 109.496 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.496 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -142.15 165.55 26.81 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.484 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 31' ' ' SER . 35.2 Cg_endo -77.38 148.36 26.57 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.634 2.223 . . . . 0.0 110.438 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.83 63.52 2.55 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.6 t -149.78 138.93 21.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -1.15 . . . . 0.0 109.592 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.477 HG12 ' NE ' ' A' ' 87' ' ' ARG . 16.5 m -102.25 155.65 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.421 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -165.07 162.29 20.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.947 . . . . 0.0 109.5 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.79 137.85 36.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.07 176.11 29.72 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mt -97.39 154.66 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.317 -1.108 . . . . 0.0 108.812 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.477 ' CG2' HD12 ' A' ' 84' ' ' ILE . 17.6 t -104.96 159.94 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 0.0 110.12 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.495 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -146.61 170.33 17.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 0.0 109.208 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.65 109.8 9.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.954 . . . . 0.0 109.378 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -176.46 164.18 2.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.931 . . . . 0.0 109.452 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 2.6 m-20 72.05 3.77 4.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.323 -0.861 . . . . 0.0 109.714 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.2 -18.09 50.3 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.6 pt -115.35 -151.17 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -1.171 . . . . 0.0 109.223 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.495 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 44.4 m-85 -112.69 160.19 18.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.951 -1.093 . . . . 0.0 109.08 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -127.16 151.42 48.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 0.0 109.762 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 61' ' ' LEU . 63.5 t -129.42 115.14 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.409 -0.807 . . . . 0.0 109.076 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -100.36 127.55 46.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.172 -0.955 . . . . 0.0 109.571 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 3.1 mp -95.17 76.33 3.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 109.485 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.0 162.75 3.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.75 -43.15 3.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.457 ' O ' ' O ' ' A' ' 55' ' ' GLU . 68.4 m-85 -85.29 -30.56 23.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -1.105 . . . . 0.0 109.686 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' TYR . 3.5 mt-10 61.04 146.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.192 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . 63.52 12.51 46.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -116.64 82.95 1.88 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -1.146 . . . . 0.0 109.264 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -100.29 105.92 17.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.309 -0.87 . . . . 0.0 109.52 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.434 ' SG ' HD13 ' A' ' 51' ' ' LEU . 4.4 m -100.19 172.67 7.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.925 . . . . 0.0 109.267 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.84 140.83 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 109.241 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.759 HD21 ' CB ' ' A' ' 64' ' ' TYR . 34.9 tp -98.14 116.82 31.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.962 . . . . 0.0 109.339 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.1 tp -128.51 -32.37 2.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.491 -0.755 . . . . 0.0 109.724 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.553 ' CB ' ' CB ' ' A' ' 99' ' ' ARG . 3.0 t70 -69.71 -47.37 63.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.621 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.759 ' CB ' HD21 ' A' ' 61' ' ' LEU . 26.5 t80 -43.25 -29.98 0.45 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 0.0 109.697 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.18 -70.15 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.153 -0.967 . . . . 0.0 109.437 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.0 t30 50.64 -159.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.494 ' CD1' ' C ' ' A' ' 67' ' ' TYR . 19.4 p90 -103.83 153.16 21.05 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.882 . . . . 0.0 109.422 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -176.11 170.47 2.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -60.76 170.58 1.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.14 70.72 7.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.47 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -59.39 137.74 57.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 109.597 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.451 ' O ' ' CB ' ' A' ' 73' ' ' ASP . 0.5 OUTLIER -45.23 -31.63 1.6 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.404 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 72' ' ' LEU . 2.6 t70 71.88 4.49 5.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.48 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -54.53 35.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.388 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.04 -26.81 60.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.91 ' O ' HG23 ' A' ' 80' ' ' VAL . 28.2 tptp -67.28 -31.12 71.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.86 . . . . 0.0 109.639 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.93 -34.5 78.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.091 -1.006 . . . . 0.0 109.489 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.484 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -77.22 -37.67 52.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.339 -0.85 . . . . 0.0 109.565 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 80' ' ' VAL . 30.1 tp -65.97 -35.79 81.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 76' ' ' LYS . 28.1 t -43.05 163.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.314 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.514 ' N ' HG12 ' A' ' 80' ' ' VAL . . . 85.19 -47.54 3.87 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.457 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -40.2 162.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.467 -1.019 . . . . 0.0 110.048 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 m -98.84 144.35 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.047 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.769 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -149.17 173.69 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -0.966 . . . . 0.0 109.629 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -104.14 106.64 17.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.148 -0.97 . . . . 0.0 109.332 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.483 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 8.5 p -112.0 175.75 5.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 0.0 109.55 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.802 ' O ' HD13 ' A' ' 98' ' ' LEU . 10.4 mpt_? -98.73 159.58 14.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.811 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.6 t -96.96 117.54 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.468 -0.77 . . . . 0.0 109.205 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.708 HG22 ' HG2' ' A' ' 99' ' ' ARG . 72.6 t -77.84 -40.33 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.519 -0.738 . . . . 0.0 110.092 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 175.99 104.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.163 -0.961 . . . . 0.0 109.585 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.808 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -96.86 135.4 38.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.66 -36.98 1.59 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.99 . . . . 0.0 109.767 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.04 -134.71 1.69 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -63.48 -17.3 62.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -1.141 . . . . 0.0 109.538 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.56 130.64 56.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 109.506 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.808 HG22 ' HA ' ' A' ' 91' ' ' ALA . 53.9 t -137.2 157.19 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.516 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 49.8 m-20 -98.32 147.21 24.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.232 -0.917 . . . . 0.0 108.661 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -134.91 136.89 42.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.048 -1.032 . . . . 0.0 110.263 -178.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.708 ' HG2' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -136.53 124.56 22.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.589 -0.695 . . . . 0.0 109.232 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.23 127.15 31.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.341 -0.85 . . . . 0.0 109.386 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.558 ' CB ' ' NE ' ' A' ' 87' ' ' ARG . 18.4 t80 -86.84 171.65 10.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.575 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.404 ' CD2' ' OXT' ' A' ' 102' ' ' PHE . 79.8 t80 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.4 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.247 0.546 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 2' ' ' THR . 9.3 t -138.27 47.86 1.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.937 . . . . 0.0 109.637 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 75.8 t -54.06 -42.99 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 109.205 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 4' ' ' ILE . 10.1 tp -123.36 156.05 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.387 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.97 169.0 10.64 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.152 -0.968 . . . . 0.0 109.577 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.23 117.57 4.13 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.627 2.218 . . . . 0.0 110.335 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.19 173.9 10.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.209 -0.932 . . . . 0.0 109.546 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.0 m -144.78 121.34 11.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 109.432 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -147.23 84.95 7.05 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.414 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.13 -168.36 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.593 2.195 . . . . 0.0 110.385 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -70.52 148.86 95.47 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.943 . . . . 0.0 109.534 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.41 95.91 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.607 2.205 . . . . 0.0 110.463 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.85 101.89 6.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.91 . . . . 0.0 109.439 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.43 -80.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.153 -0.967 . . . . 0.0 109.345 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -168.03 104.79 0.48 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.159 -0.963 . . . . 0.0 109.527 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.19 -73.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.312 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 45.82 65.17 1.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.619 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -101.11 -17.86 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.158 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 -7.8 7.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.317 -0.864 . . . . 0.0 109.403 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.79 63.67 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.329 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -126.44 92.71 3.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.216 -0.927 . . . . 0.0 109.481 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 22' ' ' THR . 9.8 t -121.51 49.12 1.57 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.486 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -83.16 131.64 35.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.354 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.45 -33.94 6.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 0.0 109.654 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.5 m -113.83 121.98 45.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.912 . . . . 0.0 109.531 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 t -124.74 69.21 1.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.65 67.85 1.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.459 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.439 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 17.3 mtp -110.64 74.51 0.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 28' ' ' MET . 64.2 m-20 63.15 -178.79 0.15 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.344 -0.848 . . . . 0.0 109.342 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.516 HD22 ' CB ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -90.5 130.31 36.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.571 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 p -127.39 160.25 61.17 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.48 134.29 12.38 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.641 2.228 . . . . 0.0 110.272 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.47 71.06 1.0 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 p -170.56 158.6 6.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -1.122 . . . . 0.0 109.58 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.41 HG12 ' NE ' ' A' ' 87' ' ' ARG . 17.8 m -107.29 149.4 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.254 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -152.09 166.35 31.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.173 -0.955 . . . . 0.0 109.823 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -99.69 151.25 21.43 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 109.14 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.38 176.63 43.32 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.729 HG23 ' O ' ' A' ' 81' ' ' GLY . 8.2 mt -97.04 149.92 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -1.184 . . . . 0.0 108.389 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 41' ' ' TYR . 24.4 t -98.14 166.38 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.074 -1.016 . . . . 0.0 110.482 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.568 ' N ' HG12 ' A' ' 40' ' ' VAL . 9.1 t80 -150.75 139.94 21.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.054 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.416 ' HB2' HG21 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -99.04 107.66 20.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.015 . . . . 0.0 109.661 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -94.27 171.22 8.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.278 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -89.22 8.14 31.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.933 . . . . 0.0 109.397 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.508 ' O ' ' CG2' ' A' ' 46' ' ' ILE . . . -135.57 -34.66 0.24 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.508 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 20.4 pt -158.38 -159.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -1.202 . . . . 0.0 109.134 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 12.8 m-85 -105.9 157.61 17.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.415 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.512 ' CB ' ' HB3' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -130.19 151.18 50.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.435 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.21 120.67 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 109.45 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -99.81 127.16 45.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.925 . . . . 0.0 109.327 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.447 ' CB ' ' HB3' ' A' ' 57' ' ' HIS . 0.1 OUTLIER -92.8 75.48 4.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 109.598 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.28 124.36 19.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 109.425 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 132.6 -41.13 1.53 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.507 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 61.7 t80 -83.8 -19.48 34.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -1.113 . . . . 0.0 109.507 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 9.1 tp10 62.85 88.68 0.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.347 -0.845 . . . . 0.0 109.792 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.8 25.28 5.74 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 54' ' ' TYR . 2.3 t-160 -108.9 92.36 4.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.075 -1.25 . . . . 0.0 109.75 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.08 115.1 29.82 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.41 -0.806 . . . . 0.0 109.278 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -116.13 163.26 16.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 60' ' ' ILE . 24.1 pt -129.52 125.59 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 109.23 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.538 HD13 HG21 ' A' ' 86' ' ' THR . 6.8 tp -98.2 121.72 40.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.007 -1.058 . . . . 0.0 109.592 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.2 -35.31 0.28 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.659 -0.651 . . . . 0.0 109.286 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 64' ' ' TYR . 0.9 OUTLIER -53.83 -30.84 47.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.126 -0.984 . . . . 0.0 108.966 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 63' ' ' ASP . 7.4 t80 -41.93 -51.07 4.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.466 -0.772 . . . . 0.0 109.234 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 66' ' ' ASN . 0.3 OUTLIER -54.51 -73.0 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.181 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER 43.05 43.23 3.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 0.0 109.538 179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.84 68.46 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.868 . . . . 0.0 109.471 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.58 107.42 0.33 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.865 . . . . 0.0 109.502 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.61 -81.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.136 -0.978 . . . . 0.0 109.476 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 71' ' ' THR . 0.7 OUTLIER -153.38 168.25 26.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.598 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 70' ' ' ASP . 3.8 t 175.26 136.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 0.0 109.332 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 mt -100.82 -4.59 27.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.751 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 46.49 48.9 13.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.348 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -31.61 71.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.945 . . . . 0.0 109.618 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -45.87 68.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.541 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -28.99 69.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 109.402 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -68.29 -32.36 72.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.878 . . . . 0.0 109.377 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.434 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -48.05 -56.38 7.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.318 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -169.61 60.16 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 109.637 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.569 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 0.9 OUTLIER -44.11 166.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.083 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.729 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 84.84 -43.38 3.23 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.518 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -45.31 178.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.652 -0.911 . . . . 0.0 110.503 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 84' ' ' ILE . 20.7 m -96.13 146.33 7.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.124 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.537 HG12 ' CG2' ' A' ' 40' ' ' VAL . 2.5 pp -156.69 175.29 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.445 -0.784 . . . . 0.0 109.402 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 85' ' ' LYS . 10.0 pttm -101.73 143.47 31.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.317 -0.864 . . . . 0.0 109.204 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.636 ' HB ' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -146.48 175.14 10.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.197 -0.94 . . . . 0.0 109.552 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.79 ' O ' HD13 ' A' ' 98' ' ' LEU . 3.9 mmm-85 -101.56 153.66 19.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.71 123.04 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 109.078 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 99' ' ' ARG . 54.4 t -82.89 -38.43 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.834 . . . . 0.0 109.923 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 172.78 105.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.993 . . . . 0.0 109.547 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.829 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -91.35 127.39 36.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.34 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -116.03 -50.45 2.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.582 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -154.91 -124.97 0.93 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -30.77 70.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.425 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -104.6 134.13 48.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 109.235 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.829 HG22 ' HA ' ' A' ' 91' ' ' ALA . 50.5 t -135.57 163.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.939 . . . . 0.0 110.068 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.547 ' N ' HG12 ' A' ' 96' ' ' VAL . 97.7 m-20 -98.73 150.9 21.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.841 . . . . 0.0 108.753 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -137.39 135.14 36.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.965 -1.085 . . . . 0.0 110.799 -179.048 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.615 ' N ' HG23 ' A' ' 89' ' ' VAL . 30.9 ttp180 -128.21 124.95 37.98 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.482 ' N ' HD11 ' A' ' 61' ' ' LEU . 3.4 ttt85 -101.82 158.24 16.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.05 -1.031 . . . . 0.0 109.985 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.41 ' CB ' ' O ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER 170.18 130.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.403 -0.811 . . . . 0.0 109.444 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.8 t80 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.075 -0.964 . . . . 0.0 109.549 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmm . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.0 m -159.73 99.24 1.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.578 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.8 t -138.33 143.68 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 109.61 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.727 HD12 ' HG3' ' A' ' 6' ' ' PRO . 6.5 pt -67.64 163.06 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.321 -0.862 . . . . 0.0 109.432 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.518 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 28.5 mtpt -144.84 61.23 8.06 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.128 -0.983 . . . . 0.0 109.626 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.727 ' HG3' HD12 ' A' ' 4' ' ' ILE . 36.0 Cg_endo -77.68 78.94 3.35 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.58 2.187 . . . . 0.0 110.261 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 8' ' ' SER . 2.4 m 61.59 -169.86 0.17 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.189 -0.944 . . . . 0.0 109.518 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 7' ' ' SER . 2.9 t 61.81 120.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 109.726 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 51.01 71.23 1.6 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.665 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 11' ' ' ARG . 35.0 Cg_endo -77.85 -55.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.634 2.223 . . . . 0.0 110.48 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 1.0 OUTLIER 68.43 92.23 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.98 -168.3 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.656 2.237 . . . . 0.0 110.45 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.514 ' O ' ' CB ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -121.78 92.07 3.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER 76.41 78.93 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.461 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -112.31 130.72 55.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.931 . . . . 0.0 109.454 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.13 46.35 0.24 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.468 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -126.95 98.94 5.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.578 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.5 pt -127.36 77.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.28 27.73 1.73 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 109.531 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 p -150.75 122.15 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 0.0 109.535 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.9 m120 56.87 69.97 0.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 109.658 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.8 m -117.32 -65.03 1.23 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.294 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.3 t80 57.47 65.94 1.25 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.213 -0.929 . . . . 0.0 109.57 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.51 -172.31 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.521 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 p -146.99 31.43 0.94 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 9.7 p -117.35 50.71 1.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.487 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 26' ' ' SER . . . 177.25 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.158 -0.964 . . . . 0.0 109.411 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.39 -17.72 13.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.628 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.64 -179.36 5.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.749 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 1.025 HD12 ' HB2' ' A' ' 91' ' ' ALA . 4.6 mt -99.31 126.25 45.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.584 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.05 140.65 51.67 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.248 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.94 92.15 1.15 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.521 2.147 . . . . 0.0 110.471 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.49 22.87 2.46 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.2 t -109.67 166.4 10.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.234 -1.156 . . . . 0.0 109.456 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -104.53 157.81 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.79 160.12 30.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.789 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.64 124.79 50.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.352 -0.843 . . . . 0.0 109.087 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.457 ' O ' ' CG1' ' A' ' 83' ' ' VAL . . . -138.93 176.36 20.96 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 40' ' ' VAL . 13.0 mt -96.85 167.04 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.143 -1.21 . . . . 0.0 108.731 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.518 ' N ' HG22 ' A' ' 39' ' ' ILE . 60.4 t -108.66 158.61 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.043 -1.036 . . . . 0.0 110.733 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.49 ' N ' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -153.65 152.0 30.33 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.472 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 4.3 p90 -103.61 125.34 50.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 0.0 109.769 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' A' ' 42' ' ' PHE . 0.5 OUTLIER 166.38 167.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.471 ' O ' HG12 ' A' ' 46' ' ' ILE . 31.9 t70 69.01 30.23 4.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.627 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.479 ' C ' HG23 ' A' ' 46' ' ' ILE . . . 51.51 21.1 6.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 1.012 HD12 ' O ' ' A' ' 61' ' ' LEU . 4.1 pt -156.32 -140.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.386 -1.067 . . . . 0.0 108.628 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.407 ' HB2' HD23 ' A' ' 61' ' ' LEU . 1.2 m-85 -116.28 166.98 11.43 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.854 -1.154 . . . . 0.0 109.424 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -141.26 143.06 33.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 59' ' ' CYS . 88.2 t -116.37 136.96 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.4 mtt-85 -108.4 123.4 48.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.219 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.523 HD13 ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -94.6 68.43 3.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.159 -0.963 . . . . 0.0 109.498 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 tt -50.87 142.25 11.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.431 -0.793 . . . . 0.0 109.436 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.56 -53.33 0.6 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 55' ' ' GLU . 1.1 m-85 -68.35 -21.55 64.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.489 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 54' ' ' TYR . 4.4 mt-10 61.49 119.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.1 29.43 62.58 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -116.12 89.97 3.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 0.0 109.328 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.9 112.43 25.4 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 0.0 109.76 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.523 ' SG ' HD13 ' A' ' 51' ' ' LEU . 25.7 m -102.56 164.75 11.48 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.302 -0.874 . . . . 0.0 109.045 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.26 131.81 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.128 -0.983 . . . . 0.0 109.367 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.012 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.2 tp -98.04 118.3 34.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 109.355 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.554 HD12 HD13 ' A' ' 46' ' ' ILE . 6.3 tt -139.27 -40.11 0.47 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.804 . . . . 0.0 109.66 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.544 ' HB3' ' CD ' ' A' ' 99' ' ' ARG . 0.5 OUTLIER -60.63 -31.75 70.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.548 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.586 ' HD2' HD21 ' A' ' 61' ' ' LEU . 2.8 t80 -50.13 -30.24 10.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.513 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.8 tp -73.43 -62.64 1.41 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 109.502 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.0 t30 57.64 -152.86 0.39 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.532 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -112.68 -39.87 4.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.348 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -48.43 -60.51 2.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.281 -0.887 . . . . 0.0 109.332 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -48.93 156.87 0.46 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.195 -0.941 . . . . 0.0 109.353 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.94 85.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.28 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -169.71 135.22 1.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.932 . . . . 0.0 109.582 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 mp -70.45 -27.49 64.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.455 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 76' ' ' LYS . 70.6 m-20 53.29 83.96 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 109.662 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.12 -31.8 61.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 109.258 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 75' ' ' LEU . 1.6 mm? -71.31 -36.41 71.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.262 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.828 ' O ' HG23 ' A' ' 80' ' ' VAL . 12.6 mmtt -58.43 -26.01 62.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.392 -0.817 . . . . 0.0 109.715 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -38.26 81.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -77.48 -31.82 53.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.248 -0.907 . . . . 0.0 110.512 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -79.02 -21.26 47.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.959 -1.088 . . . . 0.0 109.859 -179.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 76' ' ' LYS . 16.4 t -43.66 160.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.622 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 84.24 -46.52 3.68 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -45.88 172.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -1.159 . . . . 0.0 109.874 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.457 ' CG1' ' O ' ' A' ' 38' ' ' GLY . 1.6 t -98.71 150.79 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.25 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.722 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -152.93 172.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 109.836 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 85' ' ' LYS . 13.5 pttm -103.97 115.3 30.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.378 -0.827 . . . . 0.0 109.308 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.84 HG22 ' HG3' ' A' ' 100' ' ' ARG . 24.9 p -125.16 175.42 7.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.204 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.711 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -101.63 157.96 16.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.406 HG11 ' CB ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -96.76 120.04 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.56 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 91.3 t -80.21 -37.43 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.443 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 170.65 104.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.931 -1.106 . . . . 0.0 109.826 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 1.025 ' HB2' HD12 ' A' ' 30' ' ' LEU . . . -87.55 153.97 20.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 109.215 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -167.26 53.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.146 -0.971 . . . . 0.0 109.755 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.18 -158.42 14.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.757 ' C ' HD23 ' A' ' 94' ' ' LEU . 4.0 tt -60.12 -18.55 48.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.379 -1.071 . . . . 0.0 109.6 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -107.1 134.21 50.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.645 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.498 HG22 ' CB ' ' A' ' 91' ' ' ALA . 74.2 t -134.29 157.39 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.839 . . . . 0.0 109.407 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.56 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 8.8 m-20 -98.39 152.43 19.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 108.811 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -141.57 133.77 27.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.968 -1.083 . . . . 0.0 110.701 -178.702 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.556 ' N ' HG23 ' A' ' 89' ' ' VAL . 8.7 ttt180 -131.0 131.37 44.31 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.84 ' HG3' HG22 ' A' ' 86' ' ' THR . 0.0 OUTLIER -102.66 148.36 25.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.073 -1.017 . . . . 0.0 109.556 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -149.95 158.72 44.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 109.628 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.5 t80 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.463 -179.935 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.8 p -127.15 34.66 4.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 109.59 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.675 ' O ' HG13 ' A' ' 3' ' ' VAL . 7.7 p -162.72 96.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.224 -0.923 . . . . 0.0 109.399 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pp -62.04 156.58 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.395 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.0 tptp 47.1 83.22 0.22 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.48 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 7' ' ' SER . 35.5 Cg_endo -77.73 118.15 4.43 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.574 2.183 . . . . 0.0 110.393 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER 169.32 156.8 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.0 109.866 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 79.5 p -167.4 139.6 3.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.528 -0.732 . . . . 0.0 109.081 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 9' ' ' ARG . 3.5 ttm180 -174.28 62.8 0.25 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.606 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 9' ' ' ARG . 36.2 Cg_endo -79.25 149.68 22.14 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.682 2.255 . . . . 0.0 110.616 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.528 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -147.81 62.92 7.24 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.325 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 36.3 Cg_endo -78.8 142.96 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.79 2.327 . . . . 0.0 110.559 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.38 56.26 0.75 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 0.0 109.326 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 tttp 68.48 45.84 1.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.925 . . . . 0.0 109.468 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' LYS . 4.2 m-20 57.11 -164.31 0.16 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.338 -0.851 . . . . 0.0 109.516 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 15' ' ' ASN . 2.9 mtpp -42.09 -68.38 0.19 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.957 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.84 -90.63 0.3 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.148 -0.97 . . . . 0.0 109.669 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 18' ' ' ILE . 5.3 tt -150.84 124.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.878 . . . . 0.0 109.483 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -170.33 37.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.33 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 20' ' ' VAL . 41.1 t -109.82 -3.48 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.289 -0.882 . . . . 0.0 109.551 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -102.79 22.58 13.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 0.0 109.569 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.52 147.48 34.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 109.446 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -98.85 162.45 13.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.203 -0.935 . . . . 0.0 109.395 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.449 ' N ' ' HD3' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -117.7 59.52 0.78 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.395 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.15 -41.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.471 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.77 59.49 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.424 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.84 159.48 34.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.6 mtt -108.7 131.09 55.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.43 169.19 8.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.477 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.839 ' CD2' ' HB3' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -82.56 166.2 19.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.542 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER 166.15 166.19 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 109.556 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 31' ' ' SER . 35.6 Cg_endo -78.03 148.74 25.02 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.638 2.225 . . . . 0.0 110.502 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.34 41.39 6.99 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.02 168.55 19.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -1.185 . . . . 0.0 109.542 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.9 m -116.34 168.06 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.289 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 46.2 t60 -170.33 163.9 8.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.679 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.69 125.37 50.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.212 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.77 175.73 22.37 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 52' ' ' LEU . 3.7 mt -97.7 155.0 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.405 -1.056 . . . . 0.0 108.98 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.484 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 45.7 t -98.79 157.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.063 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.435 ' N ' HG12 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -154.38 141.43 19.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.438 -0.789 . . . . 0.0 109.006 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -101.71 124.66 47.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.034 . . . . 0.0 109.555 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER 179.58 153.79 0.47 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.677 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER 74.2 5.01 4.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 109.829 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.51 -20.76 29.17 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.52 HG22 HD13 ' A' ' 65' ' ' LEU . 40.4 pt -109.16 -144.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -1.153 . . . . 0.0 108.868 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 67.1 m-85 -117.9 169.76 9.37 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.879 -1.138 . . . . 0.0 109.411 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.678 ' HG3' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -143.16 139.24 30.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 109.698 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 61' ' ' LEU . 48.2 t -115.8 104.28 16.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 130.56 45.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.115 -0.991 . . . . 0.0 109.966 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 51' ' ' LEU . 10.9 mp -94.89 93.22 7.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 109.303 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.918 HD13 ' N ' ' A' ' 53' ' ' GLY . 0.9 OUTLIER -83.69 134.97 34.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 109.596 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.918 ' N ' HD13 ' A' ' 52' ' ' LEU . . . 92.85 -5.81 76.47 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.505 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -123.9 51.34 1.54 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.269 -1.136 . . . . 0.0 109.596 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.505 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 1.6 mt-10 75.87 -170.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.399 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 58' ' ' GLU . . . -81.66 9.76 54.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -41.42 97.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -1.067 . . . . 0.0 109.63 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 56' ' ' GLY . 27.9 tt0 -110.58 110.58 21.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -104.66 167.4 9.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.843 HD12 HD21 ' A' ' 62' ' ' LEU . 1.1 pt -129.58 139.0 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.405 -0.81 . . . . 0.0 109.039 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.791 HD11 ' HB2' ' A' ' 64' ' ' TYR . 49.0 tp -98.4 117.25 32.39 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.026 -1.046 . . . . 0.0 109.26 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.843 HD21 HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -126.84 -37.91 2.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.309 -0.869 . . . . 0.0 109.664 -179.641 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.522 ' HB3' ' HG2' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -63.97 -49.42 72.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.346 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.791 ' HB2' HD11 ' A' ' 61' ' ' LEU . 12.3 t80 -49.02 -45.28 42.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.194 -0.941 . . . . 0.0 109.067 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.52 HD13 HG22 ' A' ' 46' ' ' ILE . 5.4 tt -57.27 -53.4 58.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.349 -0.845 . . . . 0.0 109.305 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.486 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 1.9 t-20 -52.64 156.15 1.99 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.163 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.486 ' HB3' ' O ' ' A' ' 66' ' ' ASN . 30.6 t80 72.53 111.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.74 -162.44 1.23 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 0.0 109.333 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -176.4 51.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.579 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 69' ' ' GLN . 20.2 t70 49.99 94.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.553 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.04 136.23 23.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.442 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -33.48 73.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.67 27.59 4.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.632 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -42.38 41.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.472 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -33.64 65.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.452 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.816 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -59.73 -26.5 65.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 109.633 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -60.44 -49.43 77.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.835 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -77.24 -26.27 52.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 109.996 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -71.21 -29.71 65.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.811 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 76' ' ' LYS . 13.0 t -42.92 160.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.375 -0.828 . . . . 0.0 109.462 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 88.13 -48.03 3.58 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -41.56 164.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.406 -1.055 . . . . 0.0 109.892 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.467 ' C ' HG23 ' A' ' 84' ' ' ILE . 23.5 m -98.15 150.16 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.079 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.697 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -155.95 175.29 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.937 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 4.3 mtmt -104.25 112.87 26.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.409 -0.807 . . . . 0.0 109.253 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.614 ' OG1' HD11 ' A' ' 98' ' ' LEU . 71.3 p -118.94 175.24 5.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.725 ' O ' HD13 ' A' ' 98' ' ' LEU . 9.9 mpt_? -99.32 156.36 17.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 0.0 109.335 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 t -97.21 124.24 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.167 -0.958 . . . . 0.0 109.309 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.493 ' CG2' ' CB ' ' A' ' 99' ' ' ARG . 24.4 t -80.75 -30.3 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.413 -0.804 . . . . 0.0 109.653 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.9 OUTLIER 168.01 106.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.136 -0.977 . . . . 0.0 109.311 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.839 ' HB3' ' CD2' ' A' ' 30' ' ' LEU . . . -95.73 132.36 41.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 0.0 109.617 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -165.84 88.27 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.47 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.73 -160.6 13.57 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.7 -22.62 53.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -1.155 . . . . 0.0 109.443 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -103.65 138.99 39.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.272 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.73 HG13 ' HA ' ' A' ' 91' ' ' ALA . 77.2 t -136.74 161.8 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.185 -0.947 . . . . 0.0 109.918 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.519 ' N ' HG12 ' A' ' 96' ' ' VAL . 15.3 m-20 -98.36 150.9 21.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -138.53 135.0 34.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.932 -1.105 . . . . 0.0 110.91 -178.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.522 ' HG2' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -136.91 131.8 33.59 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.559 ' HD2' ' CE1' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -92.33 149.8 21.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.175 -0.953 . . . . 0.0 109.33 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -68.87 95.28 0.68 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.557 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 7.8 t80 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.482 179.892 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 mmt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.95 54.99 0.78 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.0 109.505 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.0 m -97.29 -165.5 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.39 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.6 mt -113.27 76.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.202 -0.936 . . . . 0.0 109.654 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.97 153.05 1.61 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.153 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.04 76.81 4.01 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.544 2.163 . . . . 0.0 110.469 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.82 162.77 6.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.9 t -96.4 21.94 8.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.388 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.553 ' N ' ' HD2' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -77.19 -53.28 1.7 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.942 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 34.8 Cg_endo -77.86 142.33 19.9 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.353 2.035 . . . . 0.0 110.357 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 55.77 71.96 1.13 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 0.0 109.28 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.85 141.83 19.53 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.666 2.244 . . . . 0.0 110.523 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.7 mtp85 -49.74 141.01 10.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.344 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -103.01 -51.67 3.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.619 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -168.83 -42.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.15 -0.969 . . . . 0.0 109.733 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -127.98 -94.72 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 109.842 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.61 -69.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 109.363 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 18' ' ' ILE . 12.9 tt -125.49 127.66 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.479 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -111.2 151.19 28.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 109.477 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.64 15.64 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.537 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -121.16 -167.25 1.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 109.49 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.59 178.15 4.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.65 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -103.27 42.57 1.15 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.876 . . . . 0.0 109.339 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -81.0 -78.78 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.577 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 p -123.51 116.81 23.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.497 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.37 92.39 0.29 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 109.376 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.79 111.92 3.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.679 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.439 ' SD ' ' N ' ' A' ' 28' ' ' MET . 3.0 mpp? -97.92 -42.7 7.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.221 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 t0 50.63 -178.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 110.085 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.635 HD21 ' CB ' ' A' ' 91' ' ' ALA . 5.6 tp -155.99 102.69 2.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.444 -0.785 . . . . 0.0 109.111 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.84 157.43 43.16 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 109.5 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 155.4 31.39 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.666 2.244 . . . . 0.0 110.422 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.73 21.99 35.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 p -119.13 154.67 32.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -1.102 . . . . 0.0 109.575 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.481 HG12 ' HD2' ' A' ' 87' ' ' ARG . 4.4 m -101.03 131.89 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.375 -0.828 . . . . 0.0 109.06 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.86 172.53 13.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.06 -1.025 . . . . 0.0 109.954 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.55 158.61 15.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.367 -0.833 . . . . 0.0 108.897 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.06 177.46 39.1 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.775 HD11 ' HB2' ' A' ' 52' ' ' LEU . 6.6 mt -95.96 152.43 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.425 -1.044 . . . . 0.0 108.451 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 82' ' ' ARG . 21.9 t -98.65 149.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.061 -1.024 . . . . 0.0 110.731 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.47 132.46 15.21 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -111.1 112.28 23.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.932 -1.105 . . . . 0.0 109.742 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -163.39 161.72 24.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.346 -0.846 . . . . 0.0 109.528 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER 68.7 6.83 5.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.852 . . . . 0.0 109.748 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.76 -13.45 60.82 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.604 HG22 ' H ' ' A' ' 47' ' ' PHE . 2.5 mm -113.23 -160.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.114 -1.227 . . . . 0.0 109.15 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.604 ' H ' HG22 ' A' ' 46' ' ' ILE . 10.1 m-85 -109.54 172.45 6.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.12 -0.988 . . . . 0.0 109.409 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 147.78 26.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.945 . . . . 0.0 109.704 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.583 HG21 ' HG ' ' A' ' 98' ' ' LEU . 2.5 t -121.74 122.02 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.399 -0.813 . . . . 0.0 109.253 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.622 ' HB3' HD12 ' A' ' 39' ' ' ILE . 54.8 ttt-85 -98.73 121.74 41.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.0 109.338 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -90.7 86.64 6.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.023 -1.048 . . . . 0.0 109.624 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.775 ' HB2' HD11 ' A' ' 39' ' ' ILE . 5.7 tp -59.41 162.99 4.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.835 . . . . 0.0 109.351 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.99 -31.05 5.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.49 -31.69 12.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 109.342 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 55.79 85.81 0.07 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.369 -0.832 . . . . 0.0 109.548 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.68 -12.28 5.4 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -89.25 94.92 10.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -1.148 . . . . 0.0 109.545 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.14 111.01 23.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.525 -0.735 . . . . 0.0 109.129 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.553 ' HB3' HD23 ' A' ' 98' ' ' LEU . 3.8 m -100.69 156.85 17.09 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.23 -0.919 . . . . 0.0 109.539 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -110.72 124.99 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.814 HD21 ' CB ' ' A' ' 64' ' ' TYR . 29.9 tp -98.17 110.55 23.11 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.046 -1.034 . . . . 0.0 109.56 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 46' ' ' ILE . 1.7 tt -113.6 -40.79 3.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.483 -0.76 . . . . 0.0 109.727 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.526 ' HB2' ' CB ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -63.07 -46.49 87.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.734 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.814 ' CB ' HD21 ' A' ' 61' ' ' LEU . 18.5 t80 -47.05 -29.3 2.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.063 -1.023 . . . . 0.0 109.606 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 66' ' ' ASN . 6.4 tt -54.84 -71.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.752 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.484 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.8 t-20 62.31 144.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.91 . . . . 0.0 109.356 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -74.5 158.19 34.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.712 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.29 146.17 16.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.641 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 69' ' ' GLN . 1.3 pt20 -105.18 79.15 1.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.359 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 28.3 p-10 -172.62 134.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.5 p -126.26 88.61 2.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.892 . . . . 0.0 109.397 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.57 39.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.89 . . . . 0.0 109.593 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -104.37 64.33 0.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.94 -31.71 61.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.513 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.39 -45.46 91.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.589 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.766 ' O ' HG23 ' A' ' 80' ' ' VAL . 8.7 ttpt -45.82 -26.52 0.68 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.899 . . . . 0.0 109.772 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -58.73 -53.82 54.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.851 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -27.35 61.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.01 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 80' ' ' VAL . 0.4 OUTLIER -66.5 -33.14 75.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.132 -0.98 . . . . 0.0 109.272 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 76' ' ' LYS . 17.8 t -44.11 161.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.335 -0.853 . . . . 0.0 109.336 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.517 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 85.43 -48.46 4.02 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.497 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -43.02 170.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.469 -1.018 . . . . 0.0 110.14 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.3 p -97.27 143.6 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.145 -0.972 . . . . 0.0 109.64 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.712 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.3 pp -145.83 174.16 2.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.456 -0.777 . . . . 0.0 109.391 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -102.89 141.78 35.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.505 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.499 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -153.33 174.55 14.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.277 -0.889 . . . . 0.0 109.46 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.781 ' O ' HD13 ' A' ' 98' ' ' LEU . 7.9 mmt180 -99.39 151.92 20.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 65.5 t -97.41 119.88 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.86 . . . . 0.0 109.002 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.849 HG21 ' HG3' ' A' ' 99' ' ' ARG . 71.2 t -82.64 -33.96 11.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.414 -0.804 . . . . 0.0 109.935 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 171.04 103.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.115 -0.99 . . . . 0.0 109.737 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.817 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -92.91 107.2 19.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.266 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.88 107.45 4.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.71 -176.39 54.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 94' ' ' LEU . 5.2 mp -59.83 -16.17 26.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -1.095 . . . . 0.0 109.529 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -99.07 133.15 43.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.479 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.817 HG13 ' HA ' ' A' ' 91' ' ' ALA . 61.7 t -138.59 151.29 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.597 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.539 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -101.17 145.5 28.72 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.781 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -138.31 137.86 37.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.966 -1.084 . . . . 0.0 110.669 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.849 ' HG3' HG21 ' A' ' 89' ' ' VAL . 9.2 mtt180 -146.19 126.41 13.87 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -88.07 162.3 16.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.566 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 100' ' ' ARG . 11.7 t80 61.21 133.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.656 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 3.0 t80 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.478 179.783 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ttt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.325 0.583 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.43 -44.63 1.54 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.948 . . . . 0.0 109.42 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.2 p -137.71 139.37 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 109.223 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.447 ' HA ' HD13 ' A' ' 4' ' ' ILE . 16.5 mm -100.74 -76.18 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.61 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -169.96 67.06 0.56 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.166 -0.959 . . . . 0.0 109.636 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -78.06 0.15 10.13 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.551 2.167 . . . . 0.0 110.319 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 54.28 76.94 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.373 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 t -139.26 120.99 15.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -0.954 . . . . 0.0 109.631 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.15 146.18 31.83 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.69 -78.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.567 2.178 . . . . 0.0 110.469 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.5 91.85 48.88 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.872 . . . . 0.0 109.386 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.8 125.22 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.614 2.21 . . . . 0.0 110.342 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.29 27.52 2.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 0.0 109.471 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.02 179.64 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 16' ' ' LYS . 11.8 m-80 -89.85 -67.13 0.86 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 109.189 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.527 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER 76.35 54.45 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.288 -0.883 . . . . 0.0 109.576 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.18 144.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.497 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 pt -106.74 131.38 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.208 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -121.03 151.18 40.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.169 -0.957 . . . . 0.0 109.994 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.449 HG13 ' N ' ' A' ' 21' ' ' ASN . 10.5 p -131.43 -37.31 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.412 -0.805 . . . . 0.0 109.02 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.449 ' N ' HG13 ' A' ' 20' ' ' VAL . 1.3 t-20 50.36 -172.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.365 -0.835 . . . . 0.0 109.761 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -159.78 148.09 17.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.347 -0.845 . . . . 0.0 109.264 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.692 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER 60.06 179.21 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.45 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -106.09 -20.05 13.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 109.475 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.11 -47.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.424 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 m 177.96 168.17 0.73 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 109.477 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.692 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . . . -99.35 104.46 16.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.905 . . . . 0.0 109.514 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.2 mtp -83.44 -72.81 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.145 -0.972 . . . . 0.0 109.401 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.63 36.53 16.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.397 -0.814 . . . . 0.0 109.351 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.535 HD21 ' O ' ' A' ' 91' ' ' ALA . 0.4 OUTLIER -97.67 7.67 46.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.375 -0.828 . . . . 0.0 109.625 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.449 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 1.3 p -62.55 164.13 12.93 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.114 -0.992 . . . . 0.0 109.493 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 31' ' ' SER . 35.6 Cg_endo -78.23 89.26 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.674 2.249 . . . . 0.0 110.435 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.65 86.16 0.67 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 62.2 m -138.59 165.65 26.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.93 146.61 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.509 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -168.71 166.0 11.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.165 -0.959 . . . . 0.0 109.612 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -104.0 138.89 39.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.322 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 83' ' ' VAL . . . -154.98 176.13 32.77 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.7 mm -97.4 152.33 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.345 -1.091 . . . . 0.0 108.815 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 41' ' ' TYR . 21.9 t -104.93 168.01 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.014 -1.054 . . . . 0.0 110.09 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.563 ' N ' HG12 ' A' ' 40' ' ' VAL . 6.3 t80 -155.87 163.78 39.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.24 140.43 40.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.333 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.758 ' O ' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -143.47 96.75 2.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.036 -1.04 . . . . 0.0 109.997 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 43' ' ' LYS . 5.9 m-20 41.89 30.48 0.17 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 110.091 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.6 -53.21 0.6 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.758 HG22 ' O ' ' A' ' 43' ' ' LYS . 5.8 tt -61.5 170.0 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.112 -1.228 . . . . 0.0 108.903 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.704 ' CB ' HD23 ' A' ' 61' ' ' LEU . 21.2 m-85 -111.94 153.9 26.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.034 -1.041 . . . . 0.0 109.51 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.487 ' HD2' ' HG3' ' A' ' 43' ' ' LYS . 3.3 tttt -129.72 149.32 51.52 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 59' ' ' CYS . 47.4 t -128.52 135.44 62.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.083 -1.011 . . . . 0.0 109.544 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.96 131.86 56.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.122 -0.986 . . . . 0.0 109.022 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -85.46 78.19 9.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 109.666 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.8 tp -62.73 125.17 23.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.351 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.49 -16.41 6.26 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.41 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 10.8 t80 -118.23 -26.13 6.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -1.127 . . . . 0.0 109.382 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 56.56 91.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.38 0.36 5.0 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.41 ' CE1' ' CD2' ' A' ' 54' ' ' TYR . 9.6 m170 -109.63 105.28 14.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -1.213 . . . . 0.0 109.483 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 95' ' ' TYR . 0.2 OUTLIER -112.67 111.41 22.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.887 . . . . 0.0 110.014 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.483 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.3 m -103.56 170.63 7.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.309 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.2 pt -132.39 128.57 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.068 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.704 HD23 ' CB ' ' A' ' 47' ' ' PHE . 20.5 tp -97.47 117.54 31.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.969 -1.082 . . . . 0.0 109.372 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.62 HD12 ' C ' ' A' ' 62' ' ' LEU . 3.6 pp -132.5 -33.99 1.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.374 -0.829 . . . . 0.0 109.794 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.514 ' N ' HD12 ' A' ' 62' ' ' LEU . 4.5 m-20 -64.14 -34.07 77.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.11 -0.994 . . . . 0.0 109.281 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.656 ' HB2' HD11 ' A' ' 61' ' ' LEU . 7.9 t80 -52.8 -48.58 66.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 109.713 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' O ' ' CB ' ' A' ' 66' ' ' ASN . 7.0 tp -44.04 -76.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.576 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER 70.12 152.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 109.495 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -63.74 95.18 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.348 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -146.85 -67.4 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 109.604 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.32 -171.9 2.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.622 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -150.34 -40.07 0.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 109.222 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.4 ' C ' ' HG ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -164.09 51.01 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.867 . . . . 0.0 109.248 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.4 ' HG ' ' C ' ' A' ' 71' ' ' THR . 2.0 mt -132.07 59.81 1.7 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.91 . . . . 0.0 109.591 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.494 ' HB3' ' CG ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -170.33 93.45 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.094 -1.004 . . . . 0.0 109.532 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.79 -28.49 65.77 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.553 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.4 mt -70.33 -26.78 63.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.529 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.494 ' CG ' ' HB3' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -62.84 -32.03 73.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 109.867 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -75.74 -28.87 58.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.0 109.665 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -77.48 -27.03 51.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 110.309 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -89.71 -39.97 12.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.09 -1.006 . . . . 0.0 110.391 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.563 HG22 ' N ' ' A' ' 81' ' ' GLY . 1.6 p -41.79 164.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.92 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.563 ' N ' HG22 ' A' ' 80' ' ' VAL . . . 85.31 -47.19 3.79 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.568 ' HE ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -41.24 165.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.436 -1.037 . . . . 0.0 110.21 -179.539 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.568 HG12 ' HE ' ' A' ' 82' ' ' ARG . 7.4 p -98.04 141.78 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.411 -0.805 . . . . 0.0 108.882 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.766 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -151.37 175.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.001 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -98.9 103.52 15.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 108.957 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.747 ' OG1' HD11 ' A' ' 98' ' ' LEU . 68.0 p -107.49 175.12 5.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.62 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -102.95 156.56 17.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 0.0 109.254 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.483 ' HA ' HD22 ' A' ' 98' ' ' LEU . 60.1 t -96.95 106.6 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.282 -0.886 . . . . 0.0 108.817 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.572 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 24.1 t -60.6 -44.54 97.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.464 -0.773 . . . . 0.0 109.87 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 9.4 ttm180 177.27 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.746 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.593 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -78.12 152.12 32.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.901 . . . . 0.0 109.322 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -167.7 62.16 0.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.924 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.87 -156.04 16.2 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -27.33 68.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -1.096 . . . . 0.0 109.647 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 2.7 m-85 -101.18 138.74 37.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.612 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 91' ' ' ALA . 40.8 t -133.69 162.86 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.774 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.572 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -99.26 145.96 26.72 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.747 HD11 ' OG1' ' A' ' 86' ' ' THR . 0.2 OUTLIER -138.02 138.63 39.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.965 -1.085 . . . . 0.0 110.899 -178.6 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.492 ' CB ' ' HB2' ' A' ' 63' ' ' ASP . 31.0 ttp180 -134.57 129.28 34.76 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.589 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -95.16 103.63 15.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 109.429 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.465 ' CD1' ' CZ ' ' A' ' 87' ' ' ARG . 27.9 p90 -49.95 144.17 6.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.656 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.468 ' CG ' ' O ' ' A' ' 102' ' ' PHE . 70.2 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.502 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 mtp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.6 p -146.82 116.5 7.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 t -69.28 134.5 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.534 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.2 mt -122.4 -70.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 44.04 82.34 0.23 Allowed Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.251 -0.906 . . . . 0.0 109.472 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.39 125.61 7.1 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.657 2.238 . . . . 0.0 110.508 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.01 135.21 57.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.386 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.6 t -135.68 96.36 3.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.383 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -73.88 147.0 85.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.578 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.95 85.9 1.74 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.686 2.257 . . . . 0.0 110.47 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.31 69.66 0.57 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.07 -46.35 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.659 2.239 . . . . 0.0 110.559 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.441 ' O ' ' CG ' ' A' ' 13' ' ' ARG . 0.4 OUTLIER -174.91 30.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.143 -0.973 . . . . 0.0 109.735 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.99 85.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.617 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 26.2 p30 -127.02 12.76 7.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.373 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 17' ' ' ASN . 27.7 mtmm 62.27 -95.21 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.868 . . . . 0.0 109.712 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 16' ' ' LYS . 1.1 t30 73.44 -170.93 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.147 -0.971 . . . . 0.0 109.359 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.6 pt -136.91 172.23 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.595 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 tptt 58.59 52.94 6.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.688 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.7 ' O ' HG13 ' A' ' 20' ' ' VAL . 14.7 p -97.6 62.17 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.453 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -139.13 93.25 2.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.935 . . . . 0.0 109.611 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.07 27.44 4.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.287 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -53.95 -179.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.44 85.24 7.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 m 60.24 156.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.845 . . . . 0.0 109.592 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.45 119.58 1.05 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.459 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -163.99 75.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -0.815 . . . . 0.0 109.253 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.76 73.43 1.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.171 -0.956 . . . . 0.0 109.747 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -46.24 -27.92 1.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 109.25 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.28 90.94 3.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.353 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.06 106.93 0.61 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.53 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.43 110.82 2.92 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.362 2.042 . . . . 0.0 110.242 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.21 25.24 2.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 t -100.52 172.13 7.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -1.114 . . . . 0.0 109.461 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.751 HG22 ' HG3' ' A' ' 87' ' ' ARG . 10.3 t -118.89 161.97 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.2 -0.937 . . . . 0.0 109.426 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.409 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -172.35 167.51 5.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.872 . . . . 0.0 109.457 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -98.7 130.63 45.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 0.0 109.26 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.41 175.69 29.34 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 81' ' ' GLY . 4.0 mt -97.91 158.29 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -1.048 . . . . 0.0 108.984 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.545 ' C ' ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -116.28 175.75 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 110.072 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.62 147.91 22.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 108.856 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 50.8 t80 -114.5 119.18 35.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.965 -1.084 . . . . 0.0 109.654 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER 174.41 174.21 0.18 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.567 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 91.1 m-20 62.99 10.96 4.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.421 -0.799 . . . . 0.0 109.854 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.74 -22.46 13.84 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 47' ' ' PHE . 10.2 pt -114.72 -153.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.294 . . . . 0.0 109.406 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.562 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 4.4 m-85 -114.9 173.99 6.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.045 -1.035 . . . . 0.0 109.189 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 5.0 tttt -142.68 158.88 43.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.144 -0.973 . . . . 0.0 109.675 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 59' ' ' CYS . 2.8 t -139.98 107.71 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.406 -0.809 . . . . 0.0 109.376 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.96 134.27 42.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -97.38 96.97 8.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.94 . . . . 0.0 109.614 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -79.2 110.97 14.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.337 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.04 -35.96 1.64 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 4.4 m-85 -85.02 -31.62 23.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.272 -1.134 . . . . 0.0 109.18 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER 71.55 97.6 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.391 -0.818 . . . . 0.0 109.589 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.73 10.34 30.98 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -100.22 88.75 3.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 0.0 109.549 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.92 99.61 9.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.36 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.798 ' SG ' HD23 ' A' ' 98' ' ' LEU . 7.4 t -101.9 169.56 8.7 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.188 -0.945 . . . . 0.0 109.234 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 pt -137.03 140.84 41.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.747 HD21 ' HG2' ' A' ' 100' ' ' ARG . 0.5 OUTLIER -98.37 126.96 44.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.934 -1.104 . . . . 0.0 109.597 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.422 ' HG ' ' HB ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER -162.5 -36.69 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.599 -0.688 . . . . 0.0 109.507 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.494 ' CB ' ' HB2' ' A' ' 99' ' ' ARG . 0.4 OUTLIER -48.22 -46.49 35.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 109.163 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -125.55 54.14 1.5 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.311 -0.868 . . . . 0.0 109.441 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.55 ' O ' HD23 ' A' ' 65' ' ' LEU . 2.6 tt -66.64 -47.37 72.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.212 -0.93 . . . . 0.0 109.463 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.42 ' O ' ' O ' ' A' ' 65' ' ' LEU . 8.9 m120 54.19 100.19 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.232 -0.918 . . . . 0.0 109.367 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.41 123.29 23.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 109.684 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -116.94 104.49 11.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 109.307 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -116.77 93.94 4.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 109.613 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -139.66 167.52 21.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.42 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.65 161.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.931 . . . . 0.0 109.648 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 72' ' ' LEU . 0.6 OUTLIER 61.35 57.03 2.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.411 -0.806 . . . . 0.0 109.634 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.98 -30.62 17.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.402 -0.811 . . . . 0.0 109.31 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 75' ' ' LEU . 12.2 mtm180 -46.62 -55.68 7.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.569 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' ARG . 5.9 tp -43.01 -56.72 3.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.733 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -48.67 -48.18 40.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.639 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.614 ' O ' HG23 ' A' ' 80' ' ' VAL . 2.3 tm-20 -53.59 -52.54 59.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 109.685 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 77' ' ' GLU . 0.5 OUTLIER -46.13 -62.08 1.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.407 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.552 ' H ' HD12 ' A' ' 79' ' ' LEU . 4.5 mp -56.35 -78.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.224 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.699 HG12 ' N ' ' A' ' 81' ' ' GLY . 38.2 t 48.93 -90.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 110.078 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.699 ' N ' HG12 ' A' ' 80' ' ' VAL . . . -80.69 15.65 18.76 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.233 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -49.05 175.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.94 -1.33 . . . . 0.0 108.695 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.5 t -97.37 122.9 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.084 -1.01 . . . . 0.0 108.627 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.744 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -141.3 174.63 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.112 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -104.19 118.13 35.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.428 -0.795 . . . . 0.0 109.127 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.851 ' OG1' HD11 ' A' ' 98' ' ' LEU . 55.5 p -125.95 175.08 7.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.751 ' HG3' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -102.15 159.88 15.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.338 -0.851 . . . . 0.0 109.477 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.451 ' HA ' HD22 ' A' ' 98' ' ' LEU . 40.7 t -97.48 123.1 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 109.031 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.586 HG23 ' N ' ' A' ' 99' ' ' ARG . 79.6 t -81.84 -33.29 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.485 -0.759 . . . . 0.0 110.045 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 47.3 ttp180 175.29 102.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.004 . . . . 0.0 109.629 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.853 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -95.83 108.37 20.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.537 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.45 -58.36 2.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.02 -93.79 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.67 -29.64 22.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -1.179 . . . . 0.0 109.194 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.14 131.08 53.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.091 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.853 HG13 ' HA ' ' A' ' 91' ' ' ALA . 59.5 t -135.0 157.61 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 109.954 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.551 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -99.91 153.89 18.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.851 HD11 ' OG1' ' A' ' 86' ' ' THR . 0.2 OUTLIER -136.81 134.2 36.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.971 -1.08 . . . . 0.0 110.878 -178.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.586 ' N ' HG23 ' A' ' 89' ' ' VAL . 28.6 ttm180 -124.17 111.56 16.04 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.747 ' HG2' HD21 ' A' ' 61' ' ' LEU . 4.2 ptm180 -95.9 163.48 13.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 110.041 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -147.19 158.59 44.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.334 -0.854 . . . . 0.0 109.164 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.8 t80 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.522 -179.882 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.4 t -90.45 145.45 24.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.565 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.52 154.34 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 109.463 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 pt -142.23 105.34 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.54 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.7 tttt 64.34 83.31 0.2 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 109.506 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.75 118.72 4.57 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.711 2.274 . . . . 0.0 110.443 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 8' ' ' SER . 0.7 OUTLIER -52.76 178.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 0.0 109.5 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 7' ' ' SER . 2.6 p 169.14 147.21 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.907 . . . . 0.0 109.5 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -47.77 146.49 3.84 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.388 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.32 113.15 3.32 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.614 2.209 . . . . 0.0 110.56 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.37 150.45 64.36 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 109.434 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.71 102.3 1.58 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.564 2.176 . . . . 0.0 110.336 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.38 36.76 0.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.76 -178.48 5.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.383 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -98.6 121.77 40.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 109.604 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.7 mttp 65.15 102.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.479 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -99.41 58.91 1.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.19 -0.944 . . . . 0.0 109.501 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 19' ' ' LYS . 58.7 mt -63.48 160.39 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.222 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.507 ' N ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -146.22 176.83 9.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.973 . . . . 0.0 109.678 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.5 t -98.14 148.2 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -102.95 126.81 50.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.196 -0.94 . . . . 0.0 109.583 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 m -149.35 16.13 0.91 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 109.541 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -142.87 87.74 2.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.47 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.0 71.22 0.93 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.512 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.56 168.23 9.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.435 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 p -101.71 16.49 25.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.333 -0.854 . . . . 0.0 109.435 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 28' ' ' MET . . . -95.78 -46.57 6.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 109.467 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ALA . 1.1 tmm? 47.91 -172.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.409 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -141.99 132.65 25.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 109.667 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.27 133.9 55.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.329 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.9 p -121.81 98.16 45.65 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.907 . . . . 0.0 109.491 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.404 ' HG3' ' CG ' ' A' ' 90' ' ' ARG . 35.4 Cg_endo -77.46 172.26 16.19 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.539 2.16 . . . . 0.0 110.43 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.99 17.8 8.72 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -113.8 163.46 15.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -1.147 . . . . 0.0 109.482 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.877 HG12 ' NE ' ' A' ' 87' ' ' ARG . 18.9 m -103.65 158.1 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.511 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.531 ' CD2' HG23 ' A' ' 88' ' ' VAL . 20.4 p80 -167.08 163.13 15.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -99.37 135.08 41.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.067 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -146.08 176.77 24.85 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' A' ' 52' ' ' LEU . 9.7 mt -96.61 154.34 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.302 -1.117 . . . . 0.0 108.641 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.717 HG23 HD12 ' A' ' 84' ' ' ILE . 53.0 t -105.54 151.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.016 -1.053 . . . . 0.0 110.481 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.523 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 2.6 t80 -142.34 145.87 34.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.425 -0.797 . . . . 0.0 108.968 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.535 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 37.2 p90 -107.34 118.12 35.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.096 -1.002 . . . . 0.0 109.779 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 2.3 mttp 165.61 158.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 109.813 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER 77.72 36.26 0.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.688 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.526 ' C ' HG23 ' A' ' 46' ' ' ILE . . . 46.69 24.41 1.8 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.826 ' CG2' HD13 ' A' ' 62' ' ' LEU . 2.5 pt -159.3 -155.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -1.115 . . . . 0.0 108.969 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.519 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 0.5 OUTLIER -116.23 163.04 16.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.037 -1.04 . . . . 0.0 108.96 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.553 ' CG ' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -135.65 129.95 33.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.166 -0.959 . . . . 0.0 109.733 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 59' ' ' CYS . 5.4 t -109.45 124.83 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 109.358 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -105.55 129.4 53.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.977 . . . . 0.0 109.393 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -90.76 81.95 5.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.432 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.56 ' HB2' HD11 ' A' ' 39' ' ' ILE . 1.2 tp -64.97 132.71 50.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.94 -42.46 1.86 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.466 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . 69.1 t80 -74.58 -29.54 61.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 109.556 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 30.4 tt0 63.54 89.3 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.53 15.28 9.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.466 ' CG ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -115.65 90.26 3.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 109.535 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 1.6 tm-20 -100.65 105.61 17.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.837 . . . . 0.0 109.444 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.651 ' HB3' HD23 ' A' ' 98' ' ' LEU . 4.9 m -101.78 159.65 15.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.145 -0.972 . . . . 0.0 109.313 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.553 HG22 ' CG ' ' A' ' 48' ' ' LYS . 4.1 pt -131.13 141.07 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.848 . . . . 0.0 108.971 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -97.93 127.63 44.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.027 . . . . 0.0 109.738 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.826 HD13 ' CG2' ' A' ' 46' ' ' ILE . 14.9 tp -173.68 -32.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.445 ' OD2' HG11 ' A' ' 89' ' ' VAL . 0.6 OUTLIER -55.3 -43.9 75.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.426 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.553 ' HB2' ' N ' ' A' ' 100' ' ' ARG . 1.4 m-30 -114.27 53.01 0.8 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 109.58 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 66' ' ' ASN . 0.6 OUTLIER -75.43 -10.08 59.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.491 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 65' ' ' LEU . 4.4 m120 43.81 45.31 6.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 109.288 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.418 ' C ' ' O ' ' A' ' 66' ' ' ASN . 43.9 t80 -42.98 142.34 0.94 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.44 -0.788 . . . . 0.0 109.725 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' A' ' 69' ' ' GLN . 6.7 mtp180 -118.28 -75.71 0.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 109.234 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.444 ' HB3' ' O ' ' A' ' 68' ' ' ARG . 6.7 pt20 171.21 -44.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.434 -0.791 . . . . 0.0 109.151 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.06 164.81 6.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.34 -0.85 . . . . 0.0 109.291 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.29 165.37 16.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.54 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 mp -118.57 3.12 11.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.532 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -54.37 -52.6 61.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 109.481 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -62.26 -34.93 77.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.78 -31.48 48.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 109.44 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.795 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -75.99 -38.27 57.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.585 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 78' ' ' ARG . 12.7 mt-10 -51.53 -28.32 13.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.656 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 79' ' ' LEU . 2.1 mtp-105 -44.35 -54.11 6.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -0.945 . . . . 0.0 109.488 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.483 ' CB ' ' O ' ' A' ' 78' ' ' ARG . 1.1 mt 165.36 48.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.645 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 76' ' ' LYS . 12.0 t -43.01 163.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.414 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 86.06 -46.86 3.68 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -41.09 164.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.579 -0.953 . . . . 0.0 110.021 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 4.3 m -98.44 153.01 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.247 -0.908 . . . . 0.0 109.219 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.781 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -151.99 174.59 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.695 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -99.35 138.17 36.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.362 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 35.5 p -149.3 173.53 13.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.889 . . . . 0.0 109.443 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.877 ' NE ' HG12 ' A' ' 35' ' ' VAL . 13.3 mmm-85 -104.23 158.13 16.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.852 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.531 HG23 ' CD2' ' A' ' 36' ' ' HIS . 53.4 t -96.74 131.82 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 109.334 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.649 HG22 ' CD ' ' A' ' 99' ' ' ARG . 42.6 t -92.41 -31.1 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.284 -0.885 . . . . 0.0 110.056 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 164.49 107.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.139 -0.975 . . . . 0.0 109.58 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.958 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -84.65 117.72 23.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -110.54 27.98 9.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.581 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.24 -148.24 17.45 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.7 OUTLIER -45.29 -31.25 1.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -1.133 . . . . 0.0 109.527 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -102.86 135.06 45.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 109.332 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.958 HG13 ' HA ' ' A' ' 91' ' ' ALA . 51.4 t -142.26 152.48 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.9 . . . . 0.0 109.695 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.488 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 50.1 m-20 -97.92 150.29 21.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.203 -0.935 . . . . 0.0 108.706 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.866 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -136.93 136.74 38.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.09 -1.006 . . . . 0.0 110.49 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.649 ' CD ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -123.84 114.46 19.89 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.553 ' N ' ' HB2' ' A' ' 64' ' ' TYR . 16.2 ttm180 -47.22 159.33 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.212 -0.93 . . . . 0.0 109.325 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.425 ' N ' ' HG2' ' A' ' 100' ' ' ARG . 8.3 t80 -89.73 114.36 26.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.28 -0.888 . . . . 0.0 109.454 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.42 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 m -128.13 14.05 6.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.516 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.3 t -126.15 110.7 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.949 . . . . 0.0 109.566 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 mp -104.51 115.34 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.6 99.63 10.45 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.91 . . . . 0.0 109.403 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.444 ' O ' ' HB3' ' A' ' 7' ' ' SER . 34.6 Cg_endo -76.97 140.89 20.65 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.331 2.02 . . . . 0.0 110.171 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 6' ' ' PRO . 7.8 t 69.4 150.43 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.005 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.1 m -118.84 158.11 26.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.078 -1.013 . . . . 0.0 109.77 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.7 ptt85 -149.26 73.2 10.05 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.91 . . . . 0.0 109.161 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.53 -76.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.581 2.188 . . . . 0.0 110.506 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.24 157.73 70.42 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.585 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.09 162.27 28.97 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.744 2.296 . . . . 0.0 110.624 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.64 61.45 1.61 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 109.397 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.45 92.31 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.879 . . . . 0.0 109.458 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -47.66 141.39 5.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.522 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 mmtt -51.16 139.86 17.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.357 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -48.38 111.65 0.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.505 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.5 tt -73.64 -19.69 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.685 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -92.29 152.74 19.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.174 -0.954 . . . . 0.0 109.643 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 19' ' ' LYS . 4.2 t 71.8 6.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 0.0 109.707 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -139.56 111.64 7.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 109.648 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.7 p -68.4 133.04 48.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 109.301 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.415 ' O ' ' O ' ' A' ' 24' ' ' ARG . 0.7 OUTLIER -98.71 -36.53 9.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.619 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' A' ' 23' ' ' TYR . 0.3 OUTLIER 58.37 162.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -0.951 . . . . 0.0 109.284 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.19 -43.81 1.3 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.464 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.16 57.18 3.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.878 . . . . 0.0 109.579 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.4 50.64 0.82 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.487 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.6 tpp -84.49 104.71 14.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.354 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -179.65 36.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.599 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 tp -174.06 50.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.534 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.29 153.5 40.35 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.147 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.24 119.85 5.13 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.609 2.206 . . . . 0.0 110.505 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.73 40.29 0.62 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 m -128.68 161.41 29.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 0.0 109.553 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 35' ' ' VAL . 6.0 m -109.7 132.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.59 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -147.03 170.01 18.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.259 -0.9 . . . . 0.0 109.43 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -100.23 153.39 19.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.852 . . . . 0.0 109.684 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.45 175.22 45.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.88 HG23 ' O ' ' A' ' 81' ' ' GLY . 1.9 mp -98.49 144.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.377 -1.072 . . . . 0.0 108.931 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.536 ' O ' ' CA ' ' A' ' 81' ' ' GLY . 2.1 t -100.94 172.36 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.514 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 1.4 t80 -156.19 147.92 22.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -0.95 . . . . 0.0 109.54 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -101.06 102.92 13.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.455 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -90.83 169.59 10.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 109.487 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -87.08 19.38 3.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 109.539 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.477 ' C ' HG23 ' A' ' 46' ' ' ILE . . . -145.78 -38.63 0.05 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.606 HG21 HD13 ' A' ' 62' ' ' LEU . 45.4 pt -155.64 -155.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.228 -1.16 . . . . 0.0 109.16 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.515 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.3 m-30 -107.9 155.1 20.67 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.021 -1.049 . . . . 0.0 109.17 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 24.3 tttt -126.07 150.46 48.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.507 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 3.4 t -138.55 112.84 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.434 -0.791 . . . . 0.0 109.104 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.73 127.55 45.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.23 85.44 5.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.634 ' HB2' HD13 ' A' ' 39' ' ' ILE . 17.8 tp -59.92 145.64 45.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.241 -0.912 . . . . 0.0 109.402 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.446 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . 101.92 -54.43 0.77 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.09 -24.35 62.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.582 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 47.78 85.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.99 -9.84 3.89 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -97.46 98.16 9.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -1.144 . . . . 0.0 109.596 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.568 ' OE2' ' CZ ' ' A' ' 95' ' ' TYR . 26.4 tt0 -101.42 107.54 18.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.2 m -104.87 162.63 13.16 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.627 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -131.01 132.68 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.576 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.525 HD12 HD12 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -97.4 124.69 41.66 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 109.831 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.631 ' O ' HD23 ' A' ' 65' ' ' LEU . 4.9 tp -151.75 -38.05 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.545 -0.722 . . . . 0.0 109.462 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.493 ' HB3' ' HA ' ' A' ' 99' ' ' ARG . 23.0 t0 -47.13 -53.39 13.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.17 -0.956 . . . . 0.0 108.963 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.482 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -118.65 49.01 1.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 0.0 109.209 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -56.35 -19.75 16.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -0.827 . . . . 0.0 109.604 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 63.9 t30 69.22 159.86 0.18 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.71 167.6 12.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.445 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.626 ' HD2' HG23 ' A' ' 71' ' ' THR . 3.6 mmt180 -116.72 154.35 30.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -87.44 66.13 8.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -0.884 . . . . 0.0 109.523 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 69' ' ' GLN . 2.2 m-20 44.6 52.23 7.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 109.357 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.626 HG23 ' HD2' ' A' ' 68' ' ' ARG . 2.9 t -139.58 126.01 20.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.621 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.41 ' O ' ' CB ' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -50.34 -31.8 15.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.487 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.499 ' OD1' ' CZ ' ' A' ' 68' ' ' ARG . 0.7 OUTLIER 70.22 81.64 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.46 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -64.41 -26.57 68.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.516 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 1.6 tp -53.59 -47.47 70.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.796 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.465 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 0.9 OUTLIER -45.47 -44.58 12.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.22 -0.925 . . . . 0.0 109.639 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 78' ' ' ARG . 0.6 OUTLIER -51.48 -46.01 63.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.381 -0.824 . . . . 0.0 109.606 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -43.04 -67.1 0.3 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.237 -0.914 . . . . 0.0 109.495 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 82' ' ' ARG . 1.3 mt -172.8 70.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -0.96 . . . . 0.0 109.732 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.531 ' CG1' ' N ' ' A' ' 81' ' ' GLY . 2.3 p -59.91 -43.07 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.77 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.88 ' O ' HG23 ' A' ' 39' ' ' ILE . . . -75.33 15.4 4.43 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.808 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.503 ' O ' ' O ' ' A' ' 81' ' ' GLY . 8.5 ttp180 -50.63 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.969 -1.313 . . . . 0.0 109.724 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.4 m -96.01 112.91 29.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 108.821 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.759 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.7 pp -133.57 175.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.95 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -98.28 151.37 20.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 109.038 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.738 ' HB ' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -154.91 170.86 20.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.812 ' O ' HD13 ' A' ' 98' ' ' LEU . 6.1 mmt180 -99.78 154.16 18.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.194 -0.941 . . . . 0.0 109.244 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.5 t -97.78 125.9 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.13 -0.981 . . . . 0.0 108.908 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.955 HG12 ' HG2' ' A' ' 90' ' ' ARG . 78.7 t -85.36 -33.88 8.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.295 -0.878 . . . . 0.0 110.251 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.955 ' HG2' HG12 ' A' ' 89' ' ' VAL . 1.9 ptt180 166.45 108.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.03 -1.044 . . . . 0.0 109.601 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.802 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -91.44 114.87 27.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.822 . . . . 0.0 109.244 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.7 64.86 1.58 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.109 -0.995 . . . . 0.0 109.794 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.75 -165.64 12.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -25.88 62.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -1.093 . . . . 0.0 109.676 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.568 ' CZ ' ' OE2' ' A' ' 58' ' ' GLU . 6.9 m-85 -99.59 140.63 33.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.353 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.802 HG22 ' HA ' ' A' ' 91' ' ' ALA . 79.9 t -142.2 162.89 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 109.944 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.573 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 30.8 m-20 -101.19 157.2 16.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.002 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.812 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.24 136.23 33.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.88 -1.137 . . . . 0.0 111.033 -178.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.589 ' N ' HG23 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -120.8 114.78 22.11 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.632 ' HA ' HG22 ' A' ' 86' ' ' THR . 0.0 OUTLIER -69.94 163.21 26.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 -179.241 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.432 ' HB3' ' NH1' ' A' ' 87' ' ' ARG . 2.5 t80 -142.62 67.61 1.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.415 -0.803 . . . . 0.0 109.213 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.9 t80 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.49 -179.879 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.29 0.567 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.97 135.73 9.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 3' ' ' VAL . 14.0 m -137.01 131.71 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.326 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.87 24.81 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.086 -1.009 . . . . 0.0 109.506 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.553 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -50.44 -52.42 55.24 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.942 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 35.0 Cg_endo -77.85 131.49 11.2 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.465 2.11 . . . . 0.0 110.625 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 m -142.27 74.1 1.44 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.495 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.81 142.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 109.56 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.3 ttt85 -123.7 84.3 53.73 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.599 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.72 -67.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.546 2.164 . . . . 0.0 110.218 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -139.78 144.0 37.09 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.923 . . . . 0.0 109.32 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.74 87.69 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.582 2.188 . . . . 0.0 110.273 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -160.6 77.74 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.552 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.441 ' O ' ' CB ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER -154.57 58.11 0.69 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 109.569 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 72.3 107.52 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 109.427 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -78.41 111.72 14.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 0.0 109.555 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -163.12 155.98 18.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 109.663 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 28.7 pt -132.22 -169.74 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 109.227 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 10.6 tttt 178.37 166.29 0.8 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.133 -0.979 . . . . 0.0 109.43 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.431 ' N ' ' CG ' ' A' ' 19' ' ' LYS . 93.8 t -144.12 116.51 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.872 . . . . 0.0 109.345 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -113.78 166.71 11.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.615 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.65 145.73 55.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.587 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.61 177.9 6.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.677 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.19 -37.52 61.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 109.414 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 p -76.04 123.71 26.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.506 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.59 130.33 41.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.577 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.61 114.76 28.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.242 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mmt -94.22 167.56 11.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.799 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.54 59.96 1.08 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.348 -0.845 . . . . 0.0 109.283 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 tt -122.67 102.08 7.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 109.419 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.57 165.08 5.38 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.18 90.34 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.674 2.249 . . . . 0.0 110.34 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.07 68.7 0.3 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.05 172.02 13.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -1.134 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.623 HG12 ' NE ' ' A' ' 87' ' ' ARG . 12.9 m -120.44 128.43 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.0 109.218 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -149.93 166.87 28.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.554 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.56 133.27 45.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.204 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.07 176.71 24.87 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 39' ' ' ILE . 2.9 mp -96.14 160.02 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -1.122 . . . . 0.0 108.581 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.542 ' CG2' HD12 ' A' ' 84' ' ' ILE . 7.1 t -111.37 167.94 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.085 -1.009 . . . . 0.0 110.237 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.507 ' N ' HG12 ' A' ' 40' ' ' VAL . 2.1 t80 -157.87 150.4 22.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.438 -0.789 . . . . 0.0 108.922 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -103.92 120.77 41.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.931 . . . . 0.0 109.704 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.29 168.47 9.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.275 -0.89 . . . . 0.0 109.471 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 8.5 t70 -87.92 6.45 35.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.771 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.53 -32.82 0.46 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.811 HG23 ' N ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -162.15 -152.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -1.179 . . . . 0.0 108.869 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.811 ' N ' HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -107.04 164.43 12.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.738 -1.226 . . . . 0.0 109.157 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.07 147.64 49.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.083 -1.011 . . . . 0.0 110.219 -179.449 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.494 ' CG2' HD13 ' A' ' 61' ' ' LEU . 71.7 t -130.8 133.66 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -114.37 123.57 49.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.11 67.69 10.05 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.174 -0.954 . . . . 0.0 109.242 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.416 ' HB2' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -47.63 147.28 1.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.701 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.24 -45.3 1.38 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.497 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -77.62 -17.03 58.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -1.152 . . . . 0.0 109.456 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.24 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.203 -0.936 . . . . 0.0 109.515 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.81 -23.96 7.66 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.574 ' NE2' ' HB1' ' A' ' 91' ' ' ALA . 1.6 t-160 -82.1 91.06 6.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.164 -1.198 . . . . 0.0 109.787 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.87 109.68 22.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.099 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.461 ' HA ' ' HB ' ' A' ' 96' ' ' VAL . 13.7 m -98.54 173.7 6.8 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.154 -0.966 . . . . 0.0 109.444 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 96' ' ' VAL . 1.8 pp -149.55 147.62 16.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.422 -0.798 . . . . 0.0 109.374 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.61 HD23 ' CD2' ' A' ' 64' ' ' TYR . 0.6 OUTLIER -98.13 102.48 14.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.298 -0.876 . . . . 0.0 109.183 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.469 ' HA ' HG12 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -123.3 -27.27 4.15 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.458 ' CB ' ' HB3' ' A' ' 99' ' ' ARG . 2.1 m-20 -85.86 -34.66 20.95 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.61 ' CD2' HD23 ' A' ' 61' ' ' LEU . 15.9 t80 -43.37 -43.65 5.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.553 -0.717 . . . . 0.0 109.106 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -65.74 -41.25 92.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.154 -0.966 . . . . 0.0 109.615 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 65' ' ' LEU . 14.3 t-20 -43.24 146.49 0.45 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 109.401 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 48.65 70.97 0.4 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.301 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -101.02 87.45 3.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.242 -0.911 . . . . 0.0 109.541 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.74 -6.26 23.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.175 -0.953 . . . . 0.0 109.42 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.81 90.06 3.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.309 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.0 p -45.81 103.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 109.571 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.73 51.07 2.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.474 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.485 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 18.8 m-20 -100.04 -11.75 20.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.165 -0.959 . . . . 0.0 109.544 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -68.1 -40.99 82.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 109.505 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 74' ' ' ARG . 1.7 tt -44.54 -32.95 1.58 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.305 -0.872 . . . . 0.0 109.491 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 73' ' ' ASP . 6.7 mtmt -49.43 -63.78 1.0 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -51.47 -31.2 22.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.957 . . . . 0.0 109.506 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.598 ' O ' HD12 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -49.86 -64.76 0.71 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.95 . . . . 0.0 109.476 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -174.58 54.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.401 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 0.9 OUTLIER -43.66 166.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.234 -0.916 . . . . 0.0 109.171 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.563 ' N ' ' CG2' ' A' ' 80' ' ' VAL . . . 88.78 -37.41 3.31 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 81' ' ' GLY . 1.5 mmt180 -43.62 172.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.633 -0.922 . . . . 0.0 110.153 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.454 ' C ' HG23 ' A' ' 84' ' ' ILE . 9.1 p -97.18 147.1 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.601 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.687 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.0 OUTLIER -155.74 176.02 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.352 -0.843 . . . . 0.0 109.605 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.482 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -98.1 110.4 22.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.323 -0.861 . . . . 0.0 108.949 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.995 HG22 ' HB2' ' A' ' 100' ' ' ARG . 82.4 p -110.35 165.45 11.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.044 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.623 ' NE ' HG12 ' A' ' 35' ' ' VAL . 6.2 mpt_? -98.56 140.79 32.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 108.65 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.605 ' HA ' ' HB3' ' A' ' 98' ' ' LEU . 58.9 t -94.25 139.16 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.469 -0.769 . . . . 0.0 109.299 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 89' ' ' VAL . 91.1 t -121.97 -10.31 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.47 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.884 ' O ' HG13 ' A' ' 96' ' ' VAL . 0.0 OUTLIER 174.38 105.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.496 -1.377 . . . . 0.0 110.444 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.813 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -116.54 88.03 2.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.506 -0.746 . . . . 0.0 109.172 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -121.65 84.19 2.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.766 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.36 -137.76 14.14 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mp -102.28 4.38 39.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -1.141 . . . . 0.0 109.674 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.458 ' CZ ' HG21 ' A' ' 60' ' ' ILE . 1.3 t80 -124.4 131.96 53.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 109.212 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.946 HG12 ' CD2' ' A' ' 98' ' ' LEU . 22.0 t -132.8 145.86 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.213 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.951 ' O ' HD23 ' A' ' 98' ' ' LEU . 2.0 m-20 -112.8 141.2 46.88 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.951 HD23 ' O ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -165.2 178.91 6.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.592 -1.317 . . . . 0.0 112.041 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.534 ' HB3' ' N ' ' A' ' 64' ' ' TYR . 3.1 ptt-85 -134.89 104.05 5.84 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.082 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.995 ' HB2' HG22 ' A' ' 86' ' ' THR . 1.2 ptt180 -51.91 159.44 0.85 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.915 -1.115 . . . . 0.0 109.518 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.44 ' O ' ' HB2' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -158.66 131.44 7.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 109.453 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 85' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.544 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tpp . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.06 152.74 51.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 0.0 109.496 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.2 m -50.8 132.06 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.307 -0.871 . . . . 0.0 109.642 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.02 85.3 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.499 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -133.37 147.28 64.27 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.552 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.87 -174.51 2.31 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.638 2.225 . . . . 0.0 110.224 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.0 t 179.88 -56.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 109.619 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 p -96.62 -31.58 12.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.62 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 mtm105 61.86 84.91 0.18 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.411 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 11' ' ' ARG . 35.5 Cg_endo -78.34 116.08 3.81 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.699 2.266 . . . . 0.0 110.353 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.537 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 4.9 ttt180 44.4 61.49 11.12 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.368 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 35.8 Cg_endo -78.11 162.49 28.77 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.654 2.236 . . . . 0.0 110.482 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -74.16 148.29 41.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.328 -0.858 . . . . 0.0 109.263 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -47.85 148.01 1.77 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.539 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -120.69 113.44 20.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 109.439 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -82.65 178.51 8.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.318 -0.864 . . . . 0.0 109.512 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -152.3 33.62 0.52 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 109.407 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 18' ' ' ILE . 23.0 pt -115.06 33.81 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.27 -0.894 . . . . 0.0 109.365 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -177.37 98.71 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.898 . . . . 0.0 109.589 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.02 143.8 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 109.251 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.28 86.25 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.3 m -85.93 -59.85 2.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.249 -0.907 . . . . 0.0 109.464 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -52.73 173.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 109.387 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -148.22 144.09 27.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 0.0 109.555 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.451 ' O ' HG22 ' A' ' 25' ' ' THR . 17.9 m 54.23 88.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 109.464 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 t -135.17 40.42 2.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.316 -0.865 . . . . 0.0 109.457 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.26 109.94 19.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.437 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.9 mtt -76.06 122.56 24.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -0.936 . . . . 0.0 109.5 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.78 -0.3 4.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.701 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.448 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER 59.38 102.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.172 -0.955 . . . . 0.0 109.341 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.89 150.25 37.23 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.619 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.12 175.15 11.19 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.734 2.289 . . . . 0.0 110.45 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.72 20.71 4.89 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.76 161.94 34.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -1.14 . . . . 0.0 109.386 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.733 HG12 ' HG3' ' A' ' 87' ' ' ARG . 9.6 m -118.29 170.4 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.576 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 11.0 m-70 -172.55 168.16 5.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -99.17 147.31 25.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.6 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -158.75 175.67 35.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 81' ' ' GLY . 6.0 mt -98.04 151.25 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -1.11 . . . . 0.0 109.053 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.567 ' CG2' HD12 ' A' ' 84' ' ' ILE . 66.9 t -99.72 147.16 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.059 -1.026 . . . . 0.0 110.19 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.56 172.29 14.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.438 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.88 135.2 54.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.928 . . . . 0.0 109.545 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 44' ' ' ASP . 0.3 OUTLIER 175.07 154.09 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.62 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER 66.97 9.58 6.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.696 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.19 -15.75 47.5 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.438 HG13 ' N ' ' A' ' 47' ' ' PHE . 35.3 pt -112.03 -147.41 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -1.176 . . . . 0.0 109.103 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.562 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.0 m-85 -111.6 173.91 6.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.119 -0.988 . . . . 0.0 109.217 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 1.8 mttp -148.08 127.2 12.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.638 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 2.4 t -101.68 111.63 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.427 -0.796 . . . . 0.0 109.287 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.54 130.63 45.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.24 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -92.7 93.4 8.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.554 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 53' ' ' GLY . 1.5 tt -66.35 143.11 57.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.189 -0.945 . . . . 0.0 109.461 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.436 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . 110.81 -43.19 1.77 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 55' ' ' GLU . 14.7 m-85 -88.6 -27.31 21.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -1.151 . . . . 0.0 109.391 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 54' ' ' TYR . 38.3 tt0 61.71 123.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.269 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 58' ' ' GLU . . . 97.27 -39.24 2.83 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -59.86 88.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -1.13 . . . . 0.0 109.33 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 56' ' ' GLY . 32.0 tt0 -104.02 104.02 13.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.447 -0.783 . . . . 0.0 109.438 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 44.4 m -99.04 155.39 17.46 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 109.095 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.9 pt -118.55 136.44 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 109.229 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.562 ' HB3' ' CB ' ' A' ' 47' ' ' PHE . 14.8 tp -98.02 110.38 22.97 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.105 -0.997 . . . . 0.0 109.053 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.655 ' C ' HD23 ' A' ' 62' ' ' LEU . 7.5 tt -118.6 -38.02 3.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.474 -0.766 . . . . 0.0 109.381 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.563 ' CB ' ' HB2' ' A' ' 99' ' ' ARG . 2.7 t70 -61.9 -56.36 20.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 109.212 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.566 ' HB2' ' CB ' ' A' ' 100' ' ' ARG . 0.6 OUTLIER -118.43 54.7 0.93 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.639 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.744 ' H ' HD23 ' A' ' 65' ' ' LEU . 1.9 pt? -64.11 -21.95 66.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.967 . . . . 0.0 109.383 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.425 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 45.9 p30 -166.94 -174.36 2.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.312 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.453 ' O ' ' O ' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -135.88 100.07 4.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.676 -179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 67' ' ' TYR . 1.5 mtm105 42.75 -164.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.347 -0.846 . . . . 0.0 109.645 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -154.73 -165.29 2.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 0.0 109.509 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 3.0 t0 176.13 -70.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.521 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 4.8 t -176.42 163.5 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.925 . . . . 0.0 109.374 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.515 ' CB ' ' O ' ' A' ' 71' ' ' THR . 0.3 OUTLIER 75.86 44.13 0.15 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.389 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -8.77 30.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.246 -0.909 . . . . 0.0 109.64 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -61.49 -39.19 90.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -0.96 . . . . 0.0 109.38 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.67 -26.76 66.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 109.266 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.677 ' O ' HG23 ' A' ' 80' ' ' VAL . 3.0 tttp -64.76 -30.63 71.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.387 -0.821 . . . . 0.0 109.769 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -48.77 80.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 109.82 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -31.26 64.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.716 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -58.3 -50.97 71.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.177 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 76' ' ' LYS . 21.9 t -43.59 164.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.324 -0.86 . . . . 0.0 109.06 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 86.15 -47.5 3.77 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -38.95 159.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.641 -0.917 . . . . 0.0 110.008 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 38' ' ' GLY . 22.2 t -98.48 141.46 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 109.028 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.772 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -141.45 166.86 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.822 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -103.59 106.97 17.63 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.723 HG22 ' CG ' ' A' ' 100' ' ' ARG . 1.3 p -118.08 174.77 6.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.744 ' O ' HD13 ' A' ' 98' ' ' LEU . 2.5 mpt_? -98.93 162.96 12.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.871 . . . . 0.0 109.21 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.9 129.33 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.275 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.562 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 57.2 t -85.27 -34.1 8.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.401 -0.812 . . . . 0.0 109.742 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 162.85 113.69 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.301 -0.874 . . . . 0.0 109.215 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.454 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -98.45 151.48 20.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.583 -0.698 . . . . 0.0 109.437 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -127.0 -69.32 0.76 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 109.326 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.455 ' C ' HD12 ' A' ' 94' ' ' LEU . . . -141.35 -75.31 0.04 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.455 HD12 ' C ' ' A' ' 93' ' ' GLY . 8.4 mp -111.52 -25.23 9.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -1.115 . . . . 0.0 109.172 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -100.4 135.57 41.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.037 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.457 ' HB ' ' SG ' ' A' ' 59' ' ' CYS . 58.1 t -140.02 151.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.101 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.562 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 94.1 m-20 -98.49 155.57 17.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 108.624 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.744 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.39 139.25 35.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.821 -1.175 . . . . 0.0 110.831 -178.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.563 ' HB2' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -144.06 125.46 14.78 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.723 ' CG ' HG22 ' A' ' 86' ' ' THR . 3.8 ttt-85 -87.75 170.62 11.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.486 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.464 ' O ' ' OXT' ' A' ' 102' ' ' PHE . 3.3 t80 -172.82 75.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.482 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.464 ' OXT' ' O ' ' A' ' 101' ' ' PHE . 3.2 m-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.551 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ptt? . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.0 m 53.08 42.52 32.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.375 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.4 t -92.55 103.02 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.89 . . . . 0.0 109.534 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 mt -98.31 -72.15 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.518 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -158.19 77.59 3.45 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.381 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.9 -161.83 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.644 2.229 . . . . 0.0 110.537 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.4 p -129.31 23.15 5.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.279 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.6 p -94.1 157.04 16.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.63 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -153.91 152.39 26.76 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.323 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.64 -24.25 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.643 2.229 . . . . 0.0 110.663 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.62 82.82 20.51 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.132 -0.98 . . . . 0.0 109.631 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.33 -33.26 1.97 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.714 2.276 . . . . 0.0 110.318 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 178.61 127.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.387 -0.821 . . . . 0.0 109.293 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -165.92 62.13 0.11 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 16' ' ' LYS . 88.0 m-20 -87.69 100.5 12.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.423 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 15' ' ' ASN . 0.9 OUTLIER 54.67 104.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.538 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.405 ' OD1' ' C ' ' A' ' 17' ' ' ASN . 20.3 t-20 -151.46 107.3 3.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.519 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 3.3 mt -52.85 152.95 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER 68.73 115.6 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 109.399 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.6 m -112.25 156.45 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 0.0 109.586 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 51.1 -158.77 0.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.752 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -156.27 148.81 23.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.426 -0.796 . . . . 0.0 109.099 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' THR . 4.8 t80 61.41 119.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 0.0 109.003 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -115.23 166.52 11.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 109.645 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.96 1.37 45.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.357 -0.84 . . . . 0.0 109.596 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -86.28 154.84 20.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.449 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 26' ' ' SER . . . 61.28 140.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 109.432 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.52 153.1 21.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.473 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.21 0.16 57.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.568 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.828 HD23 ' HB3' ' A' ' 91' ' ' ALA . 7.1 tp -50.01 -70.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.498 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.03 74.54 0.9 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.424 -0.797 . . . . 0.0 109.455 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.38 118.96 4.4 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.656 2.237 . . . . 0.0 110.378 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 44.63 48.53 8.89 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.56 162.15 17.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.238 -1.154 . . . . 0.0 109.577 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.727 HG13 ' HD2' ' A' ' 87' ' ' ARG . 1.9 t -109.33 156.23 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.326 -0.858 . . . . 0.0 109.441 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.3 169.58 20.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.613 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 154.5 17.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.234 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -168.67 176.58 42.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.693 HG23 ' O ' ' A' ' 81' ' ' GLY . 32.3 mt -97.1 148.29 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -1.142 . . . . 0.0 108.719 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.545 ' CG2' HG12 ' A' ' 84' ' ' ILE . 59.7 t -98.54 146.96 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.024 -1.048 . . . . 0.0 110.42 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -139.77 150.42 44.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.386 -0.821 . . . . 0.0 109.153 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -119.98 124.73 46.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.038 . . . . 0.0 109.671 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.422 ' O ' HG13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -163.21 144.71 9.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 59.86 13.82 3.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.393 -0.817 . . . . 0.0 109.833 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.41 -22.22 21.22 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 43' ' ' LYS . 2.7 pt -91.06 -179.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -1.164 . . . . 0.0 109.178 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.608 ' HB2' HD23 ' A' ' 61' ' ' LEU . 7.2 m-85 -109.45 167.75 9.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.947 ' HG3' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -143.13 131.92 22.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 109.442 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.552 HG21 ' HG ' ' A' ' 98' ' ' LEU . 15.6 t -106.96 116.72 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.52 127.68 44.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.314 -0.866 . . . . 0.0 109.313 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -96.13 70.56 2.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.052 -1.03 . . . . 0.0 109.567 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -58.2 139.16 55.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.226 -0.921 . . . . 0.0 109.324 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.74 -17.52 15.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.28 -30.08 7.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -1.131 . . . . 0.0 109.266 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 66.05 90.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 0.0 109.622 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.56 -11.05 10.44 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 1.3 t-160 -92.26 87.87 6.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -1.132 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -107.94 107.79 18.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.26 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.9 m -104.37 165.39 11.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.278 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.947 HG22 ' HG3' ' A' ' 48' ' ' LYS . 1.6 pt -129.24 134.11 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.335 -0.853 . . . . 0.0 108.932 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.608 HD23 ' HB2' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -97.93 120.56 38.55 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.99 -1.069 . . . . 0.0 109.19 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.476 ' CD2' HD12 ' A' ' 60' ' ' ILE . 2.9 pp -155.47 -35.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.684 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.472 ' N ' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -49.93 -40.31 43.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.117 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.484 ' HB2' ' HG3' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -136.97 69.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.617 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 62' ' ' LEU . 1.3 mp -59.0 -46.78 87.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.459 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 66.33 131.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.918 . . . . 0.0 109.548 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -130.16 136.72 49.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.43 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -108.97 31.09 5.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.0 109.488 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 68' ' ' ARG . 3.1 mp0 63.64 -92.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.703 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 69' ' ' GLN . 18.4 t0 70.22 137.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 109.338 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 71' ' ' THR . 1.6 t -65.52 88.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.595 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 67.14 8.3 6.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.641 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.65 37.81 15.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.406 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -52.41 57.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.473 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 mp -75.92 -34.09 59.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 109.438 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.613 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -63.87 -28.29 69.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.493 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.439 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 5.0 mm-40 -59.64 -46.12 89.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.194 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -26.58 55.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.345 -0.847 . . . . 0.0 109.452 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.653 HD23 ' HG3' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -63.96 -40.05 95.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 109.392 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 76' ' ' LYS . 15.1 t -40.91 162.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.482 -0.761 . . . . 0.0 109.667 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.693 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 85.76 -47.42 3.79 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.653 ' HG3' HD23 ' A' ' 79' ' ' LEU . 25.7 mmt180 -38.18 164.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.771 -0.84 . . . . 0.0 110.592 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 6.4 m -96.89 130.96 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 108.869 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.644 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 pp -135.67 174.64 12.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 109.74 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 144.26 33.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.044 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.737 ' HB ' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -152.38 173.62 14.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.903 . . . . 0.0 109.534 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.752 ' O ' HD13 ' A' ' 98' ' ' LEU . 10.4 mpt_? -99.96 156.06 17.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.239 -0.913 . . . . 0.0 109.367 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.9 t -96.96 119.79 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.315 -0.865 . . . . 0.0 108.995 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.783 HG11 ' OD2' ' A' ' 97' ' ' ASP . 75.4 t -77.6 -31.22 17.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.374 -0.829 . . . . 0.0 109.928 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 1.6 ttm180 170.23 106.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.35 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.828 ' HB3' HD23 ' A' ' 30' ' ' LEU . . . -88.12 133.82 33.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.416 -0.803 . . . . 0.0 109.172 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.66 88.31 0.34 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.67 -177.89 33.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.5 mp -58.9 -16.23 16.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -1.135 . . . . 0.0 109.662 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -108.52 127.96 54.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.644 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.753 HG22 ' HA ' ' A' ' 91' ' ' ALA . 55.4 t -129.6 158.97 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.852 . . . . 0.0 109.356 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.783 ' OD2' HG11 ' A' ' 89' ' ' VAL . 28.7 t0 -98.59 147.72 24.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.97 . . . . 0.0 108.742 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -132.76 135.51 45.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.04 -1.037 . . . . 0.0 111.088 -178.73 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.549 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 4.7 ttp-105 -132.63 129.41 38.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.507 ' HB2' HG23 ' A' ' 86' ' ' THR . 0.4 OUTLIER -100.77 149.31 23.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.021 -1.049 . . . . 0.0 109.732 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.416 ' N ' ' HG3' ' A' ' 100' ' ' ARG . 0.7 OUTLIER -142.89 147.66 35.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.342 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.441 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.18 39.24 1.43 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.924 . . . . 0.0 109.379 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 3' ' ' VAL . 7.4 p -79.89 135.35 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.385 -0.822 . . . . 0.0 109.352 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.509 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 65.2 mt -54.84 -36.8 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 109.27 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER 164.46 142.24 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.847 . . . . 0.0 109.257 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.78 -165.82 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.556 2.171 . . . . 0.0 110.479 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.6 m -125.85 48.29 2.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.403 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.1 59.05 0.83 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 0.0 109.522 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -63.73 160.66 43.03 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.94 140.55 18.27 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.691 2.261 . . . . 0.0 110.494 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.477 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -140.3 64.27 24.89 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.288 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 35.5 Cg_endo -77.45 134.6 14.07 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.735 2.29 . . . . 0.0 110.484 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -176.95 35.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.0 109.297 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 15' ' ' ASN . 1.1 ptmt -115.89 170.28 8.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.552 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 10.2 t30 170.78 138.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.05 -175.5 2.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.37 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -120.58 167.92 11.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.614 HG22 ' N ' ' A' ' 19' ' ' LYS . 1.8 mp -132.15 -86.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.349 -0.844 . . . . 0.0 109.286 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.614 ' N ' HG22 ' A' ' 18' ' ' ILE . 6.3 mttp -51.67 162.83 0.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 21' ' ' ASN . 14.7 m -132.3 -149.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.481 ' N ' HG23 ' A' ' 20' ' ' VAL . 36.7 t30 -132.22 120.57 22.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 0.0 109.383 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.73 52.26 1.78 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.399 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 57.94 41.43 24.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.36 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.01 -80.15 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.358 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.5 m -113.42 99.88 8.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.938 . . . . 0.0 109.327 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.6 p -143.57 81.51 1.7 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.958 . . . . 0.0 109.537 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.51 37.14 4.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.89 . . . . 0.0 109.295 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -87.63 124.05 33.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.581 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.422 ' CG ' ' O ' ' A' ' 28' ' ' MET . 6.1 m-20 -158.72 -74.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 109.414 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.637 HD22 HG11 ' A' ' 88' ' ' VAL . 0.2 OUTLIER -137.78 162.33 34.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.593 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.469 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -152.77 168.83 10.65 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.857 . . . . 0.0 109.354 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 31' ' ' SER . 35.1 Cg_endo -78.03 127.18 8.34 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.529 2.153 . . . . 0.0 110.411 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.52 83.04 1.0 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 t -168.74 150.56 4.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -1.161 . . . . 0.0 109.37 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 36' ' ' HIS . 20.2 t -102.55 163.33 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.476 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -172.86 163.85 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.772 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -101.35 142.05 33.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.387 -0.821 . . . . 0.0 109.305 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -153.53 176.6 31.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.511 HG23 ' O ' ' A' ' 81' ' ' GLY . 28.5 mt -97.31 154.58 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -1.21 . . . . 0.0 108.9 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 84' ' ' ILE . 77.0 t -98.66 150.61 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 110.16 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.538 ' HB3' ' CB ' ' A' ' 48' ' ' LYS . 42.9 t80 -141.98 155.03 45.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.344 -0.847 . . . . 0.0 109.142 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.506 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 28.3 p90 -106.64 124.7 50.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.95 . . . . 0.0 109.589 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.53 ' CG ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -98.51 -165.22 1.22 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.184 -0.948 . . . . 0.0 109.299 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -79.07 6.17 10.14 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.32 -0.862 . . . . 0.0 109.211 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.06 -26.62 0.08 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.623 HG22 HD13 ' A' ' 62' ' ' LEU . 3.0 pt -109.54 -174.56 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.0 -1.294 . . . . 0.0 109.687 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.43 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 5.6 m-85 -107.54 159.18 16.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.553 ' HG3' HG22 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -133.47 128.37 35.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.17 -0.956 . . . . 0.0 109.761 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.587 HG21 ' HG ' ' A' ' 98' ' ' LEU . 1.8 t -106.18 118.93 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 108.878 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.53 121.04 40.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 109.855 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.542 HD13 ' SG ' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -88.28 72.64 8.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.227 179.77 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.72 129.13 38.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.69 -33.99 4.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.43 -71.02 0.41 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -1.167 . . . . 0.0 109.531 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -178.31 55.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 109.556 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.42 7.79 48.01 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.75 118.06 2.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -1.189 . . . . 0.0 109.171 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 95' ' ' TYR . 7.4 tt0 -106.34 111.11 23.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.691 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.542 ' SG ' HD13 ' A' ' 51' ' ' LEU . 13.0 m -109.95 165.91 11.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.315 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.553 HG22 ' HG3' ' A' ' 48' ' ' LYS . 1.6 pt -133.95 135.53 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 109.49 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.654 HD12 ' HB3' ' A' ' 98' ' ' LEU . 3.9 tp -98.56 127.83 44.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.623 HD13 HG22 ' A' ' 46' ' ' ILE . 13.8 tp -143.98 -45.71 0.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.346 -0.847 . . . . 0.0 109.463 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' HB3' ' CG ' ' A' ' 99' ' ' ARG . 0.6 OUTLIER -53.0 -35.57 59.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 109.349 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.63 ' CB ' HD21 ' A' ' 61' ' ' LEU . 6.0 t80 -43.81 -68.25 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -0.895 . . . . 0.0 109.433 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 mp -54.13 -59.97 3.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.495 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.53 29.93 19.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 0.0 109.555 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.63 65.05 1.62 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.792 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.486 ' HG3' ' OE1' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -143.52 94.7 2.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.185 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.486 ' OE1' ' HG3' ' A' ' 68' ' ' ARG . 17.8 mp0 60.8 151.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.041 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.26 -58.72 2.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.687 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.71 96.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.168 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -43.48 98.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.556 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.417 ' HB3' ' HB2' ' A' ' 76' ' ' LYS . 0.4 OUTLIER 51.62 77.04 0.15 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.655 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -44.74 -26.95 0.44 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.59 -49.56 39.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.892 . . . . 0.0 109.555 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.725 ' O ' HG23 ' A' ' 80' ' ' VAL . 21.9 tptt -58.35 -26.68 63.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.728 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.62 -56.54 17.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 109.915 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.65 -26.74 57.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.139 -0.976 . . . . 0.0 110.044 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 80' ' ' VAL . 8.0 tp -65.82 -28.79 69.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.152 -0.967 . . . . 0.0 109.735 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 76' ' ' LYS . 43.2 t -43.23 165.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 0.0 109.434 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.568 ' N ' HG12 ' A' ' 80' ' ' VAL . . . 85.67 -45.61 3.51 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 81' ' ' GLY . 2.8 mmt180 -43.15 172.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.647 -0.914 . . . . 0.0 110.382 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 38' ' ' GLY . 56.0 t -97.57 139.22 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.267 -0.895 . . . . 0.0 109.222 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.889 HD13 HG23 ' A' ' 86' ' ' THR . 2.0 pp -136.75 166.64 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 85' ' ' LYS . 15.6 ptpt -101.7 128.58 47.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 109.07 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.889 HG23 HD13 ' A' ' 84' ' ' ILE . 40.6 p -141.89 175.43 9.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.851 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.802 ' O ' HD13 ' A' ' 98' ' ' LEU . 3.8 mpt_? -101.48 161.59 13.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.486 -0.759 . . . . 0.0 109.426 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.637 HG11 HD22 ' A' ' 30' ' ' LEU . 5.2 t -97.75 110.39 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.338 -0.851 . . . . 0.0 109.003 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.575 HG23 ' N ' ' A' ' 99' ' ' ARG . 41.1 t -65.62 -40.29 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 0.0 110.103 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.49 103.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 109.501 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.763 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -82.76 122.18 27.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.527 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 91' ' ' ALA . 0.4 OUTLIER -156.26 92.19 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.286 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.5 -177.33 33.26 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -15.77 41.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -1.155 . . . . 0.0 109.445 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.5 OUTLIER -107.35 125.81 51.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.191 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.763 HG13 ' HA ' ' A' ' 91' ' ' ALA . 74.2 t -122.79 160.86 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.888 . . . . 0.0 109.468 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.56 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 0.9 OUTLIER -97.91 148.01 23.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.109 -0.994 . . . . 0.0 108.576 179.453 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -133.01 135.56 45.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 110.677 -178.614 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.575 ' N ' HG23 ' A' ' 89' ' ' VAL . 4.0 ttp85 -132.84 120.61 21.78 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.544 ' HG3' HG22 ' A' ' 86' ' ' THR . 0.2 OUTLIER -82.21 163.97 21.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -120.39 139.05 53.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 0.0 109.643 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.401 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 ttm . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.3 m -163.79 -50.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 109.647 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 p -162.48 127.8 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.927 . . . . 0.0 109.539 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.08 24.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.094 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -143.88 71.78 16.9 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.783 . . . . 0.0 109.427 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.12 -164.18 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.614 2.209 . . . . 0.0 110.393 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.7 t -110.07 79.97 1.26 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.175 -0.953 . . . . 0.0 109.789 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.0 m -115.96 -76.97 0.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.333 -0.854 . . . . 0.0 108.998 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.19 80.99 0.27 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.457 -0.777 . . . . 0.0 110.159 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -79.0 -176.46 3.3 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.607 2.205 . . . . 0.0 109.837 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -130.61 76.64 77.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.035 -1.041 . . . . 0.0 109.745 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.91 -20.49 10.24 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.694 2.263 . . . . 0.0 110.231 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.17 83.12 8.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -0.864 . . . . 0.0 109.55 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 57.63 3.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 109.476 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.45 48.68 1.64 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.9 . . . . 0.0 109.524 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.94 100.27 11.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -153.55 -57.32 0.12 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.604 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 tt -112.22 161.56 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.642 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -151.26 130.52 12.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.951 . . . . 0.0 109.366 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.12 110.57 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 109.611 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -150.01 138.67 20.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.859 . . . . 0.0 109.23 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.23 106.62 0.64 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.91 129.89 44.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 108.983 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 34.2 mtt85 -99.54 -1.68 37.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.172 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' A' ' 26' ' ' SER . 7.3 m -86.83 51.87 2.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.052 -1.03 . . . . 0.0 109.54 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 93.7 p 178.21 166.02 0.76 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.645 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 26' ' ' SER . . . 64.95 38.95 6.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.813 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.1 ttp -90.67 -28.72 18.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.192 -0.943 . . . . 0.0 109.507 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.2 -157.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.514 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.47 -177.4 1.47 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.283 -0.886 . . . . 0.0 109.222 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -155.3 151.07 21.84 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.045 -1.035 . . . . 0.0 109.643 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.08 150.95 26.72 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.657 2.238 . . . . 0.0 110.394 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.12 48.61 4.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.89 129.59 52.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -1.178 . . . . 0.0 109.515 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.716 HG12 ' CD ' ' A' ' 87' ' ' ARG . 16.5 m -99.56 136.65 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -147.7 166.74 26.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.449 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.05 152.01 21.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.516 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -163.89 176.41 39.93 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.864 HG23 ' O ' ' A' ' 81' ' ' GLY . 76.6 mt -96.83 146.72 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -1.097 . . . . 0.0 108.356 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.517 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 57.2 t -99.46 137.67 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.963 -1.086 . . . . 0.0 110.591 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 2.9 t80 -122.46 154.57 37.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 109.043 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.502 ' CG ' ' O ' ' A' ' 42' ' ' PHE . 12.8 p90 -112.69 124.42 52.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.948 . . . . 0.0 109.641 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -178.55 137.2 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.93 . . . . 0.0 109.694 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 43' ' ' LYS . 26.5 t0 76.06 6.26 3.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 109.692 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.65 -26.99 9.28 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 47' ' ' PHE . 2.0 pt -92.83 -156.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.345 -1.091 . . . . 0.0 108.923 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.947 ' HB2' HD23 ' A' ' 61' ' ' LEU . 76.1 m-85 -127.05 171.99 10.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.959 -1.088 . . . . 0.0 109.43 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.812 ' HE3' HG22 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -136.79 125.4 23.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.251 -0.906 . . . . 0.0 109.669 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.875 HG23 ' HB2' ' A' ' 61' ' ' LEU . 92.9 t -98.07 105.81 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.115 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.492 ' CG ' ' HB ' ' A' ' 39' ' ' ILE . 2.3 ptm85 -101.34 128.9 47.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.7 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.26 85.54 7.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 109.364 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HB2' HD12 ' A' ' 39' ' ' ILE . 2.6 tt -62.84 149.07 45.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.212 -0.93 . . . . 0.0 109.538 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.48 -55.18 0.84 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -75.06 -27.8 60.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -1.151 . . . . 0.0 109.515 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 54' ' ' TYR . 20.3 mt-10 48.87 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.35 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.88 -17.76 3.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.7 92.86 5.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -1.182 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.65 109.06 20.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.339 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.537 ' HB3' HD23 ' A' ' 98' ' ' LEU . 3.5 m -107.05 145.65 32.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.908 . . . . 0.0 109.512 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.812 HG22 ' HE3' ' A' ' 48' ' ' LYS . 30.0 pt -99.56 135.95 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.337 -0.852 . . . . 0.0 109.0 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.947 HD23 ' HB2' ' A' ' 47' ' ' PHE . 25.2 tp -98.61 107.89 20.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 110.183 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.559 HD21 HD12 ' A' ' 60' ' ' ILE . 3.4 mt -103.29 4.81 36.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.506 -0.746 . . . . 0.0 109.069 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 63' ' ' ASP . 0.5 OUTLIER 58.23 36.61 25.84 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 6.6 t80 67.78 28.57 7.11 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.381 -0.825 . . . . 0.0 109.103 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -44.72 -72.14 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.565 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 57.62 -92.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.975 . . . . 0.0 109.567 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -153.95 28.81 0.47 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.922 . . . . 0.0 109.757 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -128.88 161.72 29.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.103 -0.998 . . . . 0.0 109.54 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -74.16 161.69 29.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.305 -0.872 . . . . 0.0 109.731 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 48.3 p-10 -156.35 154.31 30.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.376 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.9 m -139.97 98.6 3.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.543 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -159.44 27.64 0.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.33 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -74.49 -17.39 60.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 109.316 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -51.53 -36.05 43.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.34 -0.85 . . . . 0.0 109.418 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.466 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -46.1 -45.5 16.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.612 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.23 -66.46 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 109.783 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -57.83 -30.55 65.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.869 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -55.18 -56.8 15.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.586 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER 173.21 60.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 109.39 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.557 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 1.0 OUTLIER -43.04 165.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.393 -0.817 . . . . 0.0 109.31 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.864 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 86.5 -47.45 3.74 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -36.97 161.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.966 -0.726 . . . . 0.0 110.69 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 38' ' ' GLY . 99.5 t -97.14 136.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.281 -0.887 . . . . 0.0 108.967 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.712 HD13 HG23 ' A' ' 86' ' ' THR . 2.3 pp -138.96 174.93 8.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.334 -0.854 . . . . 0.0 109.883 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.47 141.22 39.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.372 -0.83 . . . . 0.0 109.198 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.712 HG23 HD13 ' A' ' 84' ' ' ILE . 19.0 p -151.37 175.26 12.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.192 -0.943 . . . . 0.0 109.315 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.831 ' O ' HD13 ' A' ' 98' ' ' LEU . 1.2 mmm-85 -98.68 158.03 15.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.265 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.6 t -98.28 110.1 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.564 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 26.9 t -63.08 -36.23 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.7 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.443 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER 168.97 106.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.237 -0.914 . . . . 0.0 109.362 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.787 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -91.96 117.27 29.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.424 -0.797 . . . . 0.0 109.235 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -103.4 -62.74 1.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.645 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -146.09 -115.79 0.95 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.04 -23.97 60.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -1.106 . . . . 0.0 109.466 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.53 129.19 55.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.122 -0.986 . . . . 0.0 109.529 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.787 HG13 ' HA ' ' A' ' 91' ' ' ALA . 95.0 t -131.41 158.34 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.856 . . . . 0.0 109.472 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.564 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 9.5 m-20 -101.04 143.39 31.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.0 108.625 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.831 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -130.14 136.91 49.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.904 -1.122 . . . . 0.0 110.659 -178.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.536 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 1.0 OUTLIER -126.35 119.63 27.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 108.89 178.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.497 ' HG3' HG22 ' A' ' 86' ' ' THR . 0.2 OUTLIER -76.31 129.36 36.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.05 . . . . 0.0 109.695 -179.57 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 101' ' ' PHE . 6.5 m-30 61.43 166.47 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.854 . . . . 0.0 109.636 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.9 t80 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.486 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 77.5 p -137.6 18.67 2.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.442 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.3 -45.93 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.87 . . . . 0.0 109.43 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.7 tt -141.4 143.84 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.94 . . . . 0.0 109.444 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.3 153.28 48.54 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.514 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.26 -64.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.677 2.251 . . . . 0.0 110.252 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.82 -151.02 0.37 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.291 -0.881 . . . . 0.0 109.376 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.8 m -142.1 147.55 36.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.228 -0.92 . . . . 0.0 109.431 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.574 ' N ' ' HD2' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -66.41 -52.03 39.07 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.876 . . . . 0.0 109.916 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 35.4 Cg_endo -78.53 109.65 2.68 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.43 2.087 . . . . 0.0 110.831 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 62.31 91.66 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.957 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.52 -176.55 3.33 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.531 2.154 . . . . 0.0 110.283 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.44 53.52 0.26 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.456 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -46.79 -49.09 20.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -136.73 177.13 8.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -91.86 -8.6 46.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.491 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -156.09 123.17 5.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.489 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 19' ' ' LYS . 2.8 mt -101.84 -34.92 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.211 -0.93 . . . . 0.0 109.49 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -46.18 169.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.542 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 20' ' ' VAL . 3.6 p -127.08 -2.79 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.498 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -108.41 135.19 50.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -0.908 . . . . 0.0 109.519 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.0 t -69.86 165.89 20.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.395 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -62.35 99.85 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.409 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -74.34 -78.69 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.329 -0.857 . . . . 0.0 109.502 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.5 m -132.89 -64.51 0.74 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.147 -0.97 . . . . 0.0 109.516 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 27' ' ' ALA . 8.0 p -144.83 -41.76 0.24 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.531 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 26' ' ' SER . . . 46.77 95.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.341 -0.849 . . . . 0.0 109.531 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.1 mmm 62.57 91.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.515 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -155.45 19.53 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.6 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 30' ' ' LEU . 38.1 tp -70.11 88.44 0.6 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.515 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.547 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -81.25 176.57 3.69 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.369 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 31' ' ' SER . 35.7 Cg_endo -78.24 170.21 18.98 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.555 2.17 . . . . 0.0 110.506 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.09 91.88 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -163.95 169.62 17.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -1.133 . . . . 0.0 109.516 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.529 HG12 ' CD ' ' A' ' 87' ' ' ARG . 17.9 m -119.04 143.55 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.13 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.543 ' NE2' HG23 ' A' ' 88' ' ' VAL . 1.9 p80 -165.35 166.8 18.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.006 -1.059 . . . . 0.0 109.956 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.555 ' HG2' HG12 ' A' ' 83' ' ' VAL . 1.7 tt0 -98.8 145.28 27.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 108.907 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.693 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -151.64 176.16 30.15 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.046 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 81' ' ' GLY . 22.0 mt -97.09 150.56 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.515 -0.991 . . . . 0.0 108.544 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.912 ' CG2' HD12 ' A' ' 84' ' ' ILE . 10.6 t -98.16 142.89 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 0.0 110.095 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.512 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 39.6 t80 -141.48 153.25 44.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.385 -0.822 . . . . 0.0 109.104 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.433 ' CD1' ' C ' ' A' ' 42' ' ' PHE . 21.8 t80 -98.92 121.97 41.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.644 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.26 163.03 15.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.848 . . . . 0.0 109.408 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 14.3 t0 -70.22 -8.46 50.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 109.627 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.757 ' C ' HD12 ' A' ' 46' ' ' ILE . . . -97.67 -62.99 0.89 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.926 HD13 ' HG ' ' A' ' 62' ' ' LEU . 2.2 mp -155.57 -94.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -1.136 . . . . 0.0 109.038 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.781 ' N ' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -127.37 162.03 27.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.031 -1.043 . . . . 0.0 109.342 179.653 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.531 ' HG2' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -138.52 125.43 21.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -101.93 118.81 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 109.329 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -98.78 127.87 44.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.953 . . . . 0.0 109.527 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 51' ' ' LEU . 1.7 mm? -93.83 69.18 3.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 0.0 109.421 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.03 128.82 37.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.908 . . . . 0.0 109.419 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.47 -30.27 9.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 1.1 t80 -99.69 51.07 0.92 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.325 -1.103 . . . . 0.0 109.279 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 72.64 -159.54 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 109.455 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' HIS . . . -82.62 11.81 50.22 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -42.72 108.69 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.329 -1.1 . . . . 0.0 109.772 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -115.15 109.83 18.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.275 -0.891 . . . . 0.0 109.407 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.644 ' HB3' HD23 ' A' ' 98' ' ' LEU . 31.0 m -102.0 156.29 17.63 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.22 -0.925 . . . . 0.0 109.666 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.531 HG22 ' HG2' ' A' ' 48' ' ' LYS . 2.1 pt -125.43 135.54 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -97.71 128.9 44.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.888 -1.133 . . . . 0.0 109.679 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.926 ' HG ' HD13 ' A' ' 46' ' ' ILE . 1.8 tt -164.86 -35.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.571 -0.706 . . . . 0.0 109.482 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.533 ' OD1' HG21 ' A' ' 89' ' ' VAL . 7.7 m-20 -50.37 -49.19 54.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.239 -0.913 . . . . 0.0 109.286 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.581 ' CD2' ' HG3' ' A' ' 100' ' ' ARG . 3.5 t80 -87.04 40.89 0.94 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.698 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 64' ' ' TYR . 1.2 tt -46.0 -38.04 7.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 0.0 109.152 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 36.5 t30 65.72 127.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.494 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -71.64 176.88 4.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.705 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.74 149.81 1.63 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.29 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -115.13 -50.27 2.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.517 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.94 179.56 5.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.937 . . . . 0.0 109.473 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 70.4 p -136.13 65.06 1.54 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.867 . . . . 0.0 109.318 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.08 56.43 0.71 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.562 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 0.8 OUTLIER -107.65 38.84 2.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.376 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -39.87 45.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 0.0 109.668 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.32 -34.44 76.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -0.819 . . . . 0.0 109.831 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 80' ' ' VAL . 3.0 mttp -66.95 -28.45 68.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.963 . . . . 0.0 109.676 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.37 -46.49 86.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 109.26 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -29.92 59.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.299 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.774 ' O ' HD23 ' A' ' 79' ' ' LEU . 5.4 tt -66.96 -26.84 67.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.345 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.552 HG12 ' N ' ' A' ' 81' ' ' GLY . 44.9 t -41.07 163.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.458 -0.776 . . . . 0.0 109.562 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 85.47 -51.76 4.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -41.3 161.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -1.072 . . . . 0.0 110.011 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 38' ' ' GLY . 52.9 t -98.75 140.5 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.024 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.912 HD12 ' CG2' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -139.65 175.28 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.735 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -99.45 127.52 45.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.46 -0.775 . . . . 0.0 109.263 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.574 ' OG1' HD11 ' A' ' 98' ' ' LEU . 69.6 p -139.25 173.61 11.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.134 -0.979 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.794 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -105.21 161.02 14.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.543 HG23 ' NE2' ' A' ' 36' ' ' HIS . 59.1 t -97.31 115.03 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.411 -0.806 . . . . 0.0 108.871 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 99' ' ' ARG . 54.8 t -74.41 -39.05 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.468 -0.77 . . . . 0.0 110.259 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 179.25 101.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.972 -1.08 . . . . 0.0 110.031 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.824 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -90.02 122.54 33.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.69 -4.19 12.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 109.953 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 154.16 -113.4 0.57 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.89 -41.13 44.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 0.0 109.579 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -99.49 126.33 45.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.349 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.824 HG22 ' HA ' ' A' ' 91' ' ' ALA . 89.1 t -128.78 162.88 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.719 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.562 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 1.2 m-20 -98.51 154.4 17.92 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -137.74 136.51 37.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.884 -1.135 . . . . 0.0 111.119 -178.442 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.591 ' N ' HG23 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -132.12 108.4 9.26 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.165 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.581 ' HG3' ' CD2' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -71.61 169.75 14.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.94 . . . . 0.0 109.413 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.451 ' O ' ' O ' ' A' ' 102' ' ' PHE . 24.1 t80 -145.96 98.96 3.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.675 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.451 ' O ' ' O ' ' A' ' 101' ' ' PHE . 7.4 m-85 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.631 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.254 0.549 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.43 135.13 45.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 109.253 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.07 147.45 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 109.839 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.774 HG23 ' O ' ' A' ' 4' ' ' ILE . 12.7 tt -135.32 98.24 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -0.906 . . . . 0.0 109.097 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.482 ' HG2' ' HD2' ' A' ' 6' ' ' PRO . 2.3 tttt -104.43 141.02 21.67 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 109.867 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.482 ' HD2' ' HG2' ' A' ' 5' ' ' LYS . 36.5 Cg_endo -80.38 -48.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.594 2.196 . . . . 0.0 110.167 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 6' ' ' PRO . 9.4 p 168.9 136.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.21 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -170.88 106.4 0.27 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.073 -1.017 . . . . 0.0 109.812 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 8' ' ' SER . 0.0 OUTLIER 53.98 104.26 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.696 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.97 -162.72 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.418 2.079 . . . . 0.0 110.252 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.08 164.77 7.41 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.191 -0.943 . . . . 0.0 109.468 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.87 117.39 4.2 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.616 2.211 . . . . 0.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.93 -179.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 109.382 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.14 50.85 1.43 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -0.944 . . . . 0.0 109.573 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -110.98 147.86 33.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.301 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -107.92 -93.67 0.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.636 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -52.67 106.2 0.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.0 mt -52.06 119.88 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.941 . . . . 0.0 109.488 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -123.37 25.67 8.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.443 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 20' ' ' VAL . 24.4 m -128.38 106.62 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 22' ' ' THR . 12.2 m-20 -61.65 -73.05 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 0.0 109.656 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.402 ' C ' ' O ' ' A' ' 21' ' ' ASN . 73.3 m 45.73 72.21 0.23 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.115 -0.991 . . . . 0.0 109.409 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -117.65 8.07 12.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.61 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.76 67.89 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 109.637 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' SER . 26.2 p -130.25 106.53 8.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.229 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER 44.43 70.16 0.36 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.311 -0.868 . . . . 0.0 109.168 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HB3' ' CE ' ' A' ' 28' ' ' MET . . . -86.95 14.33 7.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.683 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.558 ' CE ' ' HB3' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -131.2 149.3 52.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 109.432 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -166.76 65.93 0.09 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.559 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -111.29 128.63 56.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.394 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -121.29 164.24 25.32 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.388 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 31' ' ' SER . 35.1 Cg_endo -76.86 114.0 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.643 2.229 . . . . 0.0 110.557 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.26 55.76 3.4 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -113.12 162.98 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -1.166 . . . . 0.0 109.389 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.707 HG12 ' CD ' ' A' ' 87' ' ' ARG . 2.9 m -107.55 149.09 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.465 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.12 168.49 13.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.836 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 15.8 mt-10 -99.56 143.65 29.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.317 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -154.02 176.52 31.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 8.8 mt -97.08 152.63 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -1.148 . . . . 0.0 108.685 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.489 HG23 HD12 ' A' ' 84' ' ' ILE . 88.6 t -105.92 149.94 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.102 -0.999 . . . . 0.0 110.607 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.537 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -148.42 175.42 11.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.475 -0.765 . . . . 0.0 109.009 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.561 ' CZ ' ' HA2' ' A' ' 45' ' ' GLY . 58.7 t80 -123.02 124.66 43.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.153 -0.967 . . . . 0.0 109.35 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 44' ' ' ASP . 1.6 mttm -159.93 145.55 15.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.748 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 0.8 OUTLIER 61.28 12.93 4.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.323 -0.861 . . . . 0.0 109.741 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.561 ' HA2' ' CZ ' ' A' ' 42' ' ' PHE . . . 86.57 -18.71 32.43 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.77 HG21 HD22 ' A' ' 62' ' ' LEU . 12.3 pt -95.33 -153.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.135 -1.215 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 1.8 m-85 -110.64 164.69 12.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.301 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -135.55 119.72 17.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.643 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 2.7 t -103.9 108.86 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.271 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 135.64 39.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.41 107.72 19.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.1 tp -81.27 148.55 29.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.599 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.4 -21.93 32.65 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -99.31 -30.14 12.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -1.165 . . . . 0.0 109.58 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 54' ' ' TYR . 4.8 mt-10 60.93 149.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.513 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.41 40.71 78.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.76 86.61 2.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.121 -1.223 . . . . 0.0 109.48 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.72 120.31 41.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.325 -0.859 . . . . 0.0 109.556 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.2 m -117.15 170.94 8.28 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.368 -0.832 . . . . 0.0 109.204 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.498 ' HB ' HD11 ' A' ' 46' ' ' ILE . 1.3 pp -134.47 133.07 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 0.0 109.303 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 0.7 OUTLIER -98.19 131.14 44.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.078 -1.014 . . . . 0.0 109.386 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.77 HD22 HG21 ' A' ' 46' ' ' ILE . 25.3 tp -175.69 -32.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.489 -0.757 . . . . 0.0 109.413 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.401 ' CB ' HG21 ' A' ' 89' ' ' VAL . 29.2 t0 -50.1 -46.74 53.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 109.239 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.488 ' HB2' ' N ' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -119.45 45.73 2.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.488 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 7.5 tp -75.6 -51.83 11.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 109.666 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER 62.16 160.11 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.497 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.402 ' CB ' ' O ' ' A' ' 66' ' ' ASN . 3.9 t80 67.87 43.6 1.7 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.096 -1.002 . . . . 0.0 109.235 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.426 ' C ' ' HG2' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -94.61 127.7 40.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 109.603 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.426 ' HG2' ' C ' ' A' ' 68' ' ' ARG . 0.4 OUTLIER 176.27 179.79 0.18 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.481 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -88.47 93.89 9.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.839 . . . . 0.0 109.566 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -132.74 126.49 32.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 109.479 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 71' ' ' THR . 0.7 OUTLIER -44.64 -40.04 5.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.504 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 48.92 70.85 0.42 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.589 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.07 -36.08 56.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.222 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mt -73.12 -39.76 65.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.386 -0.822 . . . . 0.0 109.497 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.848 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -52.71 -26.44 13.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.79 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.13 -42.09 99.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 109.87 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.44 -29.27 52.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.98 . . . . 0.0 110.098 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 76' ' ' LYS . 82.6 mt -66.35 -50.85 62.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.114 -0.991 . . . . 0.0 109.745 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 76' ' ' LYS . 11.7 t -40.29 159.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.492 -0.755 . . . . 0.0 109.768 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 85.9 -53.47 4.67 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 81' ' ' GLY . 31.0 mtt85 -39.17 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.959 . . . . 0.0 110.357 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 66.4 t -98.47 140.46 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.737 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -146.64 174.83 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 110.157 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.517 ' O ' ' CG2' ' A' ' 86' ' ' THR . 1.5 tmmm? -100.23 147.06 26.15 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.686 ' OG1' HD11 ' A' ' 98' ' ' LEU . 67.1 p -158.51 174.22 15.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.963 . . . . 0.0 109.372 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.79 ' O ' HD13 ' A' ' 98' ' ' LEU . 20.8 mmm-85 -103.52 162.45 13.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 34' ' ' SER . 14.2 t -96.71 122.48 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.314 -0.867 . . . . 0.0 109.269 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.543 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 42.0 t -81.2 -41.1 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.445 -0.785 . . . . 0.0 109.929 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 178.59 101.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.062 -1.024 . . . . 0.0 109.749 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.852 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -71.99 135.06 46.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.567 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -128.42 32.85 4.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.387 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.58 -107.86 3.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.1 mp -79.52 -34.51 41.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -1.176 . . . . 0.0 109.311 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -102.01 131.76 48.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.887 . . . . 0.0 109.108 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.852 HG13 ' HA ' ' A' ' 91' ' ' ALA . 94.2 t -137.45 155.57 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.04 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.543 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 6.0 m-20 -99.32 156.73 16.85 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.91 140.51 34.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.083 -1.011 . . . . 0.0 110.234 -179.219 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.533 ' N ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -125.16 120.4 31.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.27 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.488 ' N ' ' HB2' ' A' ' 64' ' ' TYR . 25.3 ttt-85 -63.51 168.28 4.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.394 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.473 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 16.7 t80 -112.49 134.52 53.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.473 ' CD2' ' CE2' ' A' ' 101' ' ' PHE . 11.9 m-85 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.494 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 2' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 44.37 67.74 0.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.915 . . . . 0.0 109.452 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.2 m -81.46 169.92 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 109.47 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.742 ' O ' HG22 ' A' ' 4' ' ' ILE . 23.6 mm -111.32 66.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.36 79.8 28.61 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.454 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 4' ' ' ILE . 35.7 Cg_endo -77.95 -161.95 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.654 2.236 . . . . 0.0 110.476 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.0 m -155.24 94.13 1.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.892 . . . . 0.0 109.356 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.31 42.94 1.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 109.656 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.78 154.5 5.36 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.57 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.93 83.87 2.11 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.685 2.256 . . . . 0.0 110.303 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.33 81.63 20.35 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.509 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.83 136.08 14.76 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.647 2.231 . . . . 0.0 110.454 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.47 79.64 1.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.492 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 175.44 56.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.498 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 2.9 m120 -86.53 15.22 5.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.476 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER 61.84 39.2 14.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.897 . . . . 0.0 109.549 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -80.52 75.1 7.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.897 . . . . 0.0 109.44 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 21' ' ' ASN . 7.3 mt -135.95 84.97 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.29 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -77.18 -16.56 59.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.731 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 t -108.96 56.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 109.635 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.492 ' HB2' HG22 ' A' ' 18' ' ' ILE . 2.3 t30 -124.52 -166.7 1.55 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.348 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER 72.67 146.17 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.243 -0.911 . . . . 0.0 109.446 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.93 -66.58 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.948 . . . . 0.0 109.329 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -93.43 144.57 25.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.876 . . . . 0.0 109.288 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 t -76.63 144.46 39.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.915 . . . . 0.0 109.778 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.19 147.99 25.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.355 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.12 43.08 1.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.098 -1.001 . . . . 0.0 109.67 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.77 -167.73 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.577 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -92.58 49.48 1.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 30' ' ' LEU . 0.4 OUTLIER 65.67 129.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.418 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.6 p -80.38 143.9 56.63 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.393 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.3 122.86 5.81 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.564 2.176 . . . . 0.0 110.408 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.44 28.71 2.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 m -106.69 165.14 11.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -1.12 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.658 HG12 ' HD2' ' A' ' 87' ' ' ARG . 3.7 m -108.26 140.3 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -156.18 167.99 28.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.651 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -101.0 143.28 31.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 109.348 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.611 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -153.77 175.61 32.02 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 81' ' ' GLY . 4.3 mp -97.97 153.61 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -1.086 . . . . 0.0 108.756 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.589 HG23 HD12 ' A' ' 84' ' ' ILE . 67.8 t -104.36 146.1 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.009 -1.057 . . . . 0.0 110.343 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 3.2 t80 -146.98 -173.47 4.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 108.903 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -135.01 146.78 49.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.0 . . . . 0.0 109.522 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.99 140.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.265 -0.897 . . . . 0.0 110.076 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.7 17.66 4.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 110.116 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.29 -33.68 4.02 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.481 HG21 ' CD1' ' A' ' 62' ' ' LEU . 21.2 pt -78.26 -153.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -1.185 . . . . 0.0 109.254 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.765 ' CD1' HD11 ' A' ' 65' ' ' LEU . 2.4 m-85 -119.84 161.06 21.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.109 -0.994 . . . . 0.0 109.636 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 1.8 tttp -130.95 120.56 23.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.288 -0.882 . . . . 0.0 109.556 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 7.4 t -100.82 126.85 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.181 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.23 139.66 39.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 0.0 109.774 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.9 OUTLIER -103.02 73.23 1.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.399 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.01 168.67 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.426 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.41 -36.65 3.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.521 ' CG ' ' CD2' ' A' ' 57' ' ' HIS . 5.5 t80 -98.01 -26.69 14.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -1.104 . . . . 0.0 109.305 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 54.77 26.31 7.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.493 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.33 25.92 0.3 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.521 ' CD2' ' CG ' ' A' ' 54' ' ' TYR . 9.7 m-70 -131.12 98.94 4.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -1.102 . . . . 0.0 109.609 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -103.37 107.41 18.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.135 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.485 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 5.1 m -107.72 158.81 16.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.276 -0.89 . . . . 0.0 109.62 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 pt -127.73 137.74 56.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.45 -0.781 . . . . 0.0 108.959 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.525 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 4.3 tp -98.68 131.56 44.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.156 -0.965 . . . . 0.0 109.915 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.481 ' CD1' HG21 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -166.75 -36.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.597 -0.689 . . . . 0.0 109.159 179.76 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.421 ' HB2' HG21 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -49.03 -52.17 26.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.865 . . . . 0.0 109.049 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.476 ' CB ' ' O ' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -119.46 42.8 2.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.765 HD11 ' CD1' ' A' ' 47' ' ' PHE . 3.1 tp -55.62 -83.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -0.862 . . . . 0.0 109.369 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.407 ' OD1' HD23 ' A' ' 65' ' ' LEU . 51.0 p-10 -179.03 -150.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -103.79 156.59 17.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.33 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -85.13 46.18 1.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.615 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -53.05 142.85 18.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.26 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.98 78.19 9.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.066 -1.021 . . . . 0.0 109.673 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 m -159.68 122.26 3.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.343 -0.848 . . . . 0.0 109.257 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -32.74 69.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.408 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.46 80.55 0.15 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.242 -0.911 . . . . 0.0 109.344 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.14 -36.91 80.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.686 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 tp -54.73 -48.09 72.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.172 -0.955 . . . . 0.0 109.579 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.597 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -61.91 -26.81 68.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 109.4 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -55.4 -49.78 71.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -0.857 . . . . 0.0 109.457 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -77.35 -29.58 53.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.706 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -63.55 -29.99 71.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 109.693 -179.675 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 76' ' ' LYS . 57.3 t -44.22 165.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.146 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.661 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 85.18 -45.23 3.48 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.468 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -35.59 149.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.741 -0.858 . . . . 0.0 110.359 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 38' ' ' GLY . 65.1 t -98.81 142.69 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.465 -0.772 . . . . 0.0 109.523 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.832 HD13 ' H ' ' A' ' 84' ' ' ILE . 0.1 OUTLIER -149.22 170.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.602 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.22 112.46 24.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.134 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.613 ' OG1' HD11 ' A' ' 98' ' ' LEU . 74.1 p -116.58 175.17 5.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.635 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.801 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -102.19 161.53 13.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 67.6 t -96.85 124.67 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 108.985 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.538 ' CG2' ' HB3' ' A' ' 99' ' ' ARG . 96.4 t -85.28 -38.17 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.294 -0.879 . . . . 0.0 110.159 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.7 OUTLIER 176.9 103.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.135 -0.978 . . . . 0.0 109.637 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.659 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -99.35 123.7 43.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.377 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -115.43 -23.68 8.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 0.0 109.647 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.91 -137.7 2.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mp -57.12 -32.84 66.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -1.119 . . . . 0.0 109.627 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -99.03 131.51 45.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.659 HG13 ' HA ' ' A' ' 91' ' ' ALA . 78.3 t -135.64 158.61 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.056 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 98' ' ' LEU . 9.4 t0 -99.43 152.3 20.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 108.716 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -139.98 140.42 36.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 111.076 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.538 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 0.8 OUTLIER -126.04 119.88 28.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.502 -0.749 . . . . 0.0 109.093 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.476 ' O ' ' CB ' ' A' ' 64' ' ' TYR . 6.8 ttt-85 -71.8 163.75 27.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.507 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 51.0 p90 -83.02 171.36 13.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.464 ' HB3' ' O ' ' A' ' 101' ' ' PHE . 29.9 t80 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.506 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.8 p -115.17 157.43 23.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -1.179 . . . . 0.0 109.532 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.9 150.3 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 4.0 m-70 -156.54 163.71 39.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 0.0 109.715 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.03 137.04 43.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 108.979 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.74 176.9 28.22 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.608 ' CD1' HD23 ' A' ' 52' ' ' LEU . 7.1 mt -96.51 152.51 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.346 -1.091 . . . . 0.0 108.636 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.606 ' CG2' HD12 ' A' ' 84' ' ' ILE . 76.2 t -99.58 148.08 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.68 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -142.72 164.52 29.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.051 -1.03 . . . . 0.0 109.872 -179.784 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 pt . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 50.0 m-85 -113.9 173.85 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.16 -0.963 . . . . 0.0 109.387 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.14 132.78 22.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.371 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.773 HG23 ' HB2' ' A' ' 61' ' ' LEU . 45.8 t -104.62 115.15 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.194 -0.941 . . . . 0.0 109.591 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.701 ' NH1' HD21 ' A' ' 52' ' ' LEU . 7.0 ttt180 -98.64 130.51 45.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.161 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 51' ' ' LEU . 1.9 mm? -96.33 95.13 7.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 109.643 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.701 HD21 ' NH1' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -69.44 145.52 52.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.426 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.91 -39.96 2.7 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.23 -27.64 29.79 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -1.15 . . . . 0.0 109.292 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 57.87 96.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.239 -0.913 . . . . 0.0 109.649 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . 110.72 10.32 21.47 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.831 ' NE2' HG21 ' A' ' 96' ' ' VAL . 20.0 t-160 -109.82 96.9 6.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -1.202 . . . . 0.0 109.552 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -109.08 131.67 54.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.534 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.6 m -124.67 162.87 23.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 109.422 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.485 ' HB ' HD11 ' A' ' 62' ' ' LEU . 2.5 pt -116.01 130.23 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.89 . . . . 0.0 109.29 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.773 ' HB2' HG23 ' A' ' 49' ' ' VAL . 6.0 tt -99.35 118.07 35.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.248 -0.907 . . . . 0.0 109.876 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 62' ' ' LEU . 2.1 mp . . . . . 0 N--CA 1.488 1.465 0 O-C-N 121.479 -0.763 . . . . 0.0 109.091 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.524 HG13 HG12 ' A' ' 40' ' ' VAL . 14.3 t . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.357 0.599 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 87.28 -50.93 4.16 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -37.86 156.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.664 -0.903 . . . . 0.0 110.295 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.2 t -98.47 134.21 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 109.138 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.815 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -143.58 174.27 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 0.0 109.868 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 1.8 ttmt -104.66 124.98 50.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.446 -0.784 . . . . 0.0 109.087 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.72 HG22 ' CG ' ' A' ' 100' ' ' ARG . 24.5 p -127.95 175.44 8.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.509 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.873 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -98.55 152.85 19.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.091 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.61 131.37 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.982 . . . . 0.0 109.473 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.543 HG22 ' HG2' ' A' ' 99' ' ' ARG . 94.6 t -92.83 -35.7 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.34 -0.85 . . . . 0.0 109.86 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 96' ' ' VAL . 9.9 ttt85 178.46 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.978 . . . . 0.0 109.335 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.813 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -95.88 117.63 30.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.502 -0.749 . . . . 0.0 109.554 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -110.01 -21.6 12.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -0.935 . . . . 0.0 109.477 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 94' ' ' LEU . . . 123.33 115.31 2.21 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.576 ' CB ' ' O ' ' A' ' 93' ' ' GLY . 1.5 tp 84.39 -57.13 0.12 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.759 -0.848 . . . . 0.0 109.448 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -116.8 119.6 35.91 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 108.841 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.831 HG21 ' NE2' ' A' ' 57' ' ' HIS . 69.1 t -129.89 159.11 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 110.332 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.563 ' O ' HD22 ' A' ' 98' ' ' LEU . 9.6 m-20 -98.66 143.27 29.22 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.873 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -135.49 141.78 45.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.809 -1.182 . . . . 0.0 110.97 -178.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.543 ' HG2' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -133.72 112.27 11.25 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.642 -0.661 . . . . 0.0 109.399 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.72 ' CG ' HG22 ' A' ' 86' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.102 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -172.76 161.78 4.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -1.165 . . . . 0.0 109.598 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 35' ' ' VAL . 2.3 m -122.5 125.44 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 0.0 109.311 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -133.01 168.72 17.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.125 -0.984 . . . . 0.0 109.67 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.69 147.03 25.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.273 -0.892 . . . . 0.0 109.107 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.698 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -159.13 176.8 35.89 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.688 HD12 HG22 ' A' ' 83' ' ' VAL . 2.4 mm -96.8 154.42 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -1.158 . . . . 0.0 108.82 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 34.9 t -105.8 146.75 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 110.329 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -137.3 145.71 43.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 109.216 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 42.9 p90 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.095 -1.003 . . . . 0.0 109.657 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 47' ' ' PHE . 3.7 mt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.509 ' CB ' HD23 ' A' ' 61' ' ' LEU . 60.0 m-85 -105.79 169.75 8.3 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.046 -1.034 . . . . 0.0 109.157 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.7 135.67 24.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.519 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.848 HG23 ' HB2' ' A' ' 61' ' ' LEU . 60.3 t -104.48 119.64 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.225 -0.922 . . . . 0.0 109.736 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -98.88 120.9 40.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 109.075 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.1 OUTLIER -86.06 84.88 7.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.668 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.49 138.95 54.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.391 -0.818 . . . . 0.0 109.506 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.48 -41.48 2.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -81.37 -30.26 33.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -1.161 . . . . 0.0 109.578 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 62.53 84.49 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.85 -20.15 6.44 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -71.51 94.47 1.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -1.134 . . . . 0.0 109.649 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -108.15 105.82 15.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 109.368 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.0 m -102.58 158.38 16.27 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.24 -0.913 . . . . 0.0 109.153 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.518 HG12 ' HA ' ' A' ' 97' ' ' ASP . 25.4 pt -103.81 129.18 56.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.259 -0.901 . . . . 0.0 109.055 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.848 ' HB2' HG23 ' A' ' 49' ' ' VAL . 50.2 tp -98.68 108.66 21.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.659 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.423 ' HA ' HD13 ' A' ' 62' ' ' LEU . 3.5 mm? . . . . . 0 N--CA 1.487 1.42 0 O-C-N 121.496 -0.752 . . . . 0.0 109.205 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 81' ' ' GLY . 54.5 t . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.566 ' N ' HG12 ' A' ' 80' ' ' VAL . . . 87.4 -48.63 3.8 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 81' ' ' GLY . 5.9 mtp180 -38.96 156.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.702 -0.881 . . . . 0.0 110.016 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 38' ' ' GLY . 4.1 t -98.4 145.33 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 109.162 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.816 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -148.99 164.5 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.0 109.622 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.18 104.16 16.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.408 -0.808 . . . . 0.0 109.209 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.681 HG23 HG12 ' A' ' 84' ' ' ILE . 22.3 p -112.91 175.59 5.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.793 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -99.94 154.28 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.089 -1.007 . . . . 0.0 109.464 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.663 ' HA ' HD22 ' A' ' 98' ' ' LEU . 63.7 t -97.58 110.49 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 0.0 108.863 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 99' ' ' ARG . 2.2 t -64.33 -35.34 73.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.866 . . . . 0.0 110.082 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.03 101.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.938 . . . . 0.0 109.559 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.787 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -95.87 124.65 39.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.279 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.46 -43.69 2.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.17 -138.76 2.51 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -24.7 4.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -1.129 . . . . 0.0 109.753 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -112.34 125.55 54.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.787 HG22 ' HA ' ' A' ' 91' ' ' ALA . 49.7 t -133.27 166.62 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -0.89 . . . . 0.0 109.491 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.603 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -110.37 146.96 34.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 108.732 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -134.15 128.09 33.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.998 -1.064 . . . . 0.0 110.881 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.604 ' HB3' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -122.37 133.18 54.65 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.579 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.413 ' HB3' ' NE2' ' A' ' 36' ' ' HIS . 0.5 OUTLIER -114.14 156.41 24.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -1.121 . . . . 0.0 109.366 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 35' ' ' VAL . 4.0 m -115.56 127.49 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.309 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.413 ' NE2' ' HB3' ' A' ' 34' ' ' SER . 47.4 m-70 -143.36 168.01 20.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.789 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -101.34 141.58 34.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.255 -0.903 . . . . 0.0 109.368 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.673 ' O ' HG23 ' A' ' 83' ' ' VAL . . . -150.29 176.88 28.71 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.505 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 15.7 mt -96.42 153.87 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.243 . . . . 0.0 108.444 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 82' ' ' ARG . 38.8 t -98.99 151.8 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 110.431 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.95 150.4 35.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.419 ' HB2' HG21 ' A' ' 80' ' ' VAL . 20.5 t80 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.552 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.667 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.8 m-85 -102.97 174.93 5.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.083 -1.011 . . . . 0.0 108.975 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 59' ' ' CYS . 1.6 tttp -148.31 148.9 30.94 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.198 -0.939 . . . . 0.0 109.624 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.519 HG21 ' HG ' ' A' ' 98' ' ' LEU . 2.4 t -126.02 116.72 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 109.199 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.37 131.75 44.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 109.375 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.3 OUTLIER -88.57 95.6 10.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.192 -0.942 . . . . 0.0 109.765 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.62 138.72 55.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.35 -30.02 9.38 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 55' ' ' GLU . 2.1 m-85 -117.16 66.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -1.06 . . . . 0.0 109.073 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -41.38 107.3 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.396 -0.815 . . . . 0.0 109.665 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.02 32.54 0.79 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -140.94 92.91 2.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -1.105 . . . . 0.0 109.782 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.57 123.1 48.86 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.988 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.449 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.2 m -116.08 167.72 10.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 109.567 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 5.9 pt -122.37 130.66 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.364 -0.835 . . . . 0.0 109.087 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 100' ' ' ARG . 12.3 tp -97.91 116.67 30.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.969 . . . . 0.0 109.251 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.768 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 81' ' ' GLY . 21.4 t . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.313 0.577 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.505 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 87.73 -48.73 3.75 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.671 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -40.8 152.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.481 -1.011 . . . . 0.0 110.023 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 38' ' ' GLY . 7.4 p -99.05 137.29 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.847 . . . . 0.0 109.109 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.841 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -145.23 170.98 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 110.013 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.7 120.65 40.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 0.0 109.047 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.531 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -128.0 176.07 7.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.305 -0.872 . . . . 0.0 109.582 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.75 ' O ' HD13 ' A' ' 98' ' ' LEU . 9.0 mpt_? -97.91 155.0 17.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.0 t -97.41 121.23 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.272 -0.892 . . . . 0.0 109.661 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.55 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 40.9 t -77.0 -39.49 29.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.494 -0.754 . . . . 0.0 109.494 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.416 ' O ' HG13 ' A' ' 96' ' ' VAL . 3.5 mtp180 178.63 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.119 -0.988 . . . . 0.0 109.618 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.825 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -101.87 129.76 48.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.533 -0.729 . . . . 0.0 109.175 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -131.28 -39.83 1.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.064 -1.023 . . . . 0.0 109.511 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -151.97 -127.45 1.32 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.39 -17.74 57.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -1.139 . . . . 0.0 109.808 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -110.24 121.59 45.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -0.989 . . . . 0.0 109.282 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 91' ' ' ALA . 96.0 t -132.86 156.44 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -0.884 . . . . 0.0 109.745 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.55 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 1.7 m-20 -98.35 150.03 22.02 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -134.31 134.81 42.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.859 -1.151 . . . . 0.0 111.085 -178.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.446 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -121.72 124.55 44.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.749 ' HB2' HD11 ' A' ' 61' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.557 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.6 t -149.78 138.93 21.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -1.15 . . . . 0.0 109.592 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.477 HG12 ' NE ' ' A' ' 87' ' ' ARG . 16.5 m -102.25 155.65 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.421 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -165.07 162.29 20.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.947 . . . . 0.0 109.5 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.79 137.85 36.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.07 176.11 29.72 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mt -97.39 154.66 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.317 -1.108 . . . . 0.0 108.812 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.477 ' CG2' HD12 ' A' ' 84' ' ' ILE . 17.6 t -104.96 159.94 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 0.0 110.12 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.495 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -146.61 170.33 17.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 0.0 109.208 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.954 . . . . 0.0 109.378 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.6 pt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.495 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 44.4 m-85 -112.69 160.19 18.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.951 -1.093 . . . . 0.0 109.08 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -127.16 151.42 48.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 0.0 109.762 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 61' ' ' LEU . 63.5 t -129.42 115.14 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.409 -0.807 . . . . 0.0 109.076 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -100.36 127.55 46.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.172 -0.955 . . . . 0.0 109.571 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 3.1 mp -95.17 76.33 3.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 109.485 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.0 162.75 3.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.75 -43.15 3.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.457 ' O ' ' O ' ' A' ' 55' ' ' GLU . 68.4 m-85 -85.29 -30.56 23.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -1.105 . . . . 0.0 109.686 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' TYR . 3.5 mt-10 61.04 146.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.192 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . 63.52 12.51 46.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -116.64 82.95 1.88 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -1.146 . . . . 0.0 109.264 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -100.29 105.92 17.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.309 -0.87 . . . . 0.0 109.52 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.434 ' SG ' HD13 ' A' ' 51' ' ' LEU . 4.4 m -100.19 172.67 7.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.925 . . . . 0.0 109.267 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.84 140.83 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 109.241 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.514 ' HB2' HG23 ' A' ' 49' ' ' VAL . 34.9 tp -98.14 116.82 31.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.962 . . . . 0.0 109.339 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.1 tp . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.491 -0.755 . . . . 0.0 109.724 -179.606 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 81' ' ' GLY . 28.1 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.514 ' N ' HG12 ' A' ' 80' ' ' VAL . . . 85.19 -47.54 3.87 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.457 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -40.2 162.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.467 -1.019 . . . . 0.0 110.048 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 m -98.84 144.35 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.047 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.769 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -149.17 173.69 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -0.966 . . . . 0.0 109.629 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -104.14 106.64 17.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.148 -0.97 . . . . 0.0 109.332 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.483 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 8.5 p -112.0 175.75 5.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 0.0 109.55 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.802 ' O ' HD13 ' A' ' 98' ' ' LEU . 10.4 mpt_? -98.73 159.58 14.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.811 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.6 t -96.96 117.54 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.468 -0.77 . . . . 0.0 109.205 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.708 HG22 ' HG2' ' A' ' 99' ' ' ARG . 72.6 t -77.84 -40.33 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.519 -0.738 . . . . 0.0 110.092 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 175.99 104.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.163 -0.961 . . . . 0.0 109.585 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.808 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -96.86 135.4 38.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.66 -36.98 1.59 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.99 . . . . 0.0 109.767 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.04 -134.71 1.69 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -63.48 -17.3 62.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -1.141 . . . . 0.0 109.538 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.56 130.64 56.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 109.506 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.808 HG22 ' HA ' ' A' ' 91' ' ' ALA . 53.9 t -137.2 157.19 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.516 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 49.8 m-20 -98.32 147.21 24.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.232 -0.917 . . . . 0.0 108.661 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -134.91 136.89 42.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.048 -1.032 . . . . 0.0 110.263 -178.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.708 ' HG2' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -136.53 124.56 22.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.589 -0.695 . . . . 0.0 109.232 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.341 -0.85 . . . . 0.0 109.386 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 p -170.56 158.6 6.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -1.122 . . . . 0.0 109.58 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.41 HG12 ' NE ' ' A' ' 87' ' ' ARG . 17.8 m -107.29 149.4 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.254 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.09 166.35 31.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.173 -0.955 . . . . 0.0 109.823 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -99.69 151.25 21.43 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 109.14 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.38 176.63 43.32 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.729 HG23 ' O ' ' A' ' 81' ' ' GLY . 8.2 mt -97.04 149.92 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -1.184 . . . . 0.0 108.389 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 41' ' ' TYR . 24.4 t -98.14 166.38 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.074 -1.016 . . . . 0.0 110.482 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.568 ' N ' HG12 ' A' ' 40' ' ' VAL . 9.1 t80 -150.75 139.94 21.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.054 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.416 ' HB2' HG21 ' A' ' 80' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.015 . . . . 0.0 109.661 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.4 pt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 12.8 m-85 -105.9 157.61 17.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.415 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.512 ' CB ' ' HB3' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -130.19 151.18 50.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.435 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.21 120.67 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 109.45 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -99.81 127.16 45.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.925 . . . . 0.0 109.327 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.447 ' CB ' ' HB3' ' A' ' 57' ' ' HIS . 0.1 OUTLIER -92.8 75.48 4.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 109.598 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.28 124.36 19.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 109.425 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 132.6 -41.13 1.53 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.507 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 61.7 t80 -83.8 -19.48 34.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -1.113 . . . . 0.0 109.507 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 9.1 tp10 62.85 88.68 0.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.347 -0.845 . . . . 0.0 109.792 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.8 25.28 5.74 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 54' ' ' TYR . 2.3 t-160 -108.9 92.36 4.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.075 -1.25 . . . . 0.0 109.75 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.08 115.1 29.82 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.41 -0.806 . . . . 0.0 109.278 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -116.13 163.26 16.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.474 ' O ' HG13 ' A' ' 60' ' ' ILE . 24.1 pt -129.52 125.59 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 109.23 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.538 HD13 HG21 ' A' ' 86' ' ' THR . 6.8 tp -98.2 121.72 40.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.007 -1.058 . . . . 0.0 109.592 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.659 -0.651 . . . . 0.0 109.286 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.569 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.729 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 84.84 -43.38 3.23 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.518 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -45.31 178.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.652 -0.911 . . . . 0.0 110.503 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 84' ' ' ILE . 20.7 m -96.13 146.33 7.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.124 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.537 HG12 ' CG2' ' A' ' 40' ' ' VAL . 2.5 pp -156.69 175.29 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.445 -0.784 . . . . 0.0 109.402 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 10.0 pttm -101.73 143.47 31.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.317 -0.864 . . . . 0.0 109.204 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.636 ' HB ' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -146.48 175.14 10.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.197 -0.94 . . . . 0.0 109.552 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.79 ' O ' HD13 ' A' ' 98' ' ' LEU . 3.9 mmm-85 -101.56 153.66 19.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.71 123.04 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 109.078 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 99' ' ' ARG . 54.4 t -82.89 -38.43 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.834 . . . . 0.0 109.923 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 172.78 105.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.993 . . . . 0.0 109.547 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.829 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -91.35 127.39 36.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.34 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -116.03 -50.45 2.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.582 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -154.91 -124.97 0.93 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -30.77 70.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.425 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -104.6 134.13 48.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 109.235 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.829 HG22 ' HA ' ' A' ' 91' ' ' ALA . 50.5 t -135.57 163.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.939 . . . . 0.0 110.068 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.547 ' N ' HG12 ' A' ' 96' ' ' VAL . 97.7 m-20 -98.73 150.9 21.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.841 . . . . 0.0 108.753 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -137.39 135.14 36.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.965 -1.085 . . . . 0.0 110.799 -179.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.615 ' N ' HG23 ' A' ' 89' ' ' VAL . 30.9 ttp180 -128.21 124.95 37.98 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.482 ' N ' HD11 ' A' ' 61' ' ' LEU . 3.4 ttt85 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.05 -1.031 . . . . 0.0 109.985 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.2 t -109.67 166.4 10.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.234 -1.156 . . . . 0.0 109.456 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -104.53 157.81 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.79 160.12 30.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.789 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.64 124.79 50.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.352 -0.843 . . . . 0.0 109.087 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.457 ' O ' ' CG1' ' A' ' 83' ' ' VAL . . . -138.93 176.36 20.96 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 40' ' ' VAL . 13.0 mt -96.85 167.04 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.143 -1.21 . . . . 0.0 108.731 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.518 ' N ' HG22 ' A' ' 39' ' ' ILE . 60.4 t -108.66 158.61 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.043 -1.036 . . . . 0.0 110.733 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.49 ' N ' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -153.65 152.0 30.33 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 p90 . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 0.0 109.769 -179.841 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 1.012 HD12 ' O ' ' A' ' 61' ' ' LEU . 4.1 pt . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.407 ' HB2' HD23 ' A' ' 61' ' ' LEU . 1.2 m-85 -116.28 166.98 11.43 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.854 -1.154 . . . . 0.0 109.424 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -141.26 143.06 33.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 59' ' ' CYS . 88.2 t -116.37 136.96 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.4 mtt-85 -108.4 123.4 48.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.219 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.523 HD13 ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -94.6 68.43 3.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.159 -0.963 . . . . 0.0 109.498 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 tt -50.87 142.25 11.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.431 -0.793 . . . . 0.0 109.436 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.56 -53.33 0.6 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 55' ' ' GLU . 1.1 m-85 -68.35 -21.55 64.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.489 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 54' ' ' TYR . 4.4 mt-10 61.49 119.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.1 29.43 62.58 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -116.12 89.97 3.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 0.0 109.328 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.9 112.43 25.4 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 0.0 109.76 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.523 ' SG ' HD13 ' A' ' 51' ' ' LEU . 25.7 m -102.56 164.75 11.48 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.302 -0.874 . . . . 0.0 109.045 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.26 131.81 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.128 -0.983 . . . . 0.0 109.367 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.012 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.2 tp -98.04 118.3 34.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 109.355 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.554 HD12 HD13 ' A' ' 46' ' ' ILE . 6.3 tt . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.804 . . . . 0.0 109.66 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 81' ' ' GLY . 16.4 t . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.334 0.587 . . . . 0.0 109.622 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 84.24 -46.52 3.68 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.444 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -45.88 172.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -1.159 . . . . 0.0 109.874 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.457 ' CG1' ' O ' ' A' ' 38' ' ' GLY . 1.6 t -98.71 150.79 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.25 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.722 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -152.93 172.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 109.836 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 13.5 pttm -103.97 115.3 30.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.378 -0.827 . . . . 0.0 109.308 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.84 HG22 ' HG3' ' A' ' 100' ' ' ARG . 24.9 p -125.16 175.42 7.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.204 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.711 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -101.63 157.96 16.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.401 ' HA ' HD22 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -96.76 120.04 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.56 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 91.3 t -80.21 -37.43 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.443 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 170.65 104.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.931 -1.106 . . . . 0.0 109.826 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.498 ' CB ' HG22 ' A' ' 96' ' ' VAL . . . -87.55 153.97 20.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 109.215 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -167.26 53.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.146 -0.971 . . . . 0.0 109.755 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.18 -158.42 14.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.757 ' C ' HD23 ' A' ' 94' ' ' LEU . 4.0 tt -60.12 -18.55 48.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.379 -1.071 . . . . 0.0 109.6 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -107.1 134.21 50.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.645 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.498 HG22 ' CB ' ' A' ' 91' ' ' ALA . 74.2 t -134.29 157.39 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.839 . . . . 0.0 109.407 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.56 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 8.8 m-20 -98.39 152.43 19.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 108.811 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -141.57 133.77 27.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.968 -1.083 . . . . 0.0 110.701 -178.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.556 ' N ' HG23 ' A' ' 89' ' ' VAL . 8.7 ttt180 -131.0 131.37 44.31 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.84 ' HG3' HG22 ' A' ' 86' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.073 -1.017 . . . . 0.0 109.556 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.02 168.55 19.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -1.185 . . . . 0.0 109.542 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.9 m -116.34 168.06 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.289 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 46.2 t60 -170.33 163.9 8.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.679 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.69 125.37 50.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.212 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.77 175.73 22.37 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 52' ' ' LEU . 3.7 mt -97.7 155.0 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.405 -1.056 . . . . 0.0 108.98 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.484 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 45.7 t -98.79 157.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.063 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.435 ' N ' HG12 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -154.38 141.43 19.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.438 -0.789 . . . . 0.0 109.006 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.5 t80 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.034 . . . . 0.0 109.555 -179.855 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 47' ' ' PHE . 40.4 pt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 67.1 m-85 -117.9 169.76 9.37 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.879 -1.138 . . . . 0.0 109.411 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.678 ' HG3' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -143.16 139.24 30.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 109.698 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 61' ' ' LEU . 48.2 t -115.8 104.28 16.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 130.56 45.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.115 -0.991 . . . . 0.0 109.966 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.9 mp -94.89 93.22 7.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 109.303 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.918 HD13 ' N ' ' A' ' 53' ' ' GLY . 0.9 OUTLIER -83.69 134.97 34.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 109.596 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.918 ' N ' HD13 ' A' ' 52' ' ' LEU . . . 92.85 -5.81 76.47 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.505 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -123.9 51.34 1.54 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.269 -1.136 . . . . 0.0 109.596 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.505 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 1.6 mt-10 75.87 -170.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.399 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 58' ' ' GLU . . . -81.66 9.76 54.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -41.42 97.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -1.067 . . . . 0.0 109.63 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 56' ' ' GLY . 27.9 tt0 -110.58 110.58 21.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -104.66 167.4 9.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.843 HD12 HD21 ' A' ' 62' ' ' LEU . 1.1 pt -129.58 139.0 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.405 -0.81 . . . . 0.0 109.039 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 47' ' ' PHE . 49.0 tp -98.4 117.25 32.39 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.026 -1.046 . . . . 0.0 109.26 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.843 HD21 HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.309 -0.869 . . . . 0.0 109.664 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.411 HG13 ' CG1' ' A' ' 40' ' ' VAL . 13.0 t . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 88.13 -48.03 3.58 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -41.56 164.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.406 -1.055 . . . . 0.0 109.892 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.467 ' C ' HG23 ' A' ' 84' ' ' ILE . 23.5 m -98.15 150.16 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.079 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.697 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -155.95 175.29 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.937 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 4.3 mtmt -104.25 112.87 26.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.409 -0.807 . . . . 0.0 109.253 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.614 ' OG1' HD11 ' A' ' 98' ' ' LEU . 71.3 p -118.94 175.24 5.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.725 ' O ' HD13 ' A' ' 98' ' ' LEU . 9.9 mpt_? -99.32 156.36 17.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 0.0 109.335 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 t -97.21 124.24 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.167 -0.958 . . . . 0.0 109.309 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.493 ' CG2' ' CB ' ' A' ' 99' ' ' ARG . 24.4 t -80.75 -30.3 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.413 -0.804 . . . . 0.0 109.653 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.9 OUTLIER 168.01 106.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.136 -0.977 . . . . 0.0 109.311 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.73 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -95.73 132.36 41.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 0.0 109.617 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -165.84 88.27 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.47 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.73 -160.6 13.57 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.7 -22.62 53.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -1.155 . . . . 0.0 109.443 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -103.65 138.99 39.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.272 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.73 HG13 ' HA ' ' A' ' 91' ' ' ALA . 77.2 t -136.74 161.8 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.185 -0.947 . . . . 0.0 109.918 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.519 ' N ' HG12 ' A' ' 96' ' ' VAL . 15.3 m-20 -98.36 150.9 21.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -138.53 135.0 34.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.932 -1.105 . . . . 0.0 110.91 -178.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.493 ' CB ' ' CG2' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -136.91 131.8 33.59 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.557 ' HG3' HG22 ' A' ' 86' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.175 -0.953 . . . . 0.0 109.33 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 p -119.13 154.67 32.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -1.102 . . . . 0.0 109.575 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.481 HG12 ' HD2' ' A' ' 87' ' ' ARG . 4.4 m -101.03 131.89 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.375 -0.828 . . . . 0.0 109.06 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.86 172.53 13.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.06 -1.025 . . . . 0.0 109.954 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.55 158.61 15.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.367 -0.833 . . . . 0.0 108.897 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.06 177.46 39.1 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.775 HD11 ' HB2' ' A' ' 52' ' ' LEU . 6.6 mt -95.96 152.43 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.425 -1.044 . . . . 0.0 108.451 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 82' ' ' ARG . 21.9 t -98.65 149.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.061 -1.024 . . . . 0.0 110.731 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.47 132.46 15.21 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 t80 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 120.932 -1.105 . . . . 0.0 109.742 -179.632 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.604 HG22 ' H ' ' A' ' 47' ' ' PHE . 2.5 mm . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.604 ' H ' HG22 ' A' ' 46' ' ' ILE . 10.1 m-85 -109.54 172.45 6.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.12 -0.988 . . . . 0.0 109.409 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 147.78 26.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.945 . . . . 0.0 109.704 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.583 HG21 ' HG ' ' A' ' 98' ' ' LEU . 2.5 t -121.74 122.02 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.399 -0.813 . . . . 0.0 109.253 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.622 ' HB3' HD12 ' A' ' 39' ' ' ILE . 54.8 ttt-85 -98.73 121.74 41.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.0 109.338 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -90.7 86.64 6.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.023 -1.048 . . . . 0.0 109.624 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.775 ' HB2' HD11 ' A' ' 39' ' ' ILE . 5.7 tp -59.41 162.99 4.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.835 . . . . 0.0 109.351 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.99 -31.05 5.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.49 -31.69 12.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 109.342 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 55.79 85.81 0.07 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.369 -0.832 . . . . 0.0 109.548 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.68 -12.28 5.4 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -89.25 94.92 10.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -1.148 . . . . 0.0 109.545 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.14 111.01 23.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.525 -0.735 . . . . 0.0 109.129 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.553 ' HB3' HD23 ' A' ' 98' ' ' LEU . 3.8 m -100.69 156.85 17.09 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.23 -0.919 . . . . 0.0 109.539 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -110.72 124.99 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.539 ' HB3' ' CB ' ' A' ' 47' ' ' PHE . 29.9 tp -98.17 110.55 23.11 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.046 -1.034 . . . . 0.0 109.56 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 46' ' ' ILE . 1.7 tt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.483 -0.76 . . . . 0.0 109.727 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 81' ' ' GLY . 17.8 t . . . . . 0 N--CA 1.487 1.379 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.517 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 85.43 -48.46 4.02 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.497 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -43.02 170.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.469 -1.018 . . . . 0.0 110.14 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.3 p -97.27 143.6 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.145 -0.972 . . . . 0.0 109.64 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.712 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.3 pp -145.83 174.16 2.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.456 -0.777 . . . . 0.0 109.391 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -102.89 141.78 35.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.505 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.499 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -153.33 174.55 14.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.277 -0.889 . . . . 0.0 109.46 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.781 ' O ' HD13 ' A' ' 98' ' ' LEU . 7.9 mmt180 -99.39 151.92 20.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 65.5 t -97.41 119.88 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.86 . . . . 0.0 109.002 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.849 HG21 ' HG3' ' A' ' 99' ' ' ARG . 71.2 t -82.64 -33.96 11.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.414 -0.804 . . . . 0.0 109.935 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 171.04 103.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.115 -0.99 . . . . 0.0 109.737 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.817 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -92.91 107.2 19.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.266 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.88 107.45 4.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.71 -176.39 54.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 94' ' ' LEU . 5.2 mp -59.83 -16.17 26.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -1.095 . . . . 0.0 109.529 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -99.07 133.15 43.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.479 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.817 HG13 ' HA ' ' A' ' 91' ' ' ALA . 61.7 t -138.59 151.29 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.597 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.539 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -101.17 145.5 28.72 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.781 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -138.31 137.86 37.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.966 -1.084 . . . . 0.0 110.669 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.849 ' HG3' HG21 ' A' ' 89' ' ' VAL . 9.2 mtt180 -146.19 126.41 13.87 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.415 ' HB2' HG22 ' A' ' 86' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.566 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 62.2 m -138.59 165.65 26.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.93 146.61 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.509 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -168.71 166.0 11.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.165 -0.959 . . . . 0.0 109.612 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -104.0 138.89 39.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.322 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 83' ' ' VAL . . . -154.98 176.13 32.77 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.7 mm -97.4 152.33 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.345 -1.091 . . . . 0.0 108.815 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 41' ' ' TYR . 21.9 t -104.93 168.01 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.014 -1.054 . . . . 0.0 110.09 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.563 ' N ' HG12 ' A' ' 40' ' ' VAL . 6.3 t80 -155.87 163.78 39.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.333 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.8 tt . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.704 ' CB ' HD23 ' A' ' 61' ' ' LEU . 21.2 m-85 -111.94 153.9 26.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.034 -1.041 . . . . 0.0 109.51 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -129.72 149.32 51.52 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 59' ' ' CYS . 47.4 t -128.52 135.44 62.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.083 -1.011 . . . . 0.0 109.544 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.96 131.86 56.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.122 -0.986 . . . . 0.0 109.022 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -85.46 78.19 9.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 109.666 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.8 tp -62.73 125.17 23.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.351 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.49 -16.41 6.26 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.41 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 10.8 t80 -118.23 -26.13 6.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -1.127 . . . . 0.0 109.382 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 56.56 91.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.38 0.36 5.0 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.41 ' CE1' ' CD2' ' A' ' 54' ' ' TYR . 9.6 m170 -109.63 105.28 14.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -1.213 . . . . 0.0 109.483 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 95' ' ' TYR . 0.2 OUTLIER -112.67 111.41 22.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.887 . . . . 0.0 110.014 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.483 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.3 m -103.56 170.63 7.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.309 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.2 pt -132.39 128.57 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.068 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.704 HD23 ' CB ' ' A' ' 47' ' ' PHE . 20.5 tp -97.47 117.54 31.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.969 -1.082 . . . . 0.0 109.372 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.62 ' C ' HD12 ' A' ' 62' ' ' LEU . 3.6 pp . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.374 -0.829 . . . . 0.0 109.794 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.563 HG22 ' N ' ' A' ' 81' ' ' GLY . 1.6 p . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.705 0.764 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.563 ' N ' HG22 ' A' ' 80' ' ' VAL . . . 85.31 -47.19 3.79 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.568 ' HE ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -41.24 165.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.436 -1.037 . . . . 0.0 110.21 -179.539 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.568 HG12 ' HE ' ' A' ' 82' ' ' ARG . 7.4 p -98.04 141.78 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.411 -0.805 . . . . 0.0 108.882 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.766 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -151.37 175.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.001 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -98.9 103.52 15.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 108.957 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.747 ' OG1' HD11 ' A' ' 98' ' ' LEU . 68.0 p -107.49 175.12 5.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.62 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -102.95 156.56 17.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 0.0 109.254 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.483 ' HA ' HD22 ' A' ' 98' ' ' LEU . 60.1 t -96.95 106.6 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.282 -0.886 . . . . 0.0 108.817 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.572 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 24.1 t -60.6 -44.54 97.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.464 -0.773 . . . . 0.0 109.87 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 9.4 ttm180 177.27 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.746 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.593 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -78.12 152.12 32.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.901 . . . . 0.0 109.322 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -167.7 62.16 0.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.924 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.87 -156.04 16.2 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -27.33 68.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -1.096 . . . . 0.0 109.647 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 2.7 m-85 -101.18 138.74 37.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.612 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 91' ' ' ALA . 40.8 t -133.69 162.86 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.774 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.572 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -99.26 145.96 26.72 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.747 HD11 ' OG1' ' A' ' 86' ' ' THR . 0.2 OUTLIER -138.02 138.63 39.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.965 -1.085 . . . . 0.0 110.899 -178.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.484 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 31.0 ttp180 -134.57 129.28 34.76 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 109.429 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 t -100.52 172.13 7.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -1.114 . . . . 0.0 109.461 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.751 HG22 ' HG3' ' A' ' 87' ' ' ARG . 10.3 t -118.89 161.97 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.2 -0.937 . . . . 0.0 109.426 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.409 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -172.35 167.51 5.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.872 . . . . 0.0 109.457 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -98.7 130.63 45.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 0.0 109.26 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.41 175.69 29.34 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 81' ' ' GLY . 4.0 mt -97.91 158.29 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -1.048 . . . . 0.0 108.984 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.545 ' C ' ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -116.28 175.75 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 110.072 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.62 147.91 22.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 108.856 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 50.8 t80 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 120.965 -1.084 . . . . 0.0 109.654 -179.639 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 47' ' ' PHE . 10.2 pt . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.562 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 4.4 m-85 -114.9 173.99 6.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.045 -1.035 . . . . 0.0 109.189 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 5.0 tttt -142.68 158.88 43.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.144 -0.973 . . . . 0.0 109.675 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 59' ' ' CYS . 2.8 t -139.98 107.71 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.406 -0.809 . . . . 0.0 109.376 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.96 134.27 42.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -97.38 96.97 8.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.94 . . . . 0.0 109.614 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -79.2 110.97 14.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.337 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.04 -35.96 1.64 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 4.4 m-85 -85.02 -31.62 23.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.272 -1.134 . . . . 0.0 109.18 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER 71.55 97.6 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.391 -0.818 . . . . 0.0 109.589 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.73 10.34 30.98 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -100.22 88.75 3.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 0.0 109.549 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.92 99.61 9.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.36 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.798 ' SG ' HD23 ' A' ' 98' ' ' LEU . 7.4 t -101.9 169.56 8.7 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.188 -0.945 . . . . 0.0 109.234 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 pt -137.03 140.84 41.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.747 HD21 ' HG2' ' A' ' 100' ' ' ARG . 0.5 OUTLIER -98.37 126.96 44.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.934 -1.104 . . . . 0.0 109.597 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.422 ' HG ' ' HB ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.599 -0.688 . . . . 0.0 109.507 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.699 HG12 ' N ' ' A' ' 81' ' ' GLY . 38.2 t . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.174 0.512 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.699 ' N ' HG12 ' A' ' 80' ' ' VAL . . . -80.69 15.65 18.76 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.233 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -49.05 175.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.94 -1.33 . . . . 0.0 108.695 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.5 t -97.37 122.9 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.084 -1.01 . . . . 0.0 108.627 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.744 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -141.3 174.63 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.112 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -104.19 118.13 35.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.428 -0.795 . . . . 0.0 109.127 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.851 ' OG1' HD11 ' A' ' 98' ' ' LEU . 55.5 p -125.95 175.08 7.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.751 ' HG3' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -102.15 159.88 15.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.338 -0.851 . . . . 0.0 109.477 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.451 ' HA ' HD22 ' A' ' 98' ' ' LEU . 40.7 t -97.48 123.1 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 109.031 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.586 HG23 ' N ' ' A' ' 99' ' ' ARG . 79.6 t -81.84 -33.29 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.485 -0.759 . . . . 0.0 110.045 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 47.3 ttp180 175.29 102.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.004 . . . . 0.0 109.629 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.853 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -95.83 108.37 20.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.537 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.45 -58.36 2.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.02 -93.79 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.67 -29.64 22.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -1.179 . . . . 0.0 109.194 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.14 131.08 53.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.091 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.853 HG13 ' HA ' ' A' ' 91' ' ' ALA . 59.5 t -135.0 157.61 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 109.954 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.551 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -99.91 153.89 18.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.851 HD11 ' OG1' ' A' ' 86' ' ' THR . 0.2 OUTLIER -136.81 134.2 36.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.971 -1.08 . . . . 0.0 110.878 -178.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.586 ' N ' HG23 ' A' ' 89' ' ' VAL . 28.6 ttm180 -124.17 111.56 16.04 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.747 ' HG2' HD21 ' A' ' 61' ' ' LEU . 4.2 ptm180 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 110.041 -179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -113.8 163.46 15.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -1.147 . . . . 0.0 109.482 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.877 HG12 ' NE ' ' A' ' 87' ' ' ARG . 18.9 m -103.65 158.1 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.511 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.531 ' CD2' HG23 ' A' ' 88' ' ' VAL . 20.4 p80 -167.08 163.13 15.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -99.37 135.08 41.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.067 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -146.08 176.77 24.85 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' A' ' 52' ' ' LEU . 9.7 mt -96.61 154.34 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.302 -1.117 . . . . 0.0 108.641 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.717 HG23 HD12 ' A' ' 84' ' ' ILE . 53.0 t -105.54 151.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.016 -1.053 . . . . 0.0 110.481 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.523 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 2.6 t80 -142.34 145.87 34.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.425 -0.797 . . . . 0.0 108.968 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.535 ' O ' ' CG ' ' A' ' 42' ' ' PHE . 37.2 p90 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.096 -1.002 . . . . 0.0 109.779 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.826 ' CG2' HD13 ' A' ' 62' ' ' LEU . 2.5 pt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.519 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 0.5 OUTLIER -116.23 163.04 16.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.037 -1.04 . . . . 0.0 108.96 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.553 ' CG ' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -135.65 129.95 33.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.166 -0.959 . . . . 0.0 109.733 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 59' ' ' CYS . 5.4 t -109.45 124.83 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 109.358 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -105.55 129.4 53.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.977 . . . . 0.0 109.393 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -90.76 81.95 5.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.432 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.56 ' HB2' HD11 ' A' ' 39' ' ' ILE . 1.2 tp -64.97 132.71 50.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.94 -42.46 1.86 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.466 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . 69.1 t80 -74.58 -29.54 61.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 109.556 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 30.4 tt0 63.54 89.3 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.53 15.28 9.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.466 ' CG ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -115.65 90.26 3.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 109.535 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 1.6 tm-20 -100.65 105.61 17.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.837 . . . . 0.0 109.444 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.651 ' HB3' HD23 ' A' ' 98' ' ' LEU . 4.9 m -101.78 159.65 15.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.145 -0.972 . . . . 0.0 109.313 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.553 HG22 ' CG ' ' A' ' 48' ' ' LYS . 4.1 pt -131.13 141.07 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.848 . . . . 0.0 108.971 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -97.93 127.63 44.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.027 . . . . 0.0 109.738 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.826 HD13 ' CG2' ' A' ' 46' ' ' ILE . 14.9 tp . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 81' ' ' GLY . 12.0 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 86.06 -46.86 3.68 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -41.09 164.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.579 -0.953 . . . . 0.0 110.021 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 4.3 m -98.44 153.01 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.247 -0.908 . . . . 0.0 109.219 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.781 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -151.99 174.59 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.695 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -99.35 138.17 36.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.362 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 35.5 p -149.3 173.53 13.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.889 . . . . 0.0 109.443 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.877 ' NE ' HG12 ' A' ' 35' ' ' VAL . 13.3 mmm-85 -104.23 158.13 16.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.852 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.531 HG23 ' CD2' ' A' ' 36' ' ' HIS . 53.4 t -96.74 131.82 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 109.334 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.649 HG22 ' CD ' ' A' ' 99' ' ' ARG . 42.6 t -92.41 -31.1 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.284 -0.885 . . . . 0.0 110.056 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.488 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 164.49 107.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.139 -0.975 . . . . 0.0 109.58 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.958 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -84.65 117.72 23.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -110.54 27.98 9.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.581 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.24 -148.24 17.45 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.7 OUTLIER -45.29 -31.25 1.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -1.133 . . . . 0.0 109.527 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -102.86 135.06 45.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 109.332 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.958 HG13 ' HA ' ' A' ' 91' ' ' ALA . 51.4 t -142.26 152.48 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.9 . . . . 0.0 109.695 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.488 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 50.1 m-20 -97.92 150.29 21.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.203 -0.935 . . . . 0.0 108.706 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.866 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -136.93 136.74 38.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.09 -1.006 . . . . 0.0 110.49 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.649 ' CD ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -123.84 114.46 19.89 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.212 -0.93 . . . . 0.0 109.325 -179.922 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.228 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 m -128.68 161.41 29.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 0.0 109.553 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 35' ' ' VAL . 6.0 m -109.7 132.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.59 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -147.03 170.01 18.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.259 -0.9 . . . . 0.0 109.43 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -100.23 153.39 19.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.852 . . . . 0.0 109.684 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.45 175.22 45.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.88 HG23 ' O ' ' A' ' 81' ' ' GLY . 1.9 mp -98.49 144.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.377 -1.072 . . . . 0.0 108.931 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.536 ' O ' ' CA ' ' A' ' 81' ' ' GLY . 2.1 t -100.94 172.36 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.514 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 1.4 t80 -156.19 147.92 22.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -0.95 . . . . 0.0 109.54 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.7 t80 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.455 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.606 HG21 HD13 ' A' ' 62' ' ' LEU . 45.4 pt . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.515 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.3 m-30 -107.9 155.1 20.67 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.021 -1.049 . . . . 0.0 109.17 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 24.3 tttt -126.07 150.46 48.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.507 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 3.4 t -138.55 112.84 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.434 -0.791 . . . . 0.0 109.104 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.73 127.55 45.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.23 85.44 5.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.634 ' HB2' HD13 ' A' ' 39' ' ' ILE . 17.8 tp -59.92 145.64 45.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.241 -0.912 . . . . 0.0 109.402 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.446 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . 101.92 -54.43 0.77 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.09 -24.35 62.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.582 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 47.78 85.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.99 -9.84 3.89 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -97.46 98.16 9.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -1.144 . . . . 0.0 109.596 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.568 ' OE2' ' CZ ' ' A' ' 95' ' ' TYR . 26.4 tt0 -101.42 107.54 18.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.2 m -104.87 162.63 13.16 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.627 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -131.01 132.68 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.576 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.525 HD12 HD12 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -97.4 124.69 41.66 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 109.831 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.606 HD13 HG21 ' A' ' 46' ' ' ILE . 4.9 tp . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.545 -0.722 . . . . 0.0 109.462 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.531 ' CG1' ' N ' ' A' ' 81' ' ' GLY . 2.3 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.67 0.748 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.88 ' O ' HG23 ' A' ' 39' ' ' ILE . . . -75.33 15.4 4.43 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.808 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.503 ' O ' ' O ' ' A' ' 81' ' ' GLY . 8.5 ttp180 -50.63 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.969 -1.313 . . . . 0.0 109.724 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.4 m -96.01 112.91 29.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 108.821 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.759 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.7 pp -133.57 175.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.95 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -98.28 151.37 20.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 109.038 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.738 ' HB ' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -154.91 170.86 20.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.812 ' O ' HD13 ' A' ' 98' ' ' LEU . 6.1 mmt180 -99.78 154.16 18.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.194 -0.941 . . . . 0.0 109.244 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.5 t -97.78 125.9 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.13 -0.981 . . . . 0.0 108.908 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.955 HG12 ' HG2' ' A' ' 90' ' ' ARG . 78.7 t -85.36 -33.88 8.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.295 -0.878 . . . . 0.0 110.251 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.955 ' HG2' HG12 ' A' ' 89' ' ' VAL . 1.9 ptt180 166.45 108.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.03 -1.044 . . . . 0.0 109.601 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.802 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -91.44 114.87 27.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.822 . . . . 0.0 109.244 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.7 64.86 1.58 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.109 -0.995 . . . . 0.0 109.794 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.75 -165.64 12.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -25.88 62.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -1.093 . . . . 0.0 109.676 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.568 ' CZ ' ' OE2' ' A' ' 58' ' ' GLU . 6.9 m-85 -99.59 140.63 33.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.353 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.802 HG22 ' HA ' ' A' ' 91' ' ' ALA . 79.9 t -142.2 162.89 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 109.944 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.573 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 30.8 m-20 -101.19 157.2 16.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.002 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.812 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.24 136.23 33.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.88 -1.137 . . . . 0.0 111.033 -178.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.589 ' N ' HG23 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -120.8 114.78 22.11 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.632 ' HA ' HG22 ' A' ' 86' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.05 172.02 13.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -1.134 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.623 HG12 ' NE ' ' A' ' 87' ' ' ARG . 12.9 m -120.44 128.43 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.0 109.218 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -149.93 166.87 28.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.554 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.56 133.27 45.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.204 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.07 176.71 24.87 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 39' ' ' ILE . 2.9 mp -96.14 160.02 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -1.122 . . . . 0.0 108.581 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.542 ' CG2' HD12 ' A' ' 84' ' ' ILE . 7.1 t -111.37 167.94 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.085 -1.009 . . . . 0.0 110.237 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.507 ' N ' HG12 ' A' ' 40' ' ' VAL . 2.1 t80 -157.87 150.4 22.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.438 -0.789 . . . . 0.0 108.922 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 75.1 t80 . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.931 . . . . 0.0 109.704 -179.551 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.811 HG23 ' N ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.811 ' N ' HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -107.04 164.43 12.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.738 -1.226 . . . . 0.0 109.157 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.07 147.64 49.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.083 -1.011 . . . . 0.0 110.219 -179.449 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.494 ' CG2' HD13 ' A' ' 61' ' ' LEU . 71.7 t -130.8 133.66 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -114.37 123.57 49.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.11 67.69 10.05 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.174 -0.954 . . . . 0.0 109.242 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.416 ' HB2' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -47.63 147.28 1.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.701 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.24 -45.3 1.38 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.497 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -77.62 -17.03 58.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -1.152 . . . . 0.0 109.456 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.24 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.203 -0.936 . . . . 0.0 109.515 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.81 -23.96 7.66 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.574 ' NE2' ' HB1' ' A' ' 91' ' ' ALA . 1.6 t-160 -82.1 91.06 6.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.164 -1.198 . . . . 0.0 109.787 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.87 109.68 22.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.099 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.461 ' HA ' ' HB ' ' A' ' 96' ' ' VAL . 13.7 m -98.54 173.7 6.8 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.154 -0.966 . . . . 0.0 109.444 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 96' ' ' VAL . 1.8 pp -149.55 147.62 16.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.422 -0.798 . . . . 0.0 109.374 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.558 HD21 ' CG ' ' A' ' 100' ' ' ARG . 0.6 OUTLIER -98.13 102.48 14.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.298 -0.876 . . . . 0.0 109.183 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.469 ' HA ' HG12 ' A' ' 46' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.563 ' N ' ' CG2' ' A' ' 80' ' ' VAL . . . 88.78 -37.41 3.31 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 81' ' ' GLY . 1.5 mmt180 -43.62 172.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.633 -0.922 . . . . 0.0 110.153 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.454 ' C ' HG23 ' A' ' 84' ' ' ILE . 9.1 p -97.18 147.1 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.601 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.687 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -155.74 176.02 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.352 -0.843 . . . . 0.0 109.605 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.1 110.4 22.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.323 -0.861 . . . . 0.0 108.949 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.995 HG22 ' HB2' ' A' ' 100' ' ' ARG . 82.4 p -110.35 165.45 11.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.044 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.623 ' NE ' HG12 ' A' ' 35' ' ' VAL . 6.2 mpt_? -98.56 140.79 32.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 108.65 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.605 ' HA ' ' HB3' ' A' ' 98' ' ' LEU . 58.9 t -94.25 139.16 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.469 -0.769 . . . . 0.0 109.299 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 89' ' ' VAL . 91.1 t -121.97 -10.31 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.47 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.884 ' O ' HG13 ' A' ' 96' ' ' VAL . 0.0 OUTLIER 174.38 105.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.496 -1.377 . . . . 0.0 110.444 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.813 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -116.54 88.03 2.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.506 -0.746 . . . . 0.0 109.172 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -121.65 84.19 2.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.766 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.36 -137.76 14.14 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mp -102.28 4.38 39.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -1.141 . . . . 0.0 109.674 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.458 ' CZ ' HG21 ' A' ' 60' ' ' ILE . 1.3 t80 -124.4 131.96 53.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 109.212 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.946 HG12 ' CD2' ' A' ' 98' ' ' LEU . 22.0 t -132.8 145.86 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.213 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.951 ' O ' HD23 ' A' ' 98' ' ' LEU . 2.0 m-20 -112.8 141.2 46.88 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.951 HD23 ' O ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -165.2 178.91 6.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.592 -1.317 . . . . 0.0 112.041 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.1 ptt-85 -134.89 104.05 5.84 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.082 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.995 ' HB2' HG22 ' A' ' 86' ' ' THR . 1.2 ptt180 . . . . . 0 N--CA 1.49 1.556 0 O-C-N 120.915 -1.115 . . . . 0.0 109.518 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.76 161.94 34.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -1.14 . . . . 0.0 109.386 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.733 HG12 ' HG3' ' A' ' 87' ' ' ARG . 9.6 m -118.29 170.4 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.576 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 11.0 m-70 -172.55 168.16 5.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -99.17 147.31 25.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.6 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -158.75 175.67 35.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 81' ' ' GLY . 6.0 mt -98.04 151.25 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -1.11 . . . . 0.0 109.053 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.567 ' CG2' HD12 ' A' ' 84' ' ' ILE . 66.9 t -99.72 147.16 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.059 -1.026 . . . . 0.0 110.19 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.56 172.29 14.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.438 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.928 . . . . 0.0 109.545 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.438 HG13 ' N ' ' A' ' 47' ' ' PHE . 35.3 pt . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.562 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.0 m-85 -111.6 173.91 6.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.119 -0.988 . . . . 0.0 109.217 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 1.8 mttp -148.08 127.2 12.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.638 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 2.4 t -101.68 111.63 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.427 -0.796 . . . . 0.0 109.287 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.54 130.63 45.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.24 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -92.7 93.4 8.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.554 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 53' ' ' GLY . 1.5 tt -66.35 143.11 57.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.189 -0.945 . . . . 0.0 109.461 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.436 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . 110.81 -43.19 1.77 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 55' ' ' GLU . 14.7 m-85 -88.6 -27.31 21.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -1.151 . . . . 0.0 109.391 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 54' ' ' TYR . 38.3 tt0 61.71 123.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.269 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 58' ' ' GLU . . . 97.27 -39.24 2.83 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -59.86 88.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -1.13 . . . . 0.0 109.33 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 56' ' ' GLY . 32.0 tt0 -104.02 104.02 13.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.447 -0.783 . . . . 0.0 109.438 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 44.4 m -99.04 155.39 17.46 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 109.095 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.9 pt -118.55 136.44 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 109.229 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.562 ' HB3' ' CB ' ' A' ' 47' ' ' PHE . 14.8 tp -98.02 110.38 22.97 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.105 -0.997 . . . . 0.0 109.053 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.655 HD23 ' C ' ' A' ' 62' ' ' LEU . 7.5 tt . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.474 -0.766 . . . . 0.0 109.381 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 81' ' ' GLY . 21.9 t . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 86.15 -47.5 3.77 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -38.95 159.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.641 -0.917 . . . . 0.0 110.008 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 38' ' ' GLY . 22.2 t -98.48 141.46 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 109.028 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.772 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -141.45 166.86 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.822 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -103.59 106.97 17.63 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.723 HG22 ' CG ' ' A' ' 100' ' ' ARG . 1.3 p -118.08 174.77 6.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.744 ' O ' HD13 ' A' ' 98' ' ' LEU . 2.5 mpt_? -98.93 162.96 12.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.871 . . . . 0.0 109.21 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.9 129.33 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.275 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.562 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 57.2 t -85.27 -34.1 8.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.401 -0.812 . . . . 0.0 109.742 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 162.85 113.69 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.301 -0.874 . . . . 0.0 109.215 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.454 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -98.45 151.48 20.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.583 -0.698 . . . . 0.0 109.437 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -127.0 -69.32 0.76 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 109.326 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.455 ' C ' HD12 ' A' ' 94' ' ' LEU . . . -141.35 -75.31 0.04 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.455 HD12 ' C ' ' A' ' 93' ' ' GLY . 8.4 mp -111.52 -25.23 9.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -1.115 . . . . 0.0 109.172 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -100.4 135.57 41.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.037 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.457 ' HB ' ' SG ' ' A' ' 59' ' ' CYS . 58.1 t -140.02 151.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.101 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.562 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 94.1 m-20 -98.49 155.57 17.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 108.624 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.744 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.39 139.25 35.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.821 -1.175 . . . . 0.0 110.831 -178.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.512 ' HG2' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -144.06 125.46 14.78 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.723 ' CG ' HG22 ' A' ' 86' ' ' THR . 3.8 ttt-85 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.486 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.56 162.15 17.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.238 -1.154 . . . . 0.0 109.577 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.727 HG13 ' HD2' ' A' ' 87' ' ' ARG . 1.9 t -109.33 156.23 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.326 -0.858 . . . . 0.0 109.441 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.3 169.58 20.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.613 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 154.5 17.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.234 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -168.67 176.58 42.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.693 HG23 ' O ' ' A' ' 81' ' ' GLY . 32.3 mt -97.1 148.29 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -1.142 . . . . 0.0 108.719 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.545 ' CG2' HG12 ' A' ' 84' ' ' ILE . 59.7 t -98.54 146.96 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.024 -1.048 . . . . 0.0 110.42 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -139.77 150.42 44.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.386 -0.821 . . . . 0.0 109.153 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 76.5 t80 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.038 . . . . 0.0 109.671 -179.836 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.7 pt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.608 ' HB2' HD23 ' A' ' 61' ' ' LEU . 7.2 m-85 -109.45 167.75 9.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.947 ' HG3' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -143.13 131.92 22.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 109.442 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.552 HG21 ' HG ' ' A' ' 98' ' ' LEU . 15.6 t -106.96 116.72 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.52 127.68 44.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.314 -0.866 . . . . 0.0 109.313 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -96.13 70.56 2.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.052 -1.03 . . . . 0.0 109.567 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -58.2 139.16 55.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.226 -0.921 . . . . 0.0 109.324 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.74 -17.52 15.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.28 -30.08 7.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -1.131 . . . . 0.0 109.266 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 66.05 90.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 0.0 109.622 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.56 -11.05 10.44 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 1.3 t-160 -92.26 87.87 6.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -1.132 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -107.94 107.79 18.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.26 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.9 m -104.37 165.39 11.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.278 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.947 HG22 ' HG3' ' A' ' 48' ' ' LYS . 1.6 pt -129.24 134.11 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.335 -0.853 . . . . 0.0 108.932 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.608 HD23 ' HB2' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -97.93 120.56 38.55 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.99 -1.069 . . . . 0.0 109.19 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.476 ' CD2' HD12 ' A' ' 60' ' ' ILE . 2.9 pp . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.684 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 81' ' ' GLY . 15.1 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.149 0.499 . . . . 0.0 109.667 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.693 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 85.76 -47.42 3.79 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.501 ' O ' ' O ' ' A' ' 81' ' ' GLY . 25.7 mmt180 -38.18 164.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.771 -0.84 . . . . 0.0 110.592 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 6.4 m -96.89 130.96 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 108.869 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.644 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 pp -135.67 174.64 12.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 109.74 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 144.26 33.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.044 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.737 ' HB ' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -152.38 173.62 14.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.903 . . . . 0.0 109.534 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.752 ' O ' HD13 ' A' ' 98' ' ' LEU . 10.4 mpt_? -99.96 156.06 17.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.239 -0.913 . . . . 0.0 109.367 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.9 t -96.96 119.79 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.315 -0.865 . . . . 0.0 108.995 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.783 HG11 ' OD2' ' A' ' 97' ' ' ASP . 75.4 t -77.6 -31.22 17.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.374 -0.829 . . . . 0.0 109.928 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 1.6 ttm180 170.23 106.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.35 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.753 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -88.12 133.82 33.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.416 -0.803 . . . . 0.0 109.172 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.66 88.31 0.34 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.67 -177.89 33.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.5 mp -58.9 -16.23 16.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -1.135 . . . . 0.0 109.662 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -108.52 127.96 54.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.644 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.753 HG22 ' HA ' ' A' ' 91' ' ' ALA . 55.4 t -129.6 158.97 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.852 . . . . 0.0 109.356 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.783 ' OD2' HG11 ' A' ' 89' ' ' VAL . 28.7 t0 -98.59 147.72 24.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.97 . . . . 0.0 108.742 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -132.76 135.51 45.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.04 -1.037 . . . . 0.0 111.088 -178.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.549 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 4.7 ttp-105 -132.63 129.41 38.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.507 ' HB2' HG23 ' A' ' 86' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.021 -1.049 . . . . 0.0 109.732 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 t -168.74 150.56 4.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -1.161 . . . . 0.0 109.37 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 36' ' ' HIS . 20.2 t -102.55 163.33 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.476 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -172.86 163.85 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.772 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -101.35 142.05 33.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.387 -0.821 . . . . 0.0 109.305 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -153.53 176.6 31.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.511 HG23 ' O ' ' A' ' 81' ' ' GLY . 28.5 mt -97.31 154.58 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -1.21 . . . . 0.0 108.9 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 84' ' ' ILE . 77.0 t -98.66 150.61 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 110.16 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.538 ' HB3' ' CB ' ' A' ' 48' ' ' LYS . 42.9 t80 -141.98 155.03 45.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.344 -0.847 . . . . 0.0 109.142 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 42' ' ' PHE . 28.3 p90 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.95 . . . . 0.0 109.589 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.623 HG22 HD13 ' A' ' 62' ' ' LEU . 3.0 pt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.179 0.514 . . . . 0.0 109.687 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.43 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 5.6 m-85 -107.54 159.18 16.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.553 ' HG3' HG22 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -133.47 128.37 35.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.17 -0.956 . . . . 0.0 109.761 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.587 HG21 ' HG ' ' A' ' 98' ' ' LEU . 1.8 t -106.18 118.93 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 108.878 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.53 121.04 40.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 109.855 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.542 HD13 ' SG ' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -88.28 72.64 8.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.227 179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.72 129.13 38.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.69 -33.99 4.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.43 -71.02 0.41 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -1.167 . . . . 0.0 109.531 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -178.31 55.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 109.556 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.42 7.79 48.01 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.75 118.06 2.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -1.189 . . . . 0.0 109.171 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 95' ' ' TYR . 7.4 tt0 -106.34 111.11 23.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.691 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.542 ' SG ' HD13 ' A' ' 51' ' ' LEU . 13.0 m -109.95 165.91 11.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.315 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.553 HG22 ' HG3' ' A' ' 48' ' ' LYS . 1.6 pt -133.95 135.53 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 109.49 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.654 HD12 ' HB3' ' A' ' 98' ' ' LEU . 3.9 tp -98.56 127.83 44.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.623 HD13 HG22 ' A' ' 46' ' ' ILE . 13.8 tp . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.346 -0.847 . . . . 0.0 109.463 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 81' ' ' GLY . 43.2 t . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.568 ' N ' HG12 ' A' ' 80' ' ' VAL . . . 85.67 -45.61 3.51 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 81' ' ' GLY . 2.8 mmt180 -43.15 172.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.647 -0.914 . . . . 0.0 110.382 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 38' ' ' GLY . 56.0 t -97.57 139.22 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.267 -0.895 . . . . 0.0 109.222 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.889 HD13 HG23 ' A' ' 86' ' ' THR . 2.0 pp -136.75 166.64 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 15.6 ptpt -101.7 128.58 47.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 109.07 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.889 HG23 HD13 ' A' ' 84' ' ' ILE . 40.6 p -141.89 175.43 9.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.851 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.802 ' O ' HD13 ' A' ' 98' ' ' LEU . 3.8 mpt_? -101.48 161.59 13.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.486 -0.759 . . . . 0.0 109.426 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.2 t -97.75 110.39 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.338 -0.851 . . . . 0.0 109.003 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.575 HG23 ' N ' ' A' ' 99' ' ' ARG . 41.1 t -65.62 -40.29 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 0.0 110.103 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.49 103.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 109.501 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.763 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -82.76 122.18 27.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.527 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 91' ' ' ALA . 0.4 OUTLIER -156.26 92.19 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.286 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.5 -177.33 33.26 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -15.77 41.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -1.155 . . . . 0.0 109.445 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.5 OUTLIER -107.35 125.81 51.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.191 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.763 HG13 ' HA ' ' A' ' 91' ' ' ALA . 74.2 t -122.79 160.86 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.888 . . . . 0.0 109.468 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.56 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 0.9 OUTLIER -97.91 148.01 23.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.109 -0.994 . . . . 0.0 108.576 179.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -133.01 135.56 45.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 110.677 -178.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.575 ' N ' HG23 ' A' ' 89' ' ' VAL . 4.0 ttp85 -132.84 120.61 21.78 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.544 ' HG3' HG22 ' A' ' 86' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.89 129.59 52.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -1.178 . . . . 0.0 109.515 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.716 HG12 ' CD ' ' A' ' 87' ' ' ARG . 16.5 m -99.56 136.65 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 35' ' ' VAL . 5.7 m-70 -147.7 166.74 26.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.449 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.05 152.01 21.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.516 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -163.89 176.41 39.93 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.864 HG23 ' O ' ' A' ' 81' ' ' GLY . 76.6 mt -96.83 146.72 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -1.097 . . . . 0.0 108.356 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.517 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 57.2 t -99.46 137.67 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.963 -1.086 . . . . 0.0 110.591 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 2.9 t80 -122.46 154.57 37.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 109.043 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.502 ' O ' ' CG ' ' A' ' 42' ' ' PHE . 12.8 p90 . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.948 . . . . 0.0 109.641 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 47' ' ' PHE . 2.0 pt . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.947 ' HB2' HD23 ' A' ' 61' ' ' LEU . 76.1 m-85 -127.05 171.99 10.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.959 -1.088 . . . . 0.0 109.43 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.812 ' HE3' HG22 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -136.79 125.4 23.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.251 -0.906 . . . . 0.0 109.669 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.875 HG23 ' HB2' ' A' ' 61' ' ' LEU . 92.9 t -98.07 105.81 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.115 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.492 ' CG ' ' HB ' ' A' ' 39' ' ' ILE . 2.3 ptm85 -101.34 128.9 47.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.7 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.26 85.54 7.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 109.364 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HB2' HD12 ' A' ' 39' ' ' ILE . 2.6 tt -62.84 149.07 45.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.212 -0.93 . . . . 0.0 109.538 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.48 -55.18 0.84 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -75.06 -27.8 60.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -1.151 . . . . 0.0 109.515 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 54' ' ' TYR . 20.3 mt-10 48.87 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.35 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.88 -17.76 3.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.7 92.86 5.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -1.182 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.65 109.06 20.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.339 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.537 ' HB3' HD23 ' A' ' 98' ' ' LEU . 3.5 m -107.05 145.65 32.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.908 . . . . 0.0 109.512 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.812 HG22 ' HE3' ' A' ' 48' ' ' LYS . 30.0 pt -99.56 135.95 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.337 -0.852 . . . . 0.0 109.0 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.947 HD23 ' HB2' ' A' ' 47' ' ' PHE . 25.2 tp -98.61 107.89 20.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 110.183 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.559 HD21 HD12 ' A' ' 60' ' ' ILE . 3.4 mt . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.506 -0.746 . . . . 0.0 109.069 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.557 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.518 0.675 . . . . 0.0 109.31 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.864 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 86.5 -47.45 3.74 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -36.97 161.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.966 -0.726 . . . . 0.0 110.69 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 38' ' ' GLY . 99.5 t -97.14 136.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.281 -0.887 . . . . 0.0 108.967 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.712 HD13 HG23 ' A' ' 86' ' ' THR . 2.3 pp -138.96 174.93 8.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.334 -0.854 . . . . 0.0 109.883 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.47 141.22 39.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.372 -0.83 . . . . 0.0 109.198 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.712 HG23 HD13 ' A' ' 84' ' ' ILE . 19.0 p -151.37 175.26 12.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.192 -0.943 . . . . 0.0 109.315 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.831 ' O ' HD13 ' A' ' 98' ' ' LEU . 1.2 mmm-85 -98.68 158.03 15.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.265 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.6 t -98.28 110.1 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.564 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 26.9 t -63.08 -36.23 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.7 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.443 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER 168.97 106.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.237 -0.914 . . . . 0.0 109.362 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.787 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -91.96 117.27 29.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.424 -0.797 . . . . 0.0 109.235 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -103.4 -62.74 1.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.645 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -146.09 -115.79 0.95 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.04 -23.97 60.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -1.106 . . . . 0.0 109.466 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.53 129.19 55.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.122 -0.986 . . . . 0.0 109.529 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.787 HG13 ' HA ' ' A' ' 91' ' ' ALA . 95.0 t -131.41 158.34 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.856 . . . . 0.0 109.472 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.564 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 9.5 m-20 -101.04 143.39 31.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.0 108.625 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.831 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -130.14 136.91 49.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.904 -1.122 . . . . 0.0 110.659 -178.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.536 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 1.0 OUTLIER -126.35 119.63 27.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 108.89 178.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.497 ' HG3' HG22 ' A' ' 86' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.05 . . . . 0.0 109.695 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -163.95 169.62 17.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -1.133 . . . . 0.0 109.516 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.529 HG12 ' CD ' ' A' ' 87' ' ' ARG . 17.9 m -119.04 143.55 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.13 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.543 ' NE2' HG23 ' A' ' 88' ' ' VAL . 1.9 p80 -165.35 166.8 18.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.006 -1.059 . . . . 0.0 109.956 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.555 ' HG2' HG12 ' A' ' 83' ' ' VAL . 1.7 tt0 -98.8 145.28 27.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 108.907 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.693 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -151.64 176.16 30.15 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.046 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 81' ' ' GLY . 22.0 mt -97.09 150.56 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.515 -0.991 . . . . 0.0 108.544 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.912 ' CG2' HD12 ' A' ' 84' ' ' ILE . 10.6 t -98.16 142.89 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 0.0 110.095 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.512 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 39.6 t80 -141.48 153.25 44.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.385 -0.822 . . . . 0.0 109.104 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.433 ' CD1' ' C ' ' A' ' 42' ' ' PHE . 21.8 t80 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.644 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.926 HD13 ' HG ' ' A' ' 62' ' ' LEU . 2.2 mp . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.781 ' N ' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -127.37 162.03 27.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.031 -1.043 . . . . 0.0 109.342 179.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.531 ' HG2' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -138.52 125.43 21.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -101.93 118.81 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 109.329 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -98.78 127.87 44.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.953 . . . . 0.0 109.527 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HA ' HD13 ' A' ' 51' ' ' LEU . 1.7 mm? -93.83 69.18 3.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 0.0 109.421 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.03 128.82 37.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.908 . . . . 0.0 109.419 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.47 -30.27 9.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 1.1 t80 -99.69 51.07 0.92 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.325 -1.103 . . . . 0.0 109.279 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 72.64 -159.54 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 109.455 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' HIS . . . -82.62 11.81 50.22 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -42.72 108.69 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.329 -1.1 . . . . 0.0 109.772 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -115.15 109.83 18.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.275 -0.891 . . . . 0.0 109.407 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.644 ' HB3' HD23 ' A' ' 98' ' ' LEU . 31.0 m -102.0 156.29 17.63 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.22 -0.925 . . . . 0.0 109.666 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.531 HG22 ' HG2' ' A' ' 48' ' ' LYS . 2.1 pt -125.43 135.54 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -97.71 128.9 44.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.888 -1.133 . . . . 0.0 109.679 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.926 ' HG ' HD13 ' A' ' 46' ' ' ILE . 1.8 tt . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.571 -0.706 . . . . 0.0 109.482 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.552 HG12 ' N ' ' A' ' 81' ' ' GLY . 44.9 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.364 0.602 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 85.47 -51.76 4.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -41.3 161.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -1.072 . . . . 0.0 110.011 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 38' ' ' GLY . 52.9 t -98.75 140.5 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.024 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.912 HD12 ' CG2' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -139.65 175.28 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.735 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -99.45 127.52 45.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.46 -0.775 . . . . 0.0 109.263 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.574 ' OG1' HD11 ' A' ' 98' ' ' LEU . 69.6 p -139.25 173.61 11.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.134 -0.979 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.794 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -105.21 161.02 14.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.543 HG23 ' NE2' ' A' ' 36' ' ' HIS . 59.1 t -97.31 115.03 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.411 -0.806 . . . . 0.0 108.871 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 99' ' ' ARG . 54.8 t -74.41 -39.05 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.468 -0.77 . . . . 0.0 110.259 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 179.25 101.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.972 -1.08 . . . . 0.0 110.031 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.824 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -90.02 122.54 33.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.69 -4.19 12.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 109.953 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 154.16 -113.4 0.57 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.89 -41.13 44.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 0.0 109.579 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -99.49 126.33 45.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.349 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.824 HG22 ' HA ' ' A' ' 91' ' ' ALA . 89.1 t -128.78 162.88 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.719 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.562 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 1.2 m-20 -98.51 154.4 17.92 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -137.74 136.51 37.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.884 -1.135 . . . . 0.0 111.119 -178.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.591 ' N ' HG23 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -132.12 108.4 9.26 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.165 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.42 ' HB3' HD11 ' A' ' 61' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.94 . . . . 0.0 109.413 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.225 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -113.12 162.98 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -1.166 . . . . 0.0 109.389 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.707 HG12 ' CD ' ' A' ' 87' ' ' ARG . 2.9 m -107.55 149.09 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.465 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.12 168.49 13.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.836 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 15.8 mt-10 -99.56 143.65 29.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.317 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -154.02 176.52 31.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 8.8 mt -97.08 152.63 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -1.148 . . . . 0.0 108.685 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.489 HG23 HD12 ' A' ' 84' ' ' ILE . 88.6 t -105.92 149.94 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.102 -0.999 . . . . 0.0 110.607 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.537 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -148.42 175.42 11.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.475 -0.765 . . . . 0.0 109.009 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 58.7 t80 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.153 -0.967 . . . . 0.0 109.35 179.855 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.77 HG21 HD22 ' A' ' 62' ' ' LEU . 12.3 pt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 1.8 m-85 -110.64 164.69 12.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.301 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -135.55 119.72 17.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.643 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 2.7 t -103.9 108.86 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.271 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 135.64 39.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.41 107.72 19.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.1 tp -81.27 148.55 29.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.599 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.4 -21.93 32.65 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -99.31 -30.14 12.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -1.165 . . . . 0.0 109.58 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 54' ' ' TYR . 4.8 mt-10 60.93 149.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.513 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.41 40.71 78.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.76 86.61 2.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.121 -1.223 . . . . 0.0 109.48 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.72 120.31 41.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.325 -0.859 . . . . 0.0 109.556 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.2 m -117.15 170.94 8.28 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.368 -0.832 . . . . 0.0 109.204 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.498 ' HB ' HD11 ' A' ' 46' ' ' ILE . 1.3 pp -134.47 133.07 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 0.0 109.303 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 0.7 OUTLIER -98.19 131.14 44.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.078 -1.014 . . . . 0.0 109.386 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.77 HD22 HG21 ' A' ' 46' ' ' ILE . 25.3 tp . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.489 -0.757 . . . . 0.0 109.413 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.462 HG13 HG12 ' A' ' 40' ' ' VAL . 11.7 t . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.268 0.556 . . . . 0.0 109.768 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 85.9 -53.47 4.67 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 81' ' ' GLY . 31.0 mtt85 -39.17 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.959 . . . . 0.0 110.357 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 66.4 t -98.47 140.46 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.737 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -146.64 174.83 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 110.157 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.517 ' O ' ' CG2' ' A' ' 86' ' ' THR . 1.5 tmmm? -100.23 147.06 26.15 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.686 ' OG1' HD11 ' A' ' 98' ' ' LEU . 67.1 p -158.51 174.22 15.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.963 . . . . 0.0 109.372 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.79 ' O ' HD13 ' A' ' 98' ' ' LEU . 20.8 mmm-85 -103.52 162.45 13.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 34' ' ' SER . 14.2 t -96.71 122.48 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.314 -0.867 . . . . 0.0 109.269 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.543 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 42.0 t -81.2 -41.1 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.445 -0.785 . . . . 0.0 109.929 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 178.59 101.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.062 -1.024 . . . . 0.0 109.749 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.852 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -71.99 135.06 46.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.567 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -128.42 32.85 4.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.387 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.58 -107.86 3.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.1 mp -79.52 -34.51 41.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -1.176 . . . . 0.0 109.311 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -102.01 131.76 48.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.887 . . . . 0.0 109.108 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.852 HG13 ' HA ' ' A' ' 91' ' ' ALA . 94.2 t -137.45 155.57 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.04 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.543 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 6.0 m-20 -99.32 156.73 16.85 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.91 140.51 34.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.083 -1.011 . . . . 0.0 110.234 -179.219 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.533 ' N ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -125.16 120.4 31.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.27 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 25.3 ttt-85 . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.394 -179.863 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 m -106.69 165.14 11.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -1.12 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.658 HG12 ' HD2' ' A' ' 87' ' ' ARG . 3.7 m -108.26 140.3 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -156.18 167.99 28.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.651 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -101.0 143.28 31.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 109.348 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.611 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -153.77 175.61 32.02 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 81' ' ' GLY . 4.3 mp -97.97 153.61 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -1.086 . . . . 0.0 108.756 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.589 HG23 HD12 ' A' ' 84' ' ' ILE . 67.8 t -104.36 146.1 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.009 -1.057 . . . . 0.0 110.343 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 3.2 t80 -146.98 -173.47 4.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 108.903 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.9 t80 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.0 . . . . 0.0 109.522 -179.912 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.481 HG21 ' CD1' ' A' ' 62' ' ' LEU . 21.2 pt . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.517 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 2.4 m-85 -119.84 161.06 21.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.109 -0.994 . . . . 0.0 109.636 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 1.8 tttp -130.95 120.56 23.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.288 -0.882 . . . . 0.0 109.556 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 7.4 t -100.82 126.85 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.181 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.23 139.66 39.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 0.0 109.774 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.9 OUTLIER -103.02 73.23 1.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.399 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.01 168.67 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.426 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.41 -36.65 3.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.539 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 5.5 t80 -98.01 -26.69 14.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -1.104 . . . . 0.0 109.305 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 54.77 26.31 7.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.493 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.33 25.92 0.3 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.539 ' CE1' ' CD2' ' A' ' 54' ' ' TYR . 23.0 m170 -131.12 98.94 4.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -1.102 . . . . 0.0 109.609 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -103.37 107.41 18.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.135 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.485 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 5.1 m -107.72 158.81 16.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.276 -0.89 . . . . 0.0 109.62 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 pt -127.73 137.74 56.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.45 -0.781 . . . . 0.0 108.959 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.525 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 4.3 tp -98.68 131.56 44.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.156 -0.965 . . . . 0.0 109.915 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.481 ' CD1' HG21 ' A' ' 46' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.597 -0.689 . . . . 0.0 109.159 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.591 HG12 ' N ' ' A' ' 81' ' ' GLY . 57.3 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.661 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 85.18 -45.23 3.48 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.468 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -35.59 149.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.741 -0.858 . . . . 0.0 110.359 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 38' ' ' GLY . 65.1 t -98.81 142.69 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.465 -0.772 . . . . 0.0 109.523 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.832 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -149.22 170.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.602 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.22 112.46 24.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.134 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.613 ' OG1' HD11 ' A' ' 98' ' ' LEU . 74.1 p -116.58 175.17 5.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.635 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.801 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -102.19 161.53 13.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 67.6 t -96.85 124.67 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 108.985 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.538 ' CG2' ' HB3' ' A' ' 99' ' ' ARG . 96.4 t -85.28 -38.17 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.294 -0.879 . . . . 0.0 110.159 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.7 OUTLIER 176.9 103.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.135 -0.978 . . . . 0.0 109.637 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.659 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -99.35 123.7 43.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.377 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -115.43 -23.68 8.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 0.0 109.647 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.91 -137.7 2.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mp -57.12 -32.84 66.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -1.119 . . . . 0.0 109.627 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -99.03 131.51 45.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.659 HG13 ' HA ' ' A' ' 91' ' ' ALA . 78.3 t -135.64 158.61 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.056 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 98' ' ' LEU . 9.4 t0 -99.43 152.3 20.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 108.716 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -139.98 140.42 36.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 111.076 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.538 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 0.8 OUTLIER -126.04 119.88 28.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.502 -0.749 . . . . 0.0 109.093 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.46 ' N ' HD11 ' A' ' 61' ' ' LEU . 6.8 ttt-85 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.507 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -74.57 94.24 2.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.167 -0.958 . . . . 0.0 109.48 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 t -83.31 117.24 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.141 -0.974 . . . . 0.0 109.491 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.6 mp -111.89 -68.12 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.9 tttm -118.82 82.82 21.3 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.867 . . . . 0.0 109.344 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.44 140.67 17.3 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.61 2.207 . . . . 0.0 110.445 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.96 107.57 18.64 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.44 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.76 77.75 0.9 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.945 . . . . 0.0 109.674 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -79.79 152.05 74.41 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.148 -0.97 . . . . 0.0 109.225 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.76 139.66 17.92 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.625 2.217 . . . . 0.0 110.307 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.417 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -150.56 67.17 7.95 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.743 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 35.2 Cg_endo -78.03 112.75 3.31 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.572 2.181 . . . . 0.0 110.255 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -147.5 70.87 1.18 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.59 161.92 19.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.212 -0.93 . . . . 0.0 109.422 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -122.67 127.06 48.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.338 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -144.21 115.15 7.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 0.0 109.381 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -160.81 87.32 0.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -0.866 . . . . 0.0 109.304 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 18' ' ' ILE . 8.5 tp -110.94 -16.98 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.696 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 18' ' ' ILE . 5.6 tttt 45.98 93.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.143 -0.973 . . . . 0.0 109.413 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.53 HG13 ' O ' ' A' ' 20' ' ' VAL . 2.6 p -124.39 97.15 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.908 . . . . 0.0 109.473 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -144.99 124.36 13.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.486 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t -154.89 72.17 0.83 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.891 . . . . 0.0 109.565 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -78.69 95.78 5.38 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 109.569 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' A' ' 25' ' ' THR . 0.0 OUTLIER 61.36 -169.6 0.17 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 109.661 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.418 ' O ' ' OG ' ' A' ' 26' ' ' SER . 9.8 t -44.75 142.52 1.7 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 0.0 109.53 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.678 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 63.4 m -168.89 170.48 9.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -0.84 . . . . 0.0 109.323 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 26' ' ' SER . . . 74.34 147.81 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 109.397 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.456 ' HB3' ' O ' ' A' ' 27' ' ' ALA . 0.6 OUTLIER 168.41 147.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.357 -0.84 . . . . 0.0 109.286 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.85 140.12 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.104 -0.998 . . . . 0.0 109.872 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -151.06 21.93 0.76 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.38 -0.825 . . . . 0.0 109.075 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.78 149.31 87.96 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.419 -0.8 . . . . 0.0 109.7 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.39 171.23 17.23 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.664 2.243 . . . . 0.0 110.351 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.72 23.26 43.13 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 93.8 p -115.17 157.43 23.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.195 -1.179 . . . . 0.0 109.532 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.9 150.3 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.299 -0.876 . . . . 0.0 109.484 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 4.0 m-70 -156.54 163.71 39.06 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 0.0 109.715 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.03 137.04 43.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -0.901 . . . . 0.0 108.979 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.74 176.9 28.22 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.608 ' CD1' HD23 ' A' ' 52' ' ' LEU . 7.1 mt -96.51 152.51 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.346 -1.091 . . . . 0.0 108.636 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.606 ' CG2' HD12 ' A' ' 84' ' ' ILE . 76.2 t -99.58 148.08 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.68 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -142.72 164.52 29.87 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -126.37 134.88 50.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.051 -1.03 . . . . 0.0 109.872 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 7.4 tttt -178.95 142.46 0.2 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.502 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 43' ' ' LYS . 4.5 t70 69.51 9.77 7.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.899 . . . . 0.0 109.494 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.39 -31.03 5.64 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 pt -88.29 -164.64 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.398 -1.06 . . . . 0.0 109.139 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 50.0 m-85 -113.9 173.85 6.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.16 -0.963 . . . . 0.0 109.387 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.14 132.78 22.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.294 -0.879 . . . . 0.0 109.371 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.773 HG23 ' HB2' ' A' ' 61' ' ' LEU . 45.8 t -104.62 115.15 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.194 -0.941 . . . . 0.0 109.591 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.701 ' NH1' HD21 ' A' ' 52' ' ' LEU . 7.0 ttt180 -98.64 130.51 45.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.937 . . . . 0.0 109.161 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 51' ' ' LEU . 1.9 mm? -96.33 95.13 7.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 109.643 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.701 HD21 ' NH1' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -69.44 145.52 52.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.426 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.91 -39.96 2.7 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.23 -27.64 29.79 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.246 -1.15 . . . . 0.0 109.292 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 57.87 96.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.239 -0.913 . . . . 0.0 109.649 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . 110.72 10.32 21.47 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.831 ' NE2' HG21 ' A' ' 96' ' ' VAL . 20.0 t-160 -109.82 96.9 6.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -1.202 . . . . 0.0 109.552 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -109.08 131.67 54.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.534 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.6 m -124.67 162.87 23.23 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 109.422 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.485 ' HB ' HD11 ' A' ' 62' ' ' LEU . 2.5 pt -116.01 130.23 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.89 . . . . 0.0 109.29 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.773 ' HB2' HG23 ' A' ' 49' ' ' VAL . 6.0 tt -99.35 118.07 35.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.248 -0.907 . . . . 0.0 109.876 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 62' ' ' LEU . 2.1 mp -132.69 7.92 4.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.479 -0.763 . . . . 0.0 109.091 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 t0 57.39 40.01 27.78 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 58.3 t80 60.93 31.32 19.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.476 -0.765 . . . . 0.0 108.979 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.541 HD22 ' O ' ' A' ' 68' ' ' ARG . 5.5 mt -77.37 -82.54 0.08 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.678 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 56.72 23.89 8.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 0.0 109.194 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.5 ' CD1' ' HB2' ' A' ' 68' ' ' ARG . 15.3 t80 -176.84 112.34 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.236 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.541 ' O ' HD22 ' A' ' 65' ' ' LEU . 0.4 OUTLIER 67.08 143.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.9 . . . . 0.0 109.448 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.74 175.57 5.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 109.578 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 4.6 p30 -156.06 49.41 0.51 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.346 -0.846 . . . . 0.0 109.574 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.996 ' O ' HD12 ' A' ' 72' ' ' LEU . 42.9 p -77.31 119.62 21.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.209 -0.932 . . . . 0.0 109.365 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.996 HD12 ' O ' ' A' ' 71' ' ' THR . 0.3 OUTLIER -157.94 44.79 0.33 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.211 -0.931 . . . . 0.0 109.384 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -151.71 89.3 1.46 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.233 -0.917 . . . . 0.0 109.506 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.57 -29.82 39.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.435 -0.791 . . . . 0.0 109.739 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 9.7 tp -58.9 -40.81 85.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.199 -0.938 . . . . 0.0 109.668 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.782 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -52.92 -28.44 23.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 109.777 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -64.76 -42.2 95.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 0.0 109.942 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.24 -26.6 52.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.205 -0.935 . . . . 0.0 110.242 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.463 ' O ' ' C ' ' A' ' 80' ' ' VAL . 1.3 mp -80.86 -24.57 38.27 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.013 -1.054 . . . . 0.0 110.227 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 76' ' ' LYS . 14.3 t -40.74 160.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.25 -0.907 . . . . 0.0 109.596 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 87.28 -50.93 4.16 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -37.86 156.64 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.664 -0.903 . . . . 0.0 110.295 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.2 t -98.47 134.21 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.402 -0.811 . . . . 0.0 109.138 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.815 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -143.58 174.27 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.119 -0.988 . . . . 0.0 109.868 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 1.8 ttmt -104.66 124.98 50.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.446 -0.784 . . . . 0.0 109.087 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.72 HG22 ' CG ' ' A' ' 100' ' ' ARG . 24.5 p -127.95 175.44 8.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.509 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.873 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -98.55 152.85 19.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.9 . . . . 0.0 109.091 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 t -97.61 131.37 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.982 . . . . 0.0 109.473 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.543 HG22 ' HG2' ' A' ' 99' ' ' ARG . 94.6 t -92.83 -35.7 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.34 -0.85 . . . . 0.0 109.86 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 96' ' ' VAL . 9.9 ttt85 178.46 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.136 -0.978 . . . . 0.0 109.335 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.813 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -95.88 117.63 30.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.502 -0.749 . . . . 0.0 109.554 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -110.01 -21.6 12.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -0.935 . . . . 0.0 109.477 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.576 ' O ' ' CB ' ' A' ' 94' ' ' LEU . . . 123.33 115.31 2.21 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.576 ' CB ' ' O ' ' A' ' 93' ' ' GLY . 1.5 tp 84.39 -57.13 0.12 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.759 -0.848 . . . . 0.0 109.448 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -116.8 119.6 35.91 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 108.841 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.831 HG21 ' NE2' ' A' ' 57' ' ' HIS . 69.1 t -129.89 159.11 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.228 -0.92 . . . . 0.0 110.332 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.563 ' O ' HD22 ' A' ' 98' ' ' LEU . 9.6 m-20 -98.66 143.27 29.22 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.873 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -135.49 141.78 45.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.809 -1.182 . . . . 0.0 110.97 -178.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.543 ' HG2' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -133.72 112.27 11.25 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.642 -0.661 . . . . 0.0 109.399 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.72 ' CG ' HG22 ' A' ' 86' ' ' THR . 0.0 OUTLIER -84.18 139.96 32.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.207 -0.933 . . . . 0.0 109.102 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.32 160.55 14.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.204 -0.935 . . . . 0.0 109.599 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.515 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.263 0.554 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.534 HG22 HG13 ' A' ' 3' ' ' VAL . 34.6 m -132.22 -54.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.275 -0.891 . . . . 0.0 109.362 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.534 HG13 HG22 ' A' ' 2' ' ' THR . 3.2 m -132.12 40.69 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.374 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.442 ' O ' ' HG3' ' A' ' 5' ' ' LYS . 9.1 tp -76.25 -26.17 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 4' ' ' ILE . 2.2 mttm -172.65 67.15 0.38 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.0 109.562 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.409 ' HD3' ' N ' ' A' ' 5' ' ' LYS . 35.7 Cg_endo -78.34 -38.53 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.618 2.212 . . . . 0.0 110.412 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.51 124.45 25.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.56 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.3 p -118.16 147.13 43.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 109.4 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -154.93 85.95 3.51 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 109.543 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.451 ' O ' ' HD2' ' A' ' 11' ' ' ARG . 35.0 Cg_endo -78.38 121.71 5.33 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.544 2.163 . . . . 0.0 110.364 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.596 ' CB ' ' HD3' ' A' ' 12' ' ' PRO . 1.0 OUTLIER -179.02 -58.69 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 0.0 109.503 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 11' ' ' ARG . 35.6 Cg_endo -76.31 76.12 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 C-N-CA 122.19 1.927 . . . . 0.0 110.184 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -84.47 115.86 22.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.852 . . . . 0.0 109.589 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.91 153.96 3.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 109.458 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.52 98.84 8.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.941 . . . . 0.0 109.387 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.95 130.79 34.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.325 -0.859 . . . . 0.0 109.662 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -115.03 -31.38 6.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 109.274 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.3 mm -60.64 92.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.308 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -170.3 -36.54 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -0.934 . . . . 0.0 109.48 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.1 p -98.91 137.98 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.308 -0.87 . . . . 0.0 109.48 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -172.13 155.76 3.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.858 . . . . 0.0 109.305 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -169.4 51.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.262 -0.899 . . . . 0.0 109.491 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -123.59 75.58 1.34 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 109.67 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.519 ' O ' ' CD ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -163.05 58.47 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 109.401 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 15.4 t -49.93 167.69 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -0.917 . . . . 0.0 109.58 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.47 -164.93 1.19 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.91 . . . . 0.0 109.503 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.43 179.04 4.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.534 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.4 ttm -107.04 -21.17 13.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.425 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 29' ' ' ASP . 0.8 OUTLIER -138.68 121.14 16.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.283 -0.885 . . . . 0.0 109.401 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 91' ' ' ALA . 77.0 mt -51.7 157.31 1.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.862 . . . . 0.0 109.561 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.436 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 37.8 m -99.67 159.64 29.44 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.355 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 31' ' ' SER . 35.5 Cg_endo -77.59 131.54 11.51 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.605 2.203 . . . . 0.0 110.466 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.4 86.85 0.82 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.7 t -172.76 161.78 4.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -1.165 . . . . 0.0 109.598 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 35' ' ' VAL . 2.3 m -122.5 125.44 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 0.0 109.311 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -133.01 168.72 17.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.125 -0.984 . . . . 0.0 109.67 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.69 147.03 25.27 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.273 -0.892 . . . . 0.0 109.107 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.698 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -159.13 176.8 35.89 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.688 HD12 HG22 ' A' ' 83' ' ' VAL . 2.4 mm -96.8 154.42 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -1.158 . . . . 0.0 108.82 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.481 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 34.9 t -105.8 146.75 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 110.329 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -137.3 145.71 43.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 109.216 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.464 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 42.9 p90 -98.48 138.82 35.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.095 -1.003 . . . . 0.0 109.657 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -160.24 125.19 3.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.913 . . . . 0.0 109.639 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 43' ' ' LYS . 1.5 t70 44.04 31.16 0.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.374 -0.829 . . . . 0.0 109.734 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.28 -42.51 3.09 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 47' ' ' PHE . 3.7 mt -64.32 162.42 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -1.164 . . . . 0.0 109.176 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.509 ' CB ' HD23 ' A' ' 61' ' ' LEU . 60.0 m-85 -105.79 169.75 8.3 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.046 -1.034 . . . . 0.0 109.157 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.7 135.67 24.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.519 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.848 HG23 ' HB2' ' A' ' 61' ' ' LEU . 60.3 t -104.48 119.64 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.225 -0.922 . . . . 0.0 109.736 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -98.88 120.9 40.09 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.16 -0.962 . . . . 0.0 109.075 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.1 OUTLIER -86.06 84.88 7.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 109.668 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.49 138.95 54.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.391 -0.818 . . . . 0.0 109.506 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.48 -41.48 2.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -81.37 -30.26 33.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -1.161 . . . . 0.0 109.578 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 62.53 84.49 0.14 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.85 -20.15 6.44 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.477 ' HB2' ' HB3' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -71.51 94.47 1.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -1.134 . . . . 0.0 109.649 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -108.15 105.82 15.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 109.368 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.0 m -102.58 158.38 16.27 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.24 -0.913 . . . . 0.0 109.153 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.518 HG12 ' HA ' ' A' ' 97' ' ' ASP . 25.4 pt -103.81 129.18 56.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.259 -0.901 . . . . 0.0 109.055 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.848 ' HB2' HG23 ' A' ' 49' ' ' VAL . 50.2 tp -98.68 108.66 21.41 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.659 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 3.5 mm? -105.5 4.41 30.5 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.496 -0.752 . . . . 0.0 109.205 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 64' ' ' TYR . 0.5 OUTLIER 56.28 34.18 23.58 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -179.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.496 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 57.2 t80 62.64 36.58 13.5 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.511 ' O ' ' CB ' ' A' ' 66' ' ' ASN . 0.2 OUTLIER -66.7 -52.72 41.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.744 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 65' ' ' LEU . 9.1 t30 75.07 78.27 0.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.14 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.0 t80 64.0 177.86 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.132 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.0 -164.49 0.25 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.141 -0.974 . . . . 0.0 109.127 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -177.59 114.37 0.08 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.054 -1.029 . . . . 0.0 109.713 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.4 ' O ' HG23 ' A' ' 71' ' ' THR . 1.6 m-20 -91.73 179.04 5.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.204 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.4 HG23 ' O ' ' A' ' 70' ' ' ASP . 0.4 OUTLIER -156.19 61.33 0.57 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.628 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.428 ' CG ' ' O ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -127.01 61.35 1.35 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.162 -0.961 . . . . 0.0 109.332 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.426 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 3.1 p-10 -143.97 75.58 1.47 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.306 -0.871 . . . . 0.0 109.37 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -77.26 -56.13 4.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -0.914 . . . . 0.0 109.804 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.3 -42.24 90.89 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.262 -0.899 . . . . 0.0 109.836 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.764 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -53.47 -26.19 19.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.229 -0.919 . . . . 0.0 109.83 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -58.35 -42.97 88.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.127 -0.983 . . . . 0.0 109.93 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.415 ' HA ' ' HD3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -77.73 -30.58 51.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.09 -1.006 . . . . 0.0 110.103 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 80' ' ' VAL . 1.4 mp -78.7 -16.04 57.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.137 -0.977 . . . . 0.0 110.075 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 76' ' ' LYS . 54.5 t -42.98 165.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.254 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.566 ' N ' HG12 ' A' ' 80' ' ' VAL . . . 87.4 -48.63 3.8 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.443 ' C ' ' O ' ' A' ' 81' ' ' GLY . 5.9 mtp180 -38.96 156.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.702 -0.881 . . . . 0.0 110.016 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.698 HG13 ' O ' ' A' ' 38' ' ' GLY . 4.1 t -98.4 145.33 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.374 -0.829 . . . . 0.0 109.162 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.816 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -148.99 164.5 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.0 109.622 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.18 104.16 16.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.408 -0.808 . . . . 0.0 109.209 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.681 HG23 HG12 ' A' ' 84' ' ' ILE . 22.3 p -112.91 175.59 5.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.0 109.461 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.793 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -99.94 154.28 18.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.089 -1.007 . . . . 0.0 109.464 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.663 ' HA ' HD22 ' A' ' 98' ' ' LEU . 63.7 t -97.58 110.49 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 0.0 108.863 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.604 HG22 ' HB3' ' A' ' 99' ' ' ARG . 2.2 t -64.33 -35.34 73.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.314 -0.866 . . . . 0.0 110.082 -179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.03 101.87 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.938 . . . . 0.0 109.559 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.787 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -95.87 124.65 39.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.345 -0.847 . . . . 0.0 109.279 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.46 -43.69 2.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.629 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.17 -138.76 2.51 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.29 -24.7 4.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -1.129 . . . . 0.0 109.753 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -112.34 125.55 54.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.787 HG22 ' HA ' ' A' ' 91' ' ' ALA . 49.7 t -133.27 166.62 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.276 -0.89 . . . . 0.0 109.491 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.603 ' N ' HG12 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -110.37 146.96 34.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 108.732 179.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.793 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -134.15 128.09 33.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.998 -1.064 . . . . 0.0 110.881 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.604 ' HB3' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -122.37 133.18 54.65 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -91.12 150.25 21.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -0.949 . . . . 0.0 109.579 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.526 ' HB3' ' NH2' ' A' ' 87' ' ' ARG . 43.3 t80 -129.29 156.37 44.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.493 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.414 ' N ' ' CD1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.502 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 tpt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.37 66.74 0.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.128 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.885 HG22 HG22 ' A' ' 4' ' ' ILE . 8.4 p -74.98 115.56 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.871 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.885 HG22 HG22 ' A' ' 3' ' ' VAL . 2.7 tt 40.0 74.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.54 -0.725 . . . . 0.0 110.142 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.1 70.68 5.69 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.187 -0.946 . . . . 0.0 109.461 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.09 73.27 5.83 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.62 2.213 . . . . 0.0 110.471 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.18 -45.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.259 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.5 m 51.29 86.61 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.289 -0.882 . . . . 0.0 109.738 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -55.72 155.29 11.28 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 109.27 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.62 168.96 21.72 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.598 2.199 . . . . 0.0 110.274 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -135.31 77.24 54.71 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.572 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.69 102.68 1.62 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.627 2.218 . . . . 0.0 110.266 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -69.22 112.99 6.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.689 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.76 69.85 0.76 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.248 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -139.51 165.67 26.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.249 -0.907 . . . . 0.0 109.571 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.32 -89.85 0.38 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.277 -0.889 . . . . 0.0 109.425 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.7 m120 54.26 46.08 25.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.259 -0.9 . . . . 0.0 109.409 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -79.56 101.83 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -0.855 . . . . 0.0 109.579 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.42 99.73 6.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.278 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 20' ' ' VAL . 5.3 m -93.22 119.19 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 109.587 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -166.75 87.04 0.3 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.531 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 p -124.41 139.66 53.69 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.485 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.409 ' O ' ' C ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -91.36 62.22 4.61 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.214 -0.929 . . . . 0.0 109.411 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER 44.67 88.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.266 -0.896 . . . . 0.0 109.408 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.49 132.27 55.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 0.0 109.511 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.551 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -148.92 137.91 21.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.266 -0.896 . . . . 0.0 109.363 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 26' ' ' SER . . . 67.13 129.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.302 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.6 ttt -91.8 98.45 11.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.175 -0.953 . . . . 0.0 109.7 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -164.25 -72.01 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.455 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.91 72.56 0.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.391 -0.818 . . . . 0.0 109.334 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.22 146.36 55.94 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 109.479 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.84 132.33 10.65 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.575 2.183 . . . . 0.0 110.398 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.25 29.48 5.7 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.413 ' HB3' ' NE2' ' A' ' 36' ' ' HIS . 0.5 OUTLIER -114.14 156.41 24.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.293 -1.121 . . . . 0.0 109.366 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 35' ' ' VAL . 4.0 m -115.56 127.49 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.309 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.413 ' NE2' ' HB3' ' A' ' 34' ' ' SER . 47.4 m-70 -143.36 168.01 20.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.789 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' A' ' 83' ' ' VAL . 0.4 OUTLIER -101.34 141.58 34.01 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.255 -0.903 . . . . 0.0 109.368 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.673 ' O ' HG23 ' A' ' 83' ' ' VAL . . . -150.29 176.88 28.71 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.505 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 15.7 mt -96.42 153.87 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.243 . . . . 0.0 108.444 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.671 HG23 ' O ' ' A' ' 82' ' ' ARG . 38.8 t -98.99 151.8 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.148 -0.97 . . . . 0.0 110.431 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.95 150.4 35.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.469 -0.769 . . . . 0.0 109.129 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.429 ' O ' ' CG ' ' A' ' 43' ' ' LYS . 20.5 t80 -108.88 125.81 52.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.552 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.436 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER 174.72 148.93 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.212 -0.93 . . . . 0.0 109.833 179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.531 ' HB3' ' CG1' ' A' ' 46' ' ' ILE . 0.5 OUTLIER 71.94 42.07 0.63 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.365 -0.835 . . . . 0.0 109.503 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 44.6 25.73 0.91 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 47' ' ' PHE . 1.0 OUTLIER -151.37 -169.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.376 -1.073 . . . . 0.0 109.001 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.667 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.8 m-85 -102.97 174.93 5.65 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.083 -1.011 . . . . 0.0 108.975 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 59' ' ' CYS . 1.6 tttp -148.31 148.9 30.94 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.198 -0.939 . . . . 0.0 109.624 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.519 HG21 ' HG ' ' A' ' 98' ' ' LEU . 2.4 t -126.02 116.72 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.309 -0.869 . . . . 0.0 109.199 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.37 131.75 44.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 109.375 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.3 OUTLIER -88.57 95.6 10.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.192 -0.942 . . . . 0.0 109.765 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.62 138.72 55.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.35 -30.02 9.38 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.425 ' O ' ' C ' ' A' ' 55' ' ' GLU . 2.1 m-85 -117.16 66.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.398 -1.06 . . . . 0.0 109.073 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 54' ' ' TYR . 0.2 OUTLIER -41.38 107.3 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.396 -0.815 . . . . 0.0 109.665 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.02 32.54 0.79 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -140.94 92.91 2.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.321 -1.105 . . . . 0.0 109.782 -179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.57 123.1 48.86 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.433 -0.792 . . . . 0.0 108.988 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.449 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.2 m -116.08 167.72 10.73 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 109.567 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.426 ' O ' ' HB2' ' A' ' 98' ' ' LEU . 5.9 pt -122.37 130.66 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.364 -0.835 . . . . 0.0 109.087 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 100' ' ' ARG . 12.3 tp -97.91 116.67 30.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.149 -0.969 . . . . 0.0 109.251 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 65' ' ' LEU . 0.5 OUTLIER -127.39 12.43 7.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 109.768 -179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 56.06 39.46 30.43 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 18.5 t80 64.37 30.89 13.08 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.481 -0.762 . . . . 0.0 109.108 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.513 HD22 ' HB2' ' A' ' 68' ' ' ARG . 4.7 mt -77.3 -79.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.898 . . . . 0.0 109.487 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 m120 55.76 38.51 30.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.38 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.36 -47.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 109.357 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.513 ' HB2' HD22 ' A' ' 65' ' ' LEU . 5.8 mmp_? -114.46 167.35 10.8 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.25 -0.906 . . . . 0.0 109.324 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -106.09 173.21 6.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.487 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -101.99 161.78 13.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.166 -0.958 . . . . 0.0 109.593 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.442 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 3.8 t -161.85 166.32 26.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.374 -0.828 . . . . 0.0 109.359 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.442 ' CB ' ' O ' ' A' ' 71' ' ' THR . 0.1 OUTLIER 71.37 43.74 0.59 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.27 -0.894 . . . . 0.0 109.459 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.43 ' OD2' ' HB2' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -111.29 48.91 0.91 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.361 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 -56.24 22.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.398 -0.814 . . . . 0.0 109.629 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.7 mt -75.64 -38.33 58.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.925 . . . . 0.0 109.615 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.65 ' O ' HG23 ' A' ' 80' ' ' VAL . 18.9 mmtt -57.03 -26.61 60.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.663 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.37 -37.68 78.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.196 -0.94 . . . . 0.0 109.218 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -77.43 -30.34 53.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.338 -0.851 . . . . 0.0 110.012 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.472 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -72.35 -29.98 64.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.966 . . . . 0.0 109.803 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 76' ' ' LYS . 21.4 t -40.91 163.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.546 -0.721 . . . . 0.0 109.693 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.505 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 87.73 -48.73 3.75 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.671 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -40.8 152.86 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.481 -1.011 . . . . 0.0 110.023 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 38' ' ' GLY . 7.4 p -99.05 137.29 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.344 -0.847 . . . . 0.0 109.109 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.841 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -145.23 170.98 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 110.013 -179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.7 120.65 40.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 0.0 109.047 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.531 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -128.0 176.07 7.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.305 -0.872 . . . . 0.0 109.582 -179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.75 ' O ' HD13 ' A' ' 98' ' ' LEU . 9.0 mpt_? -97.91 155.0 17.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.922 . . . . 0.0 109.409 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.0 t -97.41 121.23 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.272 -0.892 . . . . 0.0 109.661 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.55 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 40.9 t -77.0 -39.49 29.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.494 -0.754 . . . . 0.0 109.494 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.416 ' O ' HG13 ' A' ' 96' ' ' VAL . 3.5 mtp180 178.63 103.6 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.119 -0.988 . . . . 0.0 109.618 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.825 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -101.87 129.76 48.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.533 -0.729 . . . . 0.0 109.175 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -131.28 -39.83 1.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.064 -1.023 . . . . 0.0 109.511 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -151.97 -127.45 1.32 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.39 -17.74 57.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -1.139 . . . . 0.0 109.808 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -110.24 121.59 45.65 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.117 -0.989 . . . . 0.0 109.282 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.825 HG22 ' HA ' ' A' ' 91' ' ' ALA . 96.0 t -132.86 156.44 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -0.884 . . . . 0.0 109.745 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.55 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 1.7 m-20 -98.35 150.03 22.02 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.75 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -134.31 134.81 42.27 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.859 -1.151 . . . . 0.0 111.085 -178.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.446 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -121.72 124.55 44.5 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.749 ' HB2' HD11 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -92.58 130.18 38.3 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.557 -179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -55.9 123.08 13.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.89 . . . . 0.0 109.432 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.353 179.987 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.9 p 45.94 56.7 5.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.205 -0.934 . . . . 0.0 109.399 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.64 174.46 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.592 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 5' ' ' LYS . 19.9 mm -91.13 161.42 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.404 -0.81 . . . . 0.0 109.45 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.527 ' CG ' ' HD2' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -149.73 173.29 4.38 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.527 ' HD2' ' CG ' ' A' ' 5' ' ' LYS . 35.3 Cg_endo -77.56 169.48 20.9 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.592 2.194 . . . . 0.0 110.428 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -129.1 -94.58 0.42 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.328 -0.857 . . . . 0.0 109.537 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 p -100.27 52.48 0.89 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.047 -1.033 . . . . 0.0 109.377 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.571 ' N ' ' HD2' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -67.31 -52.52 28.59 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.381 -0.825 . . . . 0.0 109.863 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 35.5 Cg_endo -77.89 127.46 8.63 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.507 2.138 . . . . 0.0 110.573 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.458 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 6.8 ptm180 -172.23 65.57 0.38 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.462 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.458 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 35.5 Cg_endo -78.28 96.04 1.08 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.642 2.228 . . . . 0.0 110.153 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.481 ' HA ' ' O ' ' A' ' 17' ' ' ASN . 5.1 ttm-85 51.57 91.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.187 -0.946 . . . . 0.0 109.275 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.93 -46.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.27 -0.894 . . . . 0.0 109.442 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -87.01 56.22 3.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.253 -0.904 . . . . 0.0 109.403 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.04 62.93 0.47 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 0.0 109.622 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -165.1 81.58 0.35 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 0.0 109.542 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.1 mt -102.66 -38.39 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.912 . . . . 0.0 109.371 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -81.66 103.68 11.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.435 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.5 m -112.05 68.68 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -49.25 -49.06 45.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.923 . . . . 0.0 109.549 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.79 77.98 8.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.4 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -83.82 119.53 24.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 0.0 109.299 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -81.93 124.2 29.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.347 -0.845 . . . . 0.0 109.574 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 26' ' ' SER . 5.3 t -110.7 54.09 0.68 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 25' ' ' THR . 0.4 OUTLIER -51.31 -177.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.458 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 52.64 57.72 6.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.392 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -62.28 157.19 20.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.921 . . . . 0.0 109.693 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.5 t70 61.45 159.21 0.05 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.296 -0.878 . . . . 0.0 109.66 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.417 HD13 ' HA ' ' A' ' 30' ' ' LEU . 0.6 OUTLIER -113.62 176.41 5.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.352 -0.843 . . . . 0.0 109.496 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.496 ' HB3' ' HD2' ' A' ' 32' ' ' PRO . 0.7 OUTLIER -142.15 165.55 26.81 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.484 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 31' ' ' SER . 35.2 Cg_endo -77.38 148.36 26.57 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.634 2.223 . . . . 0.0 110.438 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.83 63.52 2.55 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.6 t -149.78 138.93 21.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.244 -1.15 . . . . 0.0 109.592 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.477 HG12 ' NE ' ' A' ' 87' ' ' ARG . 16.5 m -102.25 155.65 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.421 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.464 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -165.07 162.29 20.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.947 . . . . 0.0 109.5 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.79 137.85 36.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 109.353 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.07 176.11 29.72 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 mt -97.39 154.66 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.317 -1.108 . . . . 0.0 108.812 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.477 ' CG2' HD12 ' A' ' 84' ' ' ILE . 17.6 t -104.96 159.94 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.118 -0.989 . . . . 0.0 110.12 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.495 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 0.3 OUTLIER -146.61 170.33 17.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.342 -0.849 . . . . 0.0 109.208 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -133.65 109.8 9.43 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.954 . . . . 0.0 109.378 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -176.46 164.18 2.54 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.931 . . . . 0.0 109.452 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 2.6 m-20 72.05 3.77 4.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.323 -0.861 . . . . 0.0 109.714 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.2 -18.09 50.3 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.6 pt -115.35 -151.17 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -1.171 . . . . 0.0 109.223 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.495 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 44.4 m-85 -112.69 160.19 18.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.951 -1.093 . . . . 0.0 109.08 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 0.6 OUTLIER -127.16 151.42 48.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 0.0 109.762 -179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 61' ' ' LEU . 63.5 t -129.42 115.14 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.409 -0.807 . . . . 0.0 109.076 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -100.36 127.55 46.65 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.172 -0.955 . . . . 0.0 109.571 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 3.1 mp -95.17 76.33 3.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 109.485 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.0 162.75 3.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.75 -43.15 3.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.457 ' O ' ' O ' ' A' ' 55' ' ' GLU . 68.4 m-85 -85.29 -30.56 23.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.321 -1.105 . . . . 0.0 109.686 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' TYR . 3.5 mt-10 61.04 146.72 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.201 -0.937 . . . . 0.0 109.192 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 94' ' ' LEU . . . 63.52 12.51 46.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -116.64 82.95 1.88 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.251 -1.146 . . . . 0.0 109.264 179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -100.29 105.92 17.51 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.309 -0.87 . . . . 0.0 109.52 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.434 ' SG ' HD13 ' A' ' 51' ' ' LEU . 4.4 m -100.19 172.67 7.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.925 . . . . 0.0 109.267 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 pp -138.84 140.83 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.33 -0.856 . . . . 0.0 109.241 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.759 HD21 ' CB ' ' A' ' 64' ' ' TYR . 34.9 tp -98.14 116.82 31.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.962 . . . . 0.0 109.339 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.1 tp -128.51 -32.37 2.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.491 -0.755 . . . . 0.0 109.724 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.553 ' CB ' ' CB ' ' A' ' 99' ' ' ARG . 3.0 t70 -69.71 -47.37 63.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.621 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.759 ' CB ' HD21 ' A' ' 61' ' ' LEU . 26.5 t80 -43.25 -29.98 0.45 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.188 -0.945 . . . . 0.0 109.697 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.18 -70.15 0.15 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.153 -0.967 . . . . 0.0 109.437 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.0 t30 50.64 -159.33 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.494 ' C ' ' CD1' ' A' ' 67' ' ' TYR . 19.4 p90 -103.83 153.16 21.05 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.288 -0.882 . . . . 0.0 109.422 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -176.11 170.47 2.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -60.76 170.58 1.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.14 70.72 7.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.47 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 72' ' ' LEU . 0.5 OUTLIER -59.39 137.74 57.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 109.597 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.451 ' O ' ' CB ' ' A' ' 73' ' ' ASP . 0.5 OUTLIER -45.23 -31.63 1.6 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.404 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 72' ' ' LEU . 2.6 t70 71.88 4.49 5.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.265 -0.897 . . . . 0.0 109.48 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -54.53 35.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 109.388 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.04 -26.81 60.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.91 ' O ' HG23 ' A' ' 80' ' ' VAL . 28.2 tptp -67.28 -31.12 71.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.86 . . . . 0.0 109.639 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.93 -34.5 78.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.091 -1.006 . . . . 0.0 109.489 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.484 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -77.22 -37.67 52.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.339 -0.85 . . . . 0.0 109.565 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 80' ' ' VAL . 30.1 tp -65.97 -35.79 81.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.257 -0.902 . . . . 0.0 109.692 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 76' ' ' LYS . 28.1 t -43.05 163.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.314 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.514 ' N ' HG12 ' A' ' 80' ' ' VAL . . . 85.19 -47.54 3.87 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.457 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -40.2 162.61 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.467 -1.019 . . . . 0.0 110.048 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.1 m -98.84 144.35 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.047 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.769 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -149.17 173.69 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.155 -0.966 . . . . 0.0 109.629 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -104.14 106.64 17.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.148 -0.97 . . . . 0.0 109.332 179.779 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.483 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 8.5 p -112.0 175.75 5.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 0.0 109.55 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.802 ' O ' HD13 ' A' ' 98' ' ' LEU . 10.4 mpt_? -98.73 159.58 14.85 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.811 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.6 t -96.96 117.54 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.468 -0.77 . . . . 0.0 109.205 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.708 HG22 ' HG2' ' A' ' 99' ' ' ARG . 72.6 t -77.84 -40.33 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.519 -0.738 . . . . 0.0 110.092 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 175.99 104.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.163 -0.961 . . . . 0.0 109.585 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.808 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -96.86 135.4 38.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -129.66 -36.98 1.59 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.115 -0.99 . . . . 0.0 109.767 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -163.04 -134.71 1.69 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 0.2 OUTLIER -63.48 -17.3 62.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -1.141 . . . . 0.0 109.538 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -114.56 130.64 56.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.285 -0.884 . . . . 0.0 109.506 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.808 HG22 ' HA ' ' A' ' 91' ' ' ALA . 53.9 t -137.2 157.19 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.516 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 49.8 m-20 -98.32 147.21 24.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.232 -0.917 . . . . 0.0 108.661 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -134.91 136.89 42.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.048 -1.032 . . . . 0.0 110.263 -178.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.708 ' HG2' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -136.53 124.56 22.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.589 -0.695 . . . . 0.0 109.232 179.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.23 127.15 31.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.341 -0.85 . . . . 0.0 109.386 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.558 ' CB ' ' NE ' ' A' ' 87' ' ' ARG . 18.4 t80 -86.84 171.65 10.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.575 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.404 ' CD2' ' OXT' ' A' ' 102' ' ' PHE . 79.8 t80 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.4 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.247 0.546 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 2' ' ' THR . 9.3 t -138.27 47.86 1.98 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.937 . . . . 0.0 109.637 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 75.8 t -54.06 -42.99 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 109.205 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 4' ' ' ILE . 10.1 tp -123.36 156.05 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.387 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.97 169.0 10.64 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.152 -0.968 . . . . 0.0 109.577 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.23 117.57 4.13 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.627 2.218 . . . . 0.0 110.335 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.19 173.9 10.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.209 -0.932 . . . . 0.0 109.546 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.0 m -144.78 121.34 11.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 109.432 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -147.23 84.95 7.05 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.414 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.13 -168.36 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.593 2.195 . . . . 0.0 110.385 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -70.52 148.86 95.47 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.943 . . . . 0.0 109.534 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.41 95.91 1.08 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.607 2.205 . . . . 0.0 110.463 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.85 101.89 6.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.91 . . . . 0.0 109.439 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.43 -80.7 0.16 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.153 -0.967 . . . . 0.0 109.345 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -168.03 104.79 0.48 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.159 -0.963 . . . . 0.0 109.527 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.19 -73.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.312 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 45.82 65.17 1.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.619 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 pt -101.11 -17.86 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.205 -0.934 . . . . 0.0 109.158 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.4 -7.8 7.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.317 -0.864 . . . . 0.0 109.403 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.9 t -91.79 63.67 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.329 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -126.44 92.71 3.62 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.216 -0.927 . . . . 0.0 109.481 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 22' ' ' THR . 9.8 t -121.51 49.12 1.57 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.486 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -83.16 131.64 35.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.354 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.45 -33.94 6.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 0.0 109.654 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.5 m -113.83 121.98 45.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.24 -0.912 . . . . 0.0 109.531 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 t -124.74 69.21 1.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.495 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.65 67.85 1.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 109.459 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.439 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 17.3 mtp -110.64 74.51 0.88 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 28' ' ' MET . 64.2 m-20 63.15 -178.79 0.15 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.344 -0.848 . . . . 0.0 109.342 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.516 HD22 ' CB ' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -90.5 130.31 36.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 109.571 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 p -127.39 160.25 61.17 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.249 -0.907 . . . . 0.0 109.4 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.48 134.29 12.38 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.641 2.228 . . . . 0.0 110.272 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.47 71.06 1.0 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 p -170.56 158.6 6.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -1.122 . . . . 0.0 109.58 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.41 HG12 ' NE ' ' A' ' 87' ' ' ARG . 17.8 m -107.29 149.4 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 0.0 109.254 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -152.09 166.35 31.91 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.173 -0.955 . . . . 0.0 109.823 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -99.69 151.25 21.43 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 109.14 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.38 176.63 43.32 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.729 HG23 ' O ' ' A' ' 81' ' ' GLY . 8.2 mt -97.04 149.92 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -1.184 . . . . 0.0 108.389 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 41' ' ' TYR . 24.4 t -98.14 166.38 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.074 -1.016 . . . . 0.0 110.482 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.568 ' N ' HG12 ' A' ' 40' ' ' VAL . 9.1 t80 -150.75 139.94 21.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.054 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.416 ' HB2' HG21 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -99.04 107.66 20.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.077 -1.015 . . . . 0.0 109.661 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -94.27 171.22 8.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.904 . . . . 0.0 109.278 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -89.22 8.14 31.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.206 -0.933 . . . . 0.0 109.397 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.508 ' O ' ' CG2' ' A' ' 46' ' ' ILE . . . -135.57 -34.66 0.24 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.508 ' CG2' ' O ' ' A' ' 45' ' ' GLY . 20.4 pt -158.38 -159.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -1.202 . . . . 0.0 109.134 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.486 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 12.8 m-85 -105.9 157.61 17.36 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.103 -0.998 . . . . 0.0 109.415 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.512 ' CB ' ' HB3' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -130.19 151.18 50.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.356 -0.84 . . . . 0.0 109.435 -179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.5 t -134.21 120.67 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 109.45 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -99.81 127.16 45.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.219 -0.925 . . . . 0.0 109.327 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.447 ' CB ' ' HB3' ' A' ' 57' ' ' HIS . 0.1 OUTLIER -92.8 75.48 4.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.0 109.598 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.28 124.36 19.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 109.425 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 132.6 -41.13 1.53 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.507 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 61.7 t80 -83.8 -19.48 34.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -1.113 . . . . 0.0 109.507 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 9.1 tp10 62.85 88.68 0.09 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.347 -0.845 . . . . 0.0 109.792 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.8 25.28 5.74 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 54' ' ' TYR . 2.3 t-160 -108.9 92.36 4.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.075 -1.25 . . . . 0.0 109.75 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.08 115.1 29.82 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.41 -0.806 . . . . 0.0 109.278 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -116.13 163.26 16.21 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.225 -0.922 . . . . 0.0 109.545 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.474 ' O ' HG13 ' A' ' 60' ' ' ILE . 24.1 pt -129.52 125.59 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.404 -0.81 . . . . 0.0 109.23 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.538 HD13 HG21 ' A' ' 86' ' ' THR . 6.8 tp -98.2 121.72 40.47 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.007 -1.058 . . . . 0.0 109.592 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.2 -35.31 0.28 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.659 -0.651 . . . . 0.0 109.286 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 64' ' ' TYR . 0.9 OUTLIER -53.83 -30.84 47.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.126 -0.984 . . . . 0.0 108.966 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.448 ' C ' ' O ' ' A' ' 63' ' ' ASP . 7.4 t80 -41.93 -51.07 4.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.466 -0.772 . . . . 0.0 109.234 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.424 ' O ' ' C ' ' A' ' 66' ' ' ASN . 0.3 OUTLIER -54.51 -73.0 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.181 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER 43.05 43.23 3.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 0.0 109.538 179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.84 68.46 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.31 -0.868 . . . . 0.0 109.471 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.58 107.42 0.33 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.315 -0.865 . . . . 0.0 109.502 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.61 -81.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.136 -0.978 . . . . 0.0 109.476 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 71' ' ' THR . 0.7 OUTLIER -153.38 168.25 26.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -0.91 . . . . 0.0 109.598 -179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 70' ' ' ASP . 3.8 t 175.26 136.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.374 -0.829 . . . . 0.0 109.332 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.9 mt -100.82 -4.59 27.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 109.751 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 46.49 48.9 13.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.233 -0.917 . . . . 0.0 109.348 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.92 -31.61 71.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.945 . . . . 0.0 109.618 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.32 -45.87 68.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.541 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -28.99 69.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 0.0 109.402 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -68.29 -32.36 72.46 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.878 . . . . 0.0 109.377 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.434 ' O ' ' HG ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -48.05 -56.38 7.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.202 -0.936 . . . . 0.0 109.318 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -169.61 60.16 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.936 . . . . 0.0 109.637 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.569 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 0.9 OUTLIER -44.11 166.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.083 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.729 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 84.84 -43.38 3.23 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.518 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -45.31 178.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.652 -0.911 . . . . 0.0 110.503 -179.502 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 84' ' ' ILE . 20.7 m -96.13 146.33 7.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.124 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.537 HG12 ' CG2' ' A' ' 40' ' ' VAL . 2.5 pp -156.69 175.29 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.445 -0.784 . . . . 0.0 109.402 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 10.0 pttm -101.73 143.47 31.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.317 -0.864 . . . . 0.0 109.204 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.636 ' HB ' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -146.48 175.14 10.79 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.197 -0.94 . . . . 0.0 109.552 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.79 ' O ' HD13 ' A' ' 98' ' ' LEU . 3.9 mmm-85 -101.56 153.66 19.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 54.9 t -97.71 123.04 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 109.078 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.615 HG23 ' N ' ' A' ' 99' ' ' ARG . 54.4 t -82.89 -38.43 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.365 -0.834 . . . . 0.0 109.923 -179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 172.78 105.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.993 . . . . 0.0 109.547 -179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.829 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -91.35 127.39 36.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.0 109.34 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -116.03 -50.45 2.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.582 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -154.91 -124.97 0.93 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -30.77 70.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -1.152 . . . . 0.0 109.425 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -104.6 134.13 48.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 109.235 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.829 HG22 ' HA ' ' A' ' 91' ' ' ALA . 50.5 t -135.57 163.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.198 -0.939 . . . . 0.0 110.068 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.547 ' N ' HG12 ' A' ' 96' ' ' VAL . 97.7 m-20 -98.73 150.9 21.34 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.355 -0.841 . . . . 0.0 108.753 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -137.39 135.14 36.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.965 -1.085 . . . . 0.0 110.799 -179.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.615 ' N ' HG23 ' A' ' 89' ' ' VAL . 30.9 ttp180 -128.21 124.95 37.98 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.482 ' N ' HD11 ' A' ' 61' ' ' LEU . 3.4 ttt85 -101.82 158.24 16.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.05 -1.031 . . . . 0.0 109.985 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.41 ' CB ' ' O ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER 170.18 130.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.403 -0.811 . . . . 0.0 109.444 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.8 t80 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.075 -0.964 . . . . 0.0 109.549 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmm . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 52.0 m -159.73 99.24 1.4 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.215 -0.928 . . . . 0.0 109.578 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.8 t -138.33 143.68 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 109.61 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.727 HD12 ' HG3' ' A' ' 6' ' ' PRO . 6.5 pt -67.64 163.06 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.321 -0.862 . . . . 0.0 109.432 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.518 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 28.5 mtpt -144.84 61.23 8.06 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.128 -0.983 . . . . 0.0 109.626 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.727 ' HG3' HD12 ' A' ' 4' ' ' ILE . 36.0 Cg_endo -77.68 78.94 3.35 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.58 2.187 . . . . 0.0 110.261 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 8' ' ' SER . 2.4 m 61.59 -169.86 0.17 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.189 -0.944 . . . . 0.0 109.518 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.453 ' HB3' ' O ' ' A' ' 7' ' ' SER . 2.9 t 61.81 120.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.319 -0.863 . . . . 0.0 109.726 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 51.01 71.23 1.6 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.358 -0.839 . . . . 0.0 109.665 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 11' ' ' ARG . 35.0 Cg_endo -77.85 -55.6 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.634 2.223 . . . . 0.0 110.48 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 10' ' ' PRO . 1.0 OUTLIER 68.43 92.23 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.98 -168.3 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.656 2.237 . . . . 0.0 110.45 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.514 ' O ' ' CB ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -121.78 92.07 3.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER 76.41 78.93 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.0 109.461 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -112.31 130.72 55.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.21 -0.931 . . . . 0.0 109.454 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.13 46.35 0.24 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.468 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -126.95 98.94 5.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.0 109.578 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.5 pt -127.36 77.41 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.255 -0.903 . . . . 0.0 109.512 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.28 27.73 1.73 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 109.531 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 p -150.75 122.15 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.945 . . . . 0.0 109.535 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.9 m120 56.87 69.97 0.7 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.932 . . . . 0.0 109.658 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.8 m -117.32 -65.03 1.23 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.294 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.3 t80 57.47 65.94 1.25 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.213 -0.929 . . . . 0.0 109.57 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 60.51 -172.31 0.13 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.521 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 12.0 p -146.99 31.43 0.94 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.428 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 27' ' ' ALA . 9.7 p -117.35 50.71 1.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.326 -0.859 . . . . 0.0 109.487 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 26' ' ' SER . . . 177.25 96.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.158 -0.964 . . . . 0.0 109.411 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -109.39 -17.72 13.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -0.923 . . . . 0.0 109.628 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.64 -179.36 5.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.225 -0.922 . . . . 0.0 109.749 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 1.025 HD12 ' HB2' ' A' ' 91' ' ' ALA . 4.6 mt -99.31 126.25 45.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.584 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.05 140.65 51.67 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 0.0 109.248 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.94 92.15 1.15 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.521 2.147 . . . . 0.0 110.471 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.49 22.87 2.46 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.2 t -109.67 166.4 10.93 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.234 -1.156 . . . . 0.0 109.456 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 t -104.53 157.81 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.207 -0.933 . . . . 0.0 109.518 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.79 160.12 30.84 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.789 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.64 124.79 50.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.352 -0.843 . . . . 0.0 109.087 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.457 ' O ' ' CG1' ' A' ' 83' ' ' VAL . . . -138.93 176.36 20.96 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 40' ' ' VAL . 13.0 mt -96.85 167.04 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.143 -1.21 . . . . 0.0 108.731 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.518 ' N ' HG22 ' A' ' 39' ' ' ILE . 60.4 t -108.66 158.61 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.043 -1.036 . . . . 0.0 110.733 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.49 ' N ' HG12 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -153.65 152.0 30.33 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.472 ' O ' ' CB ' ' A' ' 43' ' ' LYS . 4.3 p90 -103.61 125.34 50.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.02 -1.05 . . . . 0.0 109.769 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' A' ' 42' ' ' PHE . 0.5 OUTLIER 166.38 167.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.471 ' O ' HG12 ' A' ' 46' ' ' ILE . 31.9 t70 69.01 30.23 4.54 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.31 -0.869 . . . . 0.0 109.627 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.479 ' C ' HG23 ' A' ' 46' ' ' ILE . . . 51.51 21.1 6.1 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 1.012 HD12 ' O ' ' A' ' 61' ' ' LEU . 4.1 pt -156.32 -140.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.386 -1.067 . . . . 0.0 108.628 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.407 ' HB2' HD23 ' A' ' 61' ' ' LEU . 1.2 m-85 -116.28 166.98 11.43 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.854 -1.154 . . . . 0.0 109.424 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -141.26 143.06 33.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.196 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 59' ' ' CYS . 88.2 t -116.37 136.96 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 109.45 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.4 mtt-85 -108.4 123.4 48.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.206 -0.934 . . . . 0.0 109.219 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.523 HD13 ' SG ' ' A' ' 59' ' ' CYS . 0.0 OUTLIER -94.6 68.43 3.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.159 -0.963 . . . . 0.0 109.498 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.2 tt -50.87 142.25 11.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.431 -0.793 . . . . 0.0 109.436 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.56 -53.33 0.6 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.426 ' O ' ' O ' ' A' ' 55' ' ' GLU . 1.1 m-85 -68.35 -21.55 64.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.489 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' A' ' 54' ' ' TYR . 4.4 mt-10 61.49 119.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 74.1 29.43 62.58 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -116.12 89.97 3.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.155 -1.203 . . . . 0.0 109.328 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.9 112.43 25.4 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.432 -0.792 . . . . 0.0 109.76 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.523 ' SG ' HD13 ' A' ' 51' ' ' LEU . 25.7 m -102.56 164.75 11.48 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.302 -0.874 . . . . 0.0 109.045 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.26 131.81 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.128 -0.983 . . . . 0.0 109.367 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.012 ' O ' HD12 ' A' ' 46' ' ' ILE . 2.2 tp -98.04 118.3 34.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 109.355 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.554 HD12 HD13 ' A' ' 46' ' ' ILE . 6.3 tt -139.27 -40.11 0.47 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.413 -0.804 . . . . 0.0 109.66 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.544 ' HB3' ' CD ' ' A' ' 99' ' ' ARG . 0.5 OUTLIER -60.63 -31.75 70.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -0.907 . . . . 0.0 109.548 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.586 ' HD2' HD21 ' A' ' 61' ' ' LEU . 2.8 t80 -50.13 -30.24 10.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.513 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.8 tp -73.43 -62.64 1.41 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 0.0 109.502 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.0 t30 57.64 -152.86 0.39 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.532 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -112.68 -39.87 4.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 0.0 109.348 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -48.43 -60.51 2.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.281 -0.887 . . . . 0.0 109.332 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 4.0 mm100 -48.93 156.87 0.46 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.195 -0.941 . . . . 0.0 109.353 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.94 85.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.28 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -169.71 135.22 1.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.208 -0.932 . . . . 0.0 109.582 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 mp -70.45 -27.49 64.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.858 . . . . 0.0 109.455 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 76' ' ' LYS . 70.6 m-20 53.29 83.96 0.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.299 -0.876 . . . . 0.0 109.662 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.12 -31.8 61.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.235 -0.915 . . . . 0.0 109.258 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 75' ' ' LEU . 1.6 mm? -71.31 -36.41 71.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.262 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.828 ' O ' HG23 ' A' ' 80' ' ' VAL . 12.6 mmtt -58.43 -26.01 62.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.392 -0.817 . . . . 0.0 109.715 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.78 -38.26 81.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.728 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -77.48 -31.82 53.91 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.248 -0.907 . . . . 0.0 110.512 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 82' ' ' ARG . 0.4 OUTLIER -79.02 -21.26 47.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.959 -1.088 . . . . 0.0 109.859 -179.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 76' ' ' LYS . 16.4 t -43.66 160.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.286 -0.884 . . . . 0.0 109.622 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 84.24 -46.52 3.68 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -45.88 172.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -1.159 . . . . 0.0 109.874 -179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.457 ' CG1' ' O ' ' A' ' 38' ' ' GLY . 1.6 t -98.71 150.79 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.393 -0.817 . . . . 0.0 109.25 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.722 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -152.93 172.66 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.194 -0.941 . . . . 0.0 109.836 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 13.5 pttm -103.97 115.3 30.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.378 -0.827 . . . . 0.0 109.308 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.84 HG22 ' HG3' ' A' ' 100' ' ' ARG . 24.9 p -125.16 175.42 7.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.204 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.711 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -101.63 157.96 16.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.201 -0.937 . . . . 0.0 109.793 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.406 HG11 ' CB ' ' A' ' 30' ' ' LEU . 0.5 OUTLIER -96.76 120.04 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.56 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 91.3 t -80.21 -37.43 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.443 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 170.65 104.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.931 -1.106 . . . . 0.0 109.826 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 1.025 ' HB2' HD12 ' A' ' 30' ' ' LEU . . . -87.55 153.97 20.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 0.0 109.215 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -167.26 53.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.146 -0.971 . . . . 0.0 109.755 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 117.18 -158.42 14.54 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.942 -1.263 . . . . 0.0 109.942 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.757 ' C ' HD23 ' A' ' 94' ' ' LEU . 4.0 tt -60.12 -18.55 48.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.379 -1.071 . . . . 0.0 109.6 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -107.1 134.21 50.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.645 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.498 HG22 ' CB ' ' A' ' 91' ' ' ALA . 74.2 t -134.29 157.39 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.839 . . . . 0.0 109.407 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.56 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 8.8 m-20 -98.39 152.43 19.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.174 -0.954 . . . . 0.0 108.811 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -141.57 133.77 27.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.968 -1.083 . . . . 0.0 110.701 -178.702 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.556 ' N ' HG23 ' A' ' 89' ' ' VAL . 8.7 ttt180 -131.0 131.37 44.31 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.84 ' HG3' HG22 ' A' ' 86' ' ' THR . 0.0 OUTLIER -102.66 148.36 25.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.073 -1.017 . . . . 0.0 109.556 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -149.95 158.72 44.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 109.628 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.5 t80 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.463 -179.935 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.8 p -127.15 34.66 4.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.227 -0.921 . . . . 0.0 109.59 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.675 ' O ' HG13 ' A' ' 3' ' ' VAL . 7.7 p -162.72 96.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.224 -0.923 . . . . 0.0 109.399 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pp -62.04 156.58 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.395 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.0 tptp 47.1 83.22 0.22 Allowed Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.912 . . . . 0.0 109.48 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.424 ' O ' ' CB ' ' A' ' 7' ' ' SER . 35.5 Cg_endo -77.73 118.15 4.43 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.574 2.183 . . . . 0.0 110.393 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 6' ' ' PRO . 0.1 OUTLIER 169.32 156.8 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.0 109.866 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 79.5 p -167.4 139.6 3.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.528 -0.732 . . . . 0.0 109.081 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.519 ' N ' ' HD3' ' A' ' 10' ' ' PRO . 3.5 ttm180 -174.28 62.8 0.25 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.606 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 9' ' ' ARG . 36.2 Cg_endo -79.25 149.68 22.14 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.682 2.255 . . . . 0.0 110.616 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.528 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -147.81 62.92 7.24 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.325 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 36.3 Cg_endo -78.8 142.96 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.79 2.327 . . . . 0.0 110.559 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.38 56.26 0.75 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.196 -0.94 . . . . 0.0 109.326 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.8 tttp 68.48 45.84 1.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -0.925 . . . . 0.0 109.468 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' LYS . 4.2 m-20 57.11 -164.31 0.16 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.338 -0.851 . . . . 0.0 109.516 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 15' ' ' ASN . 2.9 mtpp -42.09 -68.38 0.19 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.305 -0.872 . . . . 0.0 109.957 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.84 -90.63 0.3 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.148 -0.97 . . . . 0.0 109.669 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 18' ' ' ILE . 5.3 tt -150.84 124.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.878 . . . . 0.0 109.483 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -170.33 37.96 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.33 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 20' ' ' VAL . 41.1 t -109.82 -3.48 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.289 -0.882 . . . . 0.0 109.551 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -102.79 22.58 13.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 0.0 109.569 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.52 147.48 34.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.936 . . . . 0.0 109.446 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -98.85 162.45 13.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.203 -0.935 . . . . 0.0 109.395 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.449 ' HD3' ' N ' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -117.7 59.52 0.78 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.395 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.15 -41.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.471 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.77 59.49 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.424 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.84 159.48 34.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.241 -0.912 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.6 mtt -108.7 131.09 55.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -102.43 169.19 8.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.477 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.839 ' CD2' ' HB3' ' A' ' 91' ' ' ALA . 0.2 OUTLIER -82.56 166.2 19.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.542 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 30' ' ' LEU . 0.3 OUTLIER 166.15 166.19 0.1 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 109.556 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 31' ' ' SER . 35.6 Cg_endo -78.03 148.74 25.02 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.638 2.225 . . . . 0.0 110.502 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.34 41.39 6.99 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.02 168.55 19.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -1.185 . . . . 0.0 109.542 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 24.9 m -116.34 168.06 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.34 -0.85 . . . . 0.0 109.289 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 46.2 t60 -170.33 163.9 8.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.988 . . . . 0.0 109.679 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.69 125.37 50.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.35 -0.844 . . . . 0.0 109.212 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -141.77 175.73 22.37 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.419 ' CD1' ' HB2' ' A' ' 52' ' ' LEU . 3.7 mt -97.7 155.0 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.405 -1.056 . . . . 0.0 108.98 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.484 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 45.7 t -98.79 157.27 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 110.063 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.435 ' N ' HG12 ' A' ' 40' ' ' VAL . 0.6 OUTLIER -154.38 141.43 19.33 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.438 -0.789 . . . . 0.0 109.006 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -101.71 124.66 47.73 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.046 -1.034 . . . . 0.0 109.555 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER 179.58 153.79 0.47 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.677 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER 74.2 5.01 4.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 109.829 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.51 -20.76 29.17 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.52 HG22 HD13 ' A' ' 65' ' ' LEU . 40.4 pt -109.16 -144.34 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -1.153 . . . . 0.0 108.868 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . 67.1 m-85 -117.9 169.76 9.37 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.879 -1.138 . . . . 0.0 109.411 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.678 ' HG3' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -143.16 139.24 30.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.227 -0.921 . . . . 0.0 109.698 -179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 61' ' ' LEU . 48.2 t -115.8 104.28 16.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.95 130.56 45.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.115 -0.991 . . . . 0.0 109.966 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 51' ' ' LEU . 10.9 mp -94.89 93.22 7.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.366 -0.834 . . . . 0.0 109.303 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.918 HD13 ' N ' ' A' ' 53' ' ' GLY . 0.9 OUTLIER -83.69 134.97 34.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -0.975 . . . . 0.0 109.596 -179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.918 ' N ' HD13 ' A' ' 52' ' ' LEU . . . 92.85 -5.81 76.47 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.505 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -123.9 51.34 1.54 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.269 -1.136 . . . . 0.0 109.596 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.505 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 1.6 mt-10 75.87 -170.0 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.399 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 58' ' ' GLU . . . -81.66 9.76 54.28 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -41.42 97.53 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.386 -1.067 . . . . 0.0 109.63 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 56' ' ' GLY . 27.9 tt0 -110.58 110.58 21.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.285 -0.884 . . . . 0.0 109.372 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 3.6 m -104.66 167.4 9.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.631 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.843 HD12 HD21 ' A' ' 62' ' ' LEU . 1.1 pt -129.58 139.0 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.405 -0.81 . . . . 0.0 109.039 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.791 HD11 ' HB2' ' A' ' 64' ' ' TYR . 49.0 tp -98.4 117.25 32.39 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.026 -1.046 . . . . 0.0 109.26 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.843 HD21 HD12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -126.84 -37.91 2.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.309 -0.869 . . . . 0.0 109.664 -179.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.522 ' HB3' ' HG2' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -63.97 -49.42 72.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.895 . . . . 0.0 109.346 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.791 ' HB2' HD11 ' A' ' 61' ' ' LEU . 12.3 t80 -49.02 -45.28 42.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.194 -0.941 . . . . 0.0 109.067 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.52 HD13 HG22 ' A' ' 46' ' ' ILE . 5.4 tt -57.27 -53.4 58.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.349 -0.845 . . . . 0.0 109.305 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.486 ' O ' ' HB3' ' A' ' 67' ' ' TYR . 1.9 t-20 -52.64 156.15 1.99 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.367 -0.833 . . . . 0.0 109.163 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.486 ' HB3' ' O ' ' A' ' 66' ' ' ASN . 30.6 t80 72.53 111.26 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -0.9 . . . . 0.0 109.5 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.74 -162.44 1.23 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 0.0 109.333 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.4 ' O ' ' O ' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -176.4 51.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.579 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 69' ' ' GLN . 20.2 t70 49.99 94.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.553 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.04 136.23 23.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.442 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -33.48 73.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.235 -0.916 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 51.67 27.59 4.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.245 -0.909 . . . . 0.0 109.632 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -42.38 41.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.472 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.27 -33.64 65.36 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.452 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.816 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -59.73 -26.5 65.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 109.633 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -60.44 -49.43 77.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.835 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -77.24 -26.27 52.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 109.996 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -71.21 -29.71 65.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.811 -179.497 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 76' ' ' LYS . 13.0 t -42.92 160.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.375 -0.828 . . . . 0.0 109.462 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 88.13 -48.03 3.58 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -41.56 164.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.406 -1.055 . . . . 0.0 109.892 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.467 ' C ' HG23 ' A' ' 84' ' ' ILE . 23.5 m -98.15 150.16 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.079 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.697 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -155.95 175.29 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.937 -179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 4.3 mtmt -104.25 112.87 26.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.409 -0.807 . . . . 0.0 109.253 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.614 ' OG1' HD11 ' A' ' 98' ' ' LEU . 71.3 p -118.94 175.24 5.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.725 ' O ' HD13 ' A' ' 98' ' ' LEU . 9.9 mpt_? -99.32 156.36 17.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 0.0 109.335 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 t -97.21 124.24 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.167 -0.958 . . . . 0.0 109.309 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.493 ' CG2' ' CB ' ' A' ' 99' ' ' ARG . 24.4 t -80.75 -30.3 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.413 -0.804 . . . . 0.0 109.653 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.427 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.9 OUTLIER 168.01 106.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.136 -0.977 . . . . 0.0 109.311 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.839 ' HB3' ' CD2' ' A' ' 30' ' ' LEU . . . -95.73 132.36 41.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 0.0 109.617 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -165.84 88.27 0.4 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.47 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.73 -160.6 13.57 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.7 -22.62 53.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -1.155 . . . . 0.0 109.443 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -103.65 138.99 39.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.272 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.73 HG13 ' HA ' ' A' ' 91' ' ' ALA . 77.2 t -136.74 161.8 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.185 -0.947 . . . . 0.0 109.918 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.519 ' N ' HG12 ' A' ' 96' ' ' VAL . 15.3 m-20 -98.36 150.9 21.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.725 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -138.53 135.0 34.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.932 -1.105 . . . . 0.0 110.91 -178.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.522 ' HG2' ' HB3' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -136.91 131.8 33.59 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.559 ' HD2' ' CE1' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -92.33 149.8 21.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.175 -0.953 . . . . 0.0 109.33 179.894 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -68.87 95.28 0.68 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.557 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 7.8 t80 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.482 179.892 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 mmt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.95 54.99 0.78 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.302 -0.874 . . . . 0.0 109.505 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.0 m -97.29 -165.5 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.39 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 53.6 mt -113.27 76.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.202 -0.936 . . . . 0.0 109.654 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.97 153.05 1.61 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 0.0 109.153 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.04 76.81 4.01 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.544 2.163 . . . . 0.0 110.469 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.82 162.77 6.37 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.9 t -96.4 21.94 8.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.388 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.553 ' N ' ' HD2' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -77.19 -53.28 1.7 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.942 -179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 34.8 Cg_endo -77.86 142.33 19.9 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.353 2.035 . . . . 0.0 110.357 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 55.77 71.96 1.13 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 0.0 109.28 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.85 141.83 19.53 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.666 2.244 . . . . 0.0 110.523 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 5.7 mtp85 -49.74 141.01 10.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.262 -0.899 . . . . 0.0 109.344 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.5 mmtp -103.01 -51.67 3.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.298 -0.876 . . . . 0.0 109.619 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -168.83 -42.23 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.15 -0.969 . . . . 0.0 109.733 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -127.98 -94.72 0.44 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.149 -0.969 . . . . 0.0 109.842 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.61 -69.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 109.363 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 18' ' ' ILE . 12.9 tt -125.49 127.66 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.479 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -111.2 151.19 28.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 109.477 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.4 m -141.64 15.64 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.537 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -121.16 -167.25 1.47 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 109.49 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.59 178.15 4.62 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.65 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -103.27 42.57 1.15 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.876 . . . . 0.0 109.339 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.9 mtm180 -81.0 -78.78 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.577 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 p -123.51 116.81 23.79 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.275 -0.891 . . . . 0.0 109.497 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.37 92.39 0.29 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 0.0 109.376 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -153.79 111.92 3.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.679 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.439 ' SD ' ' N ' ' A' ' 28' ' ' MET . 3.0 mpp? -97.92 -42.7 7.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.239 -0.913 . . . . 0.0 109.221 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 t0 50.63 -178.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.39 -0.819 . . . . 0.0 110.085 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.635 HD21 ' CB ' ' A' ' 91' ' ' ALA . 5.6 tp -155.99 102.69 2.17 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.444 -0.785 . . . . 0.0 109.111 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.84 157.43 43.16 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.931 . . . . 0.0 109.5 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.64 155.4 31.39 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.666 2.244 . . . . 0.0 110.422 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.73 21.99 35.04 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.2 p -119.13 154.67 32.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -1.102 . . . . 0.0 109.575 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.481 HG12 ' HD2' ' A' ' 87' ' ' ARG . 4.4 m -101.03 131.89 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.375 -0.828 . . . . 0.0 109.06 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.86 172.53 13.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.06 -1.025 . . . . 0.0 109.954 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.55 158.61 15.49 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.367 -0.833 . . . . 0.0 108.897 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -163.06 177.46 39.1 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.775 HD11 ' HB2' ' A' ' 52' ' ' LEU . 6.6 mt -95.96 152.43 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.425 -1.044 . . . . 0.0 108.451 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 82' ' ' ARG . 21.9 t -98.65 149.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.061 -1.024 . . . . 0.0 110.731 -178.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.47 132.46 15.21 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -111.1 112.28 23.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.932 -1.105 . . . . 0.0 109.742 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -163.39 161.72 24.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.346 -0.846 . . . . 0.0 109.528 179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER 68.7 6.83 5.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.336 -0.852 . . . . 0.0 109.748 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.76 -13.45 60.82 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.604 HG22 ' H ' ' A' ' 47' ' ' PHE . 2.5 mm -113.23 -160.43 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.114 -1.227 . . . . 0.0 109.15 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.604 ' H ' HG22 ' A' ' 46' ' ' ILE . 10.1 m-85 -109.54 172.45 6.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.12 -0.988 . . . . 0.0 109.409 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.44 147.78 26.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.945 . . . . 0.0 109.704 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.583 HG21 ' HG ' ' A' ' 98' ' ' LEU . 2.5 t -121.74 122.02 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.399 -0.813 . . . . 0.0 109.253 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.622 ' HB3' HD12 ' A' ' 39' ' ' ILE . 54.8 ttt-85 -98.73 121.74 41.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.0 109.338 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.401 ' HA ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -90.7 86.64 6.42 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.023 -1.048 . . . . 0.0 109.624 -179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.775 ' HB2' HD11 ' A' ' 39' ' ' ILE . 5.7 tp -59.41 162.99 4.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.365 -0.835 . . . . 0.0 109.351 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.99 -31.05 5.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -96.49 -31.69 12.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -1.133 . . . . 0.0 109.342 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 55.79 85.81 0.07 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.369 -0.832 . . . . 0.0 109.548 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.68 -12.28 5.4 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -89.25 94.92 10.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -1.148 . . . . 0.0 109.545 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.14 111.01 23.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.525 -0.735 . . . . 0.0 109.129 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.553 ' HB3' HD23 ' A' ' 98' ' ' LEU . 3.8 m -100.69 156.85 17.09 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.23 -0.919 . . . . 0.0 109.539 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -110.72 124.99 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.814 HD21 ' CB ' ' A' ' 64' ' ' TYR . 29.9 tp -98.17 110.55 23.11 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.046 -1.034 . . . . 0.0 109.56 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 46' ' ' ILE . 1.7 tt -113.6 -40.79 3.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.483 -0.76 . . . . 0.0 109.727 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.526 ' HB2' ' CB ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -63.07 -46.49 87.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.734 -179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.814 ' CB ' HD21 ' A' ' 61' ' ' LEU . 18.5 t80 -47.05 -29.3 2.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.063 -1.023 . . . . 0.0 109.606 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 66' ' ' ASN . 6.4 tt -54.84 -71.45 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.752 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.484 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.8 t-20 62.31 144.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.245 -0.91 . . . . 0.0 109.356 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -74.5 158.19 34.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 109.712 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.29 146.17 16.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 109.641 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.515 ' O ' ' CG ' ' A' ' 69' ' ' GLN . 1.3 pt20 -105.18 79.15 1.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 109.359 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.455 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 28.3 p-10 -172.62 134.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.5 p -126.26 88.61 2.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.272 -0.892 . . . . 0.0 109.397 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.57 39.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.89 . . . . 0.0 109.593 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -104.37 64.33 0.76 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.94 -31.71 61.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.513 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.39 -45.46 91.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.589 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.766 ' O ' HG23 ' A' ' 80' ' ' VAL . 8.7 ttpt -45.82 -26.52 0.68 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.899 . . . . 0.0 109.772 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -58.73 -53.82 54.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.0 109.851 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.74 -27.35 61.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.173 -0.954 . . . . 0.0 110.01 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 80' ' ' VAL . 0.4 OUTLIER -66.5 -33.14 75.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.132 -0.98 . . . . 0.0 109.272 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 76' ' ' LYS . 17.8 t -44.11 161.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.335 -0.853 . . . . 0.0 109.336 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.517 ' O ' ' CG2' ' A' ' 39' ' ' ILE . . . 85.43 -48.46 4.02 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.497 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.8 OUTLIER -43.02 170.39 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.469 -1.018 . . . . 0.0 110.14 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.3 p -97.27 143.6 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.145 -0.972 . . . . 0.0 109.64 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.712 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.3 pp -145.83 174.16 2.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.456 -0.777 . . . . 0.0 109.391 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -102.89 141.78 35.11 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.953 . . . . 0.0 109.505 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.499 ' HB ' ' CD1' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -153.33 174.55 14.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.277 -0.889 . . . . 0.0 109.46 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.781 ' O ' HD13 ' A' ' 98' ' ' LEU . 7.9 mmt180 -99.39 151.92 20.55 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 65.5 t -97.41 119.88 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.86 . . . . 0.0 109.002 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.849 HG21 ' HG3' ' A' ' 99' ' ' ARG . 71.2 t -82.64 -33.96 11.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.414 -0.804 . . . . 0.0 109.935 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 171.04 103.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.115 -0.99 . . . . 0.0 109.737 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.817 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -92.91 107.2 19.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.284 -0.885 . . . . 0.0 109.266 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.88 107.45 4.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 0.0 109.527 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.71 -176.39 54.13 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 94' ' ' LEU . 5.2 mp -59.83 -16.17 26.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -1.095 . . . . 0.0 109.529 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -99.07 133.15 43.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.479 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.817 HG13 ' HA ' ' A' ' 91' ' ' ALA . 61.7 t -138.59 151.29 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.597 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.539 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -101.17 145.5 28.72 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.781 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -138.31 137.86 37.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.966 -1.084 . . . . 0.0 110.669 -179.027 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.849 ' HG3' HG21 ' A' ' 89' ' ' VAL . 9.2 mtt180 -146.19 126.41 13.87 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -88.07 162.3 16.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.326 -0.859 . . . . 0.0 109.566 -179.666 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.452 ' O ' ' O ' ' A' ' 100' ' ' ARG . 11.7 t80 61.21 133.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.656 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 3.0 t80 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.478 179.783 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ttt . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.325 0.583 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.43 -44.63 1.54 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.948 . . . . 0.0 109.42 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.2 p -137.71 139.37 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.865 . . . . 0.0 109.223 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.447 ' HA ' HD13 ' A' ' 4' ' ' ILE . 16.5 mm -100.74 -76.18 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.61 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -169.96 67.06 0.56 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.166 -0.959 . . . . 0.0 109.636 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -78.06 0.15 10.13 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.551 2.167 . . . . 0.0 110.319 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 54.28 76.94 0.21 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.373 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.4 t -139.26 120.99 15.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -0.954 . . . . 0.0 109.631 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.15 146.18 31.83 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.256 -0.903 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.69 -78.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.567 2.178 . . . . 0.0 110.469 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.5 91.85 48.88 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.872 . . . . 0.0 109.386 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.8 125.22 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.614 2.21 . . . . 0.0 110.342 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.29 27.52 2.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 0.0 109.471 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.02 179.64 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 16' ' ' LYS . 11.8 m-80 -89.85 -67.13 0.86 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 0.0 109.189 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.527 ' CB ' ' O ' ' A' ' 15' ' ' ASN . 0.4 OUTLIER 76.35 54.45 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.288 -0.883 . . . . 0.0 109.576 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 68.18 144.45 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.497 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 pt -106.74 131.38 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.208 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 ptmm? -121.03 151.18 40.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.169 -0.957 . . . . 0.0 109.994 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.449 HG13 ' N ' ' A' ' 21' ' ' ASN . 10.5 p -131.43 -37.31 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.412 -0.805 . . . . 0.0 109.02 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.449 ' N ' HG13 ' A' ' 20' ' ' VAL . 1.3 t-20 50.36 -172.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.365 -0.835 . . . . 0.0 109.761 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -159.78 148.09 17.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.347 -0.845 . . . . 0.0 109.264 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.692 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER 60.06 179.21 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.45 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -106.09 -20.05 13.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.93 . . . . 0.0 109.475 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.11 -47.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.424 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 m 177.96 168.17 0.73 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.348 -0.845 . . . . 0.0 109.477 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.692 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . . . -99.35 104.46 16.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.251 -0.905 . . . . 0.0 109.514 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.2 mtp -83.44 -72.81 0.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.145 -0.972 . . . . 0.0 109.401 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.63 36.53 16.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.397 -0.814 . . . . 0.0 109.351 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.535 HD21 ' O ' ' A' ' 91' ' ' ALA . 0.4 OUTLIER -97.67 7.67 46.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.375 -0.828 . . . . 0.0 109.625 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.449 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 1.3 p -62.55 164.13 12.93 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.114 -0.992 . . . . 0.0 109.493 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 31' ' ' SER . 35.6 Cg_endo -78.23 89.26 1.36 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.674 2.249 . . . . 0.0 110.435 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 124.65 86.16 0.67 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 62.2 m -138.59 165.65 26.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.326 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 33.5 m -121.93 146.61 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.509 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -168.71 166.0 11.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.165 -0.959 . . . . 0.0 109.612 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -104.0 138.89 39.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.322 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.419 ' O ' HG23 ' A' ' 83' ' ' VAL . . . -154.98 176.13 32.77 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.7 mm -97.4 152.33 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.345 -1.091 . . . . 0.0 108.815 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 41' ' ' TYR . 21.9 t -104.93 168.01 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.014 -1.054 . . . . 0.0 110.09 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.563 ' N ' HG12 ' A' ' 40' ' ' VAL . 6.3 t80 -155.87 163.78 39.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.24 140.43 40.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.274 -0.891 . . . . 0.0 109.333 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.758 ' O ' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER -143.47 96.75 2.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.036 -1.04 . . . . 0.0 109.997 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 43' ' ' LYS . 5.9 m-20 41.89 30.48 0.17 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 110.091 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.6 -53.21 0.6 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.758 HG22 ' O ' ' A' ' 43' ' ' LYS . 5.8 tt -61.5 170.0 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.112 -1.228 . . . . 0.0 108.903 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.704 ' CB ' HD23 ' A' ' 61' ' ' LEU . 21.2 m-85 -111.94 153.9 26.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.034 -1.041 . . . . 0.0 109.51 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.487 ' HD2' ' HG3' ' A' ' 43' ' ' LYS . 3.3 tttt -129.72 149.32 51.52 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.483 ' HB ' ' HB2' ' A' ' 59' ' ' CYS . 47.4 t -128.52 135.44 62.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.083 -1.011 . . . . 0.0 109.544 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.96 131.86 56.46 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.122 -0.986 . . . . 0.0 109.022 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.432 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -85.46 78.19 9.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 109.666 -179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.8 tp -62.73 125.17 23.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.935 . . . . 0.0 109.351 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.49 -16.41 6.26 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.41 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 10.8 t80 -118.23 -26.13 6.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -1.127 . . . . 0.0 109.382 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 56.56 91.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.302 -0.874 . . . . 0.0 109.486 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 131.38 0.36 5.0 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.41 ' CE1' ' CD2' ' A' ' 54' ' ' TYR . 9.6 m170 -109.63 105.28 14.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -1.213 . . . . 0.0 109.483 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 95' ' ' TYR . 0.2 OUTLIER -112.67 111.41 22.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.887 . . . . 0.0 110.014 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.483 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 3.3 m -103.56 170.63 7.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.309 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.2 pt -132.39 128.57 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.228 -0.92 . . . . 0.0 109.068 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.704 HD23 ' CB ' ' A' ' 47' ' ' PHE . 20.5 tp -97.47 117.54 31.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.969 -1.082 . . . . 0.0 109.372 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.62 ' C ' HD12 ' A' ' 62' ' ' LEU . 3.6 pp -132.5 -33.99 1.22 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.374 -0.829 . . . . 0.0 109.794 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.514 ' N ' HD12 ' A' ' 62' ' ' LEU . 4.5 m-20 -64.14 -34.07 77.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.11 -0.994 . . . . 0.0 109.281 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.656 ' HB2' HD11 ' A' ' 61' ' ' LEU . 7.9 t80 -52.8 -48.58 66.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 109.713 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.425 ' O ' ' CB ' ' A' ' 66' ' ' ASN . 7.0 tp -44.04 -76.16 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.576 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER 70.12 152.32 0.1 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 109.495 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -63.74 95.18 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.348 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -146.85 -67.4 0.27 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 109.604 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.32 -171.9 2.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.229 -0.919 . . . . 0.0 109.622 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -150.34 -40.07 0.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.407 -0.808 . . . . 0.0 109.222 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.4 ' C ' ' HG ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -164.09 51.01 0.13 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.867 . . . . 0.0 109.248 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.4 ' HG ' ' C ' ' A' ' 71' ' ' THR . 2.0 mt -132.07 59.81 1.7 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.91 . . . . 0.0 109.591 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.494 ' HB3' ' CG ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -170.33 93.45 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.094 -1.004 . . . . 0.0 109.532 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.79 -28.49 65.77 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.553 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.4 mt -70.33 -26.78 63.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.3 -0.875 . . . . 0.0 109.529 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.494 ' CG ' ' HB3' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -62.84 -32.03 73.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.306 -0.871 . . . . 0.0 109.867 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -75.74 -28.87 58.69 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.938 . . . . 0.0 109.665 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -77.48 -27.03 51.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 110.309 -179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.471 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -89.71 -39.97 12.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.09 -1.006 . . . . 0.0 110.391 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.563 HG22 ' N ' ' A' ' 81' ' ' GLY . 1.6 p -41.79 164.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.244 -0.91 . . . . 0.0 109.92 -179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.563 ' N ' HG22 ' A' ' 80' ' ' VAL . . . 85.31 -47.19 3.79 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.568 ' HE ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -41.24 165.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.436 -1.037 . . . . 0.0 110.21 -179.539 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.568 HG12 ' HE ' ' A' ' 82' ' ' ARG . 7.4 p -98.04 141.78 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.411 -0.805 . . . . 0.0 108.882 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.766 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -151.37 175.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.235 -0.916 . . . . 0.0 110.001 -179.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -98.9 103.52 15.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -0.86 . . . . 0.0 108.957 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.747 ' OG1' HD11 ' A' ' 98' ' ' LEU . 68.0 p -107.49 175.12 5.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 109.597 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.62 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -102.95 156.56 17.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -0.899 . . . . 0.0 109.254 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.483 ' HA ' HD22 ' A' ' 98' ' ' LEU . 60.1 t -96.95 106.6 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.282 -0.886 . . . . 0.0 108.817 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.572 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 24.1 t -60.6 -44.54 97.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.464 -0.773 . . . . 0.0 109.87 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 9.4 ttm180 177.27 103.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.105 -0.997 . . . . 0.0 109.746 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.593 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -78.12 152.12 32.98 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.258 -0.901 . . . . 0.0 109.322 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -167.7 62.16 0.08 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.203 -0.936 . . . . 0.0 109.924 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 106.87 -156.04 16.2 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -27.33 68.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -1.096 . . . . 0.0 109.647 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 2.7 m-85 -101.18 138.74 37.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.612 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 91' ' ' ALA . 40.8 t -133.69 162.86 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.283 -0.886 . . . . 0.0 109.774 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.572 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -99.26 145.96 26.72 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.747 HD11 ' OG1' ' A' ' 86' ' ' THR . 0.2 OUTLIER -138.02 138.63 39.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.965 -1.085 . . . . 0.0 110.899 -178.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.492 ' CB ' ' HB2' ' A' ' 63' ' ' ASP . 31.0 ttp180 -134.57 129.28 34.76 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.589 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -95.16 103.63 15.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 0.0 109.429 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.465 ' CD1' ' CZ ' ' A' ' 87' ' ' ARG . 27.9 p90 -49.95 144.17 6.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.656 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.468 ' O ' ' CG ' ' A' ' 102' ' ' PHE . 70.2 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.502 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 mtp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.6 p -146.82 116.5 7.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 0.0 109.46 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 t -69.28 134.5 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.534 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.2 mt -122.4 -70.08 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 44.04 82.34 0.23 Allowed Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.251 -0.906 . . . . 0.0 109.472 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.39 125.61 7.1 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.657 2.238 . . . . 0.0 110.508 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.01 135.21 57.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.386 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.6 t -135.68 96.36 3.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.383 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -73.88 147.0 85.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.952 . . . . 0.0 109.578 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.95 85.9 1.74 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.686 2.257 . . . . 0.0 110.47 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.31 69.66 0.57 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.07 -46.35 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.659 2.239 . . . . 0.0 110.559 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.441 ' O ' ' CG ' ' A' ' 13' ' ' ARG . 0.4 OUTLIER -174.91 30.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.143 -0.973 . . . . 0.0 109.735 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 45.99 85.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.617 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 26.2 p30 -127.02 12.76 7.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.373 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 17' ' ' ASN . 27.7 mtmm 62.27 -95.21 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.868 . . . . 0.0 109.712 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 16' ' ' LYS . 1.1 t30 73.44 -170.93 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.147 -0.971 . . . . 0.0 109.359 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.6 pt -136.91 172.23 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.595 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 tptt 58.59 52.94 6.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.688 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.7 HG13 ' O ' ' A' ' 20' ' ' VAL . 14.7 p -97.6 62.17 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.902 . . . . 0.0 109.453 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -139.13 93.25 2.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.205 -0.935 . . . . 0.0 109.611 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.07 27.44 4.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.287 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -53.95 -179.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.44 85.24 7.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.3 m 60.24 156.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.347 -0.845 . . . . 0.0 109.592 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.45 119.58 1.05 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.459 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -163.99 75.32 0.33 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.395 -0.815 . . . . 0.0 109.253 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.76 73.43 1.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.171 -0.956 . . . . 0.0 109.747 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -46.24 -27.92 1.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -0.924 . . . . 0.0 109.25 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.28 90.94 3.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.353 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.06 106.93 0.61 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.53 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.43 110.82 2.92 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.362 2.042 . . . . 0.0 110.242 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.21 25.24 2.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 t -100.52 172.13 7.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.307 -1.114 . . . . 0.0 109.461 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.751 HG22 ' HG3' ' A' ' 87' ' ' ARG . 10.3 t -118.89 161.97 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.2 -0.937 . . . . 0.0 109.426 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.409 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -172.35 167.51 5.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.872 . . . . 0.0 109.457 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -98.7 130.63 45.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.88 . . . . 0.0 109.26 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.41 175.69 29.34 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 81' ' ' GLY . 4.0 mt -97.91 158.29 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -1.048 . . . . 0.0 108.984 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.545 ' C ' ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -116.28 175.75 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.193 -0.942 . . . . 0.0 110.072 -179.132 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.62 147.91 22.28 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 108.856 179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' LYS . 50.8 t80 -114.5 119.18 35.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.965 -1.084 . . . . 0.0 109.654 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER 174.41 174.21 0.18 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.567 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 91.1 m-20 62.99 10.96 4.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.421 -0.799 . . . . 0.0 109.854 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.74 -22.46 13.84 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 47' ' ' PHE . 10.2 pt -114.72 -153.89 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.0 -1.294 . . . . 0.0 109.406 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.562 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 4.4 m-85 -114.9 173.99 6.2 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.045 -1.035 . . . . 0.0 109.189 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 5.0 tttt -142.68 158.88 43.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.144 -0.973 . . . . 0.0 109.675 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 59' ' ' CYS . 2.8 t -139.98 107.71 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.406 -0.809 . . . . 0.0 109.376 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.96 134.27 42.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 109.477 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -97.38 96.97 8.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.94 . . . . 0.0 109.614 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.468 ' HB2' ' CD1' ' A' ' 39' ' ' ILE . 0.4 OUTLIER -79.2 110.97 14.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.337 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.04 -35.96 1.64 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.448 ' O ' ' CB ' ' A' ' 55' ' ' GLU . 4.4 m-85 -85.02 -31.62 23.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.272 -1.134 . . . . 0.0 109.18 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 54' ' ' TYR . 0.1 OUTLIER 71.55 97.6 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.391 -0.818 . . . . 0.0 109.589 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.73 10.34 30.98 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -100.22 88.75 3.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.33 -1.1 . . . . 0.0 109.549 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.92 99.61 9.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.221 -0.924 . . . . 0.0 109.36 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.798 ' SG ' HD23 ' A' ' 98' ' ' LEU . 7.4 t -101.9 169.56 8.7 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.188 -0.945 . . . . 0.0 109.234 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 1.6 pt -137.03 140.84 41.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.747 HD21 ' HG2' ' A' ' 100' ' ' ARG . 0.5 OUTLIER -98.37 126.96 44.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.934 -1.104 . . . . 0.0 109.597 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.422 ' HG ' ' HB ' ' A' ' 46' ' ' ILE . 0.3 OUTLIER -162.5 -36.69 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.599 -0.688 . . . . 0.0 109.507 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.494 ' CB ' ' HB2' ' A' ' 99' ' ' ARG . 0.4 OUTLIER -48.22 -46.49 35.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.3 -0.875 . . . . 0.0 109.163 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -125.55 54.14 1.5 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.311 -0.868 . . . . 0.0 109.441 179.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.55 HD23 ' O ' ' A' ' 65' ' ' LEU . 2.6 tt -66.64 -47.37 72.79 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.212 -0.93 . . . . 0.0 109.463 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.42 ' O ' ' O ' ' A' ' 65' ' ' LEU . 8.9 m120 54.19 100.19 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.232 -0.918 . . . . 0.0 109.367 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -73.41 123.29 23.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 109.684 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -116.94 104.49 11.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 109.307 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -116.77 93.94 4.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.866 . . . . 0.0 109.613 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -139.66 167.52 21.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.42 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.65 161.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.931 . . . . 0.0 109.648 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.417 ' HA ' HD23 ' A' ' 72' ' ' LEU . 0.6 OUTLIER 61.35 57.03 2.49 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.411 -0.806 . . . . 0.0 109.634 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -89.98 -30.62 17.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.402 -0.811 . . . . 0.0 109.31 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' A' ' 75' ' ' LEU . 12.2 mtm180 -46.62 -55.68 7.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -0.931 . . . . 0.0 109.569 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' ARG . 5.9 tp -43.01 -56.72 3.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.733 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -48.67 -48.18 40.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.639 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.614 ' O ' HG23 ' A' ' 80' ' ' VAL . 2.3 tm-20 -53.59 -52.54 59.47 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.181 -0.949 . . . . 0.0 109.685 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 77' ' ' GLU . 0.5 OUTLIER -46.13 -62.08 1.49 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.407 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.552 HD12 ' H ' ' A' ' 79' ' ' LEU . 4.5 mp -56.35 -78.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.224 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.699 HG12 ' N ' ' A' ' 81' ' ' GLY . 38.2 t 48.93 -90.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 110.078 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.699 ' N ' HG12 ' A' ' 80' ' ' VAL . . . -80.69 15.65 18.76 Favored Glycine 0 N--CA 1.489 2.226 0 C-N-CA 120.044 -1.074 . . . . 0.0 111.233 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -49.05 175.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.94 -1.33 . . . . 0.0 108.695 179.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 66.5 t -97.37 122.9 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.084 -1.01 . . . . 0.0 108.627 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.744 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -141.3 174.63 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.112 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -104.19 118.13 35.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.428 -0.795 . . . . 0.0 109.127 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.851 ' OG1' HD11 ' A' ' 98' ' ' LEU . 55.5 p -125.95 175.08 7.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.751 ' HG3' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -102.15 159.88 15.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.338 -0.851 . . . . 0.0 109.477 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.451 ' HA ' HD22 ' A' ' 98' ' ' LEU . 40.7 t -97.48 123.1 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.29 -0.881 . . . . 0.0 109.031 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.586 HG23 ' N ' ' A' ' 99' ' ' ARG . 79.6 t -81.84 -33.29 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.485 -0.759 . . . . 0.0 110.045 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 47.3 ttp180 175.29 102.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.094 -1.004 . . . . 0.0 109.629 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.853 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -95.83 108.37 20.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.537 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.45 -58.36 2.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.431 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -157.02 -93.79 0.1 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.67 -29.64 22.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.195 -1.179 . . . . 0.0 109.194 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.14 131.08 53.08 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.34 -0.85 . . . . 0.0 109.091 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.853 HG13 ' HA ' ' A' ' 91' ' ' ALA . 59.5 t -135.0 157.61 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 109.954 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.551 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 3.7 m-20 -99.91 153.89 18.8 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.851 HD11 ' OG1' ' A' ' 86' ' ' THR . 0.2 OUTLIER -136.81 134.2 36.73 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.971 -1.08 . . . . 0.0 110.878 -178.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.586 ' N ' HG23 ' A' ' 89' ' ' VAL . 28.6 ttm180 -124.17 111.56 16.04 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.747 ' HG2' HD21 ' A' ' 61' ' ' LEU . 4.2 ptm180 -95.9 163.48 13.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.09 -1.006 . . . . 0.0 110.041 -179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -147.19 158.59 44.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.334 -0.854 . . . . 0.0 109.164 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.8 t80 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.522 -179.882 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.4 t -90.45 145.45 24.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.246 -0.909 . . . . 0.0 109.565 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.52 154.34 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.288 -0.883 . . . . 0.0 109.463 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 pt -142.23 105.34 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.54 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.7 tttt 64.34 83.31 0.2 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 109.506 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.75 118.72 4.57 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.711 2.274 . . . . 0.0 110.443 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.445 ' O ' ' CB ' ' A' ' 8' ' ' SER . 0.7 OUTLIER -52.76 178.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 0.0 109.5 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 7' ' ' SER . 2.6 p 169.14 147.21 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.907 . . . . 0.0 109.5 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -47.77 146.49 3.84 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.388 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.32 113.15 3.32 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.614 2.209 . . . . 0.0 110.56 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.37 150.45 64.36 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 109.434 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.71 102.3 1.58 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.564 2.176 . . . . 0.0 110.336 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.38 36.76 0.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.76 -178.48 5.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.227 -0.921 . . . . 0.0 109.383 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -98.6 121.77 40.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 109.604 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.7 mttp 65.15 102.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.332 -0.855 . . . . 0.0 109.479 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -99.41 58.91 1.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.19 -0.944 . . . . 0.0 109.501 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 19' ' ' LYS . 58.7 mt -63.48 160.39 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -0.885 . . . . 0.0 109.222 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.507 ' N ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -146.22 176.83 9.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.142 -0.973 . . . . 0.0 109.678 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.5 t -98.14 148.2 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 109.418 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -102.95 126.81 50.28 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.196 -0.94 . . . . 0.0 109.583 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 m -149.35 16.13 0.91 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.233 -0.917 . . . . 0.0 109.541 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -142.87 87.74 2.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 109.47 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.0 71.22 0.93 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.207 -0.933 . . . . 0.0 109.512 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.56 168.23 9.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.435 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 p -101.71 16.49 25.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.333 -0.854 . . . . 0.0 109.435 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 28' ' ' MET . . . -95.78 -46.57 6.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.153 -0.967 . . . . 0.0 109.467 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.426 ' O ' ' O ' ' A' ' 27' ' ' ALA . 1.1 tmm? 47.91 -172.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.409 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -141.99 132.65 25.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 109.667 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.27 133.9 55.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.329 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.9 p -121.81 98.16 45.65 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.907 . . . . 0.0 109.491 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.404 ' HG3' ' CG ' ' A' ' 90' ' ' ARG . 35.4 Cg_endo -77.46 172.26 16.19 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.539 2.16 . . . . 0.0 110.43 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 110.99 17.8 8.72 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -113.8 163.46 15.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.251 -1.147 . . . . 0.0 109.482 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.877 HG12 ' NE ' ' A' ' 87' ' ' ARG . 18.9 m -103.65 158.1 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.511 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.531 ' CD2' HG23 ' A' ' 88' ' ' VAL . 20.4 p80 -167.08 163.13 15.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 0.0 109.672 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -99.37 135.08 41.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.357 -0.839 . . . . 0.0 109.067 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -146.08 176.77 24.85 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' A' ' 52' ' ' LEU . 9.7 mt -96.61 154.34 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.302 -1.117 . . . . 0.0 108.641 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.717 HG23 HD12 ' A' ' 84' ' ' ILE . 53.0 t -105.54 151.86 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.016 -1.053 . . . . 0.0 110.481 -178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.523 ' HB3' ' HB2' ' A' ' 48' ' ' LYS . 2.6 t80 -142.34 145.87 34.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.425 -0.797 . . . . 0.0 108.968 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.535 ' O ' ' CG ' ' A' ' 42' ' ' PHE . 37.2 p90 -107.34 118.12 35.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.096 -1.002 . . . . 0.0 109.779 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.506 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 2.3 mttp 165.61 158.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.208 -0.933 . . . . 0.0 109.813 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' A' ' 43' ' ' LYS . 1.0 OUTLIER 77.72 36.26 0.27 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 0.0 109.688 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.526 ' C ' HG23 ' A' ' 46' ' ' ILE . . . 46.69 24.41 1.8 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.826 ' CG2' HD13 ' A' ' 62' ' ' LEU . 2.5 pt -159.3 -155.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -1.115 . . . . 0.0 108.969 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.519 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 0.5 OUTLIER -116.23 163.04 16.57 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.037 -1.04 . . . . 0.0 108.96 179.632 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.553 ' CG ' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -135.65 129.95 33.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.166 -0.959 . . . . 0.0 109.733 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 59' ' ' CYS . 5.4 t -109.45 124.83 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.324 -0.86 . . . . 0.0 109.358 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.7 ttm-85 -105.55 129.4 53.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.136 -0.977 . . . . 0.0 109.393 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -90.76 81.95 5.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.26 -0.9 . . . . 0.0 109.432 179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.56 ' HB2' HD11 ' A' ' 39' ' ' ILE . 1.2 tp -64.97 132.71 50.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.94 -42.46 1.86 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.466 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . 69.1 t80 -74.58 -29.54 61.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -1.14 . . . . 0.0 109.556 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 30.4 tt0 63.54 89.3 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 0.0 109.424 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.53 15.28 9.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.466 ' CG ' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -115.65 90.26 3.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 109.535 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HB3' ' O ' ' A' ' 94' ' ' LEU . 1.6 tm-20 -100.65 105.61 17.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.837 . . . . 0.0 109.444 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.651 ' HB3' HD23 ' A' ' 98' ' ' LEU . 4.9 m -101.78 159.65 15.15 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.145 -0.972 . . . . 0.0 109.313 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.553 HG22 ' CG ' ' A' ' 48' ' ' LYS . 4.1 pt -131.13 141.07 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.848 . . . . 0.0 108.971 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.8 OUTLIER -97.93 127.63 44.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.057 -1.027 . . . . 0.0 109.738 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.826 HD13 ' CG2' ' A' ' 46' ' ' ILE . 14.9 tp -173.68 -32.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.445 ' OD2' HG11 ' A' ' 89' ' ' VAL . 0.6 OUTLIER -55.3 -43.9 75.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.426 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.553 ' HB2' ' N ' ' A' ' 100' ' ' ARG . 1.4 m-30 -114.27 53.01 0.8 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 109.58 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 66' ' ' ASN . 0.6 OUTLIER -75.43 -10.08 59.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.946 . . . . 0.0 109.491 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 65' ' ' LEU . 4.4 m120 43.81 45.31 6.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 109.288 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.418 ' C ' ' O ' ' A' ' 66' ' ' ASN . 43.9 t80 -42.98 142.34 0.94 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.44 -0.788 . . . . 0.0 109.725 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' A' ' 69' ' ' GLN . 6.7 mtp180 -118.28 -75.71 0.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.337 -0.852 . . . . 0.0 109.234 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.444 ' HB3' ' O ' ' A' ' 68' ' ' ARG . 6.7 pt20 171.21 -44.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.434 -0.791 . . . . 0.0 109.151 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.06 164.81 6.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.34 -0.85 . . . . 0.0 109.291 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.29 165.37 16.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.54 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.3 mp -118.57 3.12 11.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.532 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -54.37 -52.6 61.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.895 . . . . 0.0 109.481 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -62.26 -34.93 77.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.78 -31.48 48.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 109.44 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.795 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -75.99 -38.27 57.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -0.922 . . . . 0.0 109.585 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 78' ' ' ARG . 12.7 mt-10 -51.53 -28.32 13.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.656 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 79' ' ' LEU . 2.1 mtp-105 -44.35 -54.11 6.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -0.945 . . . . 0.0 109.488 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.483 ' CB ' ' O ' ' A' ' 78' ' ' ARG . 1.1 mt 165.36 48.21 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 109.645 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 76' ' ' LYS . 12.0 t -43.01 163.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.414 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 86.06 -46.86 3.68 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.46 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -41.09 164.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.579 -0.953 . . . . 0.0 110.021 -179.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 4.3 m -98.44 153.01 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.247 -0.908 . . . . 0.0 109.219 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.781 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -151.99 174.59 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.695 -179.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.3 mtpt -99.35 138.17 36.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.296 -0.878 . . . . 0.0 109.362 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 35.5 p -149.3 173.53 13.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.889 . . . . 0.0 109.443 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.877 ' NE ' HG12 ' A' ' 35' ' ' VAL . 13.3 mmm-85 -104.23 158.13 16.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.852 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.531 HG23 ' CD2' ' A' ' 36' ' ' HIS . 53.4 t -96.74 131.82 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 109.334 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.649 HG22 ' CD ' ' A' ' 99' ' ' ARG . 42.6 t -92.41 -31.1 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.284 -0.885 . . . . 0.0 110.056 -179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 164.49 107.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.139 -0.975 . . . . 0.0 109.58 -179.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.958 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -84.65 117.72 23.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.441 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -110.54 27.98 9.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.316 -0.865 . . . . 0.0 109.581 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 110.24 -148.24 17.45 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 58' ' ' GLU . 0.7 OUTLIER -45.29 -31.25 1.5 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.274 -1.133 . . . . 0.0 109.527 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -102.86 135.06 45.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 109.332 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.958 HG13 ' HA ' ' A' ' 91' ' ' ALA . 51.4 t -142.26 152.48 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.9 . . . . 0.0 109.695 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.488 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 50.1 m-20 -97.92 150.29 21.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.203 -0.935 . . . . 0.0 108.706 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.866 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -136.93 136.74 38.86 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.09 -1.006 . . . . 0.0 110.49 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.649 ' CD ' HG22 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -123.84 114.46 19.89 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.553 ' N ' ' HB2' ' A' ' 64' ' ' TYR . 16.2 ttm180 -47.22 159.33 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.212 -0.93 . . . . 0.0 109.325 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.425 ' N ' ' HG2' ' A' ' 100' ' ' ARG . 8.3 t80 -89.73 114.36 26.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.28 -0.888 . . . . 0.0 109.454 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.42 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 m -128.13 14.05 6.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.516 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.3 t -126.15 110.7 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.949 . . . . 0.0 109.566 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 mp -104.51 115.34 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.6 99.63 10.45 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.245 -0.91 . . . . 0.0 109.403 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.444 ' O ' ' HB3' ' A' ' 7' ' ' SER . 34.6 Cg_endo -76.97 140.89 20.65 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.331 2.02 . . . . 0.0 110.171 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 6' ' ' PRO . 7.8 t 69.4 150.43 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.005 -179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.1 m -118.84 158.11 26.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.078 -1.013 . . . . 0.0 109.77 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.7 ptt85 -149.26 73.2 10.05 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.91 . . . . 0.0 109.161 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.53 -76.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.581 2.188 . . . . 0.0 110.506 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.24 157.73 70.42 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.585 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.09 162.27 28.97 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.744 2.296 . . . . 0.0 110.624 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.64 61.45 1.61 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.345 -0.847 . . . . 0.0 109.397 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 60.45 92.31 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.293 -0.879 . . . . 0.0 109.458 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -47.66 141.39 5.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.522 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 mmtt -51.16 139.86 17.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.357 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -48.38 111.65 0.48 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.505 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.5 tt -73.64 -19.69 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.685 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' O ' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -92.29 152.74 19.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.174 -0.954 . . . . 0.0 109.643 -179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 19' ' ' LYS . 4.2 t 71.8 6.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.312 -0.868 . . . . 0.0 109.707 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -139.56 111.64 7.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.18 -0.95 . . . . 0.0 109.648 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.7 p -68.4 133.04 48.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.311 -0.868 . . . . 0.0 109.301 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.415 ' O ' ' O ' ' A' ' 24' ' ' ARG . 0.7 OUTLIER -98.71 -36.53 9.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.619 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.415 ' O ' ' O ' ' A' ' 23' ' ' TYR . 0.3 OUTLIER 58.37 162.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -0.951 . . . . 0.0 109.284 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.19 -43.81 1.3 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.464 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.16 57.18 3.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.294 -0.878 . . . . 0.0 109.579 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.4 50.64 0.82 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.487 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 2.6 tpp -84.49 104.71 14.73 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.354 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.6 p30 -179.65 36.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.226 -0.921 . . . . 0.0 109.599 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 tp -174.06 50.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.534 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.29 153.5 40.35 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.147 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.24 119.85 5.13 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.609 2.206 . . . . 0.0 110.505 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.73 40.29 0.62 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.9 m -128.68 161.41 29.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 0.0 109.553 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 35' ' ' VAL . 6.0 m -109.7 132.54 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.896 . . . . 0.0 109.59 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -147.03 170.01 18.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.259 -0.9 . . . . 0.0 109.43 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -100.23 153.39 19.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.336 -0.852 . . . . 0.0 109.684 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.45 175.22 45.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.88 HG23 ' O ' ' A' ' 81' ' ' GLY . 1.9 mp -98.49 144.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.377 -1.072 . . . . 0.0 108.931 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.536 ' O ' ' CA ' ' A' ' 81' ' ' GLY . 2.1 t -100.94 172.36 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.188 -0.945 . . . . 0.0 109.866 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.514 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 1.4 t80 -156.19 147.92 22.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.18 -0.95 . . . . 0.0 109.54 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -101.06 102.92 13.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 0.0 109.455 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.4 ttpp -90.83 169.59 10.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.904 . . . . 0.0 109.487 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -87.08 19.38 3.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 109.539 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.477 ' C ' HG23 ' A' ' 46' ' ' ILE . . . -145.78 -38.63 0.05 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.606 HG21 HD13 ' A' ' 62' ' ' LEU . 45.4 pt -155.64 -155.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.228 -1.16 . . . . 0.0 109.16 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.515 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.3 m-30 -107.9 155.1 20.67 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.021 -1.049 . . . . 0.0 109.17 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 24.3 tttt -126.07 150.46 48.15 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.507 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 3.4 t -138.55 112.84 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.434 -0.791 . . . . 0.0 109.104 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.73 127.55 45.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.431 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.23 85.44 5.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.634 ' HB2' HD13 ' A' ' 39' ' ' ILE . 17.8 tp -59.92 145.64 45.17 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.241 -0.912 . . . . 0.0 109.402 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.446 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . 101.92 -54.43 0.77 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -71.09 -24.35 62.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.582 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 47.78 85.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.186 -0.946 . . . . 0.0 109.588 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.99 -9.84 3.89 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -97.46 98.16 9.7 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -1.144 . . . . 0.0 109.596 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.568 ' OE2' ' CZ ' ' A' ' 95' ' ' TYR . 26.4 tt0 -101.42 107.54 18.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.418 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 48.2 m -104.87 162.63 13.16 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 109.627 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.409 ' CG1' ' O ' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -131.01 132.68 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.576 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.525 HD12 HD12 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -97.4 124.69 41.66 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.042 -1.036 . . . . 0.0 109.831 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.631 ' O ' HD23 ' A' ' 65' ' ' LEU . 4.9 tp -151.75 -38.05 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.545 -0.722 . . . . 0.0 109.462 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.493 ' HB3' ' HA ' ' A' ' 99' ' ' ARG . 23.0 t0 -47.13 -53.39 13.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.17 -0.956 . . . . 0.0 108.963 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.482 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 0.2 OUTLIER -118.65 49.01 1.34 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 0.0 109.209 179.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -56.35 -19.75 16.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -0.827 . . . . 0.0 109.604 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 63.9 t30 69.22 159.86 0.18 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.27 -0.894 . . . . 0.0 109.439 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.71 167.6 12.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.445 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.626 ' HD2' HG23 ' A' ' 71' ' ' THR . 3.6 mmt180 -116.72 154.35 30.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.237 -0.914 . . . . 0.0 109.466 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 70' ' ' ASP . 0.7 OUTLIER -87.44 66.13 8.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -0.884 . . . . 0.0 109.523 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 69' ' ' GLN . 2.2 m-20 44.6 52.23 7.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.224 -0.922 . . . . 0.0 109.357 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.626 HG23 ' HD2' ' A' ' 68' ' ' ARG . 2.9 t -139.58 126.01 20.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.228 -0.92 . . . . 0.0 109.621 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.41 ' O ' ' CB ' ' A' ' 73' ' ' ASP . 0.1 OUTLIER -50.34 -31.8 15.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.298 -0.876 . . . . 0.0 109.487 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.499 ' OD1' ' CZ ' ' A' ' 68' ' ' ARG . 0.7 OUTLIER 70.22 81.64 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.46 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -64.41 -26.57 68.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.516 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 78' ' ' ARG . 1.6 tp -53.59 -47.47 70.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.796 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.465 ' HG3' ' OD2' ' A' ' 73' ' ' ASP . 0.9 OUTLIER -45.47 -44.58 12.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.22 -0.925 . . . . 0.0 109.639 -179.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.432 ' O ' ' C ' ' A' ' 78' ' ' ARG . 0.6 OUTLIER -51.48 -46.01 63.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.381 -0.824 . . . . 0.0 109.606 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -43.04 -67.1 0.3 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.237 -0.914 . . . . 0.0 109.495 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 82' ' ' ARG . 1.3 mt -172.8 70.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.164 -0.96 . . . . 0.0 109.732 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.531 ' CG1' ' N ' ' A' ' 81' ' ' GLY . 2.3 p -59.91 -43.07 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.325 -0.859 . . . . 0.0 109.77 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.88 ' O ' HG23 ' A' ' 39' ' ' ILE . . . -75.33 15.4 4.43 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.808 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.503 ' O ' ' O ' ' A' ' 81' ' ' GLY . 8.5 ttp180 -50.63 -174.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.969 -1.313 . . . . 0.0 109.724 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.4 m -96.01 112.91 29.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.268 -0.895 . . . . 0.0 108.821 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.759 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.7 pp -133.57 175.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.95 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -98.28 151.37 20.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.383 -0.823 . . . . 0.0 109.038 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.738 ' HB ' HD11 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -154.91 170.86 20.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.489 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.812 ' O ' HD13 ' A' ' 98' ' ' LEU . 6.1 mmt180 -99.78 154.16 18.55 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.194 -0.941 . . . . 0.0 109.244 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.5 t -97.78 125.9 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.13 -0.981 . . . . 0.0 108.908 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.955 HG12 ' HG2' ' A' ' 90' ' ' ARG . 78.7 t -85.36 -33.88 8.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.295 -0.878 . . . . 0.0 110.251 -179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.955 ' HG2' HG12 ' A' ' 89' ' ' VAL . 1.9 ptt180 166.45 108.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.03 -1.044 . . . . 0.0 109.601 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.802 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -91.44 114.87 27.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.384 -0.822 . . . . 0.0 109.244 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.7 64.86 1.58 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.109 -0.995 . . . . 0.0 109.794 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 112.75 -165.64 12.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -25.88 62.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.343 -1.093 . . . . 0.0 109.676 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.568 ' CZ ' ' OE2' ' A' ' 58' ' ' GLU . 6.9 m-85 -99.59 140.63 33.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.162 -0.961 . . . . 0.0 109.353 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.802 HG22 ' HA ' ' A' ' 91' ' ' ALA . 79.9 t -142.2 162.89 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.188 -0.945 . . . . 0.0 109.944 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.573 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 30.8 m-20 -101.19 157.2 16.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.313 -0.867 . . . . 0.0 109.002 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.812 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.24 136.23 33.14 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.88 -1.137 . . . . 0.0 111.033 -178.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.589 ' N ' HG23 ' A' ' 89' ' ' VAL . 0.1 OUTLIER -120.8 114.78 22.11 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.632 ' HA ' HG22 ' A' ' 86' ' ' THR . 0.0 OUTLIER -69.94 163.21 26.51 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 -179.241 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.432 ' HB3' ' NH1' ' A' ' 87' ' ' ARG . 2.5 t80 -142.62 67.61 1.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.415 -0.803 . . . . 0.0 109.213 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.9 t80 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.49 -179.879 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ptm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.29 0.567 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.97 135.73 9.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 3' ' ' VAL . 14.0 m -137.01 131.71 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.885 . . . . 0.0 109.326 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.87 24.81 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.086 -1.009 . . . . 0.0 109.506 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.553 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 0.1 OUTLIER -50.44 -52.42 55.24 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.942 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 35.0 Cg_endo -77.85 131.49 11.2 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.465 2.11 . . . . 0.0 110.625 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.9 m -142.27 74.1 1.44 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.495 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.81 142.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -0.919 . . . . 0.0 109.56 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.3 ttt85 -123.7 84.3 53.73 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 0.0 109.599 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.72 -67.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.546 2.164 . . . . 0.0 110.218 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -139.78 144.0 37.09 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.923 . . . . 0.0 109.32 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.74 87.69 1.52 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.582 2.188 . . . . 0.0 110.273 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -160.6 77.74 0.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 109.552 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.441 ' O ' ' CB ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER -154.57 58.11 0.69 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.936 . . . . 0.0 109.569 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 15' ' ' ASN . 0.6 OUTLIER 72.3 107.52 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 109.427 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 mtmt -78.41 111.72 14.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 0.0 109.555 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -163.12 155.98 18.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 109.663 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 28.7 pt -132.22 -169.74 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 0.0 109.227 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 10.6 tttt 178.37 166.29 0.8 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.133 -0.979 . . . . 0.0 109.43 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.431 ' N ' ' CG ' ' A' ' 19' ' ' LYS . 93.8 t -144.12 116.51 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.872 . . . . 0.0 109.345 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -113.78 166.71 11.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.238 -0.914 . . . . 0.0 109.615 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.65 145.73 55.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.587 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -90.61 177.9 6.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.677 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.19 -37.52 61.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.316 -0.865 . . . . 0.0 109.414 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.7 p -76.04 123.71 26.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.506 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.59 130.33 41.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 109.577 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.61 114.76 28.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.242 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mmt -94.22 167.56 11.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.242 -0.911 . . . . 0.0 109.799 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.54 59.96 1.08 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.348 -0.845 . . . . 0.0 109.283 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.8 tt -122.67 102.08 7.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.257 -0.902 . . . . 0.0 109.419 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.57 165.08 5.38 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.18 90.34 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.674 2.249 . . . . 0.0 110.34 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.07 68.7 0.3 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.05 172.02 13.64 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.272 -1.134 . . . . 0.0 109.503 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.623 HG12 ' NE ' ' A' ' 87' ' ' ARG . 12.9 m -120.44 128.43 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.0 109.218 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -149.93 166.87 28.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.181 -0.949 . . . . 0.0 109.554 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -100.56 133.27 45.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.343 -0.848 . . . . 0.0 109.204 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.07 176.71 24.87 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.589 ' N ' HD12 ' A' ' 39' ' ' ILE . 2.9 mp -96.14 160.02 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.292 -1.122 . . . . 0.0 108.581 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.542 ' CG2' HD12 ' A' ' 84' ' ' ILE . 7.1 t -111.37 167.94 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.085 -1.009 . . . . 0.0 110.237 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.507 ' N ' HG12 ' A' ' 40' ' ' VAL . 2.1 t80 -157.87 150.4 22.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.438 -0.789 . . . . 0.0 108.922 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -103.92 120.77 41.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.211 -0.931 . . . . 0.0 109.704 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.29 168.47 9.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.275 -0.89 . . . . 0.0 109.471 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.415 ' O ' ' CG ' ' A' ' 44' ' ' ASP . 8.5 t70 -87.92 6.45 35.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.771 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.53 -32.82 0.46 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.811 HG23 ' N ' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -162.15 -152.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -1.179 . . . . 0.0 108.869 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.811 ' N ' HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -107.04 164.43 12.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.738 -1.226 . . . . 0.0 109.157 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.476 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -135.07 147.64 49.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.083 -1.011 . . . . 0.0 110.219 -179.449 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.494 ' CG2' HD13 ' A' ' 61' ' ' LEU . 71.7 t -130.8 133.66 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 6.0 ttm180 -114.37 123.57 49.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.11 67.69 10.05 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.174 -0.954 . . . . 0.0 109.242 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.416 ' HB2' HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -47.63 147.28 1.88 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.701 -179.863 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.24 -45.3 1.38 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.497 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -77.62 -17.03 58.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -1.152 . . . . 0.0 109.456 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 48.24 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.203 -0.936 . . . . 0.0 109.515 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.81 -23.96 7.66 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.574 ' NE2' ' HB1' ' A' ' 91' ' ' ALA . 1.6 t-160 -82.1 91.06 6.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.164 -1.198 . . . . 0.0 109.787 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.87 109.68 22.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.412 -0.805 . . . . 0.0 109.099 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.461 ' HA ' ' HB ' ' A' ' 96' ' ' VAL . 13.7 m -98.54 173.7 6.8 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.154 -0.966 . . . . 0.0 109.444 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 96' ' ' VAL . 1.8 pp -149.55 147.62 16.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.422 -0.798 . . . . 0.0 109.374 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.61 HD23 ' CD2' ' A' ' 64' ' ' TYR . 0.6 OUTLIER -98.13 102.48 14.24 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.298 -0.876 . . . . 0.0 109.183 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.469 ' HA ' HG12 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -123.3 -27.27 4.15 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.458 ' CB ' ' HB3' ' A' ' 99' ' ' ARG . 2.1 m-20 -85.86 -34.66 20.95 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.61 ' CD2' HD23 ' A' ' 61' ' ' LEU . 15.9 t80 -43.37 -43.65 5.22 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.553 -0.717 . . . . 0.0 109.106 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -65.74 -41.25 92.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.154 -0.966 . . . . 0.0 109.615 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 65' ' ' LEU . 50.5 t30 -43.24 146.49 0.45 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -0.944 . . . . 0.0 109.401 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 48.65 70.97 0.4 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.301 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -101.02 87.45 3.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.242 -0.911 . . . . 0.0 109.541 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.74 -6.26 23.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.175 -0.953 . . . . 0.0 109.42 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.81 90.06 3.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.309 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.0 p -45.81 103.22 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 109.571 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.73 51.07 2.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.474 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.485 ' O ' ' HE3' ' A' ' 76' ' ' LYS . 18.8 m-20 -100.04 -11.75 20.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.165 -0.959 . . . . 0.0 109.544 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -68.1 -40.99 82.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 109.505 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 74' ' ' ARG . 1.7 tt -44.54 -32.95 1.58 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.305 -0.872 . . . . 0.0 109.491 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 73' ' ' ASP . 6.7 mtmt -49.43 -63.78 1.0 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.52 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -51.47 -31.2 22.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.957 . . . . 0.0 109.506 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.598 ' O ' HD12 ' A' ' 79' ' ' LEU . 0.4 OUTLIER -49.86 -64.76 0.71 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.95 . . . . 0.0 109.476 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -174.58 54.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.401 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.563 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 0.9 OUTLIER -43.66 166.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.234 -0.916 . . . . 0.0 109.171 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.563 ' N ' ' CG2' ' A' ' 80' ' ' VAL . . . 88.78 -37.41 3.31 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.512 ' O ' ' O ' ' A' ' 81' ' ' GLY . 1.5 mmt180 -43.62 172.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.633 -0.922 . . . . 0.0 110.153 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.454 ' C ' HG23 ' A' ' 84' ' ' ILE . 9.1 p -97.18 147.1 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.601 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.687 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -155.74 176.02 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.352 -0.843 . . . . 0.0 109.605 -179.59 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.482 ' HB2' ' CE2' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -98.1 110.4 22.98 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.323 -0.861 . . . . 0.0 108.949 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.995 HG22 ' HB2' ' A' ' 100' ' ' ARG . 82.4 p -110.35 165.45 11.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 110.044 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.623 ' NE ' HG12 ' A' ' 35' ' ' VAL . 6.2 mpt_? -98.56 140.79 32.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 108.65 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.605 ' HA ' ' HB3' ' A' ' 98' ' ' LEU . 58.9 t -94.25 139.16 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.469 -0.769 . . . . 0.0 109.299 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 89' ' ' VAL . 91.1 t -121.97 -10.31 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 119.179 -1.008 . . . . 0.0 111.47 -178.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.884 ' O ' HG13 ' A' ' 96' ' ' VAL . 0.0 OUTLIER 174.38 105.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.496 -1.377 . . . . 0.0 110.444 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.813 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -116.54 88.03 2.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.506 -0.746 . . . . 0.0 109.172 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -121.65 84.19 2.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 0.0 109.766 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 115.36 -137.76 14.14 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mp -102.28 4.38 39.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.26 -1.141 . . . . 0.0 109.674 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.458 ' CZ ' HG21 ' A' ' 60' ' ' ILE . 1.3 t80 -124.4 131.96 53.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.206 -0.934 . . . . 0.0 109.212 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.946 HG12 ' CD2' ' A' ' 98' ' ' LEU . 22.0 t -132.8 145.86 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.153 -0.967 . . . . 0.0 110.213 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.951 ' O ' HD23 ' A' ' 98' ' ' LEU . 2.0 m-20 -112.8 141.2 46.88 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.951 HD23 ' O ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -165.2 178.91 6.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.592 -1.317 . . . . 0.0 112.041 -178.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.534 ' HB3' ' N ' ' A' ' 64' ' ' TYR . 3.1 ptt-85 -134.89 104.05 5.84 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.082 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.995 ' HB2' HG22 ' A' ' 86' ' ' THR . 1.2 ptt180 -51.91 159.44 0.85 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.915 -1.115 . . . . 0.0 109.518 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.44 ' O ' ' HB2' ' A' ' 102' ' ' PHE . 0.1 OUTLIER -158.66 131.44 7.09 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.932 . . . . 0.0 109.453 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 85' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.544 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tpp . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.06 152.74 51.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.235 -0.915 . . . . 0.0 109.496 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.2 m -50.8 132.06 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.307 -0.871 . . . . 0.0 109.642 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.7 mp -125.02 85.3 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.499 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -133.37 147.28 64.27 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.552 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.87 -174.51 2.31 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.638 2.225 . . . . 0.0 110.224 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.0 t 179.88 -56.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 109.619 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.3 p -96.62 -31.58 12.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.223 -0.923 . . . . 0.0 109.62 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.5 mtm105 61.86 84.91 0.18 Allowed Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.903 . . . . 0.0 109.411 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 11' ' ' ARG . 35.5 Cg_endo -78.34 116.08 3.81 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.699 2.266 . . . . 0.0 110.353 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.537 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 4.9 ttt180 44.4 61.49 11.12 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.368 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 35.8 Cg_endo -78.11 162.49 28.77 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.654 2.236 . . . . 0.0 110.482 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -74.16 148.29 41.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.328 -0.858 . . . . 0.0 109.263 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -47.85 148.01 1.77 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.539 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -120.69 113.44 20.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 109.439 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 ttmm -82.65 178.51 8.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.318 -0.864 . . . . 0.0 109.512 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -152.3 33.62 0.52 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 109.407 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 18' ' ' ILE . 23.0 pt -115.06 33.81 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.27 -0.894 . . . . 0.0 109.365 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -177.37 98.71 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.898 . . . . 0.0 109.589 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.02 143.8 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.255 -0.903 . . . . 0.0 109.251 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.28 86.25 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.3 m -85.93 -59.85 2.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.249 -0.907 . . . . 0.0 109.464 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -52.73 173.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.25 -0.906 . . . . 0.0 109.387 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -148.22 144.09 27.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.192 -0.943 . . . . 0.0 109.555 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.451 ' O ' HG22 ' A' ' 25' ' ' THR . 17.9 m 54.23 88.77 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 109.464 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 t -135.17 40.42 2.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.316 -0.865 . . . . 0.0 109.457 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.26 109.94 19.9 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 109.437 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.9 mtt -76.06 122.56 24.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -0.936 . . . . 0.0 109.5 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.78 -0.3 4.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.274 -0.891 . . . . 0.0 109.701 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.448 HD22 ' HA ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER 59.38 102.07 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.172 -0.955 . . . . 0.0 109.341 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.89 150.25 37.23 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 109.619 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -79.12 175.15 11.19 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.734 2.289 . . . . 0.0 110.45 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.72 20.71 4.89 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.76 161.94 34.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -1.14 . . . . 0.0 109.386 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.733 HG12 ' HG3' ' A' ' 87' ' ' ARG . 9.6 m -118.29 170.4 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.576 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 35' ' ' VAL . 11.0 m-70 -172.55 168.16 5.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.531 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -99.17 147.31 25.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.6 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -158.75 175.67 35.74 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.705 HG23 ' O ' ' A' ' 81' ' ' GLY . 6.0 mt -98.04 151.25 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.313 -1.11 . . . . 0.0 109.053 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.567 ' CG2' HD12 ' A' ' 84' ' ' ILE . 66.9 t -99.72 147.16 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.059 -1.026 . . . . 0.0 110.19 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.56 172.29 14.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.438 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -119.88 135.2 54.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.928 . . . . 0.0 109.545 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 44' ' ' ASP . 0.3 OUTLIER 175.07 154.09 0.14 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 109.62 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER 66.97 9.58 6.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.275 -0.891 . . . . 0.0 109.696 179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.19 -15.75 47.5 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.438 HG13 ' N ' ' A' ' 47' ' ' PHE . 35.3 pt -112.03 -147.41 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -1.176 . . . . 0.0 109.103 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.562 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 2.0 m-85 -111.6 173.91 6.12 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.119 -0.988 . . . . 0.0 109.217 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 60' ' ' ILE . 1.8 mttp -148.08 127.2 12.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.168 -0.958 . . . . 0.0 109.638 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 39' ' ' ILE . 2.4 t -101.68 111.63 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.427 -0.796 . . . . 0.0 109.287 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.54 130.63 45.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -0.965 . . . . 0.0 109.24 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.2 OUTLIER -92.7 93.4 8.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.161 -0.962 . . . . 0.0 109.554 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 53' ' ' GLY . 1.5 tt -66.35 143.11 57.36 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.189 -0.945 . . . . 0.0 109.461 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.436 ' N ' ' HG ' ' A' ' 52' ' ' LEU . . . 110.81 -43.19 1.77 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 55' ' ' GLU . 14.7 m-85 -88.6 -27.31 21.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.243 -1.151 . . . . 0.0 109.391 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.441 ' O ' ' O ' ' A' ' 54' ' ' TYR . 38.3 tt0 61.71 123.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 0.0 109.269 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 58' ' ' GLU . . . 97.27 -39.24 2.83 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -59.86 88.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -1.13 . . . . 0.0 109.33 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 56' ' ' GLY . 32.0 tt0 -104.02 104.02 13.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.447 -0.783 . . . . 0.0 109.438 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 44.4 m -99.04 155.39 17.46 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 109.095 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 48' ' ' LYS . 32.9 pt -118.55 136.44 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 109.229 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.562 ' HB3' ' CB ' ' A' ' 47' ' ' PHE . 14.8 tp -98.02 110.38 22.97 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.105 -0.997 . . . . 0.0 109.053 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.655 HD23 ' C ' ' A' ' 62' ' ' LEU . 7.5 tt -118.6 -38.02 3.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.474 -0.766 . . . . 0.0 109.381 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.563 ' CB ' ' HB2' ' A' ' 99' ' ' ARG . 2.7 t70 -61.9 -56.36 20.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -0.879 . . . . 0.0 109.212 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.566 ' HB2' ' CB ' ' A' ' 100' ' ' ARG . 0.6 OUTLIER -118.43 54.7 0.93 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.639 -179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.744 HD23 ' H ' ' A' ' 65' ' ' LEU . 1.9 pt? -64.11 -21.95 66.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.967 . . . . 0.0 109.383 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.425 ' N ' ' HG ' ' A' ' 65' ' ' LEU . 45.9 p30 -166.94 -174.36 2.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.312 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.453 ' O ' ' O ' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -135.88 100.07 4.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.676 -179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 67' ' ' TYR . 1.5 mtm105 42.75 -164.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.347 -0.846 . . . . 0.0 109.645 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 70' ' ' ASP . 0.5 OUTLIER -154.73 -165.29 2.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.369 -0.832 . . . . 0.0 109.509 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 69' ' ' GLN . 3.0 t0 176.13 -70.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.521 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.515 ' O ' ' CB ' ' A' ' 72' ' ' LEU . 4.8 t -176.42 163.5 2.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.925 . . . . 0.0 109.374 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.515 ' CB ' ' O ' ' A' ' 71' ' ' THR . 0.3 OUTLIER 75.86 44.13 0.15 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.207 -0.933 . . . . 0.0 109.389 -179.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -8.77 30.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.246 -0.909 . . . . 0.0 109.64 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.5 mmt85 -61.49 -39.19 90.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.164 -0.96 . . . . 0.0 109.38 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.67 -26.76 66.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.258 -0.901 . . . . 0.0 109.266 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.677 ' O ' HG23 ' A' ' 80' ' ' VAL . 3.0 tttp -64.76 -30.63 71.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.387 -0.821 . . . . 0.0 109.769 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -48.77 80.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.0 109.82 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -31.26 64.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.716 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.456 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -58.3 -50.97 71.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.177 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 76' ' ' LYS . 21.9 t -43.59 164.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.324 -0.86 . . . . 0.0 109.06 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 86.15 -47.5 3.77 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -38.95 159.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.641 -0.917 . . . . 0.0 110.008 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 38' ' ' GLY . 22.2 t -98.48 141.46 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 109.028 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.772 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -141.45 166.86 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.822 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -103.59 106.97 17.63 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.723 HG22 ' CG ' ' A' ' 100' ' ' ARG . 1.3 p -118.08 174.77 6.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.602 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.744 ' O ' HD13 ' A' ' 98' ' ' LEU . 2.5 mpt_? -98.93 162.96 12.8 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.307 -0.871 . . . . 0.0 109.21 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.9 129.33 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.275 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.562 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 57.2 t -85.27 -34.1 8.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.401 -0.812 . . . . 0.0 109.742 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.535 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER 162.85 113.69 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.301 -0.874 . . . . 0.0 109.215 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.454 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -98.45 151.48 20.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.583 -0.698 . . . . 0.0 109.437 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -127.0 -69.32 0.76 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 109.326 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.455 ' C ' HD12 ' A' ' 94' ' ' LEU . . . -141.35 -75.31 0.04 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.455 HD12 ' C ' ' A' ' 93' ' ' GLY . 8.4 mp -111.52 -25.23 9.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -1.115 . . . . 0.0 109.172 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -100.4 135.57 41.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.037 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.457 ' HB ' ' SG ' ' A' ' 59' ' ' CYS . 58.1 t -140.02 151.86 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.101 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.562 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 94.1 m-20 -98.49 155.57 17.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 108.624 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.744 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.39 139.25 35.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.821 -1.175 . . . . 0.0 110.831 -178.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.563 ' HB2' ' CB ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -144.06 125.46 14.78 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.723 ' CG ' HG22 ' A' ' 86' ' ' THR . 3.8 ttt-85 -87.75 170.62 11.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.0 109.486 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.464 ' O ' ' OXT' ' A' ' 102' ' ' PHE . 3.3 t80 -172.82 75.57 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 0.0 109.482 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.464 ' OXT' ' O ' ' A' ' 101' ' ' PHE . 3.2 m-85 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.551 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.7 ptt? . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.0 m 53.08 42.52 32.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.375 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.4 t -92.55 103.02 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.89 . . . . 0.0 109.534 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 mt -98.31 -72.15 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.518 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -158.19 77.59 3.45 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.185 -0.947 . . . . 0.0 109.381 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.9 -161.83 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.644 2.229 . . . . 0.0 110.537 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.4 p -129.31 23.15 5.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.279 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.6 p -94.1 157.04 16.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.63 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -153.91 152.39 26.76 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.323 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.64 -24.25 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.643 2.229 . . . . 0.0 110.663 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.62 82.82 20.51 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.132 -0.98 . . . . 0.0 109.631 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.33 -33.26 1.97 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.714 2.276 . . . . 0.0 110.318 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 178.61 127.35 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.387 -0.821 . . . . 0.0 109.293 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -165.92 62.13 0.11 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.436 ' O ' ' O ' ' A' ' 16' ' ' LYS . 88.0 m-20 -87.69 100.5 12.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.423 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 15' ' ' ASN . 0.9 OUTLIER 54.67 104.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.538 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.405 ' C ' ' OD1' ' A' ' 17' ' ' ASN . 20.3 t-20 -151.46 107.3 3.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 109.519 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' A' ' 19' ' ' LYS . 3.3 mt -52.85 152.95 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 18' ' ' ILE . 0.4 OUTLIER 68.73 115.6 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.198 -0.939 . . . . 0.0 109.399 -179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.6 m -112.25 156.45 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.232 -0.917 . . . . 0.0 109.586 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.1 t30 51.1 -158.77 0.1 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.243 -0.911 . . . . 0.0 109.752 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -156.27 148.81 23.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.426 -0.796 . . . . 0.0 109.099 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.452 ' O ' ' O ' ' A' ' 22' ' ' THR . 4.8 t80 61.41 119.16 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.212 -0.93 . . . . 0.0 109.003 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -115.23 166.52 11.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 109.645 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.96 1.37 45.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.357 -0.84 . . . . 0.0 109.596 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -86.28 154.84 20.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.449 -179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 26' ' ' SER . . . 61.28 140.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 109.432 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.52 153.1 21.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.473 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.21 0.16 57.03 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.568 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.828 HD23 ' HB3' ' A' ' 91' ' ' ALA . 7.1 tp -50.01 -70.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.0 109.498 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.03 74.54 0.9 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.424 -0.797 . . . . 0.0 109.455 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.38 118.96 4.4 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.656 2.237 . . . . 0.0 110.378 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 44.63 48.53 8.89 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.56 162.15 17.12 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.238 -1.154 . . . . 0.0 109.577 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.727 HG13 ' HD2' ' A' ' 87' ' ' ARG . 1.9 t -109.33 156.23 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.326 -0.858 . . . . 0.0 109.441 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.3 169.58 20.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.613 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 154.5 17.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 109.234 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -168.67 176.58 42.91 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.693 HG23 ' O ' ' A' ' 81' ' ' GLY . 32.3 mt -97.1 148.29 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -1.142 . . . . 0.0 108.719 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.545 ' CG2' HG12 ' A' ' 84' ' ' ILE . 59.7 t -98.54 146.96 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.024 -1.048 . . . . 0.0 110.42 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -139.77 150.42 44.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.386 -0.821 . . . . 0.0 109.153 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -119.98 124.73 46.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.038 . . . . 0.0 109.671 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.422 ' O ' HG13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -163.21 144.71 9.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 59.86 13.82 3.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.393 -0.817 . . . . 0.0 109.833 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.41 -22.22 21.22 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 43' ' ' LYS . 2.7 pt -91.06 -179.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -1.164 . . . . 0.0 109.178 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.608 ' HB2' HD23 ' A' ' 61' ' ' LEU . 7.2 m-85 -109.45 167.75 9.9 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.207 -0.933 . . . . 0.0 109.511 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.947 ' HG3' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -143.13 131.92 22.69 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.356 -0.84 . . . . 0.0 109.442 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.552 HG21 ' HG ' ' A' ' 98' ' ' LEU . 15.6 t -106.96 116.72 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.52 127.68 44.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.314 -0.866 . . . . 0.0 109.313 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 57' ' ' HIS . 0.7 OUTLIER -96.13 70.56 2.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.052 -1.03 . . . . 0.0 109.567 -179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.407 ' HA ' HD13 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -58.2 139.16 55.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.226 -0.921 . . . . 0.0 109.324 179.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.74 -17.52 15.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.28 -30.08 7.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -1.131 . . . . 0.0 109.266 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 66.05 90.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 0.0 109.622 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 120.56 -11.05 10.44 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 51' ' ' LEU . 1.3 t-160 -92.26 87.87 6.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -1.132 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -107.94 107.79 18.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.26 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 2.9 m -104.37 165.39 11.09 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.278 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.947 HG22 ' HG3' ' A' ' 48' ' ' LYS . 1.6 pt -129.24 134.11 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.335 -0.853 . . . . 0.0 108.932 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.608 HD23 ' HB2' ' A' ' 47' ' ' PHE . 0.5 OUTLIER -97.93 120.56 38.55 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.99 -1.069 . . . . 0.0 109.19 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.476 ' CD2' HD12 ' A' ' 60' ' ' ILE . 2.9 pp -155.47 -35.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.346 -0.846 . . . . 0.0 109.684 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.472 ' N ' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -49.93 -40.31 43.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.117 179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.484 ' HB2' ' HG3' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -136.97 69.7 1.41 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.617 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 62' ' ' LEU . 1.3 mp -59.0 -46.78 87.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.459 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 66.33 131.83 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.918 . . . . 0.0 109.548 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -130.16 136.72 49.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.43 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -108.97 31.09 5.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.232 -0.917 . . . . 0.0 109.488 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 68' ' ' ARG . 3.1 mp0 63.64 -92.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.703 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.403 ' CB ' ' O ' ' A' ' 69' ' ' GLN . 18.4 t0 70.22 137.02 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.169 -0.957 . . . . 0.0 109.338 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 71' ' ' THR . 1.6 t -65.52 88.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.242 -0.911 . . . . 0.0 109.595 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 67.14 8.3 6.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.641 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.65 37.81 15.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.406 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.64 -52.41 57.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 109.473 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 mp -75.92 -34.09 59.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.205 -0.934 . . . . 0.0 109.438 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.613 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -63.87 -28.29 69.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.206 -0.934 . . . . 0.0 109.493 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.439 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 5.0 mm-40 -59.64 -46.12 89.96 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.194 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.53 -26.58 55.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.345 -0.847 . . . . 0.0 109.452 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.653 HD23 ' HG3' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -63.96 -40.05 95.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.23 -0.919 . . . . 0.0 109.392 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 76' ' ' LYS . 15.1 t -40.91 162.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.482 -0.761 . . . . 0.0 109.667 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.693 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 85.76 -47.42 3.79 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.653 ' HG3' HD23 ' A' ' 79' ' ' LEU . 25.7 mmt180 -38.18 164.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.771 -0.84 . . . . 0.0 110.592 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 6.4 m -96.89 130.96 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.289 -0.882 . . . . 0.0 108.869 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.644 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.5 pp -135.67 174.64 12.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 109.74 -179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.59 144.26 33.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.044 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.737 ' HB ' HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -152.38 173.62 14.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.256 -0.903 . . . . 0.0 109.534 -179.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.752 ' O ' HD13 ' A' ' 98' ' ' LEU . 10.4 mpt_? -99.96 156.06 17.35 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.239 -0.913 . . . . 0.0 109.367 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 6.9 t -96.96 119.79 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.315 -0.865 . . . . 0.0 108.995 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.783 HG11 ' OD2' ' A' ' 97' ' ' ASP . 75.4 t -77.6 -31.22 17.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.374 -0.829 . . . . 0.0 109.928 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 1.6 ttm180 170.23 106.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.35 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.828 ' HB3' HD23 ' A' ' 30' ' ' LEU . . . -88.12 133.82 33.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.416 -0.803 . . . . 0.0 109.172 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -166.66 88.31 0.34 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.249 -0.907 . . . . 0.0 109.587 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.67 -177.89 33.42 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.5 mp -58.9 -16.23 16.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -1.135 . . . . 0.0 109.662 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -108.52 127.96 54.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.644 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.753 HG22 ' HA ' ' A' ' 91' ' ' ALA . 55.4 t -129.6 158.97 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.336 -0.852 . . . . 0.0 109.356 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.783 ' OD2' HG11 ' A' ' 89' ' ' VAL . 28.7 t0 -98.59 147.72 24.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.149 -0.97 . . . . 0.0 108.742 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.752 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -132.76 135.51 45.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.04 -1.037 . . . . 0.0 111.088 -178.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.549 ' HB2' ' CG2' ' A' ' 89' ' ' VAL . 4.7 ttp-105 -132.63 129.41 38.85 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.507 ' HB2' HG23 ' A' ' 86' ' ' THR . 0.4 OUTLIER -100.77 149.31 23.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.021 -1.049 . . . . 0.0 109.732 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.416 ' N ' ' HG3' ' A' ' 100' ' ' ARG . 0.7 OUTLIER -142.89 147.66 35.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.342 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.441 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.18 39.24 1.43 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.924 . . . . 0.0 109.379 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 3' ' ' VAL . 7.4 p -79.89 135.35 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.385 -0.822 . . . . 0.0 109.352 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.509 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 65.2 mt -54.84 -36.8 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 109.27 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.509 ' CB ' ' O ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER 164.46 142.24 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.346 -0.847 . . . . 0.0 109.257 179.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.78 -165.82 0.35 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.556 2.171 . . . . 0.0 110.479 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 73.6 m -125.85 48.29 2.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.403 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.1 59.05 0.83 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.313 -0.867 . . . . 0.0 109.522 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -63.73 160.66 43.03 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.94 140.55 18.27 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.691 2.261 . . . . 0.0 110.494 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.477 ' N ' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -140.3 64.27 24.89 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.288 179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 35.5 Cg_endo -77.45 134.6 14.07 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.735 2.29 . . . . 0.0 110.484 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -176.95 35.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.272 -0.892 . . . . 0.0 109.297 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 15' ' ' ASN . 1.1 ptmt -115.89 170.28 8.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.904 . . . . 0.0 109.552 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 10.2 t30 170.78 138.44 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.05 -175.5 2.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.37 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -120.58 167.92 11.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.614 HG22 ' N ' ' A' ' 19' ' ' LYS . 1.8 mp -132.15 -86.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.349 -0.844 . . . . 0.0 109.286 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.614 ' N ' HG22 ' A' ' 18' ' ' ILE . 6.3 mttp -51.67 162.83 0.35 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.282 -0.886 . . . . 0.0 109.506 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 21' ' ' ASN . 14.7 m -132.3 -149.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.481 ' N ' HG23 ' A' ' 20' ' ' VAL . 36.7 t30 -132.22 120.57 22.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 0.0 109.383 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -126.73 52.26 1.78 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.399 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER 57.94 41.43 24.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.28 -0.887 . . . . 0.0 109.36 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.01 -80.15 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.358 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 54.5 m -113.42 99.88 8.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.938 . . . . 0.0 109.327 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.6 p -143.57 81.51 1.7 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.958 . . . . 0.0 109.537 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.51 37.14 4.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.277 -0.89 . . . . 0.0 109.295 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.422 ' O ' ' CG ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -87.63 124.05 33.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.581 -179.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.422 ' CG ' ' O ' ' A' ' 28' ' ' MET . 6.1 m-20 -158.72 -74.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.289 -0.882 . . . . 0.0 109.414 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.637 HD22 HG11 ' A' ' 88' ' ' VAL . 0.2 OUTLIER -137.78 162.33 34.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.593 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.469 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -152.77 168.83 10.65 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.33 -0.857 . . . . 0.0 109.354 -179.952 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 31' ' ' SER . 35.1 Cg_endo -78.03 127.18 8.34 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.529 2.153 . . . . 0.0 110.411 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.52 83.04 1.0 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 t -168.74 150.56 4.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -1.161 . . . . 0.0 109.37 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.476 HG12 ' N ' ' A' ' 36' ' ' HIS . 20.2 t -102.55 163.33 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.381 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.476 ' N ' HG12 ' A' ' 35' ' ' VAL . 0.4 OUTLIER -172.86 163.85 5.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.202 -0.936 . . . . 0.0 109.772 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -101.35 142.05 33.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.387 -0.821 . . . . 0.0 109.305 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.473 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -153.53 176.6 31.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.511 HG23 ' O ' ' A' ' 81' ' ' GLY . 28.5 mt -97.31 154.58 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -1.21 . . . . 0.0 108.9 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.501 HG23 HG13 ' A' ' 84' ' ' ILE . 77.0 t -98.66 150.61 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.084 -1.01 . . . . 0.0 110.16 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.538 ' HB3' ' CB ' ' A' ' 48' ' ' LYS . 42.9 t80 -141.98 155.03 45.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.344 -0.847 . . . . 0.0 109.142 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.506 ' O ' ' CG ' ' A' ' 42' ' ' PHE . 28.3 p90 -106.64 124.7 50.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.181 -0.95 . . . . 0.0 109.589 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.53 ' CG ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -98.51 -165.22 1.22 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.184 -0.948 . . . . 0.0 109.299 179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -79.07 6.17 10.14 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.32 -0.862 . . . . 0.0 109.211 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 174.06 -26.62 0.08 OUTLIER Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.623 HG22 HD13 ' A' ' 62' ' ' LEU . 3.0 pt -109.54 -174.56 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.0 -1.294 . . . . 0.0 109.687 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.43 ' CB ' ' HB3' ' A' ' 61' ' ' LEU . 5.6 m-85 -107.54 159.18 16.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 109.374 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.553 ' HG3' HG22 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -133.47 128.37 35.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.17 -0.956 . . . . 0.0 109.761 -179.884 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.587 HG21 ' HG ' ' A' ' 98' ' ' LEU . 1.8 t -106.18 118.93 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 108.878 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.53 121.04 40.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 109.855 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.542 HD13 ' SG ' ' A' ' 59' ' ' CYS . 0.5 OUTLIER -88.28 72.64 8.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.204 -0.935 . . . . 0.0 109.227 179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.72 129.13 38.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.312 -0.868 . . . . 0.0 109.577 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.69 -33.99 4.56 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.43 -71.02 0.41 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.217 -1.167 . . . . 0.0 109.531 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -178.31 55.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 109.556 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.42 7.79 48.01 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -47.75 118.06 2.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.179 -1.189 . . . . 0.0 109.171 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 95' ' ' TYR . 7.4 tt0 -106.34 111.11 23.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 109.691 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.542 ' SG ' HD13 ' A' ' 51' ' ' LEU . 13.0 m -109.95 165.91 11.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.831 . . . . 0.0 109.315 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.553 HG22 ' HG3' ' A' ' 48' ' ' LYS . 1.6 pt -133.95 135.53 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.896 . . . . 0.0 109.49 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.654 HD12 ' HB3' ' A' ' 98' ' ' LEU . 3.9 tp -98.56 127.83 44.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.623 HD13 HG22 ' A' ' 46' ' ' ILE . 13.8 tp -143.98 -45.71 0.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.346 -0.847 . . . . 0.0 109.463 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' HB3' ' CG ' ' A' ' 99' ' ' ARG . 0.6 OUTLIER -53.0 -35.57 59.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 109.349 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.63 ' CB ' HD21 ' A' ' 61' ' ' LEU . 6.0 t80 -43.81 -68.25 0.21 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.267 -0.895 . . . . 0.0 109.433 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 mp -54.13 -59.97 3.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.495 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.53 29.93 19.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 0.0 109.555 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.63 65.05 1.62 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.792 179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.486 ' HG3' ' OE1' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -143.52 94.7 2.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.222 -0.924 . . . . 0.0 109.185 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.486 ' OE1' ' HG3' ' A' ' 68' ' ' ARG . 17.8 mp0 60.8 151.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.041 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -115.26 -58.72 2.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.148 -0.97 . . . . 0.0 109.687 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.71 96.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.165 -0.959 . . . . 0.0 109.168 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -43.48 98.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.556 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.417 ' HB3' ' HB2' ' A' ' 76' ' ' LYS . 0.4 OUTLIER 51.62 77.04 0.15 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.266 -0.896 . . . . 0.0 109.655 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -44.74 -26.95 0.44 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.59 -49.56 39.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.892 . . . . 0.0 109.555 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.725 ' O ' HG23 ' A' ' 80' ' ' VAL . 21.9 tptt -58.35 -26.68 63.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.728 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.62 -56.54 17.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 109.915 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.65 -26.74 57.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.139 -0.976 . . . . 0.0 110.044 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 80' ' ' VAL . 8.0 tp -65.82 -28.79 69.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.152 -0.967 . . . . 0.0 109.735 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 76' ' ' LYS . 43.2 t -43.23 165.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 0.0 109.434 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.568 ' N ' HG12 ' A' ' 80' ' ' VAL . . . 85.67 -45.61 3.51 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.492 ' O ' ' O ' ' A' ' 81' ' ' GLY . 2.8 mmt180 -43.15 172.17 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.647 -0.914 . . . . 0.0 110.382 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 38' ' ' GLY . 56.0 t -97.57 139.22 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.267 -0.895 . . . . 0.0 109.222 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.889 HD13 HG23 ' A' ' 86' ' ' THR . 2.0 pp -136.75 166.64 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.257 -0.902 . . . . 0.0 109.7 -179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 85' ' ' LYS . 15.6 ptpt -101.7 128.58 47.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 109.07 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.889 HG23 HD13 ' A' ' 84' ' ' ILE . 40.6 p -141.89 175.43 9.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.127 -0.983 . . . . 0.0 109.851 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.802 ' O ' HD13 ' A' ' 98' ' ' LEU . 3.8 mpt_? -101.48 161.59 13.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.486 -0.759 . . . . 0.0 109.426 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.637 HG11 HD22 ' A' ' 30' ' ' LEU . 5.2 t -97.75 110.39 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.338 -0.851 . . . . 0.0 109.003 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.575 HG23 ' N ' ' A' ' 99' ' ' ARG . 41.1 t -65.62 -40.29 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.354 -0.841 . . . . 0.0 110.103 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.49 103.66 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 109.501 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.763 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -82.76 122.18 27.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.338 -0.851 . . . . 0.0 109.527 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 91' ' ' ALA . 0.4 OUTLIER -156.26 92.19 1.31 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.904 . . . . 0.0 109.286 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.5 -177.33 33.26 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -15.77 41.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.237 -1.155 . . . . 0.0 109.445 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 58' ' ' GLU . 0.5 OUTLIER -107.35 125.81 51.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 109.191 179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.763 HG13 ' HA ' ' A' ' 91' ' ' ALA . 74.2 t -122.79 160.86 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.888 . . . . 0.0 109.468 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.56 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 0.9 OUTLIER -97.91 148.01 23.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.109 -0.994 . . . . 0.0 108.576 179.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -133.01 135.56 45.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.066 -1.021 . . . . 0.0 110.677 -178.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.575 ' N ' HG23 ' A' ' 89' ' ' VAL . 4.0 ttp85 -132.84 120.61 21.78 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.544 ' HG3' HG22 ' A' ' 86' ' ' THR . 0.2 OUTLIER -82.21 163.97 21.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.154 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -120.39 139.05 53.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.127 -0.983 . . . . 0.0 109.643 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.401 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 ttm . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.3 m -163.79 -50.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.904 . . . . 0.0 109.647 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 p -162.48 127.8 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.927 . . . . 0.0 109.539 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.08 24.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.094 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -143.88 71.78 16.9 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.783 . . . . 0.0 109.427 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.12 -164.18 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.614 2.209 . . . . 0.0 110.393 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.7 t -110.07 79.97 1.26 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.175 -0.953 . . . . 0.0 109.789 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.0 m -115.96 -76.97 0.57 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.333 -0.854 . . . . 0.0 108.998 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.19 80.99 0.27 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.457 -0.777 . . . . 0.0 110.159 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -79.0 -176.46 3.3 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.607 2.205 . . . . 0.0 109.837 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -130.61 76.64 77.09 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.035 -1.041 . . . . 0.0 109.745 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.91 -20.49 10.24 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.694 2.263 . . . . 0.0 110.231 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.17 83.12 8.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.317 -0.864 . . . . 0.0 109.55 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 57.63 3.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 109.476 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.45 48.68 1.64 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.9 . . . . 0.0 109.524 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.94 100.27 11.15 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.27 -0.894 . . . . 0.0 109.332 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -153.55 -57.32 0.12 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.604 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.6 tt -112.22 161.56 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -0.887 . . . . 0.0 109.642 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -151.26 130.52 12.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.951 . . . . 0.0 109.366 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.1 t -76.12 110.57 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -0.916 . . . . 0.0 109.611 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -150.01 138.67 20.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.326 -0.859 . . . . 0.0 109.23 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.23 106.62 0.64 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.239 -0.913 . . . . 0.0 109.815 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.91 129.89 44.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.854 . . . . 0.0 108.983 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 34.2 mtt85 -99.54 -1.68 37.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.172 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' A' ' 26' ' ' SER . 7.3 m -86.83 51.87 2.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.052 -1.03 . . . . 0.0 109.54 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 93.7 p 178.21 166.02 0.76 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.645 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 26' ' ' SER . . . 64.95 38.95 6.09 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.813 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.1 ttp -90.67 -28.72 18.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.192 -0.943 . . . . 0.0 109.507 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.2 -157.81 0.33 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.514 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.47 -177.4 1.47 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.283 -0.886 . . . . 0.0 109.222 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.0 m -155.3 151.07 21.84 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.045 -1.035 . . . . 0.0 109.643 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.08 150.95 26.72 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.657 2.238 . . . . 0.0 110.394 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.12 48.61 4.02 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.89 129.59 52.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -1.178 . . . . 0.0 109.515 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.716 HG12 ' CD ' ' A' ' 87' ' ' ARG . 16.5 m -99.56 136.65 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.0 109.548 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 35' ' ' VAL . 5.7 m-70 -147.7 166.74 26.55 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.211 -0.931 . . . . 0.0 109.449 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.05 152.01 21.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.516 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -163.89 176.41 39.93 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.864 HG23 ' O ' ' A' ' 81' ' ' GLY . 76.6 mt -96.83 146.72 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.335 -1.097 . . . . 0.0 108.356 179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.517 ' O ' ' HA2' ' A' ' 81' ' ' GLY . 57.2 t -99.46 137.67 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.963 -1.086 . . . . 0.0 110.591 -178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 2.9 t80 -122.46 154.57 37.63 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.0 109.043 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.502 ' O ' ' CG ' ' A' ' 42' ' ' PHE . 12.8 p90 -112.69 124.42 52.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.182 -0.948 . . . . 0.0 109.641 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.521 ' O ' ' CB ' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -178.55 137.2 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.93 . . . . 0.0 109.694 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 43' ' ' LYS . 26.5 t0 76.06 6.26 3.72 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.217 -0.927 . . . . 0.0 109.692 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.65 -26.99 9.28 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 47' ' ' PHE . 2.0 pt -92.83 -156.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.345 -1.091 . . . . 0.0 108.923 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.947 ' HB2' HD23 ' A' ' 61' ' ' LEU . 76.1 m-85 -127.05 171.99 10.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.959 -1.088 . . . . 0.0 109.43 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.812 ' HE3' HG22 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -136.79 125.4 23.73 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.251 -0.906 . . . . 0.0 109.669 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.875 HG23 ' HB2' ' A' ' 61' ' ' LEU . 92.9 t -98.07 105.81 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.115 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.492 ' CG ' ' HB ' ' A' ' 39' ' ' ILE . 2.3 ptm85 -101.34 128.9 47.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.7 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.26 85.54 7.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.331 -0.856 . . . . 0.0 109.364 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.51 ' HB2' HD12 ' A' ' 39' ' ' ILE . 2.6 tt -62.84 149.07 45.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.212 -0.93 . . . . 0.0 109.538 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.48 -55.18 0.84 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -75.06 -27.8 60.11 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.244 -1.151 . . . . 0.0 109.515 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 54' ' ' TYR . 20.3 mt-10 48.87 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.35 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.88 -17.76 3.2 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.7 92.86 5.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.191 -1.182 . . . . 0.0 109.53 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -102.65 109.06 20.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.339 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.537 ' HB3' HD23 ' A' ' 98' ' ' LEU . 3.5 m -107.05 145.65 32.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.908 . . . . 0.0 109.512 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.812 HG22 ' HE3' ' A' ' 48' ' ' LYS . 30.0 pt -99.56 135.95 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.337 -0.852 . . . . 0.0 109.0 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.947 HD23 ' HB2' ' A' ' 47' ' ' PHE . 25.2 tp -98.61 107.89 20.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.238 -0.914 . . . . 0.0 110.183 -179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.559 HD21 HD12 ' A' ' 60' ' ' ILE . 3.4 mt -103.29 4.81 36.95 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.506 -0.746 . . . . 0.0 109.069 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 0.5 OUTLIER 58.23 36.61 25.84 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 63' ' ' ASP . 6.6 t80 67.78 28.57 7.11 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.381 -0.825 . . . . 0.0 109.103 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -44.72 -72.14 0.06 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.565 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 57.62 -92.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.975 . . . . 0.0 109.567 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -153.95 28.81 0.47 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.922 . . . . 0.0 109.757 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -128.88 161.72 29.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.103 -0.998 . . . . 0.0 109.54 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -74.16 161.69 29.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.305 -0.872 . . . . 0.0 109.731 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 48.3 p-10 -156.35 154.31 30.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.3 -0.875 . . . . 0.0 109.376 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.9 m -139.97 98.6 3.49 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.23 -0.919 . . . . 0.0 109.543 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -159.44 27.64 0.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.33 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -74.49 -17.39 60.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.26 -0.9 . . . . 0.0 109.316 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -51.53 -36.05 43.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.34 -0.85 . . . . 0.0 109.418 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.466 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -46.1 -45.5 16.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.612 -179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -43.23 -66.46 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.274 -0.891 . . . . 0.0 109.783 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -57.83 -30.55 65.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 0.0 109.869 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.455 ' HB2' ' HA ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -55.18 -56.8 15.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 109.586 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER 173.21 60.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.24 -0.912 . . . . 0.0 109.39 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.557 ' CG2' ' N ' ' A' ' 81' ' ' GLY . 1.0 OUTLIER -43.04 165.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.393 -0.817 . . . . 0.0 109.31 -179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.864 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 86.5 -47.45 3.74 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.493 ' O ' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -36.97 161.65 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.966 -0.726 . . . . 0.0 110.69 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 38' ' ' GLY . 99.5 t -97.14 136.62 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.281 -0.887 . . . . 0.0 108.967 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.712 HD13 HG23 ' A' ' 86' ' ' THR . 2.3 pp -138.96 174.93 8.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.334 -0.854 . . . . 0.0 109.883 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.47 141.22 39.23 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.372 -0.83 . . . . 0.0 109.198 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.712 HG23 HD13 ' A' ' 84' ' ' ILE . 19.0 p -151.37 175.26 12.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.192 -0.943 . . . . 0.0 109.315 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.831 ' O ' HD13 ' A' ' 98' ' ' LEU . 1.2 mmm-85 -98.68 158.03 15.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.271 -0.893 . . . . 0.0 109.265 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.6 t -98.28 110.1 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.564 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 26.9 t -63.08 -36.23 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.429 -0.794 . . . . 0.0 109.7 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.443 ' CB ' ' O ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER 168.97 106.84 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.237 -0.914 . . . . 0.0 109.362 -179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.787 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -91.96 117.27 29.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.424 -0.797 . . . . 0.0 109.235 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -103.4 -62.74 1.25 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.645 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -146.09 -115.79 0.95 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.04 -23.97 60.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -1.106 . . . . 0.0 109.466 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.53 129.19 55.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.122 -0.986 . . . . 0.0 109.529 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.787 HG13 ' HA ' ' A' ' 91' ' ' ALA . 95.0 t -131.41 158.34 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.33 -0.856 . . . . 0.0 109.472 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.564 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 9.5 m-20 -101.04 143.39 31.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.198 -0.939 . . . . 0.0 108.625 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.831 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -130.14 136.91 49.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.904 -1.122 . . . . 0.0 110.659 -178.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.536 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 1.0 OUTLIER -126.35 119.63 27.8 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 108.89 178.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.497 ' HG3' HG22 ' A' ' 86' ' ' THR . 0.2 OUTLIER -76.31 129.36 36.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.021 -1.05 . . . . 0.0 109.695 -179.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 101' ' ' PHE . 6.5 m-30 61.43 166.47 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -0.854 . . . . 0.0 109.636 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.9 t80 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.486 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 77.5 p -137.6 18.67 2.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.442 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.3 -45.93 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.87 . . . . 0.0 109.43 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.7 tt -141.4 143.84 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.94 . . . . 0.0 109.444 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.3 153.28 48.54 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 109.514 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.26 -64.97 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.677 2.251 . . . . 0.0 110.252 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.82 -151.02 0.37 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.291 -0.881 . . . . 0.0 109.376 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.8 m -142.1 147.55 36.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.228 -0.92 . . . . 0.0 109.431 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.574 ' N ' ' HD2' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -66.41 -52.03 39.07 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.298 -0.876 . . . . 0.0 109.916 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 9' ' ' ARG . 35.4 Cg_endo -78.53 109.65 2.68 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.43 2.087 . . . . 0.0 110.831 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? 62.31 91.66 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.327 -0.858 . . . . 0.0 109.957 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.52 -176.55 3.33 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.531 2.154 . . . . 0.0 110.283 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.44 53.52 0.26 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.456 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -46.79 -49.09 20.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -136.73 177.13 8.1 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -91.86 -8.6 46.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.491 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -156.09 123.17 5.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.489 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 19' ' ' LYS . 2.8 mt -101.84 -34.92 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.211 -0.93 . . . . 0.0 109.49 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -46.18 169.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.542 -179.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.573 ' O ' HG22 ' A' ' 20' ' ' VAL . 3.6 p -127.08 -2.79 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.498 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -108.41 135.19 50.11 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -0.908 . . . . 0.0 109.519 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.0 t -69.86 165.89 20.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.395 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -62.35 99.85 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.409 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -74.34 -78.69 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.329 -0.857 . . . . 0.0 109.502 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 71.5 m -132.89 -64.51 0.74 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.147 -0.97 . . . . 0.0 109.516 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 27' ' ' ALA . 8.0 p -144.83 -41.76 0.24 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.531 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 26' ' ' SER . . . 46.77 95.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.341 -0.849 . . . . 0.0 109.531 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 8.1 mmm 62.57 91.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 109.515 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -155.45 19.53 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 109.6 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 30' ' ' LEU . 38.1 tp -70.11 88.44 0.6 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.207 -0.933 . . . . 0.0 109.515 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.547 ' CB ' ' HD2' ' A' ' 32' ' ' PRO . 0.3 OUTLIER -81.25 176.57 3.69 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.369 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 31' ' ' SER . 35.7 Cg_endo -78.24 170.21 18.98 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.555 2.17 . . . . 0.0 110.506 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.09 91.88 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -163.95 169.62 17.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -1.133 . . . . 0.0 109.516 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.529 HG12 ' CD ' ' A' ' 87' ' ' ARG . 17.9 m -119.04 143.55 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.13 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.543 ' NE2' HG23 ' A' ' 88' ' ' VAL . 1.9 p80 -165.35 166.8 18.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.006 -1.059 . . . . 0.0 109.956 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.555 ' HG2' HG12 ' A' ' 83' ' ' VAL . 1.7 tt0 -98.8 145.28 27.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.324 -0.86 . . . . 0.0 108.907 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.693 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -151.64 176.16 30.15 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.046 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 81' ' ' GLY . 22.0 mt -97.09 150.56 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.515 -0.991 . . . . 0.0 108.544 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.912 ' CG2' HD12 ' A' ' 84' ' ' ILE . 10.6 t -98.16 142.89 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 0.0 110.095 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.512 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 39.6 t80 -141.48 153.25 44.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.385 -0.822 . . . . 0.0 109.104 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.433 ' CD1' ' C ' ' A' ' 42' ' ' PHE . 21.8 t80 -98.92 121.97 41.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.172 -0.955 . . . . 0.0 109.644 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.26 163.03 15.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.342 -0.848 . . . . 0.0 109.408 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 14.3 t0 -70.22 -8.46 50.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 109.627 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.757 ' C ' HD12 ' A' ' 46' ' ' ILE . . . -97.67 -62.99 0.89 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.926 HD13 ' HG ' ' A' ' 62' ' ' LEU . 2.2 mp -155.57 -94.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -1.136 . . . . 0.0 109.038 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.781 ' N ' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -127.37 162.03 27.26 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.031 -1.043 . . . . 0.0 109.342 179.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.531 ' HG2' HG22 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -138.52 125.43 21.15 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.574 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -101.93 118.81 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 109.329 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -98.78 127.87 44.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.176 -0.953 . . . . 0.0 109.527 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.462 ' HA ' HD13 ' A' ' 51' ' ' LEU . 1.7 mm? -93.83 69.18 3.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.137 -0.977 . . . . 0.0 109.421 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.03 128.82 37.37 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.908 . . . . 0.0 109.419 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.47 -30.27 9.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 1.1 t80 -99.69 51.07 0.92 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.325 -1.103 . . . . 0.0 109.279 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER 72.64 -159.54 0.1 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.264 -0.897 . . . . 0.0 109.455 -179.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' HIS . . . -82.62 11.81 50.22 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -42.72 108.69 0.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.329 -1.1 . . . . 0.0 109.772 -179.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -115.15 109.83 18.6 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.275 -0.891 . . . . 0.0 109.407 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.644 ' HB3' HD23 ' A' ' 98' ' ' LEU . 31.0 m -102.0 156.29 17.63 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.22 -0.925 . . . . 0.0 109.666 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.531 HG22 ' HG2' ' A' ' 48' ' ' LYS . 2.1 pt -125.43 135.54 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 47' ' ' PHE . 0.9 OUTLIER -97.71 128.9 44.72 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.888 -1.133 . . . . 0.0 109.679 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.926 ' HG ' HD13 ' A' ' 46' ' ' ILE . 1.8 tt -164.86 -35.72 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.571 -0.706 . . . . 0.0 109.482 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.533 ' OD1' HG21 ' A' ' 89' ' ' VAL . 7.7 m-20 -50.37 -49.19 54.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.239 -0.913 . . . . 0.0 109.286 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.581 ' CD2' ' HG3' ' A' ' 100' ' ' ARG . 3.5 t80 -87.04 40.89 0.94 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.698 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 64' ' ' TYR . 1.2 tt -46.0 -38.04 7.3 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.2 -0.938 . . . . 0.0 109.152 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 36.5 t30 65.72 127.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.494 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -71.64 176.88 4.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.705 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.74 149.81 1.63 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.35 -0.844 . . . . 0.0 109.29 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.13 -50.27 2.76 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.517 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.94 179.56 5.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.937 . . . . 0.0 109.473 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 70.4 p -136.13 65.06 1.54 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.867 . . . . 0.0 109.318 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.08 56.43 0.71 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.562 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 0.8 OUTLIER -107.65 38.84 2.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.376 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.4 -39.87 45.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.308 -0.87 . . . . 0.0 109.668 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.32 -34.44 76.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -0.819 . . . . 0.0 109.831 -179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.544 ' O ' HG23 ' A' ' 80' ' ' VAL . 3.0 mttp -66.95 -28.45 68.29 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.158 -0.963 . . . . 0.0 109.676 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.37 -46.49 86.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.205 -0.934 . . . . 0.0 109.26 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -29.92 59.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.299 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.774 HD23 ' O ' ' A' ' 79' ' ' LEU . 5.4 tt -66.96 -26.84 67.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.345 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.552 HG12 ' N ' ' A' ' 81' ' ' GLY . 44.9 t -41.07 163.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.458 -0.776 . . . . 0.0 109.562 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 85.47 -51.76 4.53 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.823 ' O ' HG23 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -41.3 161.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.377 -1.072 . . . . 0.0 110.011 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' ' 38' ' ' GLY . 52.9 t -98.75 140.5 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.024 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.912 HD12 ' CG2' ' A' ' 40' ' ' VAL . 0.2 OUTLIER -139.65 175.28 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.735 -179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt -99.45 127.52 45.51 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.46 -0.775 . . . . 0.0 109.263 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.574 ' OG1' HD11 ' A' ' 98' ' ' LEU . 69.6 p -139.25 173.61 11.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.134 -0.979 . . . . 0.0 109.525 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.794 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -105.21 161.02 14.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.543 HG23 ' NE2' ' A' ' 36' ' ' HIS . 59.1 t -97.31 115.03 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.411 -0.806 . . . . 0.0 108.871 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.591 HG23 ' N ' ' A' ' 99' ' ' ARG . 54.8 t -74.41 -39.05 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.468 -0.77 . . . . 0.0 110.259 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 179.25 101.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.972 -1.08 . . . . 0.0 110.031 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.824 ' HA ' HG22 ' A' ' 96' ' ' VAL . . . -90.02 122.54 33.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.69 -4.19 12.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 0.0 109.953 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 154.16 -113.4 0.57 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.89 -41.13 44.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.223 -1.163 . . . . 0.0 109.579 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -99.49 126.33 45.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.323 -0.861 . . . . 0.0 109.349 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.824 HG22 ' HA ' ' A' ' 91' ' ' ALA . 89.1 t -128.78 162.88 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.719 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.562 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 1.2 m-20 -98.51 154.4 17.92 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -137.74 136.51 37.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.884 -1.135 . . . . 0.0 111.119 -178.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.591 ' N ' HG23 ' A' ' 89' ' ' VAL . 0.4 OUTLIER -132.12 108.4 9.26 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.165 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.581 ' HG3' ' CD2' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -71.61 169.75 14.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.94 . . . . 0.0 109.413 -179.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.451 ' O ' ' O ' ' A' ' 102' ' ' PHE . 24.1 t80 -145.96 98.96 3.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.217 -0.927 . . . . 0.0 109.675 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.451 ' O ' ' O ' ' A' ' 101' ' ' PHE . 7.4 m-85 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.631 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.254 0.549 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.43 135.13 45.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.25 -0.906 . . . . 0.0 109.253 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.07 147.45 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 109.839 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.774 HG23 ' O ' ' A' ' 4' ' ' ILE . 12.7 tt -135.32 98.24 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.25 -0.906 . . . . 0.0 109.097 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.482 ' HG2' ' HD2' ' A' ' 6' ' ' PRO . 2.3 tttt -104.43 141.02 21.67 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 109.867 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.482 ' HD2' ' HG2' ' A' ' 5' ' ' LYS . 36.5 Cg_endo -80.38 -48.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.594 2.196 . . . . 0.0 110.167 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 6' ' ' PRO . 9.4 p 168.9 136.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.21 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.453 ' O ' ' O ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -170.88 106.4 0.27 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.073 -1.017 . . . . 0.0 109.812 -179.746 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 8' ' ' SER . 0.0 OUTLIER 53.98 104.26 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.225 -0.922 . . . . 0.0 109.696 179.608 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.97 -162.72 0.18 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.418 2.079 . . . . 0.0 110.252 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.08 164.77 7.41 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.191 -0.943 . . . . 0.0 109.468 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.87 117.39 4.2 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.616 2.211 . . . . 0.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.93 -179.74 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.185 -0.947 . . . . 0.0 109.382 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.14 50.85 1.43 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.189 -0.944 . . . . 0.0 109.573 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -110.98 147.86 33.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.327 -0.858 . . . . 0.0 109.301 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -107.92 -93.67 0.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.141 -0.974 . . . . 0.0 109.636 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -52.67 106.2 0.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.442 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 7.0 mt -52.06 119.88 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.941 . . . . 0.0 109.488 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.7 ttpt -123.37 25.67 8.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.443 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 20' ' ' VAL . 24.4 m -128.38 106.62 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 22' ' ' THR . 4.1 m120 -61.65 -73.05 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 0.0 109.656 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.402 ' C ' ' O ' ' A' ' 21' ' ' ASN . 73.3 m 45.73 72.21 0.23 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.115 -0.991 . . . . 0.0 109.409 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -117.65 8.07 12.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.61 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.76 67.89 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.138 -0.976 . . . . 0.0 109.637 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 26' ' ' SER . 26.2 p -130.25 106.53 8.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.229 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER 44.43 70.16 0.36 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.311 -0.868 . . . . 0.0 109.168 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.558 ' HB3' ' CE ' ' A' ' 28' ' ' MET . . . -86.95 14.33 7.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.17 -0.956 . . . . 0.0 109.683 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.558 ' CE ' ' HB3' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -131.2 149.3 52.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.193 -0.942 . . . . 0.0 109.432 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -166.76 65.93 0.09 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.223 -0.923 . . . . 0.0 109.559 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tp -111.29 128.63 56.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.394 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.455 ' HB2' ' HD2' ' A' ' 32' ' ' PRO . 0.8 OUTLIER -121.29 164.24 25.32 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 109.388 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 31' ' ' SER . 35.1 Cg_endo -76.86 114.0 3.75 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.643 2.229 . . . . 0.0 110.557 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.26 55.76 3.4 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 87' ' ' ARG . 0.7 OUTLIER -113.12 162.98 15.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -1.166 . . . . 0.0 109.389 179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.707 HG12 ' CD ' ' A' ' 87' ' ' ARG . 2.9 m -107.55 149.09 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.199 -0.938 . . . . 0.0 109.465 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.12 168.49 13.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.836 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 15.8 mt-10 -99.56 143.65 29.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.317 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 83' ' ' VAL . . . -154.02 176.52 31.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 8.8 mt -97.08 152.63 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.249 -1.148 . . . . 0.0 108.685 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.489 HG23 HD12 ' A' ' 84' ' ' ILE . 88.6 t -105.92 149.94 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.102 -0.999 . . . . 0.0 110.607 -178.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.537 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -148.42 175.42 11.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.475 -0.765 . . . . 0.0 109.009 179.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.561 ' CZ ' ' HA2' ' A' ' 45' ' ' GLY . 58.7 t80 -123.02 124.66 43.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.153 -0.967 . . . . 0.0 109.35 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 44' ' ' ASP . 1.6 mttm -159.93 145.55 15.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.748 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 0.8 OUTLIER 61.28 12.93 4.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.323 -0.861 . . . . 0.0 109.741 179.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.561 ' HA2' ' CZ ' ' A' ' 42' ' ' PHE . . . 86.57 -18.71 32.43 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.77 HG21 HD22 ' A' ' 62' ' ' LEU . 12.3 pt -95.33 -153.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.135 -1.215 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . 1.8 m-85 -110.64 164.69 12.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.301 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -135.55 119.72 17.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.304 -0.873 . . . . 0.0 109.643 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 2.7 t -103.9 108.86 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.186 -0.946 . . . . 0.0 109.271 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 135.64 39.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.245 -0.91 . . . . 0.0 109.638 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.41 107.72 19.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.287 -0.883 . . . . 0.0 109.351 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.1 tp -81.27 148.55 29.4 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.599 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 91.4 -21.93 32.65 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.429 ' O ' ' O ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -99.31 -30.14 12.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -1.165 . . . . 0.0 109.58 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 54' ' ' TYR . 4.8 mt-10 60.93 149.37 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.239 -0.913 . . . . 0.0 109.513 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.41 40.71 78.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.76 86.61 2.06 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.121 -1.223 . . . . 0.0 109.48 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.72 120.31 41.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.325 -0.859 . . . . 0.0 109.556 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 96' ' ' VAL . 3.2 m -117.15 170.94 8.28 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.368 -0.832 . . . . 0.0 109.204 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.498 ' HB ' HD11 ' A' ' 46' ' ' ILE . 1.3 pp -134.47 133.07 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 0.0 109.303 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 0.7 OUTLIER -98.19 131.14 44.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.078 -1.014 . . . . 0.0 109.386 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.77 HD22 HG21 ' A' ' 46' ' ' ILE . 25.3 tp -175.69 -32.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.489 -0.757 . . . . 0.0 109.413 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.401 ' CB ' HG21 ' A' ' 89' ' ' VAL . 29.2 t0 -50.1 -46.74 53.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -0.928 . . . . 0.0 109.239 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.488 ' HB2' ' N ' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -119.45 45.73 2.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.188 -0.945 . . . . 0.0 109.488 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.487 ' HB2' ' HA ' ' A' ' 62' ' ' LEU . 7.5 tp -75.6 -51.83 11.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 109.666 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 67' ' ' TYR . 0.5 OUTLIER 62.16 160.11 0.07 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.183 -0.948 . . . . 0.0 109.497 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.402 ' CB ' ' O ' ' A' ' 66' ' ' ASN . 3.9 t80 67.87 43.6 1.7 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.096 -1.002 . . . . 0.0 109.235 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.426 ' C ' ' HG2' ' A' ' 69' ' ' GLN . 0.1 OUTLIER -94.61 127.7 40.75 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.383 -0.823 . . . . 0.0 109.603 -179.802 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.426 ' HG2' ' C ' ' A' ' 68' ' ' ARG . 0.4 OUTLIER 176.27 179.79 0.18 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.311 -0.868 . . . . 0.0 109.481 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -88.47 93.89 9.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.358 -0.839 . . . . 0.0 109.566 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -132.74 126.49 32.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.288 -0.883 . . . . 0.0 109.479 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 71' ' ' THR . 0.7 OUTLIER -44.64 -40.04 5.52 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.504 179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 48.92 70.85 0.42 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.0 109.589 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.07 -36.08 56.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.194 -0.941 . . . . 0.0 109.222 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mt -73.12 -39.76 65.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.386 -0.822 . . . . 0.0 109.497 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.848 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -52.71 -26.44 13.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.79 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.13 -42.09 99.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.135 -0.978 . . . . 0.0 109.87 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.44 -29.27 52.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.131 -0.98 . . . . 0.0 110.098 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 76' ' ' LYS . 82.6 mt -66.35 -50.85 62.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.114 -0.991 . . . . 0.0 109.745 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 76' ' ' LYS . 11.7 t -40.29 159.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.492 -0.755 . . . . 0.0 109.768 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 40' ' ' VAL . . . 85.9 -53.47 4.67 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 81' ' ' GLY . 31.0 mtt85 -39.17 160.42 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.569 -0.959 . . . . 0.0 110.357 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 66.4 t -98.47 140.46 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.737 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -146.64 174.83 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.087 -1.008 . . . . 0.0 110.157 -179.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.517 ' O ' ' CG2' ' A' ' 86' ' ' THR . 1.5 tmmm? -100.23 147.06 26.15 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.686 ' OG1' HD11 ' A' ' 98' ' ' LEU . 67.1 p -158.51 174.22 15.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.963 . . . . 0.0 109.372 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.79 ' O ' HD13 ' A' ' 98' ' ' LEU . 20.8 mmm-85 -103.52 162.45 13.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 34' ' ' SER . 14.2 t -96.71 122.48 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.314 -0.867 . . . . 0.0 109.269 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.543 ' HB ' ' CB ' ' A' ' 97' ' ' ASP . 42.0 t -81.2 -41.1 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.445 -0.785 . . . . 0.0 109.929 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 178.59 101.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.062 -1.024 . . . . 0.0 109.749 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.852 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -71.99 135.06 46.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.873 . . . . 0.0 109.567 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -128.42 32.85 4.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.387 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.58 -107.86 3.59 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.1 mp -79.52 -34.51 41.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.2 -1.176 . . . . 0.0 109.311 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -102.01 131.76 48.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.887 . . . . 0.0 109.108 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.852 HG13 ' HA ' ' A' ' 91' ' ' ALA . 94.2 t -137.45 155.57 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.267 -0.896 . . . . 0.0 110.04 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.543 ' CB ' ' HB ' ' A' ' 89' ' ' VAL . 6.0 m-20 -99.32 156.73 16.85 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.79 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -140.91 140.51 34.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.083 -1.011 . . . . 0.0 110.234 -179.219 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.533 ' N ' HG23 ' A' ' 89' ' ' VAL . 0.0 OUTLIER -125.16 120.4 31.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.482 -0.761 . . . . 0.0 109.27 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.488 ' N ' ' HB2' ' A' ' 64' ' ' TYR . 25.3 ttt-85 -63.51 168.28 4.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.394 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.473 ' CE2' ' CD2' ' A' ' 102' ' ' PHE . 16.7 t80 -112.49 134.52 53.98 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.23 -0.919 . . . . 0.0 109.485 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.473 ' CD2' ' CE2' ' A' ' 101' ' ' PHE . 11.9 m-85 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.494 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 2' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 44.37 67.74 0.64 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.915 . . . . 0.0 109.452 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.2 m -81.46 169.92 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 109.47 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.742 HG22 ' O ' ' A' ' 4' ' ' ILE . 23.6 mm -111.32 66.87 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.36 79.8 28.61 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.454 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 4' ' ' ILE . 35.7 Cg_endo -77.95 -161.95 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.654 2.236 . . . . 0.0 110.476 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.0 m -155.24 94.13 1.58 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.892 . . . . 0.0 109.356 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.31 42.94 1.09 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 109.656 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.78 154.5 5.36 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.57 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.93 83.87 2.11 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.685 2.256 . . . . 0.0 110.303 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.33 81.63 20.35 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.509 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.83 136.08 14.76 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.647 2.231 . . . . 0.0 110.454 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.47 79.64 1.41 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 109.492 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 175.44 56.33 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.278 -0.889 . . . . 0.0 109.498 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 16' ' ' LYS . 2.9 m120 -86.53 15.22 5.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.476 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 15' ' ' ASN . 0.5 OUTLIER 61.84 39.2 14.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.266 -0.897 . . . . 0.0 109.549 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -80.52 75.1 7.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.897 . . . . 0.0 109.44 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.492 HG22 ' HB2' ' A' ' 21' ' ' ASN . 7.3 mt -135.95 84.97 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.29 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -77.18 -16.56 59.06 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.731 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.8 t -108.96 56.64 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 0.0 109.635 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.492 ' HB2' HG22 ' A' ' 18' ' ' ILE . 2.3 t30 -124.52 -166.7 1.55 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.348 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 21' ' ' ASN . 0.2 OUTLIER 72.67 146.17 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.243 -0.911 . . . . 0.0 109.446 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.93 -66.58 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.184 -0.948 . . . . 0.0 109.329 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -93.43 144.57 25.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.876 . . . . 0.0 109.288 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.0 t -76.63 144.46 39.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.915 . . . . 0.0 109.778 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.19 147.99 25.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.356 -0.84 . . . . 0.0 109.355 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.12 43.08 1.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.098 -1.001 . . . . 0.0 109.67 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.77 -167.73 0.19 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.577 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -92.58 49.48 1.48 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.467 ' HA ' HD13 ' A' ' 30' ' ' LEU . 0.4 OUTLIER 65.67 129.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.418 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.6 p -80.38 143.9 56.63 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.393 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.3 122.86 5.81 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.564 2.176 . . . . 0.0 110.408 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.44 28.71 2.27 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.4 m -106.69 165.14 11.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -1.12 . . . . 0.0 109.435 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.658 HG12 ' HD2' ' A' ' 87' ' ' ARG . 3.7 m -108.26 140.3 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -156.18 167.99 28.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.945 . . . . 0.0 109.651 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -101.0 143.28 31.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.296 -0.878 . . . . 0.0 109.348 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.611 ' O ' HG13 ' A' ' 83' ' ' VAL . . . -153.77 175.61 32.02 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 81' ' ' GLY . 4.3 mp -97.97 153.61 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.355 -1.086 . . . . 0.0 108.756 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.589 HG23 HD12 ' A' ' 84' ' ' ILE . 67.8 t -104.36 146.1 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.009 -1.057 . . . . 0.0 110.343 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.511 ' HB3' ' HB3' ' A' ' 48' ' ' LYS . 3.2 t80 -146.98 -173.47 4.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -0.839 . . . . 0.0 108.903 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -135.01 146.78 49.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.099 -1.0 . . . . 0.0 109.522 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.99 140.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.265 -0.897 . . . . 0.0 110.076 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.7 17.66 4.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 110.116 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.29 -33.68 4.02 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.481 HG21 ' CD1' ' A' ' 62' ' ' LEU . 21.2 pt -78.26 -153.19 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -1.185 . . . . 0.0 109.254 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.765 ' CD1' HD11 ' A' ' 65' ' ' LEU . 2.4 m-85 -119.84 161.06 21.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.109 -0.994 . . . . 0.0 109.636 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 41' ' ' TYR . 1.8 tttp -130.95 120.56 23.73 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.288 -0.882 . . . . 0.0 109.556 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 61' ' ' LEU . 7.4 t -100.82 126.85 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.181 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.23 139.66 39.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 0.0 109.774 -179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 57' ' ' HIS . 0.9 OUTLIER -103.02 73.23 1.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.399 179.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.01 168.67 0.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.944 . . . . 0.0 109.426 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 89.41 -36.65 3.46 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.539 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 5.5 t80 -98.01 -26.69 14.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.323 -1.104 . . . . 0.0 109.305 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 54.77 26.31 7.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.493 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -160.33 25.92 0.3 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.539 ' CE1' ' CD2' ' A' ' 54' ' ' TYR . 23.0 m170 -131.12 98.94 4.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.326 -1.102 . . . . 0.0 109.609 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -103.37 107.41 18.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.279 -0.888 . . . . 0.0 109.135 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.485 ' HB2' ' HB ' ' A' ' 49' ' ' VAL . 5.1 m -107.72 158.81 16.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.276 -0.89 . . . . 0.0 109.62 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 pt -127.73 137.74 56.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.45 -0.781 . . . . 0.0 108.959 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.525 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 4.3 tp -98.68 131.56 44.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.156 -0.965 . . . . 0.0 109.915 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.481 ' CD1' HG21 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -166.75 -36.95 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.597 -0.689 . . . . 0.0 109.159 179.76 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.421 ' HB2' HG21 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -49.03 -52.17 26.8 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.865 . . . . 0.0 109.049 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.476 ' CB ' ' O ' ' A' ' 100' ' ' ARG . 0.8 OUTLIER -119.46 42.8 2.78 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.362 -0.836 . . . . 0.0 109.346 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.765 HD11 ' CD1' ' A' ' 47' ' ' PHE . 3.1 tp -55.62 -83.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.32 -0.862 . . . . 0.0 109.369 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.407 ' OD1' HD23 ' A' ' 65' ' ' LEU . 51.0 p-10 -179.03 -150.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -103.79 156.59 17.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.33 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.0 mtt85 -85.13 46.18 1.25 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.615 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -53.05 142.85 18.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.26 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -82.98 78.19 9.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.066 -1.021 . . . . 0.0 109.673 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.8 m -159.68 122.26 3.47 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.343 -0.848 . . . . 0.0 109.257 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.67 -32.74 69.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.408 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.46 80.55 0.15 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.242 -0.911 . . . . 0.0 109.344 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -68.14 -36.91 80.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.686 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 tp -54.73 -48.09 72.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.172 -0.955 . . . . 0.0 109.579 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.597 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -61.91 -26.81 68.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 109.4 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -55.4 -49.78 71.47 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.329 -0.857 . . . . 0.0 109.457 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 ttm180 -77.35 -29.58 53.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.706 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -63.55 -29.99 71.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.232 -0.917 . . . . 0.0 109.693 -179.675 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 76' ' ' LYS . 57.3 t -44.22 165.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.146 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.661 ' O ' HG23 ' A' ' 39' ' ' ILE . . . 85.18 -45.23 3.48 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.468 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -35.59 149.71 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.741 -0.858 . . . . 0.0 110.359 -179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.611 HG13 ' O ' ' A' ' 38' ' ' GLY . 65.1 t -98.81 142.69 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.465 -0.772 . . . . 0.0 109.523 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.832 ' H ' HD13 ' A' ' 84' ' ' ILE . 0.1 OUTLIER -149.22 170.37 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.602 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.22 112.46 24.61 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.134 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.613 ' OG1' HD11 ' A' ' 98' ' ' LEU . 74.1 p -116.58 175.17 5.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.884 . . . . 0.0 109.635 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.801 ' O ' HD13 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -102.19 161.53 13.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.227 -0.921 . . . . 0.0 109.511 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 67.6 t -96.85 124.67 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.38 -0.825 . . . . 0.0 108.985 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.538 ' CG2' ' HB3' ' A' ' 99' ' ' ARG . 96.4 t -85.28 -38.17 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.294 -0.879 . . . . 0.0 110.159 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 0.7 OUTLIER 176.9 103.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.135 -0.978 . . . . 0.0 109.637 -179.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.659 ' HA ' HG13 ' A' ' 96' ' ' VAL . . . -99.35 123.7 43.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.334 -0.854 . . . . 0.0 109.377 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -115.43 -23.68 8.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -0.949 . . . . 0.0 109.647 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -176.91 -137.7 2.74 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.5 mp -57.12 -32.84 66.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -1.119 . . . . 0.0 109.627 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -99.03 131.51 45.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.659 HG13 ' HA ' ' A' ' 91' ' ' ALA . 78.3 t -135.64 158.61 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.206 -0.934 . . . . 0.0 110.056 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 98' ' ' LEU . 9.4 t0 -99.43 152.3 20.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 108.716 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -139.98 140.42 36.29 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 111.076 -178.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.538 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 0.8 OUTLIER -126.04 119.88 28.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.502 -0.749 . . . . 0.0 109.093 178.726 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.476 ' O ' ' CB ' ' A' ' 64' ' ' TYR . 6.8 ttt-85 -71.8 163.75 27.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.507 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 51.0 p90 -83.02 171.36 13.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.475 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.464 ' HB3' ' O ' ' A' ' 101' ' ' PHE . 29.9 t80 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.506 -179.953 . . . . . . . . 1 1 . 1 stop_ save_